data_1ha9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ha9 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 83.7 tttt . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -66.05 145.44 55.86 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.1 0.56 . . . . 0.0 110.46 170.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.8 p -144.84 171.63 14.15 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -174.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -119.71 -28.51 5.24 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 128.205 2.602 . . . . 0.0 111.574 172.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -149.31 173.18 13.79 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.271 1.428 . . . . 0.0 112.292 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -66.09 -27.06 67.78 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.876 1.27 . . . . 0.0 112.497 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.8 m -66.36 -19.8 65.9 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.554 1.542 . . . . 0.0 112.915 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -70.04 -25.35 63.52 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 82.9 m -96.28 157.32 35.77 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.489 1.116 . . . . 0.0 113.646 -169.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.25 161.36 46.04 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.993 2.462 . . . . 0.0 112.46 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -12.34 -75.11 0.01 OUTLIER Glycine 0 N--CA 1.477 1.373 0 C-N-CA 129.506 3.432 . . . . 0.0 117.984 -173.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.51 -8.58 52.5 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -172.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.4 m -74.5 166.43 23.54 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 122.853 1.311 . . . . 0.0 113.151 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.4 pt -128.92 162.19 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 129.447 3.099 . . . . 0.0 108.599 168.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.8 t -86.19 100.15 12.03 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 169.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -65.09 171.08 3.88 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.168 2.187 . . . . 0.0 111.305 -174.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.64 -17.3 70.84 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.848 1.214 . . . . 0.0 114.6 -173.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -84.85 -2.66 58.06 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.322 1.449 . . . . 0.0 114.358 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.0 22.74 51.79 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.226 0.917 . . . . 0.0 114.884 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -130.99 159.8 36.43 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.558 1.543 . . . . 0.0 111.905 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.0 m -69.38 145.57 52.79 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.301 0.641 . . . . 0.0 112.1 175.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.781 0 C-N-CA 124.728 1.156 . . . . 0.0 111.915 174.243 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 80.8 tttt . . . . . 0 CA--C 1.537 0.46 0 CA-C-O 120.281 0.086 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -66.6 149.49 50.41 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.978 0.911 . . . . 0.0 110.236 169.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.2 p -144.73 172.17 13.37 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -128.63 -22.45 3.3 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.966 2.506 . . . . 0.0 112.23 170.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -144.38 164.03 32.01 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.482 1.913 . . . . 0.0 111.57 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -66.91 -23.08 65.95 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.394 -0.816 . . . . 0.0 112.593 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.4 m -67.4 -17.66 64.81 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.252 1.421 . . . . 0.0 113.216 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -72.9 -20.25 61.12 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.848 1.259 . . . . 0.0 113.268 173.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.4 m -106.2 163.66 16.58 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -167.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -55.84 164.4 4.67 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 124.071 3.181 . . . . 0.0 113.929 169.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.7 -54.08 18.89 Favored Glycine 0 N--CA 1.475 1.257 0 C-N-CA 125.894 1.711 . . . . 0.0 115.519 -175.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.68 -17.74 50.17 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.8 m -75.65 167.72 21.36 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 123.16 1.457 . . . . 0.0 113.192 171.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.8 pt -133.44 167.78 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 129.39 3.076 . . . . 0.0 107.467 166.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.0 t -83.89 103.05 12.83 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.479 -0.763 . . . . 0.0 109.801 169.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.38 165.67 13.75 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.794 1.638 . . . . 0.0 111.145 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.93 -14.33 75.9 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.997 1.284 . . . . 0.0 114.439 -174.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.5 p-10 -78.27 -6.18 54.22 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.643 1.577 . . . . 0.0 114.123 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.89 19.04 55.04 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.412 1.006 . . . . 0.0 114.725 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -131.56 165.02 24.55 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.063 1.745 . . . . 0.0 111.684 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 80.9 m -74.45 151.21 39.63 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.606 -0.684 . . . . 0.0 112.832 173.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.029 0 C-N-CA 124.364 0.983 . . . . 0.0 113.144 171.56 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.5 tttm . . . . . 0 N--CA 1.468 0.427 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -63.58 144.97 56.57 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.993 0.917 . . . . 0.0 110.863 172.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 p -147.21 173.47 12.51 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -174.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -133.2 -14.88 2.59 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 127.322 2.249 . . . . 0.0 113.295 172.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -144.52 163.41 33.93 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 127.096 2.158 . . . . 0.0 110.724 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -69.34 -22.55 63.75 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.615 -0.678 . . . . 0.0 112.682 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.4 m -69.51 -15.33 63.23 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.426 1.09 . . . . 0.0 113.128 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -74.1 -11.91 60.45 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.763 1.225 . . . . 0.0 113.108 174.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 76.9 m -113.73 147.58 37.95 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.597 1.159 . . . . 0.0 114.04 -168.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -80.82 160.46 21.42 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.607 2.871 . . . . 0.0 113.423 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 43.67 -118.27 2.09 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.685 2.088 . . . . 0.0 114.889 174.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.8 3.05 55.47 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.007 1.723 . . . . 0.0 113.803 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.0 m -64.5 151.84 43.36 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.764 1.269 . . . . 0.0 112.532 169.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.2 pt -120.87 164.25 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 128.203 2.601 . . . . 0.0 108.4 169.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.9 t -82.99 101.1 10.86 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 169.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -66.4 170.85 5.5 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.442 1.897 . . . . 0.0 111.1 -176.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.21 -17.63 70.34 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.721 1.153 . . . . 0.0 114.542 -173.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -82.43 -4.91 58.24 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.308 1.443 . . . . 0.0 114.369 173.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.2 22.89 46.62 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.31 0.957 . . . . 0.0 114.993 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -132.79 160.23 37.48 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.555 1.542 . . . . 0.0 111.851 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.2 m -68.98 142.51 54.64 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.602 -0.686 . . . . 0.0 112.396 176.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.111 0 C-N-CA 124.503 1.049 . . . . 0.0 112.53 172.295 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -68.38 142.78 55.34 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.239 0.616 . . . . 0.0 109.476 168.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.3 p -141.73 168.13 20.49 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -172.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -122.14 -21.04 6.04 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 127.328 2.251 . . . . 0.0 112.742 171.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.69 167.69 24.84 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.257 1.423 . . . . 0.0 111.358 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -65.92 -22.25 66.49 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.311 -0.868 . . . . 0.0 112.538 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.8 m -66.83 -19.25 65.7 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.821 1.648 . . . . 0.0 113.371 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -69.14 -30.9 69.24 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.583 1.153 . . . . 0.0 112.637 172.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.5 m -96.48 151.87 38.29 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -168.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.05 160.04 23.82 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.535 2.824 . . . . 0.0 113.079 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 23.11 -97.97 0.01 OUTLIER Glycine 0 CA--C 1.538 1.489 0 C-N-CA 129.2 3.286 . . . . 0.0 117.085 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.02 -4.28 54.7 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -173.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.5 m -72.86 163.14 28.58 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 122.905 1.336 . . . . 0.0 112.983 171.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.7 pt -130.04 165.76 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 129.642 3.177 . . . . 0.0 108.157 168.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.0 t -83.59 102.04 11.9 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 168.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -66.22 170.47 5.79 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.294 1.838 . . . . 0.0 111.251 -175.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.48 -17.89 71.15 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.709 1.147 . . . . 0.0 114.452 -173.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -82.22 -4.7 57.6 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.141 1.376 . . . . 0.0 114.337 173.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.77 20.9 52.68 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.299 0.952 . . . . 0.0 115.017 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -131.66 162.03 31.36 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.838 1.655 . . . . 0.0 111.762 176.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 75.2 m -71.86 145.36 48.62 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.523 -0.736 . . . . 0.0 112.954 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.232 0 C-N-CA 125.198 1.38 . . . . 0.0 112.08 171.825 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.0 tttm . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 119.854 -0.117 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -65.88 152.06 45.31 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.642 0.777 . . . . 0.0 111.528 174.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.4 p -147.73 169.67 19.22 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 177.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.61 -6.25 1.96 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 127.458 2.303 . . . . 0.0 113.891 169.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.4 ttt85 -144.64 170.6 15.76 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 128.356 2.662 . . . . 0.0 109.004 173.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -75.5 -24.72 56.9 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.505 -0.747 . . . . 0.0 112.297 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.6 m -66.4 -16.2 63.9 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.376 1.871 . . . . 0.0 113.173 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -73.77 -13.59 60.97 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.418 1.487 . . . . 0.0 113.834 173.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 76.7 m -113.02 146.2 34.66 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -167.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -81.83 167.39 16.53 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.907 3.072 . . . . 0.0 113.55 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 43.67 -117.48 1.79 Allowed Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.638 2.066 . . . . 0.0 114.904 174.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.98 6.59 47.5 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.954 1.701 . . . . 0.0 113.844 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.4 m -68.25 162.7 24.48 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 123.228 1.49 . . . . 0.0 113.834 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.8 pt -130.62 169.95 20.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 129.486 3.114 . . . . 0.0 107.806 168.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -82.6 104.08 12.6 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 121.7 -0.625 . . . . 0.0 109.759 168.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.06 167.84 9.28 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.186 1.394 . . . . 0.0 110.533 176.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.43 -13.93 71.41 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.818 1.199 . . . . 0.0 114.624 -174.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -79.18 -6.51 56.73 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.86 1.664 . . . . 0.0 114.399 174.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.7 23.07 56.97 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.184 0.897 . . . . 0.0 114.522 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -133.18 164.21 27.56 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.709 2.004 . . . . 0.0 111.067 173.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.6 m -71.74 147.12 47.66 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.624 -0.672 . . . . 0.0 112.524 176.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.049 0 C-N-CA 124.208 0.909 . . . . 0.0 112.038 170.61 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.45 142.51 55.32 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.444 0.698 . . . . 0.0 109.447 168.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.8 p -142.83 171.39 14.12 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -134.79 -14.86 2.1 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.43 2.292 . . . . 0.0 112.482 171.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -130.31 152.18 50.0 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.402 2.281 . . . . 0.0 110.032 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -64.39 -24.19 67.55 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 121.414 -0.804 . . . . 0.0 111.936 169.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.3 m -68.24 -20.27 64.8 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.88 2.072 . . . . 0.0 113.453 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -68.08 -25.64 65.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.959 0.903 . . . . 0.0 112.988 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.6 m -101.25 152.75 38.01 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.891 1.277 . . . . 0.0 113.497 -169.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -80.81 172.22 13.46 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.717 2.945 . . . . 0.0 113.753 -174.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 44.31 -106.99 0.11 Allowed Glycine 0 CA--C 1.535 1.286 0 C-N-CA 127.281 2.372 . . . . 0.0 114.779 172.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -118.58 13.71 13.45 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.311 1.844 . . . . 0.0 113.121 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.0 m -60.72 169.16 1.94 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 122.471 1.129 . . . . 0.0 112.558 172.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.5 pt -129.52 166.92 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 128.155 2.582 . . . . 0.0 109.622 170.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.6 t -93.16 107.02 18.91 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.782 0.833 . . . . 0.0 109.579 168.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -67.91 166.74 15.02 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.053 1.741 . . . . 0.0 111.374 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.34 -16.95 73.86 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.916 1.246 . . . . 0.0 114.45 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -80.83 -4.61 55.3 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.26 1.424 . . . . 0.0 114.11 172.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.3 25.94 32.13 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.375 0.988 . . . . 0.0 114.946 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -134.71 161.91 33.82 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.874 1.669 . . . . 0.0 111.912 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.7 m -67.96 154.45 41.59 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.388 -0.82 . . . . 0.0 113.059 175.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.096 0 C-N-CA 124.84 1.21 . . . . 0.0 112.053 176.602 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.4 tttm . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 110.623 -0.14 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -61.61 145.83 50.88 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.746 0.818 . . . . 0.0 110.478 170.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.4 p -141.59 167.49 22.04 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -120.69 -19.64 7.33 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.231 2.213 . . . . 0.0 112.948 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -159.44 161.81 35.58 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 129.508 3.123 . . . . 0.0 109.241 -169.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -66.95 -25.2 66.23 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 121.007 -1.058 . . . . 0.0 112.746 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -71.51 -13.68 61.88 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.505 1.522 . . . . 0.0 113.557 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -74.4 -8.34 55.94 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.451 1.1 . . . . 0.0 112.986 170.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.5 m -119.49 148.6 46.08 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 125.243 1.417 . . . . 0.0 112.391 -173.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.09 167.81 21.34 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.503 2.802 . . . . 0.0 114.036 -176.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 34.5 -107.05 0.03 OUTLIER Glycine 0 CA--C 1.536 1.386 0 C-N-CA 128.302 2.858 . . . . 0.0 116.597 172.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -103.41 9.92 37.57 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.598 1.959 . . . . 0.0 113.772 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.3 m -67.32 164.86 17.54 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 122.589 1.185 . . . . 0.0 111.724 169.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.5 pt -129.81 163.52 34.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 128.801 2.841 . . . . 0.0 108.553 168.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 47.0 t -94.52 104.29 16.25 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.647 0.779 . . . . 0.0 109.15 169.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -80.75 172.0 14.3 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.579 1.552 . . . . 0.0 111.849 -169.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.11 -16.28 70.66 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.657 1.122 . . . . 0.0 114.299 -173.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -74.88 -11.08 60.05 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.425 1.49 . . . . 0.0 114.218 170.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.28 16.75 56.9 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.842 1.21 . . . . 0.0 115.066 -177.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -131.58 161.22 33.15 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.414 1.486 . . . . 0.0 112.412 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.1 m -68.77 157.6 36.05 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.702 0.801 . . . . 0.0 112.879 174.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.206 0 C-N-CA 125.262 1.41 . . . . 0.0 113.127 168.568 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 70.0 tttt . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -65.09 143.8 57.67 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 168.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.0 p -140.97 171.0 14.68 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.29 -26.52 4.27 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 128.507 2.723 . . . . 0.0 111.33 173.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -135.7 158.38 44.54 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.997 2.119 . . . . 0.0 112.346 -176.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -63.58 -27.03 68.97 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.245 0.618 . . . . 0.0 111.565 169.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.1 m -66.8 -23.09 66.01 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.816 2.046 . . . . 0.0 113.242 175.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -67.87 -20.61 65.15 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 170.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.1 m -104.02 149.13 36.9 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -168.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -82.51 167.53 15.13 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 124.014 3.143 . . . . 0.0 113.421 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 45.71 -123.14 6.2 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.971 1.748 . . . . 0.0 114.495 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.8 8.73 44.21 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.921 1.688 . . . . 0.0 113.42 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.4 m -63.3 158.22 20.86 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 123.026 1.393 . . . . 0.0 112.737 171.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.6 pt -125.57 165.97 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 128.948 2.899 . . . . 0.0 108.471 169.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.6 t -85.1 101.2 12.25 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 169.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -66.73 169.08 8.42 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.22 1.808 . . . . 0.0 111.066 -174.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.07 -17.13 69.52 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.774 1.178 . . . . 0.0 114.396 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 55.1 p30 -79.15 -8.26 58.86 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.338 1.455 . . . . 0.0 114.519 173.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.4 14.72 58.24 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 124.537 1.065 . . . . 0.0 115.425 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -128.38 165.15 21.17 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.884 1.674 . . . . 0.0 111.835 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 83.3 m -70.27 143.03 52.23 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.416 -0.802 . . . . 0.0 112.484 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.093 0 C-N-CA 124.506 1.05 . . . . 0.0 112.583 171.895 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.5 tttm . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 120.525 0.202 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -62.68 146.49 52.07 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.411 1.084 . . . . 0.0 110.973 171.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.5 p -144.17 172.04 13.46 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -175.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -126.78 -22.31 3.9 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 127.813 2.445 . . . . 0.0 112.71 171.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -145.13 171.16 14.91 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.504 1.922 . . . . 0.0 111.115 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -69.81 -23.76 63.37 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.581 0.752 . . . . 0.0 112.441 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.7 m -64.5 -20.39 66.17 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.085 1.754 . . . . 0.0 113.074 174.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -73.13 -12.03 60.75 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.5 1.12 . . . . 0.0 113.595 173.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.8 m -117.87 159.56 42.17 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.959 1.304 . . . . 0.0 113.456 -168.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.57 167.06 26.59 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.249 2.633 . . . . 0.0 112.543 175.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -39.44 -58.6 2.05 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 127.457 2.456 . . . . 0.0 117.147 -169.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.72 -15.98 56.52 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -176.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.8 m -79.57 166.74 21.59 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 123.156 1.455 . . . . 0.0 113.274 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 22.8 pt -133.86 166.08 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 130.599 3.56 . . . . 0.0 107.352 167.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 22.3 t -83.42 101.54 11.43 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 168.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -64.84 168.49 6.21 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.119 1.768 . . . . 0.0 110.973 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.42 -17.44 68.56 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.749 1.166 . . . . 0.0 114.344 -176.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -80.03 -7.04 58.64 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.493 1.517 . . . . 0.0 114.439 172.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.84 17.43 56.46 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.65 1.119 . . . . 0.0 115.347 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -130.0 161.02 31.89 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.637 1.575 . . . . 0.0 111.886 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 74.6 m -68.42 139.65 55.78 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.584 -0.697 . . . . 0.0 112.018 175.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.919 0 C-N-CA 124.84 1.21 . . . . 0.0 112.246 174.802 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.2 tttm . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -60.8 144.53 52.36 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.995 0.918 . . . . 0.0 111.272 175.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.2 p -143.79 171.87 13.61 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.68 -28.65 4.15 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 128.552 2.741 . . . . 0.0 111.715 173.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -148.09 161.75 40.79 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 127.003 2.121 . . . . 0.0 111.298 -175.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -65.37 -22.75 66.84 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.326 -0.859 . . . . 0.0 112.576 -177.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.8 m -66.2 -17.79 64.95 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.709 1.603 . . . . 0.0 113.324 175.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -74.89 -10.26 59.33 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.069 1.348 . . . . 0.0 113.519 174.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.5 m -119.54 153.25 53.98 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 124.466 1.107 . . . . 0.0 113.471 -168.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -57.49 170.63 1.7 Allowed 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.827 3.685 . . . . 0.0 116.249 174.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -30.12 -72.25 0.06 OUTLIER Glycine 0 CA--C 1.537 1.467 0 C-N-CA 128.889 3.138 . . . . 0.0 117.668 -172.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.46 -0.5 57.27 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.59 1.156 . . . . 0.0 114.094 -176.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 54.7 m -75.76 169.21 18.58 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.628 1.204 . . . . 0.0 112.559 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.7 pt -135.12 163.49 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 128.657 2.783 . . . . 0.0 108.756 168.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 42.0 t -93.14 103.93 16.16 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 168.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -79.94 170.31 16.66 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.689 1.596 . . . . 0.0 112.007 -169.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.66 -15.86 71.42 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.778 1.18 . . . . 0.0 114.343 -173.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.8 p-10 -74.86 -10.95 59.98 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.244 1.418 . . . . 0.0 114.148 171.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.42 15.95 54.09 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.967 1.27 . . . . 0.0 114.978 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -132.33 160.41 36.36 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.328 1.451 . . . . 0.0 112.243 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 83.8 m -68.03 160.64 28.39 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.904 0.882 . . . . 0.0 112.663 173.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.053 0 C-N-CA 124.788 1.185 . . . . 0.0 113.529 168.662 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 79.8 tttt . . . . . 0 N--CA 1.47 0.544 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -65.31 145.7 55.87 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.141 0.976 . . . . 0.0 110.368 171.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.1 p -148.99 171.76 15.84 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -133.83 -14.45 2.44 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.761 2.424 . . . . 0.0 112.842 169.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -131.99 152.22 51.27 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 127.758 2.423 . . . . 0.0 109.94 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -65.33 -24.07 67.17 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.411 -0.806 . . . . 0.0 111.967 169.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.4 m -67.93 -20.68 65.1 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.321 1.849 . . . . 0.0 113.165 175.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -69.12 -22.29 63.97 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.768 0.827 . . . . 0.0 113.031 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 85.9 m -103.32 155.41 36.79 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.737 1.215 . . . . 0.0 113.641 -169.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.21 159.75 43.47 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.144 2.563 . . . . 0.0 112.699 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 0.35 -84.52 0.0 OUTLIER Glycine 0 CA--C 1.537 1.467 0 C-N-CA 129.926 3.631 . . . . 0.0 118.026 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.87 -7.81 55.44 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -172.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.6 m -71.99 161.94 30.19 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 123.155 1.455 . . . . 0.0 112.77 169.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.7 pt -128.21 165.43 27.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 129.707 3.203 . . . . 0.0 107.908 168.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.2 t -85.51 103.0 13.98 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 169.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -67.42 169.62 8.74 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.952 1.701 . . . . 0.0 110.946 -176.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.47 -16.05 71.19 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.714 1.15 . . . . 0.0 114.588 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -83.7 -4.52 58.68 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.569 1.548 . . . . 0.0 114.48 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.42 23.41 43.73 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-N 119.09 0.859 . . . . 0.0 114.797 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -132.87 160.79 35.94 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.831 1.653 . . . . 0.0 111.577 176.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.1 m -69.06 146.29 52.76 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.665 -0.647 . . . . 0.0 112.058 173.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.985 0 C-N-CA 124.629 1.109 . . . . 0.0 111.777 173.287 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 110.724 -0.102 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -67.34 147.02 53.49 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 166.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.6 p -143.79 169.86 16.98 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -134.15 -12.37 2.49 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.804 2.041 . . . . 0.0 113.051 170.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -145.58 160.72 41.23 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.222 2.209 . . . . 0.0 110.134 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -69.89 -23.07 63.19 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.175 -0.953 . . . . 0.0 112.898 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 70.4 m -69.85 -13.66 62.37 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.951 1.3 . . . . 0.0 113.362 176.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -70.69 -13.64 62.15 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.428 1.091 . . . . 0.0 113.21 172.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.7 m -114.87 147.31 37.97 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 125.01 1.324 . . . . 0.0 113.785 -168.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -81.68 163.31 18.8 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.519 2.812 . . . . 0.0 113.402 -177.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 43.08 -117.27 1.51 Allowed Glycine 0 CA--C 1.535 1.339 0 C-N-CA 126.475 1.988 . . . . 0.0 114.568 176.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.29 -0.87 54.73 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.903 1.681 . . . . 0.0 114.156 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.3 m -61.99 161.47 10.64 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 122.713 1.244 . . . . 0.0 113.11 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.1 pt -126.76 167.01 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 128.001 2.52 . . . . 0.0 109.51 172.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.0 t -85.08 103.93 14.53 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 168.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -69.79 170.59 10.72 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.517 1.927 . . . . 0.0 110.92 -174.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.26 -16.56 73.38 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.615 1.102 . . . . 0.0 114.661 -173.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -85.01 -3.22 58.7 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.391 1.477 . . . . 0.0 114.415 175.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.76 21.53 50.21 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.202 0.906 . . . . 0.0 114.957 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -131.56 162.65 29.82 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.944 1.697 . . . . 0.0 111.583 175.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 96.2 m -69.73 151.31 45.97 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.435 -0.791 . . . . 0.0 112.962 174.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.013 0 C-N-CA 124.085 0.85 . . . . 0.0 112.869 171.518 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.1 tttm . . . . . 0 N--CA 1.469 0.508 0 CA-C-O 120.412 0.149 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -68.97 151.25 46.76 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.686 0.794 . . . . 0.0 111.269 172.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.3 p -145.22 176.51 9.49 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.7 mmt-85 -133.37 -18.13 2.26 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 127.595 2.358 . . . . 0.0 113.242 169.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -146.13 163.81 34.17 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.885 1.674 . . . . 0.0 111.883 176.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -65.46 -22.48 66.75 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.322 -0.861 . . . . 0.0 112.539 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.9 m -68.18 -16.03 63.82 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.03 1.332 . . . . 0.0 113.284 176.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -74.33 -10.07 59.22 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.854 1.261 . . . . 0.0 113.539 173.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.2 m -123.88 150.92 63.79 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 125.091 1.357 . . . . 0.0 112.584 -169.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -79.27 166.97 22.05 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.432 2.754 . . . . 0.0 113.969 -175.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 32.81 -103.9 0.01 OUTLIER Glycine 0 CA--C 1.537 1.455 0 C-N-CA 128.62 3.01 . . . . 0.0 116.701 172.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -104.6 9.05 35.44 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.714 2.006 . . . . 0.0 113.716 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.4 m -67.52 164.51 18.78 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 122.618 1.199 . . . . 0.0 111.523 169.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.1 pt -130.54 164.4 33.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 128.65 2.78 . . . . 0.0 108.879 169.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 42.2 t -93.74 106.85 18.79 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 168.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -82.15 172.88 12.68 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.21 1.404 . . . . 0.0 111.459 -169.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.87 -17.34 71.34 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.672 1.129 . . . . 0.0 114.403 -170.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -77.79 -6.71 55.0 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.139 1.776 . . . . 0.0 114.183 171.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.73 33.09 43.45 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.147 -0.971 . . . . 0.0 113.938 -177.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -136.09 158.46 44.36 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.137 1.775 . . . . 0.0 111.531 175.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 80.0 m -69.06 158.2 35.29 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.729 0.776 . . . . 0.0 112.909 173.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.178 0 C-N-CA 125.277 1.418 . . . . 0.0 113.476 168.686 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.1 tttt . . . . . 0 N--CA 1.467 0.422 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.92 142.83 58.15 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.454 0.701 . . . . 0.0 110.219 171.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.3 p -138.77 174.01 10.97 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 -135.76 -17.23 1.7 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.041 2.136 . . . . 0.0 112.871 173.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -142.82 161.56 37.79 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.65 1.98 . . . . 0.0 110.607 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -69.87 -23.75 63.31 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.299 -0.876 . . . . 0.0 112.953 -178.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.7 m -70.84 -12.75 61.73 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.821 1.248 . . . . 0.0 113.434 175.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -70.88 -15.99 62.66 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.749 0.82 . . . . 0.0 113.082 171.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.2 m -115.58 150.32 44.5 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.737 1.215 . . . . 0.0 113.556 -168.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.96 166.52 21.01 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.67 2.913 . . . . 0.0 113.976 -174.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 40.05 -113.91 0.42 Allowed Glycine 0 CA--C 1.536 1.4 0 C-N-CA 127.313 2.387 . . . . 0.0 115.535 172.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.42 9.6 42.4 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.238 1.815 . . . . 0.0 113.743 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 61.3 m -68.26 168.5 12.26 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.553 1.168 . . . . 0.0 112.394 171.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.5 pt -136.07 169.65 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 129.088 2.955 . . . . 0.0 109.004 169.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.4 t -84.8 103.26 13.73 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 167.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -67.75 168.63 11.03 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.902 1.681 . . . . 0.0 111.176 -176.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.03 -16.61 70.87 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.859 1.219 . . . . 0.0 114.367 -175.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -77.69 -9.36 58.94 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.978 1.311 . . . . 0.0 114.208 172.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.69 14.46 56.7 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.779 1.18 . . . . 0.0 115.359 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -131.09 169.04 16.41 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.672 1.589 . . . . 0.0 111.747 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.6 m -70.2 150.47 46.43 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.123 -0.985 . . . . 0.0 113.579 177.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.243 0 C-N-CA 125.372 1.463 . . . . 0.0 112.299 174.382 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 81.8 tttt . . . . . 0 N--CA 1.466 0.328 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.49 143.6 57.69 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.604 0.762 . . . . 0.0 110.361 171.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.0 p -145.03 171.55 14.32 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -134.21 -13.93 2.36 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 127.542 2.337 . . . . 0.0 112.931 169.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -132.93 152.44 51.91 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.666 2.386 . . . . 0.0 110.093 -176.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -66.62 -25.25 66.5 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.212 -0.93 . . . . 0.0 112.263 171.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 56.7 p -72.07 -14.55 61.89 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.833 1.653 . . . . 0.0 113.988 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -68.31 -19.47 64.68 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.235 -0.916 . . . . 0.0 112.77 169.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.3 m -109.86 149.72 40.37 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 124.889 1.275 . . . . 0.0 113.275 -169.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.33 166.34 20.35 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.609 2.873 . . . . 0.0 113.899 -175.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 38.34 -110.06 0.12 Allowed Glycine 0 CA--C 1.538 1.512 0 C-N-CA 127.591 2.52 . . . . 0.0 115.848 172.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.48 7.27 42.52 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.17 1.788 . . . . 0.0 113.747 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 61.8 m -67.59 165.54 16.75 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 122.604 1.192 . . . . 0.0 111.929 171.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.6 pt -133.79 167.48 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 129.227 3.011 . . . . 0.0 108.653 169.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.9 t -85.9 103.28 14.48 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 168.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -67.03 169.38 8.45 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.721 1.608 . . . . 0.0 111.049 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.94 -16.61 70.69 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.757 1.17 . . . . 0.0 114.522 -174.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -81.05 -6.77 59.2 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.337 1.455 . . . . 0.0 114.393 173.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.59 20.38 48.12 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.485 1.041 . . . . 0.0 115.028 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -132.31 163.71 28.05 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.723 1.609 . . . . 0.0 111.687 177.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.5 m -70.21 148.32 48.76 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.307 -0.871 . . . . 0.0 112.916 176.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.156 0 C-N-CA 125.164 1.364 . . . . 0.0 112.462 174.255 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.0 tttm . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.85 146.68 53.52 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.96 0.904 . . . . 0.0 110.686 172.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.0 p -145.1 165.49 28.1 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 176.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -122.66 -17.14 7.0 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 127.509 2.324 . . . . 0.0 112.729 170.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -148.31 162.5 39.4 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 128.45 2.7 . . . . 0.0 110.016 -175.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -69.3 -23.22 63.78 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.146 -0.971 . . . . 0.0 112.953 -178.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.5 m -67.79 -17.3 64.48 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.555 1.542 . . . . 0.0 113.234 177.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -75.12 -10.75 59.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.17 1.388 . . . . 0.0 113.443 174.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 73.9 m -113.56 163.1 19.39 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -168.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.92 165.36 3.87 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.984 3.122 . . . . 0.0 114.096 169.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.43 -56.93 8.76 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 126.058 1.789 . . . . 0.0 115.942 -174.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.32 -14.54 55.18 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.6 m -74.53 166.6 23.26 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 123.051 1.405 . . . . 0.0 112.904 171.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 pt -132.78 167.68 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 129.139 2.976 . . . . 0.0 107.671 166.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.0 t -82.44 101.83 10.91 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.423 -0.798 . . . . 0.0 109.778 169.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.87 167.81 12.85 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.228 1.811 . . . . 0.0 111.567 -178.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.01 -15.18 76.29 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.911 1.244 . . . . 0.0 114.631 -173.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -77.37 -8.25 57.38 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.45 1.5 . . . . 0.0 114.166 173.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.23 13.86 59.68 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.737 1.16 . . . . 0.0 114.996 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -129.28 168.1 16.72 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.432 1.893 . . . . 0.0 111.064 177.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 82.4 m -74.03 153.84 39.5 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.262 -0.899 . . . . 0.0 113.242 176.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.124 0 C-N-CA 124.329 0.966 . . . . 0.0 113.451 171.283 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.9 tttt . . . . . 0 CA--C 1.536 0.412 0 N-CA-C 110.571 -0.159 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -65.91 143.23 57.55 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 169.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.0 p -136.45 173.49 11.65 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -175.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -136.64 -17.6 1.47 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.453 1.901 . . . . 0.0 112.577 169.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.61 155.4 39.17 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 127.846 2.458 . . . . 0.0 109.887 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -67.97 -25.76 65.6 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.223 -0.923 . . . . 0.0 112.223 169.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 77.4 p -71.33 -14.54 62.23 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.59 1.556 . . . . 0.0 114.022 175.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -65.55 -22.27 66.68 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.403 -0.81 . . . . 0.0 112.585 169.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.8 m -106.39 150.07 39.05 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -167.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -82.2 165.45 16.85 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.765 2.976 . . . . 0.0 113.523 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 44.1 -118.72 2.46 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.601 2.048 . . . . 0.0 114.877 173.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.64 7.05 47.15 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.1 1.76 . . . . 0.0 113.761 -178.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.4 m -66.03 160.04 24.61 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 123.077 1.417 . . . . 0.0 113.438 171.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.1 pt -127.55 167.3 22.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 129.505 3.122 . . . . 0.0 108.138 168.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.8 t -84.54 103.02 13.31 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 168.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -68.47 168.95 11.72 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.943 1.697 . . . . 0.0 111.073 -175.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.47 -16.41 69.46 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.659 1.123 . . . . 0.0 114.515 -176.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.8 p30 -78.77 -7.62 57.97 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.517 1.527 . . . . 0.0 114.419 173.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.33 14.54 60.07 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.649 1.119 . . . . 0.0 115.421 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -128.6 166.52 18.71 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.277 1.831 . . . . 0.0 111.866 177.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.6 m -69.38 143.1 53.79 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.476 -0.765 . . . . 0.0 112.672 174.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.167 0 C-N-CA 124.478 1.037 . . . . 0.0 112.615 171.237 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.6 tttt . . . . . 0 N--CA 1.468 0.436 0 CA-C-O 120.379 0.133 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -67.57 146.02 54.31 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.108 0.563 . . . . 0.0 110.147 169.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.9 p -139.37 172.96 12.06 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.36 -28.22 3.68 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 128.192 2.597 . . . . 0.0 111.564 174.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -148.14 164.41 33.97 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.698 1.999 . . . . 0.0 111.433 -175.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -66.92 -23.96 66.03 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.45 -0.781 . . . . 0.0 112.78 -176.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -66.7 -18.54 65.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.217 1.407 . . . . 0.0 112.825 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -71.55 -17.2 62.32 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.998 1.319 . . . . 0.0 113.219 175.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.6 m -111.31 148.67 39.25 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -167.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -81.93 163.19 18.25 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.744 2.963 . . . . 0.0 113.531 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 44.18 -119.69 2.96 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 126.332 1.92 . . . . 0.0 114.84 173.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.83 -0.86 57.81 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.694 1.598 . . . . 0.0 114.226 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.1 m -64.41 156.54 29.02 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 123.105 1.431 . . . . 0.0 113.105 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.0 pt -124.56 164.8 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 129.258 3.023 . . . . 0.0 108.562 170.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.1 t -84.41 102.84 13.07 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 168.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -67.22 169.55 8.5 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.94 1.696 . . . . 0.0 110.915 -176.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.56 -17.22 70.61 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.748 1.166 . . . . 0.0 114.605 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 56.9 p30 -81.86 -4.01 55.48 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.754 1.622 . . . . 0.0 114.375 173.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.84 29.81 45.83 Favored Glycine 0 CA--C 1.535 1.335 0 O-C-N 121.206 -0.934 . . . . 0.0 114.456 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -132.97 160.67 36.44 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.517 1.927 . . . . 0.0 111.267 172.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 77.7 m -69.0 144.55 54.07 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.817 -0.552 . . . . 0.0 112.232 172.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.04 0 C-N-CA 124.612 1.101 . . . . 0.0 111.81 172.883 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -64.45 145.26 56.37 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.235 1.014 . . . . 0.0 110.322 169.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.6 p -145.66 169.74 17.85 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.416 1.086 . . . . 0.0 113.732 -176.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -123.16 -25.26 4.53 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.53 2.332 . . . . 0.0 111.918 169.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -130.99 160.6 34.09 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.753 2.021 . . . . 0.0 110.879 -176.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -67.21 -25.51 66.15 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.438 -0.789 . . . . 0.0 112.492 173.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 56.3 p -70.7 -15.59 62.72 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.848 1.659 . . . . 0.0 113.972 175.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -68.86 -19.23 64.23 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.811 0.844 . . . . 0.0 112.937 169.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.8 m -108.25 159.86 29.13 Favored Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -168.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -57.65 167.11 4.21 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 124.509 3.473 . . . . 0.0 115.541 173.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -26.51 -72.66 0.03 OUTLIER Glycine 0 CA--C 1.536 1.344 0 C-N-CA 129.081 3.229 . . . . 0.0 117.588 -172.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.42 3.02 53.12 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.013 1.325 . . . . 0.0 113.92 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.6 m -73.14 167.06 21.93 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 122.723 1.249 . . . . 0.0 111.613 169.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.2 pt -135.16 164.64 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 129.095 2.958 . . . . 0.0 108.323 169.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.3 t -84.18 101.71 12.06 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 168.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -65.17 171.24 3.85 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.374 1.87 . . . . 0.0 111.149 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.49 -18.36 69.7 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.723 1.154 . . . . 0.0 114.451 -174.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -81.47 -6.87 59.39 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.155 1.382 . . . . 0.0 114.393 173.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.23 20.14 50.25 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 124.53 1.062 . . . . 0.0 115.266 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -130.87 161.47 31.77 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.68 1.592 . . . . 0.0 111.766 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.2 m -71.15 139.29 50.18 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.453 -0.779 . . . . 0.0 112.713 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.121 0 C-N-CA 124.499 1.047 . . . . 0.0 113.162 174.547 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 77.6 tttt . . . . . 0 N--CA 1.468 0.457 0 N-CA-C 111.314 0.116 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -63.49 146.15 54.21 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.281 1.033 . . . . 0.0 109.73 169.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.3 p -142.09 168.54 19.51 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 38.4 mtm180 -124.19 -21.45 5.01 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 128.494 2.717 . . . . 0.0 112.428 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -154.88 163.42 40.31 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 128.81 2.844 . . . . 0.0 109.965 -174.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -67.74 -24.96 65.41 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.276 -0.89 . . . . 0.0 112.65 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.5 m -71.59 -13.91 61.92 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.729 1.212 . . . . 0.0 113.48 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -72.32 -18.64 61.75 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.832 1.253 . . . . 0.0 112.376 171.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 76.2 m -104.93 159.78 28.18 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.092 1.357 . . . . 0.0 113.724 -169.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.08 166.62 27.39 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.191 2.594 . . . . 0.0 112.659 175.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -34.14 -63.09 0.44 Allowed Glycine 0 CA--C 1.537 1.446 0 C-N-CA 127.967 2.699 . . . . 0.0 117.449 -169.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.35 -12.03 57.0 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.5 m -78.41 164.69 24.57 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 123.14 1.447 . . . . 0.0 113.204 173.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.5 pt -130.0 163.87 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 129.706 3.202 . . . . 0.0 107.72 167.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 39.7 t -89.37 102.93 15.6 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 121.612 -0.68 . . . . 0.0 109.856 171.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -82.0 173.45 12.18 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.681 1.192 . . . . 0.0 111.828 -169.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.57 -16.11 71.46 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.771 1.177 . . . . 0.0 114.32 -170.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 39.4 p-10 -77.06 -9.06 58.47 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.32 1.448 . . . . 0.0 114.273 172.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.73 16.96 57.56 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.687 1.137 . . . . 0.0 115.082 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -131.34 162.79 29.29 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.449 1.499 . . . . 0.0 112.029 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.3 m -69.89 144.85 52.36 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.717 0.807 . . . . 0.0 112.223 172.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.134 0 C-N-CA 124.416 1.008 . . . . 0.0 113.386 174.023 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 81.8 tttt . . . . . 0 N--CA 1.467 0.396 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -66.04 143.7 57.18 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.357 0.663 . . . . 0.0 110.567 171.176 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.9 p -149.12 170.23 18.88 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.732 1.213 . . . . 0.0 113.924 -172.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -136.26 -8.89 1.99 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.991 2.116 . . . . 0.0 112.836 169.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -132.41 151.42 51.88 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 127.687 2.395 . . . . 0.0 109.813 -179.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -66.99 -24.18 66.01 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.362 -0.836 . . . . 0.0 112.219 171.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.7 p -72.29 -16.34 61.9 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.765 1.626 . . . . 0.0 114.004 174.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -65.93 -28.25 68.78 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.099 0.863 . . . . 0.0 112.383 169.119 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.5 m -96.0 161.23 28.0 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.352 1.461 . . . . 0.0 113.295 -170.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -68.2 162.57 39.7 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.95 2.433 . . . . 0.0 112.136 173.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -36.79 -58.65 1.15 Allowed Glycine 0 N--CA 1.475 1.28 0 C-N-CA 127.607 2.527 . . . . 0.0 117.283 -169.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.21 -17.18 53.05 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -175.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.9 m -77.16 168.75 19.53 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 123.046 1.403 . . . . 0.0 113.864 171.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.8 pt -132.35 166.16 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 130.472 3.509 . . . . 0.0 107.806 168.294 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.8 t -86.26 103.92 15.32 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.557 -0.715 . . . . 0.0 109.151 169.022 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -67.77 170.57 7.73 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.194 1.798 . . . . 0.0 111.029 -175.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.58 -16.15 71.55 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.733 1.158 . . . . 0.0 114.604 -173.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -83.54 -3.11 57.36 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.45 1.5 . . . . 0.0 114.341 174.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.95 21.93 56.35 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.154 0.883 . . . . 0.0 114.603 -179.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -131.84 159.99 36.95 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.898 1.679 . . . . 0.0 111.581 175.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.9 m -68.63 147.27 52.14 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.638 -0.664 . . . . 0.0 112.166 176.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.864 0 C-N-CA 124.776 1.179 . . . . 0.0 111.449 173.814 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt . . . . . 0 N--CA 1.471 0.613 0 CA-C-O 120.483 0.182 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -67.96 142.06 56.1 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 167.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 p -141.1 171.03 14.63 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -171.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -133.39 -15.2 2.51 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.686 2.394 . . . . 0.0 112.662 174.065 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -135.06 153.62 51.98 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.329 2.252 . . . . 0.0 110.152 -176.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -66.4 -23.23 66.28 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.475 -0.765 . . . . 0.0 111.793 168.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.0 m -68.62 -20.46 64.49 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.779 2.032 . . . . 0.0 113.427 175.604 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -67.53 -29.95 69.49 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.681 0.792 . . . . 0.0 112.425 172.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.9 m -96.03 159.46 32.19 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.228 1.411 . . . . 0.0 113.702 -169.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.74 167.1 26.7 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.29 2.66 . . . . 0.0 112.712 175.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -34.85 -62.25 0.56 Allowed Glycine 0 CA--C 1.536 1.354 0 C-N-CA 128.067 2.746 . . . . 0.0 117.489 -169.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.05 -13.88 58.96 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -175.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.3 m -81.17 167.55 19.53 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 123.268 1.508 . . . . 0.0 113.722 173.735 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.5 pt -133.18 166.54 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 131.19 3.796 . . . . 0.0 107.234 167.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.4 t -84.91 102.75 13.38 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.408 -0.807 . . . . 0.0 108.986 169.042 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -66.82 168.0 10.43 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.93 1.692 . . . . 0.0 111.194 -174.618 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.2 -17.72 68.43 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.79 1.186 . . . . 0.0 114.325 -178.283 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -77.88 -7.73 57.11 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.499 1.519 . . . . 0.0 114.331 172.153 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.17 13.99 61.13 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.64 1.114 . . . . 0.0 115.485 178.407 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -130.28 166.05 21.16 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.031 1.733 . . . . 0.0 111.418 176.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.2 m -70.85 141.74 51.25 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.435 -0.791 . . . . 0.0 112.894 178.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.181 0 C-N-CA 125.49 1.519 . . . . 0.0 112.201 174.515 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -54.63 136.47 45.37 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.55 -0.719 . . . . 0.0 111.504 173.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.4 p -140.13 169.65 17.3 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -170.457 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -119.83 -30.14 4.82 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 128.381 2.672 . . . . 0.0 111.56 -179.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -152.8 164.61 37.5 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 127.922 2.489 . . . . 0.0 110.694 -172.526 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -65.73 -23.8 66.83 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.512 -0.743 . . . . 0.0 112.79 -177.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.1 m -67.28 -18.41 65.19 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.4 1.48 . . . . 0.0 113.217 177.648 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -74.0 -13.76 60.92 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.723 1.209 . . . . 0.0 113.193 174.134 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.2 m -111.57 149.28 40.47 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 125.008 1.323 . . . . 0.0 112.897 -172.46 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -77.46 163.84 29.27 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.362 2.708 . . . . 0.0 113.846 -175.38 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 36.91 -112.29 0.15 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 127.449 2.452 . . . . 0.0 115.746 173.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.01 5.45 48.77 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.42 1.888 . . . . 0.0 113.909 -177.531 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.2 m -66.81 168.29 9.9 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 122.423 1.106 . . . . 0.0 112.188 174.184 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.3 pt -135.27 162.91 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 128.093 2.557 . . . . 0.0 109.745 173.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.2 t -86.02 103.28 14.56 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 168.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -65.74 169.3 6.57 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.364 1.865 . . . . 0.0 111.21 -176.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.51 -17.95 71.27 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.814 1.197 . . . . 0.0 114.416 -173.218 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -82.02 -5.43 58.35 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.195 1.398 . . . . 0.0 114.348 173.116 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.92 24.29 38.55 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.369 0.985 . . . . 0.0 114.931 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -133.5 164.2 27.68 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.396 1.879 . . . . 0.0 111.161 177.526 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 89.5 m -73.84 156.21 37.99 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.038 -1.039 . . . . 0.0 112.948 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.142 0 C-N-CA 124.96 1.267 . . . . 0.0 112.271 172.692 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.9 tttp . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -64.27 145.62 55.7 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.678 0.791 . . . . 0.0 110.093 173.453 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.3 p -141.86 168.12 20.51 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -173.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -116.33 -28.5 6.49 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.572 2.349 . . . . 0.0 112.016 177.374 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -151.64 172.97 15.24 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.632 2.373 . . . . 0.0 110.133 -176.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -70.53 -26.39 63.54 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.501 0.72 . . . . 0.0 112.532 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.7 p -68.61 -16.02 63.71 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.637 1.575 . . . . 0.0 113.858 174.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -73.61 -12.04 60.62 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.875 0.87 . . . . 0.0 113.167 169.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 79.8 m -112.01 158.3 37.25 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -169.071 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.74 167.11 7.26 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 124.32 3.347 . . . . 0.0 115.652 176.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -1.89 -86.4 0.0 OUTLIER Glycine 0 N--CA 1.477 1.388 0 C-N-CA 130.238 3.78 . . . . 0.0 117.645 177.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -107.86 10.53 28.57 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.239 1.415 . . . . 0.0 113.502 -178.026 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 67.2 m -66.99 167.13 12.3 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.468 1.128 . . . . 0.0 111.761 169.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.7 pt -133.11 161.69 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 128.03 2.532 . . . . 0.0 109.27 169.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.5 t -86.95 99.82 12.14 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.741 0.816 . . . . 0.0 109.65 170.335 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -77.06 174.65 10.41 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.97 1.308 . . . . 0.0 111.868 -170.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.39 -16.04 68.84 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.898 1.237 . . . . 0.0 114.464 -171.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -76.04 -8.05 56.09 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.589 1.556 . . . . 0.0 114.253 170.412 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.26 15.33 64.69 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.947 1.261 . . . . 0.0 114.859 -178.565 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -131.39 160.97 33.5 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.856 1.662 . . . . 0.0 112.114 -178.071 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 70.9 m -68.33 141.88 55.67 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.904 0.881 . . . . 0.0 112.211 176.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.068 0 C-N-CA 123.794 0.712 . . . . 0.0 113.151 176.008 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.7 tttm . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 120.386 0.136 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.83 148.09 50.22 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.812 1.245 . . . . 0.0 110.822 176.257 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.4 p -144.78 171.32 14.59 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 177.013 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -128.41 -24.55 3.06 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 128.408 2.683 . . . . 0.0 112.098 169.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.7 ptm85 -145.12 166.17 26.17 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.442 1.897 . . . . 0.0 111.834 178.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -67.58 -20.98 65.44 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.281 -0.887 . . . . 0.0 112.724 -176.135 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.2 m -67.47 -17.09 64.55 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.618 1.167 . . . . 0.0 113.182 175.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -74.49 -10.75 59.87 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.387 1.475 . . . . 0.0 113.347 173.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.5 m -119.09 158.39 48.3 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.07 1.348 . . . . 0.0 113.346 -168.668 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.08 165.97 30.67 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.123 2.549 . . . . 0.0 112.254 174.086 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -39.34 -57.7 2.15 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 127.426 2.441 . . . . 0.0 117.234 -169.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.03 -17.46 52.71 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -177.099 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.4 m -79.09 164.8 24.0 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 123.283 1.515 . . . . 0.0 112.752 169.686 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.9 pt -132.52 167.31 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 129.767 3.227 . . . . 0.0 107.512 167.065 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.9 t -80.08 101.61 8.84 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.299 -0.876 . . . . 0.0 109.744 169.455 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.86 169.57 12.86 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.104 1.762 . . . . 0.0 111.632 -177.669 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.45 -13.96 79.71 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.848 1.213 . . . . 0.0 114.598 -173.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -79.15 -6.73 57.22 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.638 1.575 . . . . 0.0 114.29 174.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.41 12.72 62.59 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.642 1.115 . . . . 0.0 114.805 -177.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -129.71 167.96 17.23 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.405 1.882 . . . . 0.0 111.031 176.392 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.2 m -70.04 152.95 43.8 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.25 -0.907 . . . . 0.0 112.679 173.664 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.973 0 C-N-CA 124.423 1.011 . . . . 0.0 113.781 171.662 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.4 tttp . . . . . 0 N--CA 1.468 0.449 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -63.63 143.75 57.57 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.997 0.919 . . . . 0.0 111.141 174.232 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 p -144.04 173.1 12.02 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.937 1.295 . . . . 0.0 114.193 -176.052 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -132.27 -20.04 2.43 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.256 2.222 . . . . 0.0 112.628 170.034 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -142.6 164.36 30.32 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.113 1.765 . . . . 0.0 111.754 178.015 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -67.4 -22.65 65.53 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.509 -0.744 . . . . 0.0 112.554 -176.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.0 m -66.99 -18.0 65.18 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.458 1.503 . . . . 0.0 113.128 176.423 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -74.14 -12.65 60.65 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.056 1.342 . . . . 0.0 113.371 174.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 81.6 m -115.99 151.18 46.23 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -168.402 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -80.58 167.37 18.99 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.662 2.908 . . . . 0.0 113.941 -174.658 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 39.8 -108.03 0.09 OUTLIER Glycine 0 CA--C 1.534 1.264 0 C-N-CA 127.644 2.545 . . . . 0.0 115.497 172.256 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.35 6.88 30.89 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.281 1.832 . . . . 0.0 113.673 -177.823 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 75.3 m -66.41 168.82 8.31 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 122.626 1.203 . . . . 0.0 112.938 175.693 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.6 pt -131.83 169.69 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 129.067 2.947 . . . . 0.0 108.962 169.061 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.9 t -87.73 108.36 19.08 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.659 -0.651 . . . . 0.0 109.333 168.091 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 -66.1 168.35 8.55 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.61 1.564 . . . . 0.0 111.451 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.51 -17.91 73.15 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.832 1.206 . . . . 0.0 114.478 -176.837 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -80.37 -5.96 57.26 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.694 1.197 . . . . 0.0 114.092 172.684 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.82 24.08 36.65 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.521 1.058 . . . . 0.0 114.972 -179.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -134.84 161.96 33.75 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.675 1.59 . . . . 0.0 111.9 177.125 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.5 m -69.24 144.78 53.57 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.321 -0.862 . . . . 0.0 113.319 179.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.035 0 C-N-CA 124.543 1.068 . . . . 0.0 113.167 179.007 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 76.3 tttt . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -54.86 136.3 47.02 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.417 -0.802 . . . . 0.0 111.404 172.638 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.8 p -141.99 165.53 27.21 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.143 1.377 . . . . 0.0 114.191 -170.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -116.73 -19.5 9.91 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.871 2.068 . . . . 0.0 112.841 -179.069 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -160.69 163.41 32.46 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 128.863 2.865 . . . . 0.0 109.468 -169.011 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -66.95 -26.7 66.96 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.139 -0.976 . . . . 0.0 112.666 179.286 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.3 m -71.05 -15.42 62.54 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.509 1.524 . . . . 0.0 113.622 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -72.37 -22.49 61.14 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.192 0.997 . . . . 0.0 112.389 170.507 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 75.3 m -94.6 151.37 39.16 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.4 1.08 . . . . 0.0 112.813 -174.575 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.16 160.78 26.46 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.444 2.763 . . . . 0.0 113.168 -178.282 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 27.4 -99.04 0.01 OUTLIER Glycine 0 CA--C 1.536 1.348 0 C-N-CA 128.694 3.045 . . . . 0.0 116.671 174.233 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -95.92 -3.63 44.9 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 -173.122 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.3 m -68.74 165.04 20.38 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 122.992 1.377 . . . . 0.0 113.153 175.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.5 pt -124.21 166.17 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 129.551 3.14 . . . . 0.0 107.844 167.539 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.6 t -97.6 107.0 19.41 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.771 0.828 . . . . 0.0 108.815 169.267 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -65.1 165.81 10.57 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.619 1.168 . . . . 0.0 111.132 179.236 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.13 -16.71 71.18 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.052 1.31 . . . . 0.0 114.475 -175.803 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -77.41 -5.92 51.52 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.044 1.338 . . . . 0.0 114.027 170.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.62 28.26 30.06 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.487 1.041 . . . . 0.0 114.683 179.088 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -135.93 158.5 44.24 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.54 1.536 . . . . 0.0 111.862 176.743 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.9 m -77.54 163.83 25.93 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 122.124 0.964 . . . . 0.0 113.366 -179.829 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.131 0 C-N-CA 125.402 1.477 . . . . 0.0 111.897 169.652 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt . . . . . 0 N--CA 1.469 0.485 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -67.41 141.56 57.0 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.219 0.607 . . . . 0.0 109.976 168.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.5 p -141.31 171.36 14.17 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.471 1.108 . . . . 0.0 113.741 -171.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -136.3 -10.12 1.95 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.326 1.85 . . . . 0.0 113.158 172.692 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.3 ttt-85 -141.31 168.2 20.34 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.672 1.589 . . . . 0.0 110.451 171.66 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -72.5 -26.97 61.98 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.371 0.669 . . . . 0.0 112.253 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.0 p -70.03 -13.41 62.21 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.28 1.832 . . . . 0.0 113.82 175.481 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.58 -23.49 65.4 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.486 -0.759 . . . . 0.0 112.403 168.995 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.8 m -107.22 161.71 22.11 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 124.838 1.255 . . . . 0.0 114.137 -168.535 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -56.54 167.3 2.88 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 124.594 3.529 . . . . 0.0 115.446 173.038 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -32.09 -67.52 0.16 Allowed Glycine 0 CA--C 1.538 1.493 0 C-N-CA 128.521 2.963 . . . . 0.0 117.095 -171.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.38 -0.51 56.53 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -177.32 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 65.1 m -74.07 169.64 17.09 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.668 1.223 . . . . 0.0 112.044 173.517 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 24.4 pt -137.13 166.61 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 128.762 2.825 . . . . 0.0 108.707 169.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.6 t -86.96 104.42 16.26 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 167.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -66.37 169.46 7.34 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.683 1.593 . . . . 0.0 111.026 -175.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.71 -17.32 68.99 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.701 1.143 . . . . 0.0 114.242 -176.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 53.9 p30 -79.34 -6.52 56.95 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.469 1.507 . . . . 0.0 114.405 172.446 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.57 17.81 57.88 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.662 1.125 . . . . 0.0 115.22 179.885 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -130.88 161.8 31.03 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.839 1.655 . . . . 0.0 111.928 178.275 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 97.7 m -68.2 145.81 53.96 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.614 -0.679 . . . . 0.0 112.727 178.038 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.088 0 C-N-CA 124.64 1.115 . . . . 0.0 112.469 174.542 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.1 145.33 53.58 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.462 1.105 . . . . 0.0 110.822 173.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 p -143.99 167.05 23.28 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 177.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -121.98 -21.52 5.98 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.674 2.39 . . . . 0.0 112.463 169.276 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.67 168.97 20.69 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.278 1.831 . . . . 0.0 111.417 177.164 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -66.23 -22.91 66.34 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.27 -0.894 . . . . 0.0 112.755 -177.51 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.2 m -66.27 -17.74 64.93 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.741 1.617 . . . . 0.0 113.378 177.471 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -74.27 -13.73 60.81 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.446 1.498 . . . . 0.0 113.747 174.133 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.5 m -117.44 159.12 43.06 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -167.469 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -56.05 168.69 1.75 Allowed 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 125.106 3.87 . . . . 0.0 116.189 172.198 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -35.66 -65.52 0.45 Allowed Glycine 0 CA--C 1.535 1.287 0 C-N-CA 128.45 2.928 . . . . 0.0 117.451 -170.633 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.46 1.8 55.75 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.635 1.174 . . . . 0.0 114.035 -178.797 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.9 m -74.97 168.21 20.4 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.777 1.275 . . . . 0.0 112.109 170.841 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.5 pt -136.58 165.15 29.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 129.586 3.154 . . . . 0.0 107.894 168.224 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.3 t -83.21 101.23 11.09 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 168.015 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -65.97 169.5 6.69 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.876 1.67 . . . . 0.0 110.748 -175.231 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.91 -16.96 69.0 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.662 1.125 . . . . 0.0 114.39 -174.751 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -79.7 -9.29 59.62 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.32 1.448 . . . . 0.0 114.454 173.841 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.43 15.74 56.53 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.667 1.127 . . . . 0.0 115.336 -178.35 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -129.67 164.86 23.0 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.513 1.525 . . . . 0.0 111.245 176.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.6 m -70.19 146.45 50.75 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.264 -0.898 . . . . 0.0 112.734 177.397 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.035 0 C-N-CA 125.139 1.352 . . . . 0.0 111.598 174.301 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt . . . . . 0 N--CA 1.47 0.544 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -63.19 144.11 57.21 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.356 1.062 . . . . 0.0 110.926 171.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.0 p -143.9 172.6 12.63 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -175.445 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -132.63 -15.47 2.74 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 127.373 2.269 . . . . 0.0 113.649 171.166 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.5 ttp180 -144.06 170.82 15.21 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.032 1.733 . . . . 0.0 110.971 172.382 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -70.72 -24.2 62.59 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.46 0.704 . . . . 0.0 112.286 178.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.4 m -64.32 -20.64 66.23 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.141 1.776 . . . . 0.0 113.017 174.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.86 -16.03 62.67 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.443 1.097 . . . . 0.0 113.437 173.107 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 56.0 m -116.14 151.82 47.09 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.911 1.285 . . . . 0.0 113.313 -169.035 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.06 164.21 22.44 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.316 2.677 . . . . 0.0 113.592 -176.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 26.85 -100.9 0.01 OUTLIER Glycine 0 CA--C 1.537 1.448 0 C-N-CA 129.033 3.206 . . . . 0.0 117.307 172.429 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.69 2.11 51.72 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.791 1.636 . . . . 0.0 113.929 -174.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.0 m -72.04 166.16 22.81 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 122.771 1.272 . . . . 0.0 112.063 172.597 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.9 pt -135.46 166.15 28.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 129.514 3.126 . . . . 0.0 108.045 168.514 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.9 t -83.14 101.28 11.08 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 168.011 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -65.42 170.27 5.05 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.153 1.781 . . . . 0.0 110.911 -175.805 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.71 -17.4 69.09 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.648 1.118 . . . . 0.0 114.517 -173.799 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.9 p-10 -79.97 -8.04 59.13 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.379 1.472 . . . . 0.0 114.434 172.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.4 20.08 49.92 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.634 1.111 . . . . 0.0 115.091 -178.128 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -132.27 161.56 33.17 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.606 1.562 . . . . 0.0 111.761 178.287 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.6 m -70.17 140.31 52.54 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.322 -0.862 . . . . 0.0 112.565 178.236 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.077 0 C-N-CA 125.289 1.423 . . . . 0.0 111.649 175.273 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -93.79 -1.91 65.31 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 123.998 0.809 . . . . 0.0 113.941 173.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.7 m 64.17 -42.92 0.27 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 129.569 3.148 . . . . 0.0 116.36 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -62.77 -30.66 71.62 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.433 1.493 . . . . 0.0 113.355 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.37 1.57 82.27 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.406 1.479 . . . . 0.0 114.671 174.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 113.48 -175.08 16.19 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 126.31 1.909 . . . . 0.0 112.964 -172.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 55.3 t -78.92 112.48 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.465 1.106 . . . . 0.0 110.308 170.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.8 t -79.87 139.57 53.89 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.106 168.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -55.16 -8.17 1.44 Allowed 'Trans proline' 0 CA--C 1.548 1.224 1 C-N-CA 125.503 4.135 . . . . 0.0 117.427 168.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt 51.83 64.84 1.69 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 127.35 2.26 . . . . 0.0 113.665 174.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 47.4 pt -78.84 147.85 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.701 1.201 . . . . 0.0 110.826 172.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.8 mp -80.66 42.45 0.61 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.743 1.617 . . . . 0.0 111.774 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -79.49 113.23 17.47 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.24 1.416 . . . . 0.0 109.956 173.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -66.05 145.44 55.86 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.1 0.56 . . . . 0.0 110.46 170.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.8 p -144.84 171.63 14.15 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -174.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -119.71 -28.51 5.24 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 128.205 2.602 . . . . 0.0 111.574 172.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -149.31 173.18 13.79 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.271 1.428 . . . . 0.0 112.292 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -66.09 -27.06 67.78 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.876 1.27 . . . . 0.0 112.497 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.8 m -66.36 -19.8 65.9 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.554 1.542 . . . . 0.0 112.915 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -70.04 -25.35 63.52 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 82.9 m -96.28 157.32 35.77 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.489 1.116 . . . . 0.0 113.646 -169.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.25 161.36 46.04 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.993 2.462 . . . . 0.0 112.46 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -12.34 -75.11 0.01 OUTLIER Glycine 0 N--CA 1.477 1.373 0 C-N-CA 129.506 3.432 . . . . 0.0 117.984 -173.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.51 -8.58 52.5 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -172.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.4 m -74.5 166.43 23.54 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 122.853 1.311 . . . . 0.0 113.151 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.4 pt -128.92 162.19 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 129.447 3.099 . . . . 0.0 108.599 168.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.8 t -86.19 100.15 12.03 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 169.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -65.09 171.08 3.88 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.168 2.187 . . . . 0.0 111.305 -174.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.64 -17.3 70.84 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.848 1.214 . . . . 0.0 114.6 -173.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -84.85 -2.66 58.06 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.322 1.449 . . . . 0.0 114.358 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.0 22.74 51.79 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.226 0.917 . . . . 0.0 114.884 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -130.99 159.8 36.43 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.558 1.543 . . . . 0.0 111.905 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.0 m -69.38 145.57 52.79 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.301 0.641 . . . . 0.0 112.1 175.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.781 0 C-N-CA 124.728 1.156 . . . . 0.0 111.915 174.243 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.7 m . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.91 153.6 17.07 Favored Glycine 0 N--CA 1.472 1.044 0 C-N-CA 124.361 0.981 . . . . 0.0 112.254 173.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.6 m -61.66 -35.54 78.26 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.434 1.093 . . . . 0.0 113.667 -175.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -88.42 -12.87 41.95 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.132 1.373 . . . . 0.0 113.337 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.25 -48.72 3.22 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.613 1.578 . . . . 0.0 113.762 -176.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 118.73 -170.49 13.82 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.242 1.401 . . . . 0.0 114.157 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 m -65.59 96.22 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.006 1.322 . . . . 0.0 112.307 171.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.7 t -83.87 141.84 41.44 Favored Pre-proline 0 CA--C 1.547 0.833 0 O-C-N 121.73 -0.606 . . . . 0.0 110.846 168.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.96 -4.14 0.34 Allowed 'Trans proline' 0 CA--C 1.551 1.369 1 C-N-CA 125.563 4.175 . . . . 0.0 117.392 167.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt 48.02 68.53 0.66 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 127.842 2.457 . . . . 0.0 113.527 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 45.3 pt -78.55 155.6 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.865 1.266 . . . . 0.0 111.07 174.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.9 mp -82.17 19.76 1.13 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.871 1.668 . . . . 0.0 112.808 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -66.49 117.02 8.12 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.088 1.355 . . . . 0.0 110.966 174.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -66.6 149.49 50.41 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.978 0.911 . . . . 0.0 110.236 169.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.2 p -144.73 172.17 13.37 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -128.63 -22.45 3.3 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.966 2.506 . . . . 0.0 112.23 170.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -144.38 164.03 32.01 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.482 1.913 . . . . 0.0 111.57 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -66.91 -23.08 65.95 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.394 -0.816 . . . . 0.0 112.593 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.4 m -67.4 -17.66 64.81 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.252 1.421 . . . . 0.0 113.216 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -72.9 -20.25 61.12 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.848 1.259 . . . . 0.0 113.268 173.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.4 m -106.2 163.66 16.58 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -167.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -55.84 164.4 4.67 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 124.071 3.181 . . . . 0.0 113.929 169.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.7 -54.08 18.89 Favored Glycine 0 N--CA 1.475 1.257 0 C-N-CA 125.894 1.711 . . . . 0.0 115.519 -175.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.68 -17.74 50.17 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.8 m -75.65 167.72 21.36 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 123.16 1.457 . . . . 0.0 113.192 171.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.8 pt -133.44 167.78 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 129.39 3.076 . . . . 0.0 107.467 166.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.0 t -83.89 103.05 12.83 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.479 -0.763 . . . . 0.0 109.801 169.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.38 165.67 13.75 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.794 1.638 . . . . 0.0 111.145 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.93 -14.33 75.9 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.997 1.284 . . . . 0.0 114.439 -174.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.5 p-10 -78.27 -6.18 54.22 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.643 1.577 . . . . 0.0 114.123 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.89 19.04 55.04 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.412 1.006 . . . . 0.0 114.725 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -131.56 165.02 24.55 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.063 1.745 . . . . 0.0 111.684 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 80.9 m -74.45 151.21 39.63 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.606 -0.684 . . . . 0.0 112.832 173.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.029 0 C-N-CA 124.364 0.983 . . . . 0.0 113.144 171.56 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -99.13 -6.3 55.79 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.442 1.02 . . . . 0.0 115.597 -175.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.3 t -146.14 130.4 17.57 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.97 1.308 . . . . 0.0 111.872 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -70.81 -11.35 60.9 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.917 1.287 . . . . 0.0 113.53 169.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.79 -0.06 88.91 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.405 1.479 . . . . 0.0 114.687 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -146.36 -169.28 14.08 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 126.662 2.077 . . . . 0.0 112.358 177.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.1 m -130.79 153.02 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.663 1.185 . . . . 0.0 112.785 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.4 t -141.44 140.58 20.83 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.037 1.335 . . . . 0.0 109.434 168.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -54.66 -8.62 1.33 Allowed 'Trans proline' 0 CA--C 1.547 1.148 1 C-N-CA 125.856 4.371 . . . . 0.0 118.56 171.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.5 mttp 49.69 45.2 24.67 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 127.132 2.173 . . . . 0.0 114.022 -177.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.4 pt -79.06 148.92 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 125.501 1.521 . . . . 0.0 111.023 176.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.1 mp -78.92 45.94 0.65 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.058 1.743 . . . . 0.0 111.324 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -80.93 108.5 14.65 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.566 1.546 . . . . 0.0 110.284 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -63.58 144.97 56.57 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.993 0.917 . . . . 0.0 110.863 172.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 p -147.21 173.47 12.51 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -174.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -133.2 -14.88 2.59 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 127.322 2.249 . . . . 0.0 113.295 172.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -144.52 163.41 33.93 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 127.096 2.158 . . . . 0.0 110.724 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -69.34 -22.55 63.75 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.615 -0.678 . . . . 0.0 112.682 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.4 m -69.51 -15.33 63.23 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.426 1.09 . . . . 0.0 113.128 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -74.1 -11.91 60.45 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.763 1.225 . . . . 0.0 113.108 174.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 76.9 m -113.73 147.58 37.95 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.597 1.159 . . . . 0.0 114.04 -168.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -80.82 160.46 21.42 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.607 2.871 . . . . 0.0 113.423 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 43.67 -118.27 2.09 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.685 2.088 . . . . 0.0 114.889 174.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.8 3.05 55.47 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.007 1.723 . . . . 0.0 113.803 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.0 m -64.5 151.84 43.36 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.764 1.269 . . . . 0.0 112.532 169.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.2 pt -120.87 164.25 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 128.203 2.601 . . . . 0.0 108.4 169.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.9 t -82.99 101.1 10.86 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 169.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -66.4 170.85 5.5 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.442 1.897 . . . . 0.0 111.1 -176.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.21 -17.63 70.34 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.721 1.153 . . . . 0.0 114.542 -173.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -82.43 -4.91 58.24 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.308 1.443 . . . . 0.0 114.369 173.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.2 22.89 46.62 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.31 0.957 . . . . 0.0 114.993 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -132.79 160.23 37.48 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.555 1.542 . . . . 0.0 111.851 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.2 m -68.98 142.51 54.64 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.602 -0.686 . . . . 0.0 112.396 176.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.111 0 C-N-CA 124.503 1.049 . . . . 0.0 112.53 172.295 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -102.48 -176.15 27.31 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.376 0.989 . . . . 0.0 115.313 -176.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.4 m -60.43 -12.41 9.44 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.548 1.939 . . . . 0.0 115.067 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -58.63 -28.57 65.76 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.405 1.482 . . . . 0.0 112.779 169.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 82.28 -3.02 83.22 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.37 1.462 . . . . 0.0 115.387 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.53 164.68 50.71 Favored Glycine 0 CA--C 1.537 1.437 0 CA-C-N 118.744 1.272 . . . . 0.0 113.203 173.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.3 t -84.78 97.67 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.166 0.986 . . . . 0.0 111.053 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.1 t -79.55 141.14 56.08 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 166.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -54.88 -6.97 0.75 Allowed 'Trans proline' 0 CA--C 1.55 1.297 0 C-N-CA 125.25 3.967 . . . . 0.0 117.953 168.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 45.66 55.89 6.35 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 127.582 2.353 . . . . 0.0 113.955 178.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.56 152.22 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.925 1.29 . . . . 0.0 111.382 176.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.0 mt -79.35 35.16 0.27 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.765 1.626 . . . . 0.0 113.362 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -70.27 112.49 6.64 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.962 -1.086 . . . . 0.0 110.086 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -68.38 142.78 55.34 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.239 0.616 . . . . 0.0 109.476 168.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.3 p -141.73 168.13 20.49 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -172.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -122.14 -21.04 6.04 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 127.328 2.251 . . . . 0.0 112.742 171.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.69 167.69 24.84 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.257 1.423 . . . . 0.0 111.358 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -65.92 -22.25 66.49 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.311 -0.868 . . . . 0.0 112.538 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.8 m -66.83 -19.25 65.7 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.821 1.648 . . . . 0.0 113.371 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -69.14 -30.9 69.24 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.583 1.153 . . . . 0.0 112.637 172.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.5 m -96.48 151.87 38.29 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -168.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.05 160.04 23.82 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.535 2.824 . . . . 0.0 113.079 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 23.11 -97.97 0.01 OUTLIER Glycine 0 CA--C 1.538 1.489 0 C-N-CA 129.2 3.286 . . . . 0.0 117.085 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.02 -4.28 54.7 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -173.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.5 m -72.86 163.14 28.58 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 122.905 1.336 . . . . 0.0 112.983 171.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.7 pt -130.04 165.76 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 129.642 3.177 . . . . 0.0 108.157 168.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.0 t -83.59 102.04 11.9 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 168.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -66.22 170.47 5.79 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.294 1.838 . . . . 0.0 111.251 -175.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.48 -17.89 71.15 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.709 1.147 . . . . 0.0 114.452 -173.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -82.22 -4.7 57.6 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.141 1.376 . . . . 0.0 114.337 173.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.77 20.9 52.68 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.299 0.952 . . . . 0.0 115.017 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -131.66 162.03 31.36 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.838 1.655 . . . . 0.0 111.762 176.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 75.2 m -71.86 145.36 48.62 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.523 -0.736 . . . . 0.0 112.954 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.232 0 C-N-CA 125.198 1.38 . . . . 0.0 112.08 171.825 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.5 m . . . . . 0 N--CA 1.475 0.797 0 CA-C-O 119.344 -0.36 . . . . 0.0 111.746 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -117.49 -2.41 17.48 Favored Glycine 0 N--CA 1.478 1.484 0 C-N-CA 124.541 1.067 . . . . 0.0 115.762 -174.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.4 t -143.16 144.54 32.24 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.884 1.342 . . . . 0.0 112.396 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -75.76 -14.03 60.31 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.439 1.496 . . . . 0.0 113.06 170.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.01 3.34 57.79 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.691 1.615 . . . . 0.0 115.652 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -170.66 -167.95 31.75 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.545 1.545 . . . . 0.0 113.203 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.5 t -124.96 150.84 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 126.019 1.728 . . . . 0.0 109.493 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.9 t -118.63 130.1 24.99 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.014 0.926 . . . . 0.0 111.97 171.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.26 104.95 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 124.242 3.295 . . . . 0.0 112.168 167.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -75.2 90.85 2.58 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.658 1.583 . . . . 0.0 112.011 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.44 162.96 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.727 1.611 . . . . 0.0 111.737 171.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.9 mt -78.39 76.29 4.9 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.818 1.247 . . . . 0.0 111.512 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -109.91 110.91 22.02 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.898 1.679 . . . . 0.0 110.769 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -65.88 152.06 45.31 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.642 0.777 . . . . 0.0 111.528 174.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.4 p -147.73 169.67 19.22 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 177.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.61 -6.25 1.96 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 127.458 2.303 . . . . 0.0 113.891 169.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.4 ttt85 -144.64 170.6 15.76 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 128.356 2.662 . . . . 0.0 109.004 173.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -75.5 -24.72 56.9 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.505 -0.747 . . . . 0.0 112.297 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.6 m -66.4 -16.2 63.9 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.376 1.871 . . . . 0.0 113.173 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -73.77 -13.59 60.97 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.418 1.487 . . . . 0.0 113.834 173.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 76.7 m -113.02 146.2 34.66 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -167.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -81.83 167.39 16.53 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.907 3.072 . . . . 0.0 113.55 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 43.67 -117.48 1.79 Allowed Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.638 2.066 . . . . 0.0 114.904 174.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.98 6.59 47.5 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.954 1.701 . . . . 0.0 113.844 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.4 m -68.25 162.7 24.48 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 123.228 1.49 . . . . 0.0 113.834 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.8 pt -130.62 169.95 20.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 129.486 3.114 . . . . 0.0 107.806 168.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -82.6 104.08 12.6 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 121.7 -0.625 . . . . 0.0 109.759 168.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.06 167.84 9.28 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.186 1.394 . . . . 0.0 110.533 176.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.43 -13.93 71.41 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.818 1.199 . . . . 0.0 114.624 -174.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -79.18 -6.51 56.73 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.86 1.664 . . . . 0.0 114.399 174.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.7 23.07 56.97 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.184 0.897 . . . . 0.0 114.522 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -133.18 164.21 27.56 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.709 2.004 . . . . 0.0 111.067 173.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.6 m -71.74 147.12 47.66 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.624 -0.672 . . . . 0.0 112.524 176.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.049 0 C-N-CA 124.208 0.909 . . . . 0.0 112.038 170.61 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.8 p . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.81 -8.66 7.35 Favored Glycine 0 CA--C 1.541 1.698 0 C-N-CA 125.165 1.364 . . . . 0.0 115.405 -174.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.5 t -156.42 147.66 22.31 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.921 2.089 . . . . 0.0 110.575 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -66.01 -23.07 66.49 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.096 0.958 . . . . 0.0 112.995 170.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.02 -4.38 60.08 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.445 1.498 . . . . 0.0 115.095 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.46 117.9 4.59 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-N 118.57 1.185 . . . . 0.0 112.375 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.64 96.61 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.678 1.591 . . . . 0.0 110.478 169.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 47.5 t -147.2 110.38 3.99 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 125.231 1.412 . . . . 0.0 110.759 -176.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -61.75 -0.26 1.47 Allowed 'Trans proline' 0 CA--C 1.55 1.277 0 C-N-CA 124.376 3.384 . . . . 0.0 116.977 174.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 50.01 59.26 4.67 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 127.466 2.306 . . . . 0.0 113.044 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 47.3 pt -78.28 159.57 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.071 1.348 . . . . 0.0 112.313 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.2 mt -86.41 16.94 4.07 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.014 1.726 . . . . 0.0 113.706 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -61.59 117.42 5.74 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.038 -1.039 . . . . 0.0 110.163 169.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.45 142.51 55.32 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.444 0.698 . . . . 0.0 109.447 168.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.8 p -142.83 171.39 14.12 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -134.79 -14.86 2.1 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.43 2.292 . . . . 0.0 112.482 171.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -130.31 152.18 50.0 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.402 2.281 . . . . 0.0 110.032 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -64.39 -24.19 67.55 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 121.414 -0.804 . . . . 0.0 111.936 169.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.3 m -68.24 -20.27 64.8 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.88 2.072 . . . . 0.0 113.453 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -68.08 -25.64 65.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.959 0.903 . . . . 0.0 112.988 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.6 m -101.25 152.75 38.01 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.891 1.277 . . . . 0.0 113.497 -169.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -80.81 172.22 13.46 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.717 2.945 . . . . 0.0 113.753 -174.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 44.31 -106.99 0.11 Allowed Glycine 0 CA--C 1.535 1.286 0 C-N-CA 127.281 2.372 . . . . 0.0 114.779 172.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -118.58 13.71 13.45 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.311 1.844 . . . . 0.0 113.121 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.0 m -60.72 169.16 1.94 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 122.471 1.129 . . . . 0.0 112.558 172.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.5 pt -129.52 166.92 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 128.155 2.582 . . . . 0.0 109.622 170.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.6 t -93.16 107.02 18.91 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.782 0.833 . . . . 0.0 109.579 168.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -67.91 166.74 15.02 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.053 1.741 . . . . 0.0 111.374 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.34 -16.95 73.86 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.916 1.246 . . . . 0.0 114.45 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -80.83 -4.61 55.3 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.26 1.424 . . . . 0.0 114.11 172.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.3 25.94 32.13 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.375 0.988 . . . . 0.0 114.946 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -134.71 161.91 33.82 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.874 1.669 . . . . 0.0 111.912 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.7 m -67.96 154.45 41.59 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.388 -0.82 . . . . 0.0 113.059 175.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.096 0 C-N-CA 124.84 1.21 . . . . 0.0 112.053 176.602 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -117.04 -16.06 6.39 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 115.324 0.89 . . . . 0.0 115.324 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.0 p -152.96 172.19 17.19 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.863 1.332 . . . . 0.0 112.935 173.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -84.32 1.26 45.8 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.259 1.824 . . . . 0.0 113.94 170.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.04 6.45 13.5 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 125.944 1.735 . . . . 0.0 116.453 -172.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 168.24 -169.92 41.77 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 126.442 1.972 . . . . 0.0 112.085 -175.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m -87.86 154.52 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.571 1.148 . . . . 0.0 112.35 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.7 t -149.96 124.48 4.67 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 126.217 1.807 . . . . 0.0 109.168 168.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.21 -9.24 19.05 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.19 2.593 . . . . 0.0 115.511 -172.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt 45.53 63.4 1.8 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.989 2.116 . . . . 0.0 113.638 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.0 pp -124.24 169.22 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.904 1.681 . . . . 0.0 112.219 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.0 mt -75.11 35.53 0.11 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.844 2.058 . . . . 0.0 114.607 -170.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -71.49 105.81 3.73 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.544 1.538 . . . . 0.0 110.623 170.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -61.61 145.83 50.88 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.746 0.818 . . . . 0.0 110.478 170.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.4 p -141.59 167.49 22.04 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -120.69 -19.64 7.33 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.231 2.213 . . . . 0.0 112.948 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -159.44 161.81 35.58 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 129.508 3.123 . . . . 0.0 109.241 -169.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -66.95 -25.2 66.23 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 121.007 -1.058 . . . . 0.0 112.746 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -71.51 -13.68 61.88 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.505 1.522 . . . . 0.0 113.557 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -74.4 -8.34 55.94 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.451 1.1 . . . . 0.0 112.986 170.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.5 m -119.49 148.6 46.08 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 125.243 1.417 . . . . 0.0 112.391 -173.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.09 167.81 21.34 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.503 2.802 . . . . 0.0 114.036 -176.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 34.5 -107.05 0.03 OUTLIER Glycine 0 CA--C 1.536 1.386 0 C-N-CA 128.302 2.858 . . . . 0.0 116.597 172.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -103.41 9.92 37.57 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.598 1.959 . . . . 0.0 113.772 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.3 m -67.32 164.86 17.54 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 122.589 1.185 . . . . 0.0 111.724 169.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.5 pt -129.81 163.52 34.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 128.801 2.841 . . . . 0.0 108.553 168.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 47.0 t -94.52 104.29 16.25 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.647 0.779 . . . . 0.0 109.15 169.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -80.75 172.0 14.3 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.579 1.552 . . . . 0.0 111.849 -169.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.11 -16.28 70.66 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.657 1.122 . . . . 0.0 114.299 -173.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -74.88 -11.08 60.05 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.425 1.49 . . . . 0.0 114.218 170.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.28 16.75 56.9 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.842 1.21 . . . . 0.0 115.066 -177.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -131.58 161.22 33.15 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.414 1.486 . . . . 0.0 112.412 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.1 m -68.77 157.6 36.05 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.702 0.801 . . . . 0.0 112.879 174.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.206 0 C-N-CA 125.262 1.41 . . . . 0.0 113.127 168.568 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -99.34 -176.57 31.52 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.119 0.866 . . . . 0.0 115.202 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.1 p -66.39 -5.2 10.0 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.772 2.029 . . . . 0.0 115.518 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.8 -28.68 64.24 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.571 1.548 . . . . 0.0 113.458 172.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.81 -7.19 82.0 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.338 1.447 . . . . 0.0 115.465 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.91 -179.2 45.33 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.763 1.173 . . . . 0.0 113.048 169.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.5 m -88.76 156.61 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.36 1.064 . . . . 0.0 112.379 172.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.5 t -135.23 133.0 20.33 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.943 1.297 . . . . 0.0 110.196 168.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -73.28 75.47 2.87 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.835 3.023 . . . . 0.0 110.652 169.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -59.43 116.2 3.79 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.559 1.944 . . . . 0.0 113.014 -175.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.0 pp -133.88 169.98 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.808 2.043 . . . . 0.0 110.465 169.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.9 mt -74.94 35.85 0.11 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.306 1.842 . . . . 0.0 114.915 -169.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -71.78 109.43 5.65 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.798 1.639 . . . . 0.0 111.898 176.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -65.09 143.8 57.67 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 168.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.0 p -140.97 171.0 14.68 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.29 -26.52 4.27 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 128.507 2.723 . . . . 0.0 111.33 173.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -135.7 158.38 44.54 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.997 2.119 . . . . 0.0 112.346 -176.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -63.58 -27.03 68.97 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.245 0.618 . . . . 0.0 111.565 169.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.1 m -66.8 -23.09 66.01 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.816 2.046 . . . . 0.0 113.242 175.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -67.87 -20.61 65.15 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 170.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.1 m -104.02 149.13 36.9 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -168.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -82.51 167.53 15.13 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 124.014 3.143 . . . . 0.0 113.421 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 45.71 -123.14 6.2 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.971 1.748 . . . . 0.0 114.495 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.8 8.73 44.21 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.921 1.688 . . . . 0.0 113.42 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.4 m -63.3 158.22 20.86 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 123.026 1.393 . . . . 0.0 112.737 171.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.6 pt -125.57 165.97 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 128.948 2.899 . . . . 0.0 108.471 169.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.6 t -85.1 101.2 12.25 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 169.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -66.73 169.08 8.42 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.22 1.808 . . . . 0.0 111.066 -174.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.07 -17.13 69.52 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.774 1.178 . . . . 0.0 114.396 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 55.1 p30 -79.15 -8.26 58.86 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.338 1.455 . . . . 0.0 114.519 173.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.4 14.72 58.24 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 124.537 1.065 . . . . 0.0 115.425 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -128.38 165.15 21.17 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.884 1.674 . . . . 0.0 111.835 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 83.3 m -70.27 143.03 52.23 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.416 -0.802 . . . . 0.0 112.484 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.093 0 C-N-CA 124.506 1.05 . . . . 0.0 112.583 171.895 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 N--CA 1.476 0.849 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -101.92 1.3 51.74 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.319 0.961 . . . . 0.0 114.174 171.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.8 m 65.97 -57.46 0.35 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 129.126 2.97 . . . . 0.0 114.759 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -62.58 -30.88 71.65 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.985 1.314 . . . . 0.0 112.894 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.61 -4.65 88.96 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.115 1.341 . . . . 0.0 114.765 172.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 110.16 -179.73 20.54 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 126.088 1.804 . . . . 0.0 113.921 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.66 112.97 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.775 1.23 . . . . 0.0 108.896 168.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.7 t -82.55 130.63 58.0 Favored Pre-proline 0 CA--C 1.545 0.784 0 O-C-N 121.931 -0.481 . . . . 0.0 111.465 170.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.08 90.82 0.55 Allowed 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.256 2.638 . . . . 0.0 109.439 167.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -56.71 144.18 33.54 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.753 2.021 . . . . 0.0 113.499 -169.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.8 pt -141.49 159.26 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 127.54 2.336 . . . . 0.0 111.162 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -80.51 29.02 0.31 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.576 1.55 . . . . 0.0 112.789 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -74.79 102.74 4.79 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.591 -1.318 . . . . 0.0 110.83 174.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -62.68 146.49 52.07 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.411 1.084 . . . . 0.0 110.973 171.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.5 p -144.17 172.04 13.46 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -175.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -126.78 -22.31 3.9 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 127.813 2.445 . . . . 0.0 112.71 171.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -145.13 171.16 14.91 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.504 1.922 . . . . 0.0 111.115 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -69.81 -23.76 63.37 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.581 0.752 . . . . 0.0 112.441 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.7 m -64.5 -20.39 66.17 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.085 1.754 . . . . 0.0 113.074 174.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -73.13 -12.03 60.75 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.5 1.12 . . . . 0.0 113.595 173.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.8 m -117.87 159.56 42.17 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.959 1.304 . . . . 0.0 113.456 -168.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.57 167.06 26.59 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.249 2.633 . . . . 0.0 112.543 175.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -39.44 -58.6 2.05 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 127.457 2.456 . . . . 0.0 117.147 -169.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.72 -15.98 56.52 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -176.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.8 m -79.57 166.74 21.59 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 123.156 1.455 . . . . 0.0 113.274 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 22.8 pt -133.86 166.08 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 130.599 3.56 . . . . 0.0 107.352 167.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 22.3 t -83.42 101.54 11.43 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 168.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -64.84 168.49 6.21 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.119 1.768 . . . . 0.0 110.973 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.42 -17.44 68.56 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.749 1.166 . . . . 0.0 114.344 -176.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -80.03 -7.04 58.64 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.493 1.517 . . . . 0.0 114.439 172.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.84 17.43 56.46 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.65 1.119 . . . . 0.0 115.347 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -130.0 161.02 31.89 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.637 1.575 . . . . 0.0 111.886 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 74.6 m -68.42 139.65 55.78 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.584 -0.697 . . . . 0.0 112.018 175.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.919 0 C-N-CA 124.84 1.21 . . . . 0.0 112.246 174.802 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.9 m . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -106.16 -58.7 0.62 Allowed Glycine 0 N--CA 1.471 0.967 0 C-N-CA 124.38 0.991 . . . . 0.0 111.875 173.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.6 m -71.25 -24.56 62.2 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 176.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.2 t70 61.28 -27.74 0.05 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 130.096 3.358 . . . . 0.0 117.326 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -84.75 9.05 66.61 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 126.267 1.889 . . . . 0.0 115.233 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.64 -175.56 15.24 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.919 1.723 . . . . 0.0 113.917 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.7 t -68.18 104.91 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.525 1.53 . . . . 0.0 112.481 -172.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.7 t -141.99 107.76 5.83 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.822 1.249 . . . . 0.0 111.17 168.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -71.32 112.83 3.43 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.196 2.597 . . . . 0.0 110.472 170.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -77.66 84.99 4.0 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.936 1.294 . . . . 0.0 111.483 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.27 166.09 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.668 1.587 . . . . 0.0 111.778 174.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.7 mt -77.32 48.92 0.67 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.751 1.62 . . . . 0.0 113.191 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -77.6 103.68 7.68 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.798 1.639 . . . . 0.0 110.153 170.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -60.8 144.53 52.36 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.995 0.918 . . . . 0.0 111.272 175.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.2 p -143.79 171.87 13.61 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.68 -28.65 4.15 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 128.552 2.741 . . . . 0.0 111.715 173.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -148.09 161.75 40.79 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 127.003 2.121 . . . . 0.0 111.298 -175.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -65.37 -22.75 66.84 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.326 -0.859 . . . . 0.0 112.576 -177.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.8 m -66.2 -17.79 64.95 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.709 1.603 . . . . 0.0 113.324 175.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -74.89 -10.26 59.33 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.069 1.348 . . . . 0.0 113.519 174.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.5 m -119.54 153.25 53.98 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 124.466 1.107 . . . . 0.0 113.471 -168.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -57.49 170.63 1.7 Allowed 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.827 3.685 . . . . 0.0 116.249 174.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -30.12 -72.25 0.06 OUTLIER Glycine 0 CA--C 1.537 1.467 0 C-N-CA 128.889 3.138 . . . . 0.0 117.668 -172.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.46 -0.5 57.27 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.59 1.156 . . . . 0.0 114.094 -176.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 54.7 m -75.76 169.21 18.58 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.628 1.204 . . . . 0.0 112.559 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.7 pt -135.12 163.49 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 128.657 2.783 . . . . 0.0 108.756 168.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 42.0 t -93.14 103.93 16.16 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 168.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -79.94 170.31 16.66 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.689 1.596 . . . . 0.0 112.007 -169.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.66 -15.86 71.42 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.778 1.18 . . . . 0.0 114.343 -173.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.8 p-10 -74.86 -10.95 59.98 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.244 1.418 . . . . 0.0 114.148 171.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.42 15.95 54.09 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.967 1.27 . . . . 0.0 114.978 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -132.33 160.41 36.36 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.328 1.451 . . . . 0.0 112.243 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 83.8 m -68.03 160.64 28.39 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.904 0.882 . . . . 0.0 112.663 173.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.053 0 C-N-CA 124.788 1.185 . . . . 0.0 113.529 168.662 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.4 t . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -104.18 2.97 43.86 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.677 1.132 . . . . 0.0 113.45 172.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m 57.87 16.44 3.63 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.988 2.115 . . . . 0.0 114.989 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -66.43 -28.02 68.28 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.178 1.391 . . . . 0.0 114.505 -170.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -157.74 18.28 0.35 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.697 1.141 . . . . 0.0 115.131 -177.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.0 -158.93 29.57 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.284 1.421 . . . . 0.0 112.408 -172.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.9 t -112.36 117.56 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.53 1.532 . . . . 0.0 109.479 171.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.7 t -79.9 132.57 60.27 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.873 -0.584 . . . . 0.0 110.279 169.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.75 8.22 0.82 Allowed 'Trans proline' 0 CA--C 1.552 1.392 0 C-N-CA 124.501 3.467 . . . . 0.0 115.895 174.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt 54.56 70.16 0.65 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 127.553 2.341 . . . . 0.0 113.729 174.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 47.9 pt -78.25 150.87 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.867 1.267 . . . . 0.0 111.085 175.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.2 mt -79.56 27.05 0.28 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.877 1.671 . . . . 0.0 113.489 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -69.02 115.15 7.98 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.035 1.334 . . . . 0.0 110.474 173.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -65.31 145.7 55.87 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.141 0.976 . . . . 0.0 110.368 171.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.1 p -148.99 171.76 15.84 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -133.83 -14.45 2.44 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.761 2.424 . . . . 0.0 112.842 169.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -131.99 152.22 51.27 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 127.758 2.423 . . . . 0.0 109.94 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -65.33 -24.07 67.17 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.411 -0.806 . . . . 0.0 111.967 169.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.4 m -67.93 -20.68 65.1 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.321 1.849 . . . . 0.0 113.165 175.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -69.12 -22.29 63.97 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.768 0.827 . . . . 0.0 113.031 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 85.9 m -103.32 155.41 36.79 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.737 1.215 . . . . 0.0 113.641 -169.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.21 159.75 43.47 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.144 2.563 . . . . 0.0 112.699 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 0.35 -84.52 0.0 OUTLIER Glycine 0 CA--C 1.537 1.467 0 C-N-CA 129.926 3.631 . . . . 0.0 118.026 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.87 -7.81 55.44 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -172.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.6 m -71.99 161.94 30.19 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 123.155 1.455 . . . . 0.0 112.77 169.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.7 pt -128.21 165.43 27.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 129.707 3.203 . . . . 0.0 107.908 168.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.2 t -85.51 103.0 13.98 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 169.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -67.42 169.62 8.74 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.952 1.701 . . . . 0.0 110.946 -176.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.47 -16.05 71.19 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.714 1.15 . . . . 0.0 114.588 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -83.7 -4.52 58.68 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.569 1.548 . . . . 0.0 114.48 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.42 23.41 43.73 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-N 119.09 0.859 . . . . 0.0 114.797 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -132.87 160.79 35.94 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.831 1.653 . . . . 0.0 111.577 176.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.1 m -69.06 146.29 52.76 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.665 -0.647 . . . . 0.0 112.058 173.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.985 0 C-N-CA 124.629 1.109 . . . . 0.0 111.777 173.287 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 89.4 p . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.25 19.77 68.6 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.317 1.437 . . . . 0.0 114.581 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.4 m 65.22 -15.65 0.1 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 128.572 2.749 . . . . 0.0 115.648 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -70.18 -18.52 63.2 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.884 1.674 . . . . 0.0 113.585 174.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.43 21.95 74.09 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.277 0.941 . . . . 0.0 114.457 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.73 171.57 11.26 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.938 1.256 . . . . 0.0 113.944 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t -71.89 84.77 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.686 1.194 . . . . 0.0 111.856 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.3 t -120.05 120.79 29.99 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 124.954 1.302 . . . . 0.0 109.611 168.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.22 93.1 0.4 Allowed 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.077 2.518 . . . . 0.0 109.439 169.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.8 mtmt -52.19 124.82 14.03 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.76 2.024 . . . . 0.0 113.42 -169.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pp -137.43 170.1 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 127.506 2.323 . . . . 0.0 111.548 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.1 mp -111.97 35.36 3.75 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.927 1.691 . . . . 0.0 111.673 178.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -64.56 123.93 20.53 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.166 0.986 . . . . 0.0 110.724 170.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -67.34 147.02 53.49 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 166.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.6 p -143.79 169.86 16.98 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -134.15 -12.37 2.49 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.804 2.041 . . . . 0.0 113.051 170.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -145.58 160.72 41.23 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.222 2.209 . . . . 0.0 110.134 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -69.89 -23.07 63.19 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.175 -0.953 . . . . 0.0 112.898 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 70.4 m -69.85 -13.66 62.37 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.951 1.3 . . . . 0.0 113.362 176.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -70.69 -13.64 62.15 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.428 1.091 . . . . 0.0 113.21 172.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.7 m -114.87 147.31 37.97 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 125.01 1.324 . . . . 0.0 113.785 -168.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -81.68 163.31 18.8 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.519 2.812 . . . . 0.0 113.402 -177.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 43.08 -117.27 1.51 Allowed Glycine 0 CA--C 1.535 1.339 0 C-N-CA 126.475 1.988 . . . . 0.0 114.568 176.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.29 -0.87 54.73 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.903 1.681 . . . . 0.0 114.156 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.3 m -61.99 161.47 10.64 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 122.713 1.244 . . . . 0.0 113.11 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.1 pt -126.76 167.01 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 128.001 2.52 . . . . 0.0 109.51 172.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.0 t -85.08 103.93 14.53 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 168.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -69.79 170.59 10.72 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.517 1.927 . . . . 0.0 110.92 -174.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.26 -16.56 73.38 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.615 1.102 . . . . 0.0 114.661 -173.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -85.01 -3.22 58.7 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.391 1.477 . . . . 0.0 114.415 175.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.76 21.53 50.21 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.202 0.906 . . . . 0.0 114.957 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -131.56 162.65 29.82 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.944 1.697 . . . . 0.0 111.583 175.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 96.2 m -69.73 151.31 45.97 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.435 -0.791 . . . . 0.0 112.962 174.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.013 0 C-N-CA 124.085 0.85 . . . . 0.0 112.869 171.518 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.476 0.833 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.66 -12.05 17.67 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.324 0.964 . . . . 0.0 114.448 170.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.0 t -149.65 154.81 39.2 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.718 1.607 . . . . 0.0 111.478 173.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -82.19 -8.28 59.64 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.287 1.435 . . . . 0.0 112.815 169.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.99 2.65 33.12 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.988 1.756 . . . . 0.0 116.502 -173.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -172.11 -176.32 40.87 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.452 1.501 . . . . 0.0 113.118 177.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.4 m -75.64 138.19 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.681 1.192 . . . . 0.0 112.66 -177.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.7 t -151.28 112.64 3.04 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 125.292 1.437 . . . . 0.0 110.081 167.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -80.05 -0.11 10.43 Favored 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.645 2.897 . . . . 0.0 115.218 -173.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 48.21 49.21 17.92 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 127.026 2.13 . . . . 0.0 113.78 -177.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.8 pt -78.88 161.19 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.388 1.475 . . . . 0.0 112.127 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.1 mt -77.75 15.98 0.76 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.647 1.979 . . . . 0.0 113.791 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -63.61 113.07 3.1 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.118 1.367 . . . . 0.0 110.762 172.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -68.97 151.25 46.76 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.686 0.794 . . . . 0.0 111.269 172.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.3 p -145.22 176.51 9.49 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.7 mmt-85 -133.37 -18.13 2.26 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 127.595 2.358 . . . . 0.0 113.242 169.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -146.13 163.81 34.17 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.885 1.674 . . . . 0.0 111.883 176.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -65.46 -22.48 66.75 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.322 -0.861 . . . . 0.0 112.539 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.9 m -68.18 -16.03 63.82 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.03 1.332 . . . . 0.0 113.284 176.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -74.33 -10.07 59.22 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.854 1.261 . . . . 0.0 113.539 173.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.2 m -123.88 150.92 63.79 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 125.091 1.357 . . . . 0.0 112.584 -169.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -79.27 166.97 22.05 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.432 2.754 . . . . 0.0 113.969 -175.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 32.81 -103.9 0.01 OUTLIER Glycine 0 CA--C 1.537 1.455 0 C-N-CA 128.62 3.01 . . . . 0.0 116.701 172.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -104.6 9.05 35.44 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.714 2.006 . . . . 0.0 113.716 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.4 m -67.52 164.51 18.78 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 122.618 1.199 . . . . 0.0 111.523 169.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.1 pt -130.54 164.4 33.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 128.65 2.78 . . . . 0.0 108.879 169.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 42.2 t -93.74 106.85 18.79 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 168.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -82.15 172.88 12.68 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.21 1.404 . . . . 0.0 111.459 -169.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.87 -17.34 71.34 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.672 1.129 . . . . 0.0 114.403 -170.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -77.79 -6.71 55.0 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.139 1.776 . . . . 0.0 114.183 171.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.73 33.09 43.45 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.147 -0.971 . . . . 0.0 113.938 -177.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -136.09 158.46 44.36 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.137 1.775 . . . . 0.0 111.531 175.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 80.0 m -69.06 158.2 35.29 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.729 0.776 . . . . 0.0 112.909 173.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.178 0 C-N-CA 125.277 1.418 . . . . 0.0 113.476 168.686 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.6 m . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.06 -7.28 0.19 Allowed Glycine 0 CA--C 1.536 1.367 0 N-CA-C 116.549 1.379 . . . . 0.0 116.549 173.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.5 t -146.73 152.58 39.05 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.238 1.519 . . . . 0.0 111.888 175.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -82.5 -8.85 59.61 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.64 1.576 . . . . 0.0 113.049 171.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.22 0.52 39.42 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.762 1.648 . . . . 0.0 116.413 -173.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -178.19 -175.44 45.32 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.485 1.517 . . . . 0.0 113.222 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.2 p -76.86 150.58 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.757 1.223 . . . . 0.0 111.652 173.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.6 t -135.5 106.46 10.03 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 125.294 1.438 . . . . 0.0 110.66 168.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -73.8 119.54 5.94 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.868 2.379 . . . . 0.0 109.416 168.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -79.18 67.89 5.02 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.191 1.396 . . . . 0.0 111.536 -174.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.8 pt -78.59 146.0 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 126.093 1.757 . . . . 0.0 111.52 -177.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 pp -75.76 22.57 0.14 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.968 1.707 . . . . 0.0 114.253 173.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -66.86 110.63 3.38 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.819 1.248 . . . . 0.0 109.392 168.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.92 142.83 58.15 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.454 0.701 . . . . 0.0 110.219 171.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.3 p -138.77 174.01 10.97 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 -135.76 -17.23 1.7 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.041 2.136 . . . . 0.0 112.871 173.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -142.82 161.56 37.79 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.65 1.98 . . . . 0.0 110.607 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -69.87 -23.75 63.31 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.299 -0.876 . . . . 0.0 112.953 -178.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.7 m -70.84 -12.75 61.73 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.821 1.248 . . . . 0.0 113.434 175.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -70.88 -15.99 62.66 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.749 0.82 . . . . 0.0 113.082 171.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.2 m -115.58 150.32 44.5 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.737 1.215 . . . . 0.0 113.556 -168.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.96 166.52 21.01 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.67 2.913 . . . . 0.0 113.976 -174.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 40.05 -113.91 0.42 Allowed Glycine 0 CA--C 1.536 1.4 0 C-N-CA 127.313 2.387 . . . . 0.0 115.535 172.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.42 9.6 42.4 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.238 1.815 . . . . 0.0 113.743 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 61.3 m -68.26 168.5 12.26 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.553 1.168 . . . . 0.0 112.394 171.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.5 pt -136.07 169.65 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 129.088 2.955 . . . . 0.0 109.004 169.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.4 t -84.8 103.26 13.73 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 167.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -67.75 168.63 11.03 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.902 1.681 . . . . 0.0 111.176 -176.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.03 -16.61 70.87 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.859 1.219 . . . . 0.0 114.367 -175.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -77.69 -9.36 58.94 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.978 1.311 . . . . 0.0 114.208 172.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.69 14.46 56.7 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.779 1.18 . . . . 0.0 115.359 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -131.09 169.04 16.41 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.672 1.589 . . . . 0.0 111.747 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.6 m -70.2 150.47 46.43 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.123 -0.985 . . . . 0.0 113.579 177.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.243 0 C-N-CA 125.372 1.463 . . . . 0.0 112.299 174.382 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 53.0 m . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.88 -1.03 34.16 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.547 1.07 . . . . 0.0 114.77 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.9 p -143.15 160.14 40.97 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.669 1.588 . . . . 0.0 112.496 175.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -67.31 105.96 1.92 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.193 1.397 . . . . 0.0 112.243 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.33 15.11 80.33 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 124.105 0.86 . . . . 0.0 115.104 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.48 164.35 25.51 Favored Glycine 0 CA--C 1.537 1.458 0 CA-C-N 118.504 1.152 . . . . 0.0 114.081 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.5 m -73.68 74.38 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.814 1.646 . . . . 0.0 112.672 174.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.5 t -125.34 113.5 25.82 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 125.603 1.561 . . . . 0.0 111.166 175.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -57.9 -12.71 12.83 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 124.964 3.776 . . . . 0.0 117.579 175.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 47.38 47.71 16.84 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 126.875 2.07 . . . . 0.0 113.774 -173.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.4 pt -78.96 148.04 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.263 1.425 . . . . 0.0 111.052 176.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.24 35.03 0.14 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.33 1.852 . . . . 0.0 113.084 176.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -70.94 113.5 8.05 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.66 1.584 . . . . 0.0 109.82 169.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.49 143.6 57.69 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.604 0.762 . . . . 0.0 110.361 171.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.0 p -145.03 171.55 14.32 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -134.21 -13.93 2.36 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 127.542 2.337 . . . . 0.0 112.931 169.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -132.93 152.44 51.91 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.666 2.386 . . . . 0.0 110.093 -176.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -66.62 -25.25 66.5 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.212 -0.93 . . . . 0.0 112.263 171.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 56.7 p -72.07 -14.55 61.89 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.833 1.653 . . . . 0.0 113.988 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -68.31 -19.47 64.68 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.235 -0.916 . . . . 0.0 112.77 169.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.3 m -109.86 149.72 40.37 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 124.889 1.275 . . . . 0.0 113.275 -169.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.33 166.34 20.35 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.609 2.873 . . . . 0.0 113.899 -175.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 38.34 -110.06 0.12 Allowed Glycine 0 CA--C 1.538 1.512 0 C-N-CA 127.591 2.52 . . . . 0.0 115.848 172.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.48 7.27 42.52 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.17 1.788 . . . . 0.0 113.747 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 61.8 m -67.59 165.54 16.75 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 122.604 1.192 . . . . 0.0 111.929 171.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.6 pt -133.79 167.48 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 129.227 3.011 . . . . 0.0 108.653 169.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.9 t -85.9 103.28 14.48 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 168.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -67.03 169.38 8.45 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.721 1.608 . . . . 0.0 111.049 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.94 -16.61 70.69 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.757 1.17 . . . . 0.0 114.522 -174.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -81.05 -6.77 59.2 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.337 1.455 . . . . 0.0 114.393 173.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.59 20.38 48.12 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.485 1.041 . . . . 0.0 115.028 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -132.31 163.71 28.05 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.723 1.609 . . . . 0.0 111.687 177.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.5 m -70.21 148.32 48.76 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.307 -0.871 . . . . 0.0 112.916 176.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.156 0 C-N-CA 125.164 1.364 . . . . 0.0 112.462 174.255 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.2 m . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 112.656 0.614 . . . . 0.0 112.656 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -96.8 161.27 21.88 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 123.78 0.705 . . . . 0.0 112.733 173.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.5 p -61.33 -57.28 12.96 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.959 1.304 . . . . 0.0 112.45 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -74.5 -23.17 58.8 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.109 1.364 . . . . 0.0 112.868 171.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.51 -48.65 42.69 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.21 1.386 . . . . 0.0 114.059 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 111.36 -174.58 16.87 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.247 1.403 . . . . 0.0 113.833 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.6 t -66.38 101.32 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.535 1.134 . . . . 0.0 110.182 172.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.6 t -86.7 130.65 48.09 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-O 119.076 -0.488 . . . . 0.0 110.567 169.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.8 92.83 0.31 Allowed 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 123.15 2.567 . . . . 0.0 109.168 167.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -54.28 137.03 42.33 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 127.229 2.211 . . . . 0.0 113.811 -168.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.0 pt -138.99 149.19 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 127.38 2.272 . . . . 0.0 110.507 174.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.26 42.77 0.76 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.049 1.34 . . . . 0.0 111.636 177.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -80.09 115.46 19.67 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.47 1.508 . . . . 0.0 110.286 174.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.85 146.68 53.52 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.96 0.904 . . . . 0.0 110.686 172.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.0 p -145.1 165.49 28.1 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 176.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -122.66 -17.14 7.0 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 127.509 2.324 . . . . 0.0 112.729 170.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -148.31 162.5 39.4 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 128.45 2.7 . . . . 0.0 110.016 -175.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -69.3 -23.22 63.78 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.146 -0.971 . . . . 0.0 112.953 -178.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.5 m -67.79 -17.3 64.48 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.555 1.542 . . . . 0.0 113.234 177.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -75.12 -10.75 59.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.17 1.388 . . . . 0.0 113.443 174.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 73.9 m -113.56 163.1 19.39 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -168.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.92 165.36 3.87 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.984 3.122 . . . . 0.0 114.096 169.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.43 -56.93 8.76 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 126.058 1.789 . . . . 0.0 115.942 -174.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.32 -14.54 55.18 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.6 m -74.53 166.6 23.26 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 123.051 1.405 . . . . 0.0 112.904 171.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 pt -132.78 167.68 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 129.139 2.976 . . . . 0.0 107.671 166.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.0 t -82.44 101.83 10.91 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.423 -0.798 . . . . 0.0 109.778 169.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.87 167.81 12.85 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.228 1.811 . . . . 0.0 111.567 -178.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.01 -15.18 76.29 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.911 1.244 . . . . 0.0 114.631 -173.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -77.37 -8.25 57.38 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.45 1.5 . . . . 0.0 114.166 173.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.23 13.86 59.68 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.737 1.16 . . . . 0.0 114.996 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -129.28 168.1 16.72 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.432 1.893 . . . . 0.0 111.064 177.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 82.4 m -74.03 153.84 39.5 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.262 -0.899 . . . . 0.0 113.242 176.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.124 0 C-N-CA 124.329 0.966 . . . . 0.0 113.451 171.283 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 63.1 m . . . . . 0 N--CA 1.477 0.894 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -98.63 -15.38 34.62 Favored Glycine 0 CA--C 1.535 1.34 0 N-CA-C 115.979 1.151 . . . . 0.0 115.979 -173.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.0 p -154.46 170.35 21.62 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.037 1.418 . . . . 0.0 113.29 175.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -80.18 -3.15 47.85 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.4 1.48 . . . . 0.0 113.426 170.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.47 2.66 57.2 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 125.711 1.624 . . . . 0.0 115.907 -175.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.11 -161.68 25.68 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 126.088 1.804 . . . . 0.0 112.16 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.7 p -125.86 151.85 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.071 1.349 . . . . 0.0 111.779 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.3 t -136.47 136.8 22.64 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 123.978 0.911 . . . . 0.0 109.555 166.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.2 -1.62 8.33 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 123.983 3.122 . . . . 0.0 115.371 172.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt 47.3 63.21 2.06 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 127.713 2.405 . . . . 0.0 113.138 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.6 pt -78.0 155.76 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.448 1.499 . . . . 0.0 111.577 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -79.69 16.54 1.08 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.228 1.811 . . . . 0.0 113.164 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.54 112.36 2.76 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.098 1.359 . . . . 0.0 110.571 169.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -65.91 143.23 57.55 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 169.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.0 p -136.45 173.49 11.65 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -175.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -136.64 -17.6 1.47 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.453 1.901 . . . . 0.0 112.577 169.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.61 155.4 39.17 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 127.846 2.458 . . . . 0.0 109.887 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -67.97 -25.76 65.6 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.223 -0.923 . . . . 0.0 112.223 169.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 77.4 p -71.33 -14.54 62.23 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.59 1.556 . . . . 0.0 114.022 175.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -65.55 -22.27 66.68 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.403 -0.81 . . . . 0.0 112.585 169.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.8 m -106.39 150.07 39.05 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -167.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -82.2 165.45 16.85 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.765 2.976 . . . . 0.0 113.523 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 44.1 -118.72 2.46 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.601 2.048 . . . . 0.0 114.877 173.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.64 7.05 47.15 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.1 1.76 . . . . 0.0 113.761 -178.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.4 m -66.03 160.04 24.61 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 123.077 1.417 . . . . 0.0 113.438 171.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.1 pt -127.55 167.3 22.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 129.505 3.122 . . . . 0.0 108.138 168.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.8 t -84.54 103.02 13.31 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 168.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -68.47 168.95 11.72 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.943 1.697 . . . . 0.0 111.073 -175.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.47 -16.41 69.46 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.659 1.123 . . . . 0.0 114.515 -176.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.8 p30 -78.77 -7.62 57.97 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.517 1.527 . . . . 0.0 114.419 173.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.33 14.54 60.07 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.649 1.119 . . . . 0.0 115.421 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -128.6 166.52 18.71 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.277 1.831 . . . . 0.0 111.866 177.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.6 m -69.38 143.1 53.79 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.476 -0.765 . . . . 0.0 112.672 174.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.167 0 C-N-CA 124.478 1.037 . . . . 0.0 112.615 171.237 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -116.65 -61.25 0.32 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.397 1.475 . . . . 0.0 113.064 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.5 m -72.57 101.53 3.03 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.172 1.389 . . . . 0.0 112.47 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -58.23 -22.07 50.62 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.526 1.53 . . . . 0.0 114.699 -176.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.54 -0.91 74.77 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 125.301 1.429 . . . . 0.0 115.445 175.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.54 -165.54 10.3 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 126.031 1.776 . . . . 0.0 113.566 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.1 p -132.33 152.39 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.52 1.528 . . . . 0.0 111.61 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.3 t -133.5 136.29 26.69 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.457 1.103 . . . . 0.0 110.664 169.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -55.83 -11.93 6.06 Favored 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 124.991 3.794 . . . . 0.0 117.044 169.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt 48.92 60.19 3.9 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 127.446 2.299 . . . . 0.0 113.195 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 36.6 pt -78.28 157.35 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 125.798 1.639 . . . . 0.0 111.688 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.0 mt -79.58 19.55 0.63 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.219 1.808 . . . . 0.0 113.712 178.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -63.83 115.58 4.96 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.179 1.392 . . . . 0.0 110.806 173.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -67.57 146.02 54.31 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.108 0.563 . . . . 0.0 110.147 169.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.9 p -139.37 172.96 12.06 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.36 -28.22 3.68 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 128.192 2.597 . . . . 0.0 111.564 174.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -148.14 164.41 33.97 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.698 1.999 . . . . 0.0 111.433 -175.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -66.92 -23.96 66.03 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.45 -0.781 . . . . 0.0 112.78 -176.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -66.7 -18.54 65.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.217 1.407 . . . . 0.0 112.825 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -71.55 -17.2 62.32 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.998 1.319 . . . . 0.0 113.219 175.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.6 m -111.31 148.67 39.25 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -167.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -81.93 163.19 18.25 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.744 2.963 . . . . 0.0 113.531 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 44.18 -119.69 2.96 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 126.332 1.92 . . . . 0.0 114.84 173.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.83 -0.86 57.81 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.694 1.598 . . . . 0.0 114.226 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.1 m -64.41 156.54 29.02 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 123.105 1.431 . . . . 0.0 113.105 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.0 pt -124.56 164.8 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 129.258 3.023 . . . . 0.0 108.562 170.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.1 t -84.41 102.84 13.07 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 168.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -67.22 169.55 8.5 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.94 1.696 . . . . 0.0 110.915 -176.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.56 -17.22 70.61 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.748 1.166 . . . . 0.0 114.605 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 56.9 p30 -81.86 -4.01 55.48 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.754 1.622 . . . . 0.0 114.375 173.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.84 29.81 45.83 Favored Glycine 0 CA--C 1.535 1.335 0 O-C-N 121.206 -0.934 . . . . 0.0 114.456 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -132.97 160.67 36.44 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.517 1.927 . . . . 0.0 111.267 172.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 77.7 m -69.0 144.55 54.07 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.817 -0.552 . . . . 0.0 112.232 172.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.04 0 C-N-CA 124.612 1.101 . . . . 0.0 111.81 172.883 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.2 m . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -94.11 -14.91 50.28 Favored Glycine 0 CA--C 1.539 1.57 0 C-N-CA 123.863 0.744 . . . . 0.0 112.45 168.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.9 t -140.12 106.45 5.27 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 127.345 2.258 . . . . 0.0 108.975 169.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -61.63 -23.46 66.05 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.735 1.214 . . . . 0.0 114.166 -173.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.72 -3.66 85.83 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.067 1.318 . . . . 0.0 115.0 175.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.78 176.87 25.25 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.522 1.534 . . . . 0.0 114.405 -177.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.1 t -75.57 93.07 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.325 1.45 . . . . 0.0 111.389 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.1 t -135.03 104.12 10.6 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.539 1.136 . . . . 0.0 111.275 169.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -57.66 -18.41 33.01 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 124.688 3.592 . . . . 0.0 117.335 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt 47.04 77.22 0.09 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 127.233 2.213 . . . . 0.0 113.596 -176.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.36 169.27 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 126.054 1.742 . . . . 0.0 112.418 -177.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.0 mt -72.55 25.87 0.05 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.468 1.907 . . . . 0.0 114.612 -178.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -69.74 101.43 1.69 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.97 1.308 . . . . 0.0 110.402 170.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -64.45 145.26 56.37 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.235 1.014 . . . . 0.0 110.322 169.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.6 p -145.66 169.74 17.85 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.416 1.086 . . . . 0.0 113.732 -176.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -123.16 -25.26 4.53 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.53 2.332 . . . . 0.0 111.918 169.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -130.99 160.6 34.09 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.753 2.021 . . . . 0.0 110.879 -176.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -67.21 -25.51 66.15 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.438 -0.789 . . . . 0.0 112.492 173.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 56.3 p -70.7 -15.59 62.72 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.848 1.659 . . . . 0.0 113.972 175.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -68.86 -19.23 64.23 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.811 0.844 . . . . 0.0 112.937 169.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.8 m -108.25 159.86 29.13 Favored Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -168.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -57.65 167.11 4.21 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 124.509 3.473 . . . . 0.0 115.541 173.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -26.51 -72.66 0.03 OUTLIER Glycine 0 CA--C 1.536 1.344 0 C-N-CA 129.081 3.229 . . . . 0.0 117.588 -172.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.42 3.02 53.12 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.013 1.325 . . . . 0.0 113.92 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.6 m -73.14 167.06 21.93 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 122.723 1.249 . . . . 0.0 111.613 169.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.2 pt -135.16 164.64 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 129.095 2.958 . . . . 0.0 108.323 169.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.3 t -84.18 101.71 12.06 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 168.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -65.17 171.24 3.85 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.374 1.87 . . . . 0.0 111.149 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.49 -18.36 69.7 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.723 1.154 . . . . 0.0 114.451 -174.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -81.47 -6.87 59.39 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.155 1.382 . . . . 0.0 114.393 173.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.23 20.14 50.25 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 124.53 1.062 . . . . 0.0 115.266 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -130.87 161.47 31.77 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.68 1.592 . . . . 0.0 111.766 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.2 m -71.15 139.29 50.18 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.453 -0.779 . . . . 0.0 112.713 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.121 0 C-N-CA 124.499 1.047 . . . . 0.0 113.162 174.547 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -118.6 27.48 7.2 Favored Glycine 0 N--CA 1.473 1.104 0 C-N-CA 125.414 1.483 . . . . 0.0 114.716 -175.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.6 m 51.51 -88.15 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 127.856 2.462 . . . . 0.0 114.037 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -64.27 -19.59 65.5 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 119.626 1.103 . . . . 0.0 113.578 171.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.9 -9.86 86.42 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.024 1.297 . . . . 0.0 114.37 169.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.88 170.87 24.34 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 126.795 2.14 . . . . 0.0 114.402 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.6 t -76.4 110.61 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.998 1.319 . . . . 0.0 108.95 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.2 t -88.17 128.74 52.41 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 119.062 -0.494 . . . . 0.0 111.33 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -65.61 97.29 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.958 2.438 . . . . 0.0 109.169 167.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -54.37 142.07 28.12 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.228 2.211 . . . . 0.0 113.956 -168.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.3 pt -138.95 157.97 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 127.439 2.296 . . . . 0.0 110.843 176.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 90.4 mt -85.79 22.86 1.55 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.178 1.391 . . . . 0.0 113.267 178.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -68.21 109.71 3.7 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.076 1.35 . . . . 0.0 111.314 175.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -63.49 146.15 54.21 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.281 1.033 . . . . 0.0 109.73 169.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.3 p -142.09 168.54 19.51 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 38.4 mtm180 -124.19 -21.45 5.01 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 128.494 2.717 . . . . 0.0 112.428 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -154.88 163.42 40.31 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 128.81 2.844 . . . . 0.0 109.965 -174.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -67.74 -24.96 65.41 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.276 -0.89 . . . . 0.0 112.65 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.5 m -71.59 -13.91 61.92 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.729 1.212 . . . . 0.0 113.48 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -72.32 -18.64 61.75 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.832 1.253 . . . . 0.0 112.376 171.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 76.2 m -104.93 159.78 28.18 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.092 1.357 . . . . 0.0 113.724 -169.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.08 166.62 27.39 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.191 2.594 . . . . 0.0 112.659 175.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -34.14 -63.09 0.44 Allowed Glycine 0 CA--C 1.537 1.446 0 C-N-CA 127.967 2.699 . . . . 0.0 117.449 -169.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.35 -12.03 57.0 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.5 m -78.41 164.69 24.57 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 123.14 1.447 . . . . 0.0 113.204 173.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.5 pt -130.0 163.87 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 129.706 3.202 . . . . 0.0 107.72 167.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 39.7 t -89.37 102.93 15.6 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 121.612 -0.68 . . . . 0.0 109.856 171.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -82.0 173.45 12.18 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.681 1.192 . . . . 0.0 111.828 -169.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.57 -16.11 71.46 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.771 1.177 . . . . 0.0 114.32 -170.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 39.4 p-10 -77.06 -9.06 58.47 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.32 1.448 . . . . 0.0 114.273 172.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.73 16.96 57.56 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.687 1.137 . . . . 0.0 115.082 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -131.34 162.79 29.29 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.449 1.499 . . . . 0.0 112.029 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.3 m -69.89 144.85 52.36 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.717 0.807 . . . . 0.0 112.223 172.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.134 0 C-N-CA 124.416 1.008 . . . . 0.0 113.386 174.023 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -153.67 -167.15 15.55 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.583 1.087 . . . . 0.0 114.47 -171.272 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.0 m -67.35 -4.34 10.64 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.533 1.933 . . . . 0.0 115.72 -175.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.58 158.92 11.46 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.148 1.379 . . . . 0.0 112.843 174.142 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.38 -17.33 77.59 Favored Glycine 0 CA--C 1.54 1.651 0 O-C-N 121.112 -0.993 . . . . 0.0 115.256 179.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.28 -173.78 49.87 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.631 1.586 . . . . 0.0 114.086 175.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.2 t -122.22 117.39 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.041 1.736 . . . . 0.0 108.971 174.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.7 t -79.45 133.41 59.89 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.918 172.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.41 3.75 2.43 Favored 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 124.327 3.352 . . . . 0.0 115.466 170.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt 55.22 70.88 0.58 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 127.511 2.324 . . . . 0.0 113.44 171.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.5 pt -78.51 149.06 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.761 1.225 . . . . 0.0 111.134 175.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.2 mt -79.78 38.37 0.39 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.591 1.556 . . . . 0.0 112.912 177.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -79.53 112.22 16.57 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.06 1.344 . . . . 0.0 109.977 172.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -66.04 143.7 57.18 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.357 0.663 . . . . 0.0 110.567 171.176 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.9 p -149.12 170.23 18.88 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.732 1.213 . . . . 0.0 113.924 -172.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -136.26 -8.89 1.99 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.991 2.116 . . . . 0.0 112.836 169.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -132.41 151.42 51.88 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 127.687 2.395 . . . . 0.0 109.813 -179.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -66.99 -24.18 66.01 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.362 -0.836 . . . . 0.0 112.219 171.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.7 p -72.29 -16.34 61.9 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.765 1.626 . . . . 0.0 114.004 174.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -65.93 -28.25 68.78 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.099 0.863 . . . . 0.0 112.383 169.119 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.5 m -96.0 161.23 28.0 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.352 1.461 . . . . 0.0 113.295 -170.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -68.2 162.57 39.7 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.95 2.433 . . . . 0.0 112.136 173.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -36.79 -58.65 1.15 Allowed Glycine 0 N--CA 1.475 1.28 0 C-N-CA 127.607 2.527 . . . . 0.0 117.283 -169.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.21 -17.18 53.05 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -175.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.9 m -77.16 168.75 19.53 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 123.046 1.403 . . . . 0.0 113.864 171.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.8 pt -132.35 166.16 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 130.472 3.509 . . . . 0.0 107.806 168.294 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.8 t -86.26 103.92 15.32 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.557 -0.715 . . . . 0.0 109.151 169.022 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -67.77 170.57 7.73 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.194 1.798 . . . . 0.0 111.029 -175.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.58 -16.15 71.55 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.733 1.158 . . . . 0.0 114.604 -173.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -83.54 -3.11 57.36 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.45 1.5 . . . . 0.0 114.341 174.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.95 21.93 56.35 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.154 0.883 . . . . 0.0 114.603 -179.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -131.84 159.99 36.95 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.898 1.679 . . . . 0.0 111.581 175.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.9 m -68.63 147.27 52.14 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.638 -0.664 . . . . 0.0 112.166 176.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.864 0 C-N-CA 124.776 1.179 . . . . 0.0 111.449 173.814 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.6 m . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.11 178.8 17.91 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.65 1.119 . . . . 0.0 115.154 -177.029 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.8 m -66.4 -4.47 8.24 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.873 2.069 . . . . 0.0 115.847 -173.103 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -60.91 -21.0 62.93 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.476 1.51 . . . . 0.0 113.889 175.23 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.54 -5.53 60.45 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.641 1.591 . . . . 0.0 114.954 174.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.9 -178.71 47.25 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 124.771 1.177 . . . . 0.0 113.264 170.119 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 p -124.04 122.8 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.52 1.528 . . . . 0.0 110.103 169.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.9 t -90.49 119.28 69.12 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 123.541 0.736 . . . . 0.0 111.916 178.289 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -69.28 93.96 0.48 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.211 2.607 . . . . 0.0 109.949 168.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -57.69 151.3 17.66 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.11 1.764 . . . . 0.0 114.228 -171.424 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.22 162.2 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 128.369 2.667 . . . . 0.0 110.016 171.603 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.4 mt -78.75 28.37 0.21 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.138 1.375 . . . . 0.0 113.791 -178.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -70.52 103.91 2.62 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.851 -1.155 . . . . 0.0 110.776 173.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -67.96 142.06 56.1 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 167.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 p -141.1 171.03 14.63 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -171.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -133.39 -15.2 2.51 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.686 2.394 . . . . 0.0 112.662 174.065 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -135.06 153.62 51.98 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.329 2.252 . . . . 0.0 110.152 -176.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -66.4 -23.23 66.28 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.475 -0.765 . . . . 0.0 111.793 168.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.0 m -68.62 -20.46 64.49 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.779 2.032 . . . . 0.0 113.427 175.604 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -67.53 -29.95 69.49 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.681 0.792 . . . . 0.0 112.425 172.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.9 m -96.03 159.46 32.19 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.228 1.411 . . . . 0.0 113.702 -169.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.74 167.1 26.7 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.29 2.66 . . . . 0.0 112.712 175.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -34.85 -62.25 0.56 Allowed Glycine 0 CA--C 1.536 1.354 0 C-N-CA 128.067 2.746 . . . . 0.0 117.489 -169.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.05 -13.88 58.96 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -175.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.3 m -81.17 167.55 19.53 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 123.268 1.508 . . . . 0.0 113.722 173.735 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.5 pt -133.18 166.54 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 131.19 3.796 . . . . 0.0 107.234 167.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.4 t -84.91 102.75 13.38 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.408 -0.807 . . . . 0.0 108.986 169.042 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -66.82 168.0 10.43 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.93 1.692 . . . . 0.0 111.194 -174.618 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.2 -17.72 68.43 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.79 1.186 . . . . 0.0 114.325 -178.283 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -77.88 -7.73 57.11 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.499 1.519 . . . . 0.0 114.331 172.153 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.17 13.99 61.13 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.64 1.114 . . . . 0.0 115.485 178.407 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -130.28 166.05 21.16 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.031 1.733 . . . . 0.0 111.418 176.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.2 m -70.85 141.74 51.25 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.435 -0.791 . . . . 0.0 112.894 178.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.181 0 C-N-CA 125.49 1.519 . . . . 0.0 112.201 174.515 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -140.52 -73.4 0.04 OUTLIER Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.238 1.399 . . . . 0.0 112.771 -178.741 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.0 m -74.31 99.96 3.62 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.741 1.216 . . . . 0.0 111.993 -178.218 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -58.77 -21.33 55.52 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.792 1.637 . . . . 0.0 114.755 -176.227 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.23 -0.44 71.15 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.277 1.417 . . . . 0.0 115.741 177.012 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.36 -173.1 13.54 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.542 1.544 . . . . 0.0 113.896 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.4 m -107.38 138.76 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.385 1.474 . . . . 0.0 112.366 -175.557 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.4 t -131.46 105.75 14.52 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 125.414 1.486 . . . . 0.0 111.141 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.31 110.99 0.65 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.376 2.718 . . . . 0.0 110.405 167.456 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -79.23 57.25 2.24 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.612 1.165 . . . . 0.0 113.38 -172.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -79.09 170.65 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.786 1.635 . . . . 0.0 110.836 168.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -74.9 -72.0 0.32 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.349 1.06 . . . . 0.0 110.89 176.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm 38.82 90.41 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 128.813 2.845 . . . . 0.0 114.146 -178.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -54.63 136.47 45.37 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.55 -0.719 . . . . 0.0 111.504 173.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.4 p -140.13 169.65 17.3 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -170.457 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -119.83 -30.14 4.82 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 128.381 2.672 . . . . 0.0 111.56 -179.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -152.8 164.61 37.5 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 127.922 2.489 . . . . 0.0 110.694 -172.526 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -65.73 -23.8 66.83 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.512 -0.743 . . . . 0.0 112.79 -177.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.1 m -67.28 -18.41 65.19 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.4 1.48 . . . . 0.0 113.217 177.648 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -74.0 -13.76 60.92 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.723 1.209 . . . . 0.0 113.193 174.134 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.2 m -111.57 149.28 40.47 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 125.008 1.323 . . . . 0.0 112.897 -172.46 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -77.46 163.84 29.27 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.362 2.708 . . . . 0.0 113.846 -175.38 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 36.91 -112.29 0.15 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 127.449 2.452 . . . . 0.0 115.746 173.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.01 5.45 48.77 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.42 1.888 . . . . 0.0 113.909 -177.531 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.2 m -66.81 168.29 9.9 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 122.423 1.106 . . . . 0.0 112.188 174.184 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.3 pt -135.27 162.91 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 128.093 2.557 . . . . 0.0 109.745 173.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.2 t -86.02 103.28 14.56 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 168.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -65.74 169.3 6.57 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.364 1.865 . . . . 0.0 111.21 -176.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.51 -17.95 71.27 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.814 1.197 . . . . 0.0 114.416 -173.218 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -82.02 -5.43 58.35 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.195 1.398 . . . . 0.0 114.348 173.116 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.92 24.29 38.55 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.369 0.985 . . . . 0.0 114.931 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -133.5 164.2 27.68 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.396 1.879 . . . . 0.0 111.161 177.526 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 89.5 m -73.84 156.21 37.99 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.038 -1.039 . . . . 0.0 112.948 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.142 0 C-N-CA 124.96 1.267 . . . . 0.0 112.271 172.692 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.2 p . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -93.28 177.39 37.89 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.5 1.048 . . . . 0.0 112.709 171.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.8 p -62.44 -18.57 62.03 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -176.627 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -68.18 -20.01 64.83 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.789 1.636 . . . . 0.0 114.313 172.46 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 68.27 15.05 67.34 Favored Glycine 0 CA--C 1.54 1.632 0 N-CA-C 116.22 1.248 . . . . 0.0 116.22 176.203 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.17 -177.36 25.69 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.426 1.489 . . . . 0.0 114.996 -179.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.8 t -59.56 100.47 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 126.008 1.723 . . . . 0.0 112.179 -177.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.4 t -136.8 116.36 10.63 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.442 1.497 . . . . 0.0 110.41 172.637 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -72.72 -7.84 21.44 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 123.689 2.926 . . . . 0.0 114.969 -179.491 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt 49.39 45.29 23.82 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 127.014 2.126 . . . . 0.0 114.124 175.552 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.6 pp -79.5 157.34 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.508 1.523 . . . . 0.0 111.572 174.418 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.1 mt -80.04 64.18 4.79 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.535 1.534 . . . . 0.0 112.278 -174.172 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -108.91 107.21 17.51 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.957 2.103 . . . . 0.0 110.155 177.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -64.27 145.62 55.7 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.678 0.791 . . . . 0.0 110.093 173.453 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.3 p -141.86 168.12 20.51 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -173.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -116.33 -28.5 6.49 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.572 2.349 . . . . 0.0 112.016 177.374 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -151.64 172.97 15.24 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.632 2.373 . . . . 0.0 110.133 -176.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -70.53 -26.39 63.54 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.501 0.72 . . . . 0.0 112.532 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.7 p -68.61 -16.02 63.71 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.637 1.575 . . . . 0.0 113.858 174.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -73.61 -12.04 60.62 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.875 0.87 . . . . 0.0 113.167 169.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 79.8 m -112.01 158.3 37.25 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -169.071 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.74 167.11 7.26 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 124.32 3.347 . . . . 0.0 115.652 176.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -1.89 -86.4 0.0 OUTLIER Glycine 0 N--CA 1.477 1.388 0 C-N-CA 130.238 3.78 . . . . 0.0 117.645 177.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -107.86 10.53 28.57 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.239 1.415 . . . . 0.0 113.502 -178.026 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 67.2 m -66.99 167.13 12.3 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.468 1.128 . . . . 0.0 111.761 169.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.7 pt -133.11 161.69 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 128.03 2.532 . . . . 0.0 109.27 169.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.5 t -86.95 99.82 12.14 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.741 0.816 . . . . 0.0 109.65 170.335 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -77.06 174.65 10.41 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.97 1.308 . . . . 0.0 111.868 -170.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.39 -16.04 68.84 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.898 1.237 . . . . 0.0 114.464 -171.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -76.04 -8.05 56.09 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.589 1.556 . . . . 0.0 114.253 170.412 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.26 15.33 64.69 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.947 1.261 . . . . 0.0 114.859 -178.565 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -131.39 160.97 33.5 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.856 1.662 . . . . 0.0 112.114 -178.071 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 70.9 m -68.33 141.88 55.67 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.904 0.881 . . . . 0.0 112.211 176.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.068 0 C-N-CA 123.794 0.712 . . . . 0.0 113.151 176.008 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -111.05 112.46 3.21 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 169.721 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -56.21 -23.95 38.86 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -169.311 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -67.43 -27.28 66.93 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.534 1.134 . . . . 0.0 113.359 172.193 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -101.39 -32.88 5.04 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 126.412 1.958 . . . . 0.0 113.971 176.205 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 136.0 -171.74 22.63 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.066 1.317 . . . . 0.0 115.174 172.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.5 t -72.48 111.3 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.703 1.201 . . . . 0.0 109.069 168.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.6 t -83.59 127.78 66.56 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 122.877 0.471 . . . . 0.0 111.56 173.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.19 69.06 4.05 Favored 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.84 3.026 . . . . 0.0 109.729 167.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -61.01 140.7 57.76 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 127.986 2.515 . . . . 0.0 113.434 -169.268 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.0 pp -131.75 169.85 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 127.584 2.353 . . . . 0.0 110.629 169.284 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.3 mt -74.53 86.0 2.06 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.058 0.943 . . . . 0.0 111.849 -178.07 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -127.09 109.94 12.4 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.16 1.784 . . . . 0.0 110.8 176.087 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.83 148.09 50.22 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.812 1.245 . . . . 0.0 110.822 176.257 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.4 p -144.78 171.32 14.59 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 177.013 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -128.41 -24.55 3.06 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 128.408 2.683 . . . . 0.0 112.098 169.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.7 ptm85 -145.12 166.17 26.17 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.442 1.897 . . . . 0.0 111.834 178.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -67.58 -20.98 65.44 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.281 -0.887 . . . . 0.0 112.724 -176.135 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.2 m -67.47 -17.09 64.55 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.618 1.167 . . . . 0.0 113.182 175.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -74.49 -10.75 59.87 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.387 1.475 . . . . 0.0 113.347 173.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.5 m -119.09 158.39 48.3 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.07 1.348 . . . . 0.0 113.346 -168.668 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.08 165.97 30.67 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.123 2.549 . . . . 0.0 112.254 174.086 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -39.34 -57.7 2.15 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 127.426 2.441 . . . . 0.0 117.234 -169.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.03 -17.46 52.71 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -177.099 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.4 m -79.09 164.8 24.0 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 123.283 1.515 . . . . 0.0 112.752 169.686 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.9 pt -132.52 167.31 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 129.767 3.227 . . . . 0.0 107.512 167.065 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.9 t -80.08 101.61 8.84 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.299 -0.876 . . . . 0.0 109.744 169.455 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.86 169.57 12.86 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.104 1.762 . . . . 0.0 111.632 -177.669 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.45 -13.96 79.71 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.848 1.213 . . . . 0.0 114.598 -173.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -79.15 -6.73 57.22 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.638 1.575 . . . . 0.0 114.29 174.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.41 12.72 62.59 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.642 1.115 . . . . 0.0 114.805 -177.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -129.71 167.96 17.23 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.405 1.882 . . . . 0.0 111.031 176.392 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.2 m -70.04 152.95 43.8 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.25 -0.907 . . . . 0.0 112.679 173.664 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.973 0 C-N-CA 124.423 1.011 . . . . 0.0 113.781 171.662 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.28 9.92 73.43 Favored Glycine 0 CA--C 1.539 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 113.354 -168.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.5 m 71.01 -3.92 1.9 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 128.717 2.807 . . . . 0.0 115.229 -177.558 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -140.45 -0.65 1.56 Allowed 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 178.452 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.62 176.3 48.53 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.849 1.214 . . . . 0.0 115.294 -177.275 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.69 -123.24 1.57 Allowed Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.956 1.741 . . . . 0.0 113.922 -176.088 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 m -64.79 85.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 126.159 1.784 . . . . 0.0 113.014 178.787 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.6 t -131.76 113.42 15.18 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.112 1.365 . . . . 0.0 110.837 174.697 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.71 -5.55 16.11 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 123.998 3.132 . . . . 0.0 115.207 179.14 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.4 mttp 54.04 44.28 29.53 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 126.929 2.092 . . . . 0.0 114.163 171.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.04 160.6 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.547 1.139 . . . . 0.0 111.515 -178.357 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 90.9 mt -76.55 36.05 0.15 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.184 1.794 . . . . 0.0 113.675 -179.449 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -76.75 105.07 7.59 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.39 1.876 . . . . 0.0 109.432 169.892 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -63.63 143.75 57.57 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.997 0.919 . . . . 0.0 111.141 174.232 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 p -144.04 173.1 12.02 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.937 1.295 . . . . 0.0 114.193 -176.052 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -132.27 -20.04 2.43 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.256 2.222 . . . . 0.0 112.628 170.034 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -142.6 164.36 30.32 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.113 1.765 . . . . 0.0 111.754 178.015 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -67.4 -22.65 65.53 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.509 -0.744 . . . . 0.0 112.554 -176.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.0 m -66.99 -18.0 65.18 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.458 1.503 . . . . 0.0 113.128 176.423 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -74.14 -12.65 60.65 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.056 1.342 . . . . 0.0 113.371 174.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 81.6 m -115.99 151.18 46.23 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -168.402 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -80.58 167.37 18.99 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.662 2.908 . . . . 0.0 113.941 -174.658 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 39.8 -108.03 0.09 OUTLIER Glycine 0 CA--C 1.534 1.264 0 C-N-CA 127.644 2.545 . . . . 0.0 115.497 172.256 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.35 6.88 30.89 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.281 1.832 . . . . 0.0 113.673 -177.823 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 75.3 m -66.41 168.82 8.31 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 122.626 1.203 . . . . 0.0 112.938 175.693 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.6 pt -131.83 169.69 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 129.067 2.947 . . . . 0.0 108.962 169.061 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.9 t -87.73 108.36 19.08 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.659 -0.651 . . . . 0.0 109.333 168.091 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 -66.1 168.35 8.55 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.61 1.564 . . . . 0.0 111.451 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.51 -17.91 73.15 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.832 1.206 . . . . 0.0 114.478 -176.837 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -80.37 -5.96 57.26 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.694 1.197 . . . . 0.0 114.092 172.684 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.82 24.08 36.65 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.521 1.058 . . . . 0.0 114.972 -179.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -134.84 161.96 33.75 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.675 1.59 . . . . 0.0 111.9 177.125 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.5 m -69.24 144.78 53.57 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.321 -0.862 . . . . 0.0 113.319 179.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.035 0 C-N-CA 124.543 1.068 . . . . 0.0 113.167 179.007 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.03 172.78 15.03 Favored Glycine 0 N--CA 1.475 1.252 0 C-N-CA 123.92 0.771 . . . . 0.0 114.915 -176.69 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.5 p -64.01 -15.24 58.93 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.023 1.729 . . . . 0.0 114.935 -177.329 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -64.9 -18.3 65.08 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.338 1.455 . . . . 0.0 113.508 170.262 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.96 2.15 84.2 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.219 1.39 . . . . 0.0 114.557 -178.159 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.08 111.63 4.27 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.589 1.566 . . . . 0.0 112.017 174.448 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.8 t -68.02 99.37 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.83 1.252 . . . . 0.0 111.248 -177.582 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.0 t -82.2 141.74 46.75 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 166.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -50.81 13.54 0.01 OUTLIER 'Trans proline' 0 CA--C 1.553 1.444 1 C-N-CA 127.242 5.295 . . . . 0.0 119.676 169.561 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt 50.25 46.48 24.88 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 128.428 2.691 . . . . 0.0 114.745 173.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.5 pp -79.4 147.54 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.464 1.506 . . . . 0.0 110.018 169.707 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.0 mt -71.93 -68.66 0.44 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.396 1.078 . . . . 0.0 111.882 -178.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 76.3 tttt 33.63 97.29 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 129.852 3.261 . . . . 0.0 115.135 179.565 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -54.86 136.3 47.02 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.417 -0.802 . . . . 0.0 111.404 172.638 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.8 p -141.99 165.53 27.21 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.143 1.377 . . . . 0.0 114.191 -170.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -116.73 -19.5 9.91 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.871 2.068 . . . . 0.0 112.841 -179.069 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -160.69 163.41 32.46 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 128.863 2.865 . . . . 0.0 109.468 -169.011 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -66.95 -26.7 66.96 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.139 -0.976 . . . . 0.0 112.666 179.286 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.3 m -71.05 -15.42 62.54 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.509 1.524 . . . . 0.0 113.622 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -72.37 -22.49 61.14 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.192 0.997 . . . . 0.0 112.389 170.507 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 75.3 m -94.6 151.37 39.16 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.4 1.08 . . . . 0.0 112.813 -174.575 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.16 160.78 26.46 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.444 2.763 . . . . 0.0 113.168 -178.282 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 27.4 -99.04 0.01 OUTLIER Glycine 0 CA--C 1.536 1.348 0 C-N-CA 128.694 3.045 . . . . 0.0 116.671 174.233 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -95.92 -3.63 44.9 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 -173.122 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.3 m -68.74 165.04 20.38 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 122.992 1.377 . . . . 0.0 113.153 175.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.5 pt -124.21 166.17 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 129.551 3.14 . . . . 0.0 107.844 167.539 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.6 t -97.6 107.0 19.41 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.771 0.828 . . . . 0.0 108.815 169.267 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -65.1 165.81 10.57 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.619 1.168 . . . . 0.0 111.132 179.236 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.13 -16.71 71.18 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.052 1.31 . . . . 0.0 114.475 -175.803 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -77.41 -5.92 51.52 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.044 1.338 . . . . 0.0 114.027 170.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.62 28.26 30.06 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.487 1.041 . . . . 0.0 114.683 179.088 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -135.93 158.5 44.24 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.54 1.536 . . . . 0.0 111.862 176.743 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.9 m -77.54 163.83 25.93 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 122.124 0.964 . . . . 0.0 113.366 -179.829 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.131 0 C-N-CA 125.402 1.477 . . . . 0.0 111.897 169.652 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.25 17.18 59.8 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 124.574 1.083 . . . . 0.0 113.736 171.399 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.3 m 65.19 11.76 7.46 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 127.279 2.232 . . . . 0.0 115.239 -178.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.16 -26.6 68.24 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.967 1.307 . . . . 0.0 113.205 176.006 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.82 -3.42 81.09 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.695 1.617 . . . . 0.0 115.029 176.286 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.1 -165.43 37.72 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.606 1.574 . . . . 0.0 113.645 174.214 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 51.1 t -66.89 101.38 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.548 1.539 . . . . 0.0 112.555 -176.737 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.2 t -135.19 102.71 10.77 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.796 1.239 . . . . 0.0 110.391 166.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.06 -1.83 11.9 Favored 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 123.912 3.074 . . . . 0.0 115.206 -179.518 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt 50.69 51.17 17.48 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 127.072 2.149 . . . . 0.0 113.636 175.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.78 158.28 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 125.383 1.473 . . . . 0.0 112.027 178.517 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.1 mt -78.17 30.06 0.18 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.242 1.817 . . . . 0.0 113.824 -178.792 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -72.01 111.86 7.61 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 120.657 -1.277 . . . . 0.0 109.937 169.776 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -67.41 141.56 57.0 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.219 0.607 . . . . 0.0 109.976 168.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.5 p -141.31 171.36 14.17 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.471 1.108 . . . . 0.0 113.741 -171.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -136.3 -10.12 1.95 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.326 1.85 . . . . 0.0 113.158 172.692 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.3 ttt-85 -141.31 168.2 20.34 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.672 1.589 . . . . 0.0 110.451 171.66 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -72.5 -26.97 61.98 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.371 0.669 . . . . 0.0 112.253 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.0 p -70.03 -13.41 62.21 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.28 1.832 . . . . 0.0 113.82 175.481 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.58 -23.49 65.4 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.486 -0.759 . . . . 0.0 112.403 168.995 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.8 m -107.22 161.71 22.11 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 124.838 1.255 . . . . 0.0 114.137 -168.535 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -56.54 167.3 2.88 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 124.594 3.529 . . . . 0.0 115.446 173.038 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -32.09 -67.52 0.16 Allowed Glycine 0 CA--C 1.538 1.493 0 C-N-CA 128.521 2.963 . . . . 0.0 117.095 -171.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.38 -0.51 56.53 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -177.32 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 65.1 m -74.07 169.64 17.09 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.668 1.223 . . . . 0.0 112.044 173.517 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 24.4 pt -137.13 166.61 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 128.762 2.825 . . . . 0.0 108.707 169.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.6 t -86.96 104.42 16.26 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 167.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -66.37 169.46 7.34 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.683 1.593 . . . . 0.0 111.026 -175.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.71 -17.32 68.99 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.701 1.143 . . . . 0.0 114.242 -176.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 53.9 p30 -79.34 -6.52 56.95 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.469 1.507 . . . . 0.0 114.405 172.446 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.57 17.81 57.88 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.662 1.125 . . . . 0.0 115.22 179.885 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -130.88 161.8 31.03 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.839 1.655 . . . . 0.0 111.928 178.275 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 97.7 m -68.2 145.81 53.96 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.614 -0.679 . . . . 0.0 112.727 178.038 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.088 0 C-N-CA 124.64 1.115 . . . . 0.0 112.469 174.542 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.0 m . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -148.0 -4.33 0.35 Allowed Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.82 1.2 . . . . 0.0 115.504 173.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.9 t -147.62 179.72 7.49 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.137 1.775 . . . . 0.0 111.662 -178.403 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -121.76 -3.22 9.24 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 127.207 2.203 . . . . 0.0 112.595 171.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.37 27.5 3.21 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.249 1.88 . . . . 0.0 115.442 -176.668 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 172.61 -152.35 16.35 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.925 1.726 . . . . 0.0 112.349 -172.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.5 p -119.72 147.8 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.472 1.509 . . . . 0.0 111.45 176.525 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.6 t -137.0 105.72 8.79 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.277 1.031 . . . . 0.0 111.422 169.049 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -58.37 -18.32 37.83 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 124.449 3.432 . . . . 0.0 116.881 177.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 49.98 74.51 0.21 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 126.974 2.11 . . . . 0.0 112.722 -174.034 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.1 pt -127.83 162.57 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 126.252 1.821 . . . . 0.0 112.567 -172.948 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -68.89 22.67 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.156 2.182 . . . . 0.0 115.923 178.534 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -65.27 104.73 0.98 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.277 1.431 . . . . 0.0 109.901 169.262 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.1 145.33 53.58 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.462 1.105 . . . . 0.0 110.822 173.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 p -143.99 167.05 23.28 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 177.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -121.98 -21.52 5.98 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.674 2.39 . . . . 0.0 112.463 169.276 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.67 168.97 20.69 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.278 1.831 . . . . 0.0 111.417 177.164 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -66.23 -22.91 66.34 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.27 -0.894 . . . . 0.0 112.755 -177.51 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.2 m -66.27 -17.74 64.93 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.741 1.617 . . . . 0.0 113.378 177.471 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -74.27 -13.73 60.81 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.446 1.498 . . . . 0.0 113.747 174.133 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.5 m -117.44 159.12 43.06 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -167.469 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -56.05 168.69 1.75 Allowed 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 125.106 3.87 . . . . 0.0 116.189 172.198 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -35.66 -65.52 0.45 Allowed Glycine 0 CA--C 1.535 1.287 0 C-N-CA 128.45 2.928 . . . . 0.0 117.451 -170.633 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.46 1.8 55.75 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.635 1.174 . . . . 0.0 114.035 -178.797 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.9 m -74.97 168.21 20.4 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.777 1.275 . . . . 0.0 112.109 170.841 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.5 pt -136.58 165.15 29.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 129.586 3.154 . . . . 0.0 107.894 168.224 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.3 t -83.21 101.23 11.09 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 168.015 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -65.97 169.5 6.69 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.876 1.67 . . . . 0.0 110.748 -175.231 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.91 -16.96 69.0 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.662 1.125 . . . . 0.0 114.39 -174.751 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -79.7 -9.29 59.62 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.32 1.448 . . . . 0.0 114.454 173.841 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.43 15.74 56.53 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.667 1.127 . . . . 0.0 115.336 -178.35 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -129.67 164.86 23.0 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.513 1.525 . . . . 0.0 111.245 176.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.6 m -70.19 146.45 50.75 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.264 -0.898 . . . . 0.0 112.734 177.397 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.035 0 C-N-CA 125.139 1.352 . . . . 0.0 111.598 174.301 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.5 m . . . . . 0 N--CA 1.477 0.92 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.12 -9.46 20.11 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.259 0.933 . . . . 0.0 114.468 171.499 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.3 p -105.25 174.84 5.71 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.099 1.76 . . . . 0.0 112.134 173.095 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -68.98 -17.49 63.94 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.515 1.126 . . . . 0.0 113.589 174.475 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 166.83 96.75 0.11 Allowed Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.994 1.283 . . . . 0.0 112.251 -176.095 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -152.15 -172.99 21.31 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.258 1.409 . . . . 0.0 113.284 -179.552 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.3 m -67.41 74.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 126.259 1.824 . . . . 0.0 113.405 -179.066 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.8 t -129.43 106.39 17.45 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.66 1.584 . . . . 0.0 110.842 169.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -60.78 -13.78 28.43 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 124.318 3.345 . . . . 0.0 117.534 -178.898 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 97.7 mttt 47.61 77.73 0.09 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 127.306 2.243 . . . . 0.0 113.516 -174.782 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.98 164.67 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.703 1.601 . . . . 0.0 112.477 -178.414 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 90.5 mt -74.6 29.79 0.09 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.272 1.829 . . . . 0.0 114.336 -178.072 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -70.59 99.99 1.75 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.134 1.373 . . . . 0.0 109.918 169.657 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -63.19 144.11 57.21 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.356 1.062 . . . . 0.0 110.926 171.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.0 p -143.9 172.6 12.63 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -175.445 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -132.63 -15.47 2.74 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 127.373 2.269 . . . . 0.0 113.649 171.166 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.5 ttp180 -144.06 170.82 15.21 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.032 1.733 . . . . 0.0 110.971 172.382 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -70.72 -24.2 62.59 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.46 0.704 . . . . 0.0 112.286 178.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.4 m -64.32 -20.64 66.23 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.141 1.776 . . . . 0.0 113.017 174.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.86 -16.03 62.67 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.443 1.097 . . . . 0.0 113.437 173.107 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 56.0 m -116.14 151.82 47.09 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.911 1.285 . . . . 0.0 113.313 -169.035 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.06 164.21 22.44 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.316 2.677 . . . . 0.0 113.592 -176.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 26.85 -100.9 0.01 OUTLIER Glycine 0 CA--C 1.537 1.448 0 C-N-CA 129.033 3.206 . . . . 0.0 117.307 172.429 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.69 2.11 51.72 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.791 1.636 . . . . 0.0 113.929 -174.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.0 m -72.04 166.16 22.81 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 122.771 1.272 . . . . 0.0 112.063 172.597 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.9 pt -135.46 166.15 28.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 129.514 3.126 . . . . 0.0 108.045 168.514 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.9 t -83.14 101.28 11.08 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 168.011 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -65.42 170.27 5.05 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.153 1.781 . . . . 0.0 110.911 -175.805 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.71 -17.4 69.09 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.648 1.118 . . . . 0.0 114.517 -173.799 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.9 p-10 -79.97 -8.04 59.13 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.379 1.472 . . . . 0.0 114.434 172.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.4 20.08 49.92 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.634 1.111 . . . . 0.0 115.091 -178.128 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -132.27 161.56 33.17 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.606 1.562 . . . . 0.0 111.761 178.287 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.6 m -70.17 140.31 52.54 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.322 -0.862 . . . . 0.0 112.565 178.236 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.077 0 C-N-CA 125.289 1.423 . . . . 0.0 111.649 175.273 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 83.7 tttt . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -66.05 145.44 55.86 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.1 0.56 . . . . 0.0 110.46 170.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.8 p -144.84 171.63 14.15 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -174.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -119.71 -28.51 5.24 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 128.205 2.602 . . . . 0.0 111.574 172.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -149.31 173.18 13.79 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.271 1.428 . . . . 0.0 112.292 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -66.09 -27.06 67.78 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.876 1.27 . . . . 0.0 112.497 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.8 m -66.36 -19.8 65.9 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.554 1.542 . . . . 0.0 112.915 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -70.04 -25.35 63.52 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 82.9 m -96.28 157.32 35.77 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.489 1.116 . . . . 0.0 113.646 -169.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.25 161.36 46.04 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.993 2.462 . . . . 0.0 112.46 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -12.34 -75.11 0.01 OUTLIER Glycine 0 N--CA 1.477 1.373 0 C-N-CA 129.506 3.432 . . . . 0.0 117.984 -173.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.51 -8.58 52.5 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -172.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.4 m -74.5 166.43 23.54 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 122.853 1.311 . . . . 0.0 113.151 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.4 pt -128.92 162.19 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 129.447 3.099 . . . . 0.0 108.599 168.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.8 t -86.19 100.15 12.03 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 169.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -65.09 171.08 3.88 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.168 2.187 . . . . 0.0 111.305 -174.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.64 -17.3 70.84 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.848 1.214 . . . . 0.0 114.6 -173.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -84.85 -2.66 58.06 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.322 1.449 . . . . 0.0 114.358 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.0 22.74 51.79 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.226 0.917 . . . . 0.0 114.884 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -130.99 159.8 36.43 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.558 1.543 . . . . 0.0 111.905 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.0 m -69.38 145.57 52.79 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.301 0.641 . . . . 0.0 112.1 175.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.781 0 C-N-CA 124.728 1.156 . . . . 0.0 111.915 174.243 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 80.8 tttt . . . . . 0 CA--C 1.537 0.46 0 CA-C-O 120.281 0.086 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -66.6 149.49 50.41 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.978 0.911 . . . . 0.0 110.236 169.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.2 p -144.73 172.17 13.37 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -128.63 -22.45 3.3 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.966 2.506 . . . . 0.0 112.23 170.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -144.38 164.03 32.01 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.482 1.913 . . . . 0.0 111.57 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -66.91 -23.08 65.95 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.394 -0.816 . . . . 0.0 112.593 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.4 m -67.4 -17.66 64.81 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.252 1.421 . . . . 0.0 113.216 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -72.9 -20.25 61.12 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.848 1.259 . . . . 0.0 113.268 173.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.4 m -106.2 163.66 16.58 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -167.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -55.84 164.4 4.67 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 124.071 3.181 . . . . 0.0 113.929 169.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.7 -54.08 18.89 Favored Glycine 0 N--CA 1.475 1.257 0 C-N-CA 125.894 1.711 . . . . 0.0 115.519 -175.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.68 -17.74 50.17 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.8 m -75.65 167.72 21.36 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 123.16 1.457 . . . . 0.0 113.192 171.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.8 pt -133.44 167.78 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 129.39 3.076 . . . . 0.0 107.467 166.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.0 t -83.89 103.05 12.83 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.479 -0.763 . . . . 0.0 109.801 169.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.38 165.67 13.75 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.794 1.638 . . . . 0.0 111.145 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.93 -14.33 75.9 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.997 1.284 . . . . 0.0 114.439 -174.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.5 p-10 -78.27 -6.18 54.22 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.643 1.577 . . . . 0.0 114.123 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.89 19.04 55.04 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.412 1.006 . . . . 0.0 114.725 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -131.56 165.02 24.55 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.063 1.745 . . . . 0.0 111.684 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 80.9 m -74.45 151.21 39.63 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.606 -0.684 . . . . 0.0 112.832 173.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.029 0 C-N-CA 124.364 0.983 . . . . 0.0 113.144 171.56 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.5 tttm . . . . . 0 N--CA 1.468 0.427 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -63.58 144.97 56.57 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.993 0.917 . . . . 0.0 110.863 172.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 p -147.21 173.47 12.51 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -174.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -133.2 -14.88 2.59 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 127.322 2.249 . . . . 0.0 113.295 172.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -144.52 163.41 33.93 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 127.096 2.158 . . . . 0.0 110.724 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -69.34 -22.55 63.75 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.615 -0.678 . . . . 0.0 112.682 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.4 m -69.51 -15.33 63.23 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.426 1.09 . . . . 0.0 113.128 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -74.1 -11.91 60.45 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.763 1.225 . . . . 0.0 113.108 174.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 76.9 m -113.73 147.58 37.95 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.597 1.159 . . . . 0.0 114.04 -168.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -80.82 160.46 21.42 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.607 2.871 . . . . 0.0 113.423 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 43.67 -118.27 2.09 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.685 2.088 . . . . 0.0 114.889 174.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.8 3.05 55.47 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.007 1.723 . . . . 0.0 113.803 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.0 m -64.5 151.84 43.36 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.764 1.269 . . . . 0.0 112.532 169.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.2 pt -120.87 164.25 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 128.203 2.601 . . . . 0.0 108.4 169.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.9 t -82.99 101.1 10.86 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 169.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -66.4 170.85 5.5 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.442 1.897 . . . . 0.0 111.1 -176.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.21 -17.63 70.34 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.721 1.153 . . . . 0.0 114.542 -173.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -82.43 -4.91 58.24 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.308 1.443 . . . . 0.0 114.369 173.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.2 22.89 46.62 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.31 0.957 . . . . 0.0 114.993 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -132.79 160.23 37.48 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.555 1.542 . . . . 0.0 111.851 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.2 m -68.98 142.51 54.64 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.602 -0.686 . . . . 0.0 112.396 176.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.111 0 C-N-CA 124.503 1.049 . . . . 0.0 112.53 172.295 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -68.38 142.78 55.34 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.239 0.616 . . . . 0.0 109.476 168.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.3 p -141.73 168.13 20.49 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -172.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -122.14 -21.04 6.04 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 127.328 2.251 . . . . 0.0 112.742 171.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.69 167.69 24.84 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.257 1.423 . . . . 0.0 111.358 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -65.92 -22.25 66.49 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.311 -0.868 . . . . 0.0 112.538 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.8 m -66.83 -19.25 65.7 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.821 1.648 . . . . 0.0 113.371 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -69.14 -30.9 69.24 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.583 1.153 . . . . 0.0 112.637 172.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.5 m -96.48 151.87 38.29 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -168.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.05 160.04 23.82 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.535 2.824 . . . . 0.0 113.079 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 23.11 -97.97 0.01 OUTLIER Glycine 0 CA--C 1.538 1.489 0 C-N-CA 129.2 3.286 . . . . 0.0 117.085 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.02 -4.28 54.7 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -173.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.5 m -72.86 163.14 28.58 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 122.905 1.336 . . . . 0.0 112.983 171.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.7 pt -130.04 165.76 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 129.642 3.177 . . . . 0.0 108.157 168.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.0 t -83.59 102.04 11.9 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 168.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -66.22 170.47 5.79 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.294 1.838 . . . . 0.0 111.251 -175.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.48 -17.89 71.15 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.709 1.147 . . . . 0.0 114.452 -173.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -82.22 -4.7 57.6 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.141 1.376 . . . . 0.0 114.337 173.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.77 20.9 52.68 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.299 0.952 . . . . 0.0 115.017 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -131.66 162.03 31.36 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.838 1.655 . . . . 0.0 111.762 176.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 75.2 m -71.86 145.36 48.62 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.523 -0.736 . . . . 0.0 112.954 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.232 0 C-N-CA 125.198 1.38 . . . . 0.0 112.08 171.825 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.0 tttm . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 119.854 -0.117 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -65.88 152.06 45.31 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.642 0.777 . . . . 0.0 111.528 174.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.4 p -147.73 169.67 19.22 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 177.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.61 -6.25 1.96 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 127.458 2.303 . . . . 0.0 113.891 169.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.4 ttt85 -144.64 170.6 15.76 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 128.356 2.662 . . . . 0.0 109.004 173.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -75.5 -24.72 56.9 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.505 -0.747 . . . . 0.0 112.297 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.6 m -66.4 -16.2 63.9 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.376 1.871 . . . . 0.0 113.173 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -73.77 -13.59 60.97 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.418 1.487 . . . . 0.0 113.834 173.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 76.7 m -113.02 146.2 34.66 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -167.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -81.83 167.39 16.53 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.907 3.072 . . . . 0.0 113.55 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 43.67 -117.48 1.79 Allowed Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.638 2.066 . . . . 0.0 114.904 174.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.98 6.59 47.5 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.954 1.701 . . . . 0.0 113.844 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.4 m -68.25 162.7 24.48 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 123.228 1.49 . . . . 0.0 113.834 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.8 pt -130.62 169.95 20.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 129.486 3.114 . . . . 0.0 107.806 168.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -82.6 104.08 12.6 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 121.7 -0.625 . . . . 0.0 109.759 168.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.06 167.84 9.28 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.186 1.394 . . . . 0.0 110.533 176.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.43 -13.93 71.41 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.818 1.199 . . . . 0.0 114.624 -174.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -79.18 -6.51 56.73 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.86 1.664 . . . . 0.0 114.399 174.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.7 23.07 56.97 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.184 0.897 . . . . 0.0 114.522 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -133.18 164.21 27.56 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.709 2.004 . . . . 0.0 111.067 173.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.6 m -71.74 147.12 47.66 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.624 -0.672 . . . . 0.0 112.524 176.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.049 0 C-N-CA 124.208 0.909 . . . . 0.0 112.038 170.61 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.45 142.51 55.32 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.444 0.698 . . . . 0.0 109.447 168.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.8 p -142.83 171.39 14.12 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -134.79 -14.86 2.1 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.43 2.292 . . . . 0.0 112.482 171.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -130.31 152.18 50.0 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.402 2.281 . . . . 0.0 110.032 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -64.39 -24.19 67.55 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 121.414 -0.804 . . . . 0.0 111.936 169.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.3 m -68.24 -20.27 64.8 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.88 2.072 . . . . 0.0 113.453 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -68.08 -25.64 65.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.959 0.903 . . . . 0.0 112.988 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.6 m -101.25 152.75 38.01 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.891 1.277 . . . . 0.0 113.497 -169.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -80.81 172.22 13.46 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.717 2.945 . . . . 0.0 113.753 -174.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 44.31 -106.99 0.11 Allowed Glycine 0 CA--C 1.535 1.286 0 C-N-CA 127.281 2.372 . . . . 0.0 114.779 172.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -118.58 13.71 13.45 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.311 1.844 . . . . 0.0 113.121 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.0 m -60.72 169.16 1.94 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 122.471 1.129 . . . . 0.0 112.558 172.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.5 pt -129.52 166.92 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 128.155 2.582 . . . . 0.0 109.622 170.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.6 t -93.16 107.02 18.91 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.782 0.833 . . . . 0.0 109.579 168.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -67.91 166.74 15.02 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.053 1.741 . . . . 0.0 111.374 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.34 -16.95 73.86 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.916 1.246 . . . . 0.0 114.45 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -80.83 -4.61 55.3 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.26 1.424 . . . . 0.0 114.11 172.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.3 25.94 32.13 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.375 0.988 . . . . 0.0 114.946 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -134.71 161.91 33.82 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.874 1.669 . . . . 0.0 111.912 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.7 m -67.96 154.45 41.59 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.388 -0.82 . . . . 0.0 113.059 175.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.096 0 C-N-CA 124.84 1.21 . . . . 0.0 112.053 176.602 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.4 tttm . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 110.623 -0.14 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -61.61 145.83 50.88 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.746 0.818 . . . . 0.0 110.478 170.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.4 p -141.59 167.49 22.04 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -120.69 -19.64 7.33 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.231 2.213 . . . . 0.0 112.948 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -159.44 161.81 35.58 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 129.508 3.123 . . . . 0.0 109.241 -169.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -66.95 -25.2 66.23 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 121.007 -1.058 . . . . 0.0 112.746 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -71.51 -13.68 61.88 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.505 1.522 . . . . 0.0 113.557 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -74.4 -8.34 55.94 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.451 1.1 . . . . 0.0 112.986 170.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.5 m -119.49 148.6 46.08 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 125.243 1.417 . . . . 0.0 112.391 -173.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.09 167.81 21.34 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.503 2.802 . . . . 0.0 114.036 -176.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 34.5 -107.05 0.03 OUTLIER Glycine 0 CA--C 1.536 1.386 0 C-N-CA 128.302 2.858 . . . . 0.0 116.597 172.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -103.41 9.92 37.57 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.598 1.959 . . . . 0.0 113.772 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.3 m -67.32 164.86 17.54 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 122.589 1.185 . . . . 0.0 111.724 169.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.5 pt -129.81 163.52 34.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 128.801 2.841 . . . . 0.0 108.553 168.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 47.0 t -94.52 104.29 16.25 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.647 0.779 . . . . 0.0 109.15 169.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -80.75 172.0 14.3 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.579 1.552 . . . . 0.0 111.849 -169.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.11 -16.28 70.66 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.657 1.122 . . . . 0.0 114.299 -173.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -74.88 -11.08 60.05 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.425 1.49 . . . . 0.0 114.218 170.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.28 16.75 56.9 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.842 1.21 . . . . 0.0 115.066 -177.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -131.58 161.22 33.15 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.414 1.486 . . . . 0.0 112.412 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.1 m -68.77 157.6 36.05 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.702 0.801 . . . . 0.0 112.879 174.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.206 0 C-N-CA 125.262 1.41 . . . . 0.0 113.127 168.568 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 70.0 tttt . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -65.09 143.8 57.67 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 168.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.0 p -140.97 171.0 14.68 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.29 -26.52 4.27 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 128.507 2.723 . . . . 0.0 111.33 173.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -135.7 158.38 44.54 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.997 2.119 . . . . 0.0 112.346 -176.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -63.58 -27.03 68.97 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.245 0.618 . . . . 0.0 111.565 169.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.1 m -66.8 -23.09 66.01 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.816 2.046 . . . . 0.0 113.242 175.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -67.87 -20.61 65.15 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 170.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.1 m -104.02 149.13 36.9 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -168.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -82.51 167.53 15.13 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 124.014 3.143 . . . . 0.0 113.421 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 45.71 -123.14 6.2 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.971 1.748 . . . . 0.0 114.495 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.8 8.73 44.21 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.921 1.688 . . . . 0.0 113.42 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.4 m -63.3 158.22 20.86 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 123.026 1.393 . . . . 0.0 112.737 171.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.6 pt -125.57 165.97 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 128.948 2.899 . . . . 0.0 108.471 169.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.6 t -85.1 101.2 12.25 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 169.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -66.73 169.08 8.42 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.22 1.808 . . . . 0.0 111.066 -174.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.07 -17.13 69.52 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.774 1.178 . . . . 0.0 114.396 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 55.1 p30 -79.15 -8.26 58.86 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.338 1.455 . . . . 0.0 114.519 173.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.4 14.72 58.24 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 124.537 1.065 . . . . 0.0 115.425 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -128.38 165.15 21.17 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.884 1.674 . . . . 0.0 111.835 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 83.3 m -70.27 143.03 52.23 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.416 -0.802 . . . . 0.0 112.484 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.093 0 C-N-CA 124.506 1.05 . . . . 0.0 112.583 171.895 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.5 tttm . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 120.525 0.202 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -62.68 146.49 52.07 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.411 1.084 . . . . 0.0 110.973 171.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.5 p -144.17 172.04 13.46 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -175.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -126.78 -22.31 3.9 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 127.813 2.445 . . . . 0.0 112.71 171.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -145.13 171.16 14.91 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.504 1.922 . . . . 0.0 111.115 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -69.81 -23.76 63.37 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.581 0.752 . . . . 0.0 112.441 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.7 m -64.5 -20.39 66.17 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.085 1.754 . . . . 0.0 113.074 174.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -73.13 -12.03 60.75 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.5 1.12 . . . . 0.0 113.595 173.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.8 m -117.87 159.56 42.17 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.959 1.304 . . . . 0.0 113.456 -168.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.57 167.06 26.59 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.249 2.633 . . . . 0.0 112.543 175.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -39.44 -58.6 2.05 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 127.457 2.456 . . . . 0.0 117.147 -169.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.72 -15.98 56.52 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -176.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.8 m -79.57 166.74 21.59 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 123.156 1.455 . . . . 0.0 113.274 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 22.8 pt -133.86 166.08 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 130.599 3.56 . . . . 0.0 107.352 167.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 22.3 t -83.42 101.54 11.43 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 168.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -64.84 168.49 6.21 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.119 1.768 . . . . 0.0 110.973 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.42 -17.44 68.56 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.749 1.166 . . . . 0.0 114.344 -176.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -80.03 -7.04 58.64 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.493 1.517 . . . . 0.0 114.439 172.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.84 17.43 56.46 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.65 1.119 . . . . 0.0 115.347 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -130.0 161.02 31.89 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.637 1.575 . . . . 0.0 111.886 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 74.6 m -68.42 139.65 55.78 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.584 -0.697 . . . . 0.0 112.018 175.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.919 0 C-N-CA 124.84 1.21 . . . . 0.0 112.246 174.802 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.2 tttm . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -60.8 144.53 52.36 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.995 0.918 . . . . 0.0 111.272 175.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.2 p -143.79 171.87 13.61 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.68 -28.65 4.15 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 128.552 2.741 . . . . 0.0 111.715 173.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -148.09 161.75 40.79 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 127.003 2.121 . . . . 0.0 111.298 -175.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -65.37 -22.75 66.84 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.326 -0.859 . . . . 0.0 112.576 -177.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.8 m -66.2 -17.79 64.95 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.709 1.603 . . . . 0.0 113.324 175.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -74.89 -10.26 59.33 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.069 1.348 . . . . 0.0 113.519 174.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.5 m -119.54 153.25 53.98 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 124.466 1.107 . . . . 0.0 113.471 -168.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -57.49 170.63 1.7 Allowed 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.827 3.685 . . . . 0.0 116.249 174.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -30.12 -72.25 0.06 OUTLIER Glycine 0 CA--C 1.537 1.467 0 C-N-CA 128.889 3.138 . . . . 0.0 117.668 -172.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.46 -0.5 57.27 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.59 1.156 . . . . 0.0 114.094 -176.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 54.7 m -75.76 169.21 18.58 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.628 1.204 . . . . 0.0 112.559 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.7 pt -135.12 163.49 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 128.657 2.783 . . . . 0.0 108.756 168.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 42.0 t -93.14 103.93 16.16 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 168.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -79.94 170.31 16.66 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.689 1.596 . . . . 0.0 112.007 -169.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.66 -15.86 71.42 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.778 1.18 . . . . 0.0 114.343 -173.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.8 p-10 -74.86 -10.95 59.98 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.244 1.418 . . . . 0.0 114.148 171.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.42 15.95 54.09 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.967 1.27 . . . . 0.0 114.978 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -132.33 160.41 36.36 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.328 1.451 . . . . 0.0 112.243 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 83.8 m -68.03 160.64 28.39 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.904 0.882 . . . . 0.0 112.663 173.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.053 0 C-N-CA 124.788 1.185 . . . . 0.0 113.529 168.662 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 79.8 tttt . . . . . 0 N--CA 1.47 0.544 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -65.31 145.7 55.87 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.141 0.976 . . . . 0.0 110.368 171.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.1 p -148.99 171.76 15.84 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -133.83 -14.45 2.44 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.761 2.424 . . . . 0.0 112.842 169.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -131.99 152.22 51.27 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 127.758 2.423 . . . . 0.0 109.94 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -65.33 -24.07 67.17 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.411 -0.806 . . . . 0.0 111.967 169.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.4 m -67.93 -20.68 65.1 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.321 1.849 . . . . 0.0 113.165 175.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -69.12 -22.29 63.97 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.768 0.827 . . . . 0.0 113.031 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 85.9 m -103.32 155.41 36.79 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.737 1.215 . . . . 0.0 113.641 -169.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.21 159.75 43.47 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.144 2.563 . . . . 0.0 112.699 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 0.35 -84.52 0.0 OUTLIER Glycine 0 CA--C 1.537 1.467 0 C-N-CA 129.926 3.631 . . . . 0.0 118.026 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.87 -7.81 55.44 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -172.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.6 m -71.99 161.94 30.19 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 123.155 1.455 . . . . 0.0 112.77 169.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.7 pt -128.21 165.43 27.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 129.707 3.203 . . . . 0.0 107.908 168.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.2 t -85.51 103.0 13.98 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 169.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -67.42 169.62 8.74 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.952 1.701 . . . . 0.0 110.946 -176.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.47 -16.05 71.19 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.714 1.15 . . . . 0.0 114.588 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -83.7 -4.52 58.68 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.569 1.548 . . . . 0.0 114.48 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.42 23.41 43.73 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-N 119.09 0.859 . . . . 0.0 114.797 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -132.87 160.79 35.94 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.831 1.653 . . . . 0.0 111.577 176.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.1 m -69.06 146.29 52.76 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.665 -0.647 . . . . 0.0 112.058 173.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.985 0 C-N-CA 124.629 1.109 . . . . 0.0 111.777 173.287 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 110.724 -0.102 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -67.34 147.02 53.49 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 166.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.6 p -143.79 169.86 16.98 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -134.15 -12.37 2.49 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.804 2.041 . . . . 0.0 113.051 170.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -145.58 160.72 41.23 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.222 2.209 . . . . 0.0 110.134 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -69.89 -23.07 63.19 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.175 -0.953 . . . . 0.0 112.898 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 70.4 m -69.85 -13.66 62.37 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.951 1.3 . . . . 0.0 113.362 176.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -70.69 -13.64 62.15 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.428 1.091 . . . . 0.0 113.21 172.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.7 m -114.87 147.31 37.97 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 125.01 1.324 . . . . 0.0 113.785 -168.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -81.68 163.31 18.8 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.519 2.812 . . . . 0.0 113.402 -177.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 43.08 -117.27 1.51 Allowed Glycine 0 CA--C 1.535 1.339 0 C-N-CA 126.475 1.988 . . . . 0.0 114.568 176.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.29 -0.87 54.73 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.903 1.681 . . . . 0.0 114.156 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.3 m -61.99 161.47 10.64 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 122.713 1.244 . . . . 0.0 113.11 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.1 pt -126.76 167.01 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 128.001 2.52 . . . . 0.0 109.51 172.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.0 t -85.08 103.93 14.53 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 168.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -69.79 170.59 10.72 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.517 1.927 . . . . 0.0 110.92 -174.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.26 -16.56 73.38 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.615 1.102 . . . . 0.0 114.661 -173.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -85.01 -3.22 58.7 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.391 1.477 . . . . 0.0 114.415 175.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.76 21.53 50.21 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.202 0.906 . . . . 0.0 114.957 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -131.56 162.65 29.82 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.944 1.697 . . . . 0.0 111.583 175.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 96.2 m -69.73 151.31 45.97 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.435 -0.791 . . . . 0.0 112.962 174.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.013 0 C-N-CA 124.085 0.85 . . . . 0.0 112.869 171.518 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.1 tttm . . . . . 0 N--CA 1.469 0.508 0 CA-C-O 120.412 0.149 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -68.97 151.25 46.76 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.686 0.794 . . . . 0.0 111.269 172.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.3 p -145.22 176.51 9.49 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.7 mmt-85 -133.37 -18.13 2.26 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 127.595 2.358 . . . . 0.0 113.242 169.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -146.13 163.81 34.17 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.885 1.674 . . . . 0.0 111.883 176.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -65.46 -22.48 66.75 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.322 -0.861 . . . . 0.0 112.539 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.9 m -68.18 -16.03 63.82 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.03 1.332 . . . . 0.0 113.284 176.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -74.33 -10.07 59.22 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.854 1.261 . . . . 0.0 113.539 173.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.2 m -123.88 150.92 63.79 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 125.091 1.357 . . . . 0.0 112.584 -169.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -79.27 166.97 22.05 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.432 2.754 . . . . 0.0 113.969 -175.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 32.81 -103.9 0.01 OUTLIER Glycine 0 CA--C 1.537 1.455 0 C-N-CA 128.62 3.01 . . . . 0.0 116.701 172.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -104.6 9.05 35.44 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.714 2.006 . . . . 0.0 113.716 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.4 m -67.52 164.51 18.78 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 122.618 1.199 . . . . 0.0 111.523 169.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.1 pt -130.54 164.4 33.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 128.65 2.78 . . . . 0.0 108.879 169.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 42.2 t -93.74 106.85 18.79 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 168.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -82.15 172.88 12.68 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.21 1.404 . . . . 0.0 111.459 -169.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.87 -17.34 71.34 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.672 1.129 . . . . 0.0 114.403 -170.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -77.79 -6.71 55.0 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.139 1.776 . . . . 0.0 114.183 171.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.73 33.09 43.45 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.147 -0.971 . . . . 0.0 113.938 -177.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -136.09 158.46 44.36 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.137 1.775 . . . . 0.0 111.531 175.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 80.0 m -69.06 158.2 35.29 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.729 0.776 . . . . 0.0 112.909 173.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.178 0 C-N-CA 125.277 1.418 . . . . 0.0 113.476 168.686 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.1 tttt . . . . . 0 N--CA 1.467 0.422 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.92 142.83 58.15 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.454 0.701 . . . . 0.0 110.219 171.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.3 p -138.77 174.01 10.97 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 -135.76 -17.23 1.7 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.041 2.136 . . . . 0.0 112.871 173.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -142.82 161.56 37.79 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.65 1.98 . . . . 0.0 110.607 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -69.87 -23.75 63.31 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.299 -0.876 . . . . 0.0 112.953 -178.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.7 m -70.84 -12.75 61.73 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.821 1.248 . . . . 0.0 113.434 175.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -70.88 -15.99 62.66 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.749 0.82 . . . . 0.0 113.082 171.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.2 m -115.58 150.32 44.5 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.737 1.215 . . . . 0.0 113.556 -168.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.96 166.52 21.01 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.67 2.913 . . . . 0.0 113.976 -174.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 40.05 -113.91 0.42 Allowed Glycine 0 CA--C 1.536 1.4 0 C-N-CA 127.313 2.387 . . . . 0.0 115.535 172.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.42 9.6 42.4 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.238 1.815 . . . . 0.0 113.743 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 61.3 m -68.26 168.5 12.26 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.553 1.168 . . . . 0.0 112.394 171.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.5 pt -136.07 169.65 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 129.088 2.955 . . . . 0.0 109.004 169.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.4 t -84.8 103.26 13.73 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 167.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -67.75 168.63 11.03 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.902 1.681 . . . . 0.0 111.176 -176.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.03 -16.61 70.87 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.859 1.219 . . . . 0.0 114.367 -175.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -77.69 -9.36 58.94 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.978 1.311 . . . . 0.0 114.208 172.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.69 14.46 56.7 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.779 1.18 . . . . 0.0 115.359 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -131.09 169.04 16.41 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.672 1.589 . . . . 0.0 111.747 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.6 m -70.2 150.47 46.43 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.123 -0.985 . . . . 0.0 113.579 177.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.243 0 C-N-CA 125.372 1.463 . . . . 0.0 112.299 174.382 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 81.8 tttt . . . . . 0 N--CA 1.466 0.328 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.49 143.6 57.69 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.604 0.762 . . . . 0.0 110.361 171.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.0 p -145.03 171.55 14.32 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -134.21 -13.93 2.36 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 127.542 2.337 . . . . 0.0 112.931 169.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -132.93 152.44 51.91 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.666 2.386 . . . . 0.0 110.093 -176.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -66.62 -25.25 66.5 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.212 -0.93 . . . . 0.0 112.263 171.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 56.7 p -72.07 -14.55 61.89 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.833 1.653 . . . . 0.0 113.988 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -68.31 -19.47 64.68 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.235 -0.916 . . . . 0.0 112.77 169.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.3 m -109.86 149.72 40.37 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 124.889 1.275 . . . . 0.0 113.275 -169.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.33 166.34 20.35 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.609 2.873 . . . . 0.0 113.899 -175.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 38.34 -110.06 0.12 Allowed Glycine 0 CA--C 1.538 1.512 0 C-N-CA 127.591 2.52 . . . . 0.0 115.848 172.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.48 7.27 42.52 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.17 1.788 . . . . 0.0 113.747 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 61.8 m -67.59 165.54 16.75 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 122.604 1.192 . . . . 0.0 111.929 171.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.6 pt -133.79 167.48 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 129.227 3.011 . . . . 0.0 108.653 169.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.9 t -85.9 103.28 14.48 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 168.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -67.03 169.38 8.45 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.721 1.608 . . . . 0.0 111.049 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.94 -16.61 70.69 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.757 1.17 . . . . 0.0 114.522 -174.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -81.05 -6.77 59.2 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.337 1.455 . . . . 0.0 114.393 173.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.59 20.38 48.12 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.485 1.041 . . . . 0.0 115.028 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -132.31 163.71 28.05 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.723 1.609 . . . . 0.0 111.687 177.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.5 m -70.21 148.32 48.76 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.307 -0.871 . . . . 0.0 112.916 176.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.156 0 C-N-CA 125.164 1.364 . . . . 0.0 112.462 174.255 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.0 tttm . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.85 146.68 53.52 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.96 0.904 . . . . 0.0 110.686 172.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.0 p -145.1 165.49 28.1 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 176.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -122.66 -17.14 7.0 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 127.509 2.324 . . . . 0.0 112.729 170.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -148.31 162.5 39.4 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 128.45 2.7 . . . . 0.0 110.016 -175.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -69.3 -23.22 63.78 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.146 -0.971 . . . . 0.0 112.953 -178.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.5 m -67.79 -17.3 64.48 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.555 1.542 . . . . 0.0 113.234 177.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -75.12 -10.75 59.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.17 1.388 . . . . 0.0 113.443 174.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 73.9 m -113.56 163.1 19.39 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -168.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.92 165.36 3.87 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.984 3.122 . . . . 0.0 114.096 169.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.43 -56.93 8.76 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 126.058 1.789 . . . . 0.0 115.942 -174.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.32 -14.54 55.18 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.6 m -74.53 166.6 23.26 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 123.051 1.405 . . . . 0.0 112.904 171.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 pt -132.78 167.68 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 129.139 2.976 . . . . 0.0 107.671 166.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.0 t -82.44 101.83 10.91 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.423 -0.798 . . . . 0.0 109.778 169.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.87 167.81 12.85 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.228 1.811 . . . . 0.0 111.567 -178.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.01 -15.18 76.29 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.911 1.244 . . . . 0.0 114.631 -173.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -77.37 -8.25 57.38 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.45 1.5 . . . . 0.0 114.166 173.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.23 13.86 59.68 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.737 1.16 . . . . 0.0 114.996 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -129.28 168.1 16.72 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.432 1.893 . . . . 0.0 111.064 177.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 82.4 m -74.03 153.84 39.5 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.262 -0.899 . . . . 0.0 113.242 176.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.124 0 C-N-CA 124.329 0.966 . . . . 0.0 113.451 171.283 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.9 tttt . . . . . 0 CA--C 1.536 0.412 0 N-CA-C 110.571 -0.159 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -65.91 143.23 57.55 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 169.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.0 p -136.45 173.49 11.65 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -175.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -136.64 -17.6 1.47 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.453 1.901 . . . . 0.0 112.577 169.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.61 155.4 39.17 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 127.846 2.458 . . . . 0.0 109.887 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -67.97 -25.76 65.6 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.223 -0.923 . . . . 0.0 112.223 169.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 77.4 p -71.33 -14.54 62.23 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.59 1.556 . . . . 0.0 114.022 175.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -65.55 -22.27 66.68 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.403 -0.81 . . . . 0.0 112.585 169.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.8 m -106.39 150.07 39.05 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -167.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -82.2 165.45 16.85 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.765 2.976 . . . . 0.0 113.523 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 44.1 -118.72 2.46 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.601 2.048 . . . . 0.0 114.877 173.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.64 7.05 47.15 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.1 1.76 . . . . 0.0 113.761 -178.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.4 m -66.03 160.04 24.61 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 123.077 1.417 . . . . 0.0 113.438 171.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.1 pt -127.55 167.3 22.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 129.505 3.122 . . . . 0.0 108.138 168.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.8 t -84.54 103.02 13.31 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 168.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -68.47 168.95 11.72 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.943 1.697 . . . . 0.0 111.073 -175.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.47 -16.41 69.46 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.659 1.123 . . . . 0.0 114.515 -176.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.8 p30 -78.77 -7.62 57.97 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.517 1.527 . . . . 0.0 114.419 173.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.33 14.54 60.07 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.649 1.119 . . . . 0.0 115.421 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -128.6 166.52 18.71 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.277 1.831 . . . . 0.0 111.866 177.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.6 m -69.38 143.1 53.79 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.476 -0.765 . . . . 0.0 112.672 174.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.167 0 C-N-CA 124.478 1.037 . . . . 0.0 112.615 171.237 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.6 tttt . . . . . 0 N--CA 1.468 0.436 0 CA-C-O 120.379 0.133 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -67.57 146.02 54.31 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.108 0.563 . . . . 0.0 110.147 169.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.9 p -139.37 172.96 12.06 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.36 -28.22 3.68 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 128.192 2.597 . . . . 0.0 111.564 174.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -148.14 164.41 33.97 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.698 1.999 . . . . 0.0 111.433 -175.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -66.92 -23.96 66.03 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.45 -0.781 . . . . 0.0 112.78 -176.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -66.7 -18.54 65.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.217 1.407 . . . . 0.0 112.825 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -71.55 -17.2 62.32 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.998 1.319 . . . . 0.0 113.219 175.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.6 m -111.31 148.67 39.25 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -167.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -81.93 163.19 18.25 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.744 2.963 . . . . 0.0 113.531 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 44.18 -119.69 2.96 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 126.332 1.92 . . . . 0.0 114.84 173.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.83 -0.86 57.81 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.694 1.598 . . . . 0.0 114.226 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.1 m -64.41 156.54 29.02 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 123.105 1.431 . . . . 0.0 113.105 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.0 pt -124.56 164.8 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 129.258 3.023 . . . . 0.0 108.562 170.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.1 t -84.41 102.84 13.07 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 168.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -67.22 169.55 8.5 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.94 1.696 . . . . 0.0 110.915 -176.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.56 -17.22 70.61 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.748 1.166 . . . . 0.0 114.605 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 56.9 p30 -81.86 -4.01 55.48 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.754 1.622 . . . . 0.0 114.375 173.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.84 29.81 45.83 Favored Glycine 0 CA--C 1.535 1.335 0 O-C-N 121.206 -0.934 . . . . 0.0 114.456 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -132.97 160.67 36.44 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.517 1.927 . . . . 0.0 111.267 172.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 77.7 m -69.0 144.55 54.07 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.817 -0.552 . . . . 0.0 112.232 172.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.04 0 C-N-CA 124.612 1.101 . . . . 0.0 111.81 172.883 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -64.45 145.26 56.37 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.235 1.014 . . . . 0.0 110.322 169.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.6 p -145.66 169.74 17.85 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.416 1.086 . . . . 0.0 113.732 -176.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -123.16 -25.26 4.53 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.53 2.332 . . . . 0.0 111.918 169.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -130.99 160.6 34.09 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.753 2.021 . . . . 0.0 110.879 -176.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -67.21 -25.51 66.15 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.438 -0.789 . . . . 0.0 112.492 173.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 56.3 p -70.7 -15.59 62.72 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.848 1.659 . . . . 0.0 113.972 175.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -68.86 -19.23 64.23 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.811 0.844 . . . . 0.0 112.937 169.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.8 m -108.25 159.86 29.13 Favored Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -168.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -57.65 167.11 4.21 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 124.509 3.473 . . . . 0.0 115.541 173.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -26.51 -72.66 0.03 OUTLIER Glycine 0 CA--C 1.536 1.344 0 C-N-CA 129.081 3.229 . . . . 0.0 117.588 -172.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.42 3.02 53.12 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.013 1.325 . . . . 0.0 113.92 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.6 m -73.14 167.06 21.93 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 122.723 1.249 . . . . 0.0 111.613 169.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.2 pt -135.16 164.64 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 129.095 2.958 . . . . 0.0 108.323 169.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.3 t -84.18 101.71 12.06 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 168.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -65.17 171.24 3.85 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.374 1.87 . . . . 0.0 111.149 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.49 -18.36 69.7 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.723 1.154 . . . . 0.0 114.451 -174.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -81.47 -6.87 59.39 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.155 1.382 . . . . 0.0 114.393 173.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.23 20.14 50.25 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 124.53 1.062 . . . . 0.0 115.266 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -130.87 161.47 31.77 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.68 1.592 . . . . 0.0 111.766 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.2 m -71.15 139.29 50.18 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.453 -0.779 . . . . 0.0 112.713 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.121 0 C-N-CA 124.499 1.047 . . . . 0.0 113.162 174.547 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 77.6 tttt . . . . . 0 N--CA 1.468 0.457 0 N-CA-C 111.314 0.116 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -63.49 146.15 54.21 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.281 1.033 . . . . 0.0 109.73 169.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.3 p -142.09 168.54 19.51 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 38.4 mtm180 -124.19 -21.45 5.01 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 128.494 2.717 . . . . 0.0 112.428 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -154.88 163.42 40.31 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 128.81 2.844 . . . . 0.0 109.965 -174.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -67.74 -24.96 65.41 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.276 -0.89 . . . . 0.0 112.65 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.5 m -71.59 -13.91 61.92 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.729 1.212 . . . . 0.0 113.48 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -72.32 -18.64 61.75 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.832 1.253 . . . . 0.0 112.376 171.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 76.2 m -104.93 159.78 28.18 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.092 1.357 . . . . 0.0 113.724 -169.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.08 166.62 27.39 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.191 2.594 . . . . 0.0 112.659 175.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -34.14 -63.09 0.44 Allowed Glycine 0 CA--C 1.537 1.446 0 C-N-CA 127.967 2.699 . . . . 0.0 117.449 -169.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.35 -12.03 57.0 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.5 m -78.41 164.69 24.57 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 123.14 1.447 . . . . 0.0 113.204 173.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.5 pt -130.0 163.87 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 129.706 3.202 . . . . 0.0 107.72 167.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 39.7 t -89.37 102.93 15.6 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 121.612 -0.68 . . . . 0.0 109.856 171.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -82.0 173.45 12.18 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.681 1.192 . . . . 0.0 111.828 -169.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.57 -16.11 71.46 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.771 1.177 . . . . 0.0 114.32 -170.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 39.4 p-10 -77.06 -9.06 58.47 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.32 1.448 . . . . 0.0 114.273 172.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.73 16.96 57.56 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.687 1.137 . . . . 0.0 115.082 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -131.34 162.79 29.29 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.449 1.499 . . . . 0.0 112.029 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.3 m -69.89 144.85 52.36 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.717 0.807 . . . . 0.0 112.223 172.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.134 0 C-N-CA 124.416 1.008 . . . . 0.0 113.386 174.023 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 81.8 tttt . . . . . 0 N--CA 1.467 0.396 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -66.04 143.7 57.18 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.357 0.663 . . . . 0.0 110.567 171.176 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.9 p -149.12 170.23 18.88 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.732 1.213 . . . . 0.0 113.924 -172.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -136.26 -8.89 1.99 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.991 2.116 . . . . 0.0 112.836 169.302 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -132.41 151.42 51.88 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 127.687 2.395 . . . . 0.0 109.813 -179.349 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -66.99 -24.18 66.01 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.362 -0.836 . . . . 0.0 112.219 171.74 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.7 p -72.29 -16.34 61.9 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.765 1.626 . . . . 0.0 114.004 174.339 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -65.93 -28.25 68.78 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.099 0.863 . . . . 0.0 112.383 169.119 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.5 m -96.0 161.23 28.0 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.352 1.461 . . . . 0.0 113.295 -170.574 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -68.2 162.57 39.7 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.95 2.433 . . . . 0.0 112.136 173.084 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -36.79 -58.65 1.15 Allowed Glycine 0 N--CA 1.475 1.28 0 C-N-CA 127.607 2.527 . . . . 0.0 117.283 -169.643 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.21 -17.18 53.05 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -175.741 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.9 m -77.16 168.75 19.53 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 123.046 1.403 . . . . 0.0 113.864 171.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.8 pt -132.35 166.16 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 130.472 3.509 . . . . 0.0 107.806 168.294 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.8 t -86.26 103.92 15.32 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.557 -0.715 . . . . 0.0 109.151 169.022 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -67.77 170.57 7.73 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.194 1.798 . . . . 0.0 111.029 -175.642 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.58 -16.15 71.55 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.733 1.158 . . . . 0.0 114.604 -173.387 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -83.54 -3.11 57.36 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.45 1.5 . . . . 0.0 114.341 174.246 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.95 21.93 56.35 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.154 0.883 . . . . 0.0 114.603 -179.07 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -131.84 159.99 36.95 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.898 1.679 . . . . 0.0 111.581 175.67 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.9 m -68.63 147.27 52.14 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.638 -0.664 . . . . 0.0 112.166 176.631 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.864 0 C-N-CA 124.776 1.179 . . . . 0.0 111.449 173.814 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt . . . . . 0 N--CA 1.471 0.613 0 CA-C-O 120.483 0.182 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -67.96 142.06 56.1 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 167.577 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 p -141.1 171.03 14.63 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -171.683 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -133.39 -15.2 2.51 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.686 2.394 . . . . 0.0 112.662 174.065 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -135.06 153.62 51.98 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.329 2.252 . . . . 0.0 110.152 -176.681 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -66.4 -23.23 66.28 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.475 -0.765 . . . . 0.0 111.793 168.999 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.0 m -68.62 -20.46 64.49 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.779 2.032 . . . . 0.0 113.427 175.604 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -67.53 -29.95 69.49 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.681 0.792 . . . . 0.0 112.425 172.577 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.9 m -96.03 159.46 32.19 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.228 1.411 . . . . 0.0 113.702 -169.577 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.74 167.1 26.7 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.29 2.66 . . . . 0.0 112.712 175.089 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -34.85 -62.25 0.56 Allowed Glycine 0 CA--C 1.536 1.354 0 C-N-CA 128.067 2.746 . . . . 0.0 117.489 -169.817 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.05 -13.88 58.96 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -175.579 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.3 m -81.17 167.55 19.53 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 123.268 1.508 . . . . 0.0 113.722 173.735 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.5 pt -133.18 166.54 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 131.19 3.796 . . . . 0.0 107.234 167.074 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.4 t -84.91 102.75 13.38 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.408 -0.807 . . . . 0.0 108.986 169.042 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -66.82 168.0 10.43 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.93 1.692 . . . . 0.0 111.194 -174.618 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.2 -17.72 68.43 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.79 1.186 . . . . 0.0 114.325 -178.283 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -77.88 -7.73 57.11 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.499 1.519 . . . . 0.0 114.331 172.153 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.17 13.99 61.13 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.64 1.114 . . . . 0.0 115.485 178.407 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -130.28 166.05 21.16 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.031 1.733 . . . . 0.0 111.418 176.711 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.2 m -70.85 141.74 51.25 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.435 -0.791 . . . . 0.0 112.894 178.266 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.181 0 C-N-CA 125.49 1.519 . . . . 0.0 112.201 174.515 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -54.63 136.47 45.37 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.55 -0.719 . . . . 0.0 111.504 173.816 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.4 p -140.13 169.65 17.3 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -170.457 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -119.83 -30.14 4.82 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 128.381 2.672 . . . . 0.0 111.56 -179.782 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -152.8 164.61 37.5 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 127.922 2.489 . . . . 0.0 110.694 -172.526 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -65.73 -23.8 66.83 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.512 -0.743 . . . . 0.0 112.79 -177.719 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.1 m -67.28 -18.41 65.19 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.4 1.48 . . . . 0.0 113.217 177.648 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -74.0 -13.76 60.92 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.723 1.209 . . . . 0.0 113.193 174.134 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.2 m -111.57 149.28 40.47 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 125.008 1.323 . . . . 0.0 112.897 -172.46 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -77.46 163.84 29.27 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.362 2.708 . . . . 0.0 113.846 -175.38 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 36.91 -112.29 0.15 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 127.449 2.452 . . . . 0.0 115.746 173.959 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.01 5.45 48.77 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.42 1.888 . . . . 0.0 113.909 -177.531 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.2 m -66.81 168.29 9.9 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 122.423 1.106 . . . . 0.0 112.188 174.184 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.3 pt -135.27 162.91 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 128.093 2.557 . . . . 0.0 109.745 173.863 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.2 t -86.02 103.28 14.56 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 168.849 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -65.74 169.3 6.57 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.364 1.865 . . . . 0.0 111.21 -176.582 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.51 -17.95 71.27 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.814 1.197 . . . . 0.0 114.416 -173.218 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -82.02 -5.43 58.35 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.195 1.398 . . . . 0.0 114.348 173.116 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.92 24.29 38.55 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.369 0.985 . . . . 0.0 114.931 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -133.5 164.2 27.68 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.396 1.879 . . . . 0.0 111.161 177.526 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 89.5 m -73.84 156.21 37.99 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.038 -1.039 . . . . 0.0 112.948 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.142 0 C-N-CA 124.96 1.267 . . . . 0.0 112.271 172.692 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.9 tttp . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -64.27 145.62 55.7 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.678 0.791 . . . . 0.0 110.093 173.453 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.3 p -141.86 168.12 20.51 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -173.828 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -116.33 -28.5 6.49 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.572 2.349 . . . . 0.0 112.016 177.374 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -151.64 172.97 15.24 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.632 2.373 . . . . 0.0 110.133 -176.819 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -70.53 -26.39 63.54 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.501 0.72 . . . . 0.0 112.532 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.7 p -68.61 -16.02 63.71 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.637 1.575 . . . . 0.0 113.858 174.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -73.61 -12.04 60.62 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.875 0.87 . . . . 0.0 113.167 169.71 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 79.8 m -112.01 158.3 37.25 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -169.071 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.74 167.11 7.26 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 124.32 3.347 . . . . 0.0 115.652 176.598 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -1.89 -86.4 0.0 OUTLIER Glycine 0 N--CA 1.477 1.388 0 C-N-CA 130.238 3.78 . . . . 0.0 117.645 177.976 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -107.86 10.53 28.57 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.239 1.415 . . . . 0.0 113.502 -178.026 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 67.2 m -66.99 167.13 12.3 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.468 1.128 . . . . 0.0 111.761 169.528 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.7 pt -133.11 161.69 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 128.03 2.532 . . . . 0.0 109.27 169.568 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.5 t -86.95 99.82 12.14 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.741 0.816 . . . . 0.0 109.65 170.335 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -77.06 174.65 10.41 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.97 1.308 . . . . 0.0 111.868 -170.698 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.39 -16.04 68.84 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.898 1.237 . . . . 0.0 114.464 -171.917 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -76.04 -8.05 56.09 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.589 1.556 . . . . 0.0 114.253 170.412 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.26 15.33 64.69 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.947 1.261 . . . . 0.0 114.859 -178.565 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -131.39 160.97 33.5 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.856 1.662 . . . . 0.0 112.114 -178.071 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 70.9 m -68.33 141.88 55.67 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.904 0.881 . . . . 0.0 112.211 176.967 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.068 0 C-N-CA 123.794 0.712 . . . . 0.0 113.151 176.008 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.7 tttm . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 120.386 0.136 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.83 148.09 50.22 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.812 1.245 . . . . 0.0 110.822 176.257 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.4 p -144.78 171.32 14.59 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 177.013 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -128.41 -24.55 3.06 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 128.408 2.683 . . . . 0.0 112.098 169.713 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.7 ptm85 -145.12 166.17 26.17 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.442 1.897 . . . . 0.0 111.834 178.762 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -67.58 -20.98 65.44 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.281 -0.887 . . . . 0.0 112.724 -176.135 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.2 m -67.47 -17.09 64.55 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.618 1.167 . . . . 0.0 113.182 175.75 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -74.49 -10.75 59.87 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.387 1.475 . . . . 0.0 113.347 173.662 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.5 m -119.09 158.39 48.3 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.07 1.348 . . . . 0.0 113.346 -168.668 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.08 165.97 30.67 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.123 2.549 . . . . 0.0 112.254 174.086 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -39.34 -57.7 2.15 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 127.426 2.441 . . . . 0.0 117.234 -169.768 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.03 -17.46 52.71 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -177.099 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.4 m -79.09 164.8 24.0 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 123.283 1.515 . . . . 0.0 112.752 169.686 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.9 pt -132.52 167.31 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 129.767 3.227 . . . . 0.0 107.512 167.065 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.9 t -80.08 101.61 8.84 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.299 -0.876 . . . . 0.0 109.744 169.455 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.86 169.57 12.86 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.104 1.762 . . . . 0.0 111.632 -177.669 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.45 -13.96 79.71 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.848 1.213 . . . . 0.0 114.598 -173.792 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -79.15 -6.73 57.22 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.638 1.575 . . . . 0.0 114.29 174.885 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.41 12.72 62.59 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.642 1.115 . . . . 0.0 114.805 -177.504 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -129.71 167.96 17.23 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.405 1.882 . . . . 0.0 111.031 176.392 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.2 m -70.04 152.95 43.8 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.25 -0.907 . . . . 0.0 112.679 173.664 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.973 0 C-N-CA 124.423 1.011 . . . . 0.0 113.781 171.662 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.4 tttp . . . . . 0 N--CA 1.468 0.449 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -63.63 143.75 57.57 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.997 0.919 . . . . 0.0 111.141 174.232 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 p -144.04 173.1 12.02 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.937 1.295 . . . . 0.0 114.193 -176.052 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -132.27 -20.04 2.43 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.256 2.222 . . . . 0.0 112.628 170.034 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -142.6 164.36 30.32 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.113 1.765 . . . . 0.0 111.754 178.015 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -67.4 -22.65 65.53 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.509 -0.744 . . . . 0.0 112.554 -176.751 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.0 m -66.99 -18.0 65.18 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.458 1.503 . . . . 0.0 113.128 176.423 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -74.14 -12.65 60.65 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.056 1.342 . . . . 0.0 113.371 174.952 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 81.6 m -115.99 151.18 46.23 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -168.402 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -80.58 167.37 18.99 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.662 2.908 . . . . 0.0 113.941 -174.658 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 39.8 -108.03 0.09 OUTLIER Glycine 0 CA--C 1.534 1.264 0 C-N-CA 127.644 2.545 . . . . 0.0 115.497 172.256 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.35 6.88 30.89 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.281 1.832 . . . . 0.0 113.673 -177.823 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 75.3 m -66.41 168.82 8.31 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 122.626 1.203 . . . . 0.0 112.938 175.693 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.6 pt -131.83 169.69 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 129.067 2.947 . . . . 0.0 108.962 169.061 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.9 t -87.73 108.36 19.08 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.659 -0.651 . . . . 0.0 109.333 168.091 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 -66.1 168.35 8.55 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.61 1.564 . . . . 0.0 111.451 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.51 -17.91 73.15 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.832 1.206 . . . . 0.0 114.478 -176.837 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -80.37 -5.96 57.26 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.694 1.197 . . . . 0.0 114.092 172.684 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.82 24.08 36.65 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.521 1.058 . . . . 0.0 114.972 -179.87 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -134.84 161.96 33.75 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.675 1.59 . . . . 0.0 111.9 177.125 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.5 m -69.24 144.78 53.57 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.321 -0.862 . . . . 0.0 113.319 179.797 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.035 0 C-N-CA 124.543 1.068 . . . . 0.0 113.167 179.007 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 76.3 tttt . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -54.86 136.3 47.02 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.417 -0.802 . . . . 0.0 111.404 172.638 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.8 p -141.99 165.53 27.21 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.143 1.377 . . . . 0.0 114.191 -170.831 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -116.73 -19.5 9.91 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.871 2.068 . . . . 0.0 112.841 -179.069 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -160.69 163.41 32.46 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 128.863 2.865 . . . . 0.0 109.468 -169.011 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -66.95 -26.7 66.96 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.139 -0.976 . . . . 0.0 112.666 179.286 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.3 m -71.05 -15.42 62.54 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.509 1.524 . . . . 0.0 113.622 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -72.37 -22.49 61.14 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.192 0.997 . . . . 0.0 112.389 170.507 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 75.3 m -94.6 151.37 39.16 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.4 1.08 . . . . 0.0 112.813 -174.575 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.16 160.78 26.46 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.444 2.763 . . . . 0.0 113.168 -178.282 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 27.4 -99.04 0.01 OUTLIER Glycine 0 CA--C 1.536 1.348 0 C-N-CA 128.694 3.045 . . . . 0.0 116.671 174.233 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -95.92 -3.63 44.9 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 -173.122 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.3 m -68.74 165.04 20.38 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 122.992 1.377 . . . . 0.0 113.153 175.954 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.5 pt -124.21 166.17 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 129.551 3.14 . . . . 0.0 107.844 167.539 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.6 t -97.6 107.0 19.41 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.771 0.828 . . . . 0.0 108.815 169.267 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -65.1 165.81 10.57 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.619 1.168 . . . . 0.0 111.132 179.236 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.13 -16.71 71.18 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.052 1.31 . . . . 0.0 114.475 -175.803 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -77.41 -5.92 51.52 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.044 1.338 . . . . 0.0 114.027 170.801 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.62 28.26 30.06 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.487 1.041 . . . . 0.0 114.683 179.088 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -135.93 158.5 44.24 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.54 1.536 . . . . 0.0 111.862 176.743 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.9 m -77.54 163.83 25.93 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 122.124 0.964 . . . . 0.0 113.366 -179.829 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.131 0 C-N-CA 125.402 1.477 . . . . 0.0 111.897 169.652 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt . . . . . 0 N--CA 1.469 0.485 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -67.41 141.56 57.0 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.219 0.607 . . . . 0.0 109.976 168.955 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.5 p -141.31 171.36 14.17 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.471 1.108 . . . . 0.0 113.741 -171.97 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -136.3 -10.12 1.95 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.326 1.85 . . . . 0.0 113.158 172.692 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.3 ttt-85 -141.31 168.2 20.34 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.672 1.589 . . . . 0.0 110.451 171.66 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -72.5 -26.97 61.98 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.371 0.669 . . . . 0.0 112.253 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.0 p -70.03 -13.41 62.21 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.28 1.832 . . . . 0.0 113.82 175.481 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.58 -23.49 65.4 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.486 -0.759 . . . . 0.0 112.403 168.995 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.8 m -107.22 161.71 22.11 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 124.838 1.255 . . . . 0.0 114.137 -168.535 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -56.54 167.3 2.88 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 124.594 3.529 . . . . 0.0 115.446 173.038 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -32.09 -67.52 0.16 Allowed Glycine 0 CA--C 1.538 1.493 0 C-N-CA 128.521 2.963 . . . . 0.0 117.095 -171.82 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.38 -0.51 56.53 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -177.32 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 65.1 m -74.07 169.64 17.09 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.668 1.223 . . . . 0.0 112.044 173.517 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 24.4 pt -137.13 166.61 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 128.762 2.825 . . . . 0.0 108.707 169.966 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.6 t -86.96 104.42 16.26 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 167.875 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -66.37 169.46 7.34 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.683 1.593 . . . . 0.0 111.026 -175.906 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.71 -17.32 68.99 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.701 1.143 . . . . 0.0 114.242 -176.482 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 53.9 p30 -79.34 -6.52 56.95 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.469 1.507 . . . . 0.0 114.405 172.446 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.57 17.81 57.88 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.662 1.125 . . . . 0.0 115.22 179.885 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -130.88 161.8 31.03 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.839 1.655 . . . . 0.0 111.928 178.275 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 97.7 m -68.2 145.81 53.96 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.614 -0.679 . . . . 0.0 112.727 178.038 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.088 0 C-N-CA 124.64 1.115 . . . . 0.0 112.469 174.542 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.1 145.33 53.58 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.462 1.105 . . . . 0.0 110.822 173.834 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 p -143.99 167.05 23.28 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 177.93 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -121.98 -21.52 5.98 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.674 2.39 . . . . 0.0 112.463 169.276 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.67 168.97 20.69 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.278 1.831 . . . . 0.0 111.417 177.164 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -66.23 -22.91 66.34 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.27 -0.894 . . . . 0.0 112.755 -177.51 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.2 m -66.27 -17.74 64.93 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.741 1.617 . . . . 0.0 113.378 177.471 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -74.27 -13.73 60.81 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.446 1.498 . . . . 0.0 113.747 174.133 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.5 m -117.44 159.12 43.06 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -167.469 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -56.05 168.69 1.75 Allowed 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 125.106 3.87 . . . . 0.0 116.189 172.198 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -35.66 -65.52 0.45 Allowed Glycine 0 CA--C 1.535 1.287 0 C-N-CA 128.45 2.928 . . . . 0.0 117.451 -170.633 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.46 1.8 55.75 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.635 1.174 . . . . 0.0 114.035 -178.797 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.9 m -74.97 168.21 20.4 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.777 1.275 . . . . 0.0 112.109 170.841 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.5 pt -136.58 165.15 29.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 129.586 3.154 . . . . 0.0 107.894 168.224 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.3 t -83.21 101.23 11.09 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 168.015 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -65.97 169.5 6.69 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.876 1.67 . . . . 0.0 110.748 -175.231 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.91 -16.96 69.0 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.662 1.125 . . . . 0.0 114.39 -174.751 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -79.7 -9.29 59.62 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.32 1.448 . . . . 0.0 114.454 173.841 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.43 15.74 56.53 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.667 1.127 . . . . 0.0 115.336 -178.35 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -129.67 164.86 23.0 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.513 1.525 . . . . 0.0 111.245 176.922 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.6 m -70.19 146.45 50.75 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.264 -0.898 . . . . 0.0 112.734 177.397 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.035 0 C-N-CA 125.139 1.352 . . . . 0.0 111.598 174.301 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt . . . . . 0 N--CA 1.47 0.544 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -63.19 144.11 57.21 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.356 1.062 . . . . 0.0 110.926 171.863 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.0 p -143.9 172.6 12.63 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -175.445 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -132.63 -15.47 2.74 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 127.373 2.269 . . . . 0.0 113.649 171.166 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.5 ttp180 -144.06 170.82 15.21 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.032 1.733 . . . . 0.0 110.971 172.382 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -70.72 -24.2 62.59 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.46 0.704 . . . . 0.0 112.286 178.9 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.4 m -64.32 -20.64 66.23 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.141 1.776 . . . . 0.0 113.017 174.959 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.86 -16.03 62.67 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.443 1.097 . . . . 0.0 113.437 173.107 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 56.0 m -116.14 151.82 47.09 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.911 1.285 . . . . 0.0 113.313 -169.035 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.06 164.21 22.44 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.316 2.677 . . . . 0.0 113.592 -176.959 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 26.85 -100.9 0.01 OUTLIER Glycine 0 CA--C 1.537 1.448 0 C-N-CA 129.033 3.206 . . . . 0.0 117.307 172.429 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.69 2.11 51.72 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.791 1.636 . . . . 0.0 113.929 -174.764 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.0 m -72.04 166.16 22.81 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 122.771 1.272 . . . . 0.0 112.063 172.597 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.9 pt -135.46 166.15 28.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 129.514 3.126 . . . . 0.0 108.045 168.514 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.9 t -83.14 101.28 11.08 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 168.011 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -65.42 170.27 5.05 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.153 1.781 . . . . 0.0 110.911 -175.805 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.71 -17.4 69.09 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.648 1.118 . . . . 0.0 114.517 -173.799 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.9 p-10 -79.97 -8.04 59.13 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.379 1.472 . . . . 0.0 114.434 172.918 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.4 20.08 49.92 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.634 1.111 . . . . 0.0 115.091 -178.128 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -132.27 161.56 33.17 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.606 1.562 . . . . 0.0 111.761 178.287 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.6 m -70.17 140.31 52.54 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.322 -0.862 . . . . 0.0 112.565 178.236 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.077 0 C-N-CA 125.289 1.423 . . . . 0.0 111.649 175.273 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -93.79 -1.91 65.31 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 123.998 0.809 . . . . 0.0 113.941 173.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.7 m 64.17 -42.92 0.27 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 129.569 3.148 . . . . 0.0 116.36 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -62.77 -30.66 71.62 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.433 1.493 . . . . 0.0 113.355 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.37 1.57 82.27 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.406 1.479 . . . . 0.0 114.671 174.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 113.48 -175.08 16.19 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 126.31 1.909 . . . . 0.0 112.964 -172.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 55.3 t -78.92 112.48 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.465 1.106 . . . . 0.0 110.308 170.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.8 t -79.87 139.57 53.89 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.106 168.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -55.16 -8.17 1.44 Allowed 'Trans proline' 0 CA--C 1.548 1.224 1 C-N-CA 125.503 4.135 . . . . 0.0 117.427 168.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt 51.83 64.84 1.69 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 127.35 2.26 . . . . 0.0 113.665 174.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 47.4 pt -78.84 147.85 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.701 1.201 . . . . 0.0 110.826 172.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.8 mp -80.66 42.45 0.61 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.743 1.617 . . . . 0.0 111.774 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -79.49 113.23 17.47 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.24 1.416 . . . . 0.0 109.956 173.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -66.05 145.44 55.86 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.1 0.56 . . . . 0.0 110.46 170.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.8 p -144.84 171.63 14.15 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -174.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -119.71 -28.51 5.24 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 128.205 2.602 . . . . 0.0 111.574 172.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -149.31 173.18 13.79 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.271 1.428 . . . . 0.0 112.292 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -66.09 -27.06 67.78 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.876 1.27 . . . . 0.0 112.497 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.8 m -66.36 -19.8 65.9 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.554 1.542 . . . . 0.0 112.915 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -70.04 -25.35 63.52 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 82.9 m -96.28 157.32 35.77 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.489 1.116 . . . . 0.0 113.646 -169.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.25 161.36 46.04 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.993 2.462 . . . . 0.0 112.46 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -12.34 -75.11 0.01 OUTLIER Glycine 0 N--CA 1.477 1.373 0 C-N-CA 129.506 3.432 . . . . 0.0 117.984 -173.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.51 -8.58 52.5 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -172.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.4 m -74.5 166.43 23.54 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 122.853 1.311 . . . . 0.0 113.151 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.4 pt -128.92 162.19 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 129.447 3.099 . . . . 0.0 108.599 168.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.8 t -86.19 100.15 12.03 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 169.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -65.09 171.08 3.88 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.168 2.187 . . . . 0.0 111.305 -174.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.64 -17.3 70.84 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.848 1.214 . . . . 0.0 114.6 -173.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -84.85 -2.66 58.06 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.322 1.449 . . . . 0.0 114.358 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.0 22.74 51.79 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.226 0.917 . . . . 0.0 114.884 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -130.99 159.8 36.43 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.558 1.543 . . . . 0.0 111.905 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.0 m -69.38 145.57 52.79 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.301 0.641 . . . . 0.0 112.1 175.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.781 0 C-N-CA 124.728 1.156 . . . . 0.0 111.915 174.243 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.7 m . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.91 153.6 17.07 Favored Glycine 0 N--CA 1.472 1.044 0 C-N-CA 124.361 0.981 . . . . 0.0 112.254 173.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.6 m -61.66 -35.54 78.26 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.434 1.093 . . . . 0.0 113.667 -175.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -88.42 -12.87 41.95 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.132 1.373 . . . . 0.0 113.337 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.25 -48.72 3.22 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.613 1.578 . . . . 0.0 113.762 -176.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 118.73 -170.49 13.82 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.242 1.401 . . . . 0.0 114.157 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 m -65.59 96.22 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.006 1.322 . . . . 0.0 112.307 171.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.7 t -83.87 141.84 41.44 Favored Pre-proline 0 CA--C 1.547 0.833 0 O-C-N 121.73 -0.606 . . . . 0.0 110.846 168.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.96 -4.14 0.34 Allowed 'Trans proline' 0 CA--C 1.551 1.369 1 C-N-CA 125.563 4.175 . . . . 0.0 117.392 167.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt 48.02 68.53 0.66 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 127.842 2.457 . . . . 0.0 113.527 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 45.3 pt -78.55 155.6 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.865 1.266 . . . . 0.0 111.07 174.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.9 mp -82.17 19.76 1.13 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.871 1.668 . . . . 0.0 112.808 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -66.49 117.02 8.12 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.088 1.355 . . . . 0.0 110.966 174.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -66.6 149.49 50.41 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.978 0.911 . . . . 0.0 110.236 169.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.2 p -144.73 172.17 13.37 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -128.63 -22.45 3.3 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.966 2.506 . . . . 0.0 112.23 170.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -144.38 164.03 32.01 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.482 1.913 . . . . 0.0 111.57 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -66.91 -23.08 65.95 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.394 -0.816 . . . . 0.0 112.593 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.4 m -67.4 -17.66 64.81 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.252 1.421 . . . . 0.0 113.216 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -72.9 -20.25 61.12 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.848 1.259 . . . . 0.0 113.268 173.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.4 m -106.2 163.66 16.58 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -167.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -55.84 164.4 4.67 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 124.071 3.181 . . . . 0.0 113.929 169.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.7 -54.08 18.89 Favored Glycine 0 N--CA 1.475 1.257 0 C-N-CA 125.894 1.711 . . . . 0.0 115.519 -175.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.68 -17.74 50.17 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.8 m -75.65 167.72 21.36 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 123.16 1.457 . . . . 0.0 113.192 171.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.8 pt -133.44 167.78 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 129.39 3.076 . . . . 0.0 107.467 166.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.0 t -83.89 103.05 12.83 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.479 -0.763 . . . . 0.0 109.801 169.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.38 165.67 13.75 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.794 1.638 . . . . 0.0 111.145 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.93 -14.33 75.9 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.997 1.284 . . . . 0.0 114.439 -174.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.5 p-10 -78.27 -6.18 54.22 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.643 1.577 . . . . 0.0 114.123 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.89 19.04 55.04 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.412 1.006 . . . . 0.0 114.725 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -131.56 165.02 24.55 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.063 1.745 . . . . 0.0 111.684 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 80.9 m -74.45 151.21 39.63 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.606 -0.684 . . . . 0.0 112.832 173.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.029 0 C-N-CA 124.364 0.983 . . . . 0.0 113.144 171.56 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -99.13 -6.3 55.79 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.442 1.02 . . . . 0.0 115.597 -175.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.3 t -146.14 130.4 17.57 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.97 1.308 . . . . 0.0 111.872 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -70.81 -11.35 60.9 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.917 1.287 . . . . 0.0 113.53 169.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.79 -0.06 88.91 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.405 1.479 . . . . 0.0 114.687 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -146.36 -169.28 14.08 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 126.662 2.077 . . . . 0.0 112.358 177.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.1 m -130.79 153.02 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.663 1.185 . . . . 0.0 112.785 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.4 t -141.44 140.58 20.83 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.037 1.335 . . . . 0.0 109.434 168.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -54.66 -8.62 1.33 Allowed 'Trans proline' 0 CA--C 1.547 1.148 1 C-N-CA 125.856 4.371 . . . . 0.0 118.56 171.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.5 mttp 49.69 45.2 24.67 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 127.132 2.173 . . . . 0.0 114.022 -177.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.4 pt -79.06 148.92 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 125.501 1.521 . . . . 0.0 111.023 176.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.1 mp -78.92 45.94 0.65 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.058 1.743 . . . . 0.0 111.324 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -80.93 108.5 14.65 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.566 1.546 . . . . 0.0 110.284 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -63.58 144.97 56.57 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.993 0.917 . . . . 0.0 110.863 172.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 p -147.21 173.47 12.51 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -174.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -133.2 -14.88 2.59 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 127.322 2.249 . . . . 0.0 113.295 172.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -144.52 163.41 33.93 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 127.096 2.158 . . . . 0.0 110.724 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -69.34 -22.55 63.75 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.615 -0.678 . . . . 0.0 112.682 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.4 m -69.51 -15.33 63.23 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.426 1.09 . . . . 0.0 113.128 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -74.1 -11.91 60.45 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.763 1.225 . . . . 0.0 113.108 174.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 76.9 m -113.73 147.58 37.95 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.597 1.159 . . . . 0.0 114.04 -168.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -80.82 160.46 21.42 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.607 2.871 . . . . 0.0 113.423 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 43.67 -118.27 2.09 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.685 2.088 . . . . 0.0 114.889 174.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.8 3.05 55.47 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.007 1.723 . . . . 0.0 113.803 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.0 m -64.5 151.84 43.36 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.764 1.269 . . . . 0.0 112.532 169.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.2 pt -120.87 164.25 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 128.203 2.601 . . . . 0.0 108.4 169.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.9 t -82.99 101.1 10.86 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 169.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -66.4 170.85 5.5 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.442 1.897 . . . . 0.0 111.1 -176.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.21 -17.63 70.34 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.721 1.153 . . . . 0.0 114.542 -173.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -82.43 -4.91 58.24 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.308 1.443 . . . . 0.0 114.369 173.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.2 22.89 46.62 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.31 0.957 . . . . 0.0 114.993 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -132.79 160.23 37.48 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.555 1.542 . . . . 0.0 111.851 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.2 m -68.98 142.51 54.64 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.602 -0.686 . . . . 0.0 112.396 176.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.111 0 C-N-CA 124.503 1.049 . . . . 0.0 112.53 172.295 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -102.48 -176.15 27.31 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.376 0.989 . . . . 0.0 115.313 -176.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.4 m -60.43 -12.41 9.44 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.548 1.939 . . . . 0.0 115.067 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -58.63 -28.57 65.76 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.405 1.482 . . . . 0.0 112.779 169.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 82.28 -3.02 83.22 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.37 1.462 . . . . 0.0 115.387 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.53 164.68 50.71 Favored Glycine 0 CA--C 1.537 1.437 0 CA-C-N 118.744 1.272 . . . . 0.0 113.203 173.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.3 t -84.78 97.67 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.166 0.986 . . . . 0.0 111.053 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.1 t -79.55 141.14 56.08 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 166.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -54.88 -6.97 0.75 Allowed 'Trans proline' 0 CA--C 1.55 1.297 0 C-N-CA 125.25 3.967 . . . . 0.0 117.953 168.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 45.66 55.89 6.35 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 127.582 2.353 . . . . 0.0 113.955 178.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.56 152.22 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.925 1.29 . . . . 0.0 111.382 176.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.0 mt -79.35 35.16 0.27 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.765 1.626 . . . . 0.0 113.362 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -70.27 112.49 6.64 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.962 -1.086 . . . . 0.0 110.086 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -68.38 142.78 55.34 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.239 0.616 . . . . 0.0 109.476 168.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.3 p -141.73 168.13 20.49 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -172.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -122.14 -21.04 6.04 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 127.328 2.251 . . . . 0.0 112.742 171.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.69 167.69 24.84 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.257 1.423 . . . . 0.0 111.358 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -65.92 -22.25 66.49 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.311 -0.868 . . . . 0.0 112.538 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.8 m -66.83 -19.25 65.7 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.821 1.648 . . . . 0.0 113.371 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -69.14 -30.9 69.24 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.583 1.153 . . . . 0.0 112.637 172.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.5 m -96.48 151.87 38.29 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -168.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.05 160.04 23.82 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.535 2.824 . . . . 0.0 113.079 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 23.11 -97.97 0.01 OUTLIER Glycine 0 CA--C 1.538 1.489 0 C-N-CA 129.2 3.286 . . . . 0.0 117.085 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.02 -4.28 54.7 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -173.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.5 m -72.86 163.14 28.58 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 122.905 1.336 . . . . 0.0 112.983 171.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.7 pt -130.04 165.76 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 129.642 3.177 . . . . 0.0 108.157 168.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.0 t -83.59 102.04 11.9 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 168.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -66.22 170.47 5.79 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.294 1.838 . . . . 0.0 111.251 -175.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.48 -17.89 71.15 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.709 1.147 . . . . 0.0 114.452 -173.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -82.22 -4.7 57.6 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.141 1.376 . . . . 0.0 114.337 173.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.77 20.9 52.68 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.299 0.952 . . . . 0.0 115.017 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -131.66 162.03 31.36 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.838 1.655 . . . . 0.0 111.762 176.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 75.2 m -71.86 145.36 48.62 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.523 -0.736 . . . . 0.0 112.954 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.232 0 C-N-CA 125.198 1.38 . . . . 0.0 112.08 171.825 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.5 m . . . . . 0 N--CA 1.475 0.797 0 CA-C-O 119.344 -0.36 . . . . 0.0 111.746 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -117.49 -2.41 17.48 Favored Glycine 0 N--CA 1.478 1.484 0 C-N-CA 124.541 1.067 . . . . 0.0 115.762 -174.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.4 t -143.16 144.54 32.24 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.884 1.342 . . . . 0.0 112.396 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -75.76 -14.03 60.31 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.439 1.496 . . . . 0.0 113.06 170.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.01 3.34 57.79 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.691 1.615 . . . . 0.0 115.652 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -170.66 -167.95 31.75 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.545 1.545 . . . . 0.0 113.203 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.5 t -124.96 150.84 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 126.019 1.728 . . . . 0.0 109.493 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.9 t -118.63 130.1 24.99 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.014 0.926 . . . . 0.0 111.97 171.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.26 104.95 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 124.242 3.295 . . . . 0.0 112.168 167.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -75.2 90.85 2.58 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.658 1.583 . . . . 0.0 112.011 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.44 162.96 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.727 1.611 . . . . 0.0 111.737 171.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.9 mt -78.39 76.29 4.9 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.818 1.247 . . . . 0.0 111.512 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -109.91 110.91 22.02 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.898 1.679 . . . . 0.0 110.769 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -65.88 152.06 45.31 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.642 0.777 . . . . 0.0 111.528 174.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.4 p -147.73 169.67 19.22 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 177.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.61 -6.25 1.96 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 127.458 2.303 . . . . 0.0 113.891 169.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.4 ttt85 -144.64 170.6 15.76 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 128.356 2.662 . . . . 0.0 109.004 173.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -75.5 -24.72 56.9 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.505 -0.747 . . . . 0.0 112.297 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.6 m -66.4 -16.2 63.9 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.376 1.871 . . . . 0.0 113.173 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -73.77 -13.59 60.97 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.418 1.487 . . . . 0.0 113.834 173.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 76.7 m -113.02 146.2 34.66 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -167.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -81.83 167.39 16.53 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.907 3.072 . . . . 0.0 113.55 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 43.67 -117.48 1.79 Allowed Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.638 2.066 . . . . 0.0 114.904 174.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.98 6.59 47.5 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.954 1.701 . . . . 0.0 113.844 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.4 m -68.25 162.7 24.48 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 123.228 1.49 . . . . 0.0 113.834 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.8 pt -130.62 169.95 20.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 129.486 3.114 . . . . 0.0 107.806 168.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -82.6 104.08 12.6 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 121.7 -0.625 . . . . 0.0 109.759 168.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.06 167.84 9.28 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.186 1.394 . . . . 0.0 110.533 176.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.43 -13.93 71.41 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.818 1.199 . . . . 0.0 114.624 -174.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -79.18 -6.51 56.73 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.86 1.664 . . . . 0.0 114.399 174.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.7 23.07 56.97 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.184 0.897 . . . . 0.0 114.522 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -133.18 164.21 27.56 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.709 2.004 . . . . 0.0 111.067 173.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.6 m -71.74 147.12 47.66 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.624 -0.672 . . . . 0.0 112.524 176.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.049 0 C-N-CA 124.208 0.909 . . . . 0.0 112.038 170.61 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.8 p . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.81 -8.66 7.35 Favored Glycine 0 CA--C 1.541 1.698 0 C-N-CA 125.165 1.364 . . . . 0.0 115.405 -174.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.5 t -156.42 147.66 22.31 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.921 2.089 . . . . 0.0 110.575 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -66.01 -23.07 66.49 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.096 0.958 . . . . 0.0 112.995 170.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.02 -4.38 60.08 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.445 1.498 . . . . 0.0 115.095 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.46 117.9 4.59 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-N 118.57 1.185 . . . . 0.0 112.375 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.64 96.61 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.678 1.591 . . . . 0.0 110.478 169.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 47.5 t -147.2 110.38 3.99 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 125.231 1.412 . . . . 0.0 110.759 -176.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -61.75 -0.26 1.47 Allowed 'Trans proline' 0 CA--C 1.55 1.277 0 C-N-CA 124.376 3.384 . . . . 0.0 116.977 174.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 50.01 59.26 4.67 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 127.466 2.306 . . . . 0.0 113.044 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 47.3 pt -78.28 159.57 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.071 1.348 . . . . 0.0 112.313 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.2 mt -86.41 16.94 4.07 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.014 1.726 . . . . 0.0 113.706 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -61.59 117.42 5.74 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.038 -1.039 . . . . 0.0 110.163 169.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.45 142.51 55.32 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.444 0.698 . . . . 0.0 109.447 168.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.8 p -142.83 171.39 14.12 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -134.79 -14.86 2.1 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.43 2.292 . . . . 0.0 112.482 171.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -130.31 152.18 50.0 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.402 2.281 . . . . 0.0 110.032 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -64.39 -24.19 67.55 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 121.414 -0.804 . . . . 0.0 111.936 169.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.3 m -68.24 -20.27 64.8 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.88 2.072 . . . . 0.0 113.453 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -68.08 -25.64 65.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.959 0.903 . . . . 0.0 112.988 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.6 m -101.25 152.75 38.01 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.891 1.277 . . . . 0.0 113.497 -169.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -80.81 172.22 13.46 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.717 2.945 . . . . 0.0 113.753 -174.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 44.31 -106.99 0.11 Allowed Glycine 0 CA--C 1.535 1.286 0 C-N-CA 127.281 2.372 . . . . 0.0 114.779 172.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -118.58 13.71 13.45 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.311 1.844 . . . . 0.0 113.121 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.0 m -60.72 169.16 1.94 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 122.471 1.129 . . . . 0.0 112.558 172.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.5 pt -129.52 166.92 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 128.155 2.582 . . . . 0.0 109.622 170.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.6 t -93.16 107.02 18.91 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.782 0.833 . . . . 0.0 109.579 168.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -67.91 166.74 15.02 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.053 1.741 . . . . 0.0 111.374 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.34 -16.95 73.86 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.916 1.246 . . . . 0.0 114.45 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -80.83 -4.61 55.3 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.26 1.424 . . . . 0.0 114.11 172.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.3 25.94 32.13 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.375 0.988 . . . . 0.0 114.946 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -134.71 161.91 33.82 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.874 1.669 . . . . 0.0 111.912 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.7 m -67.96 154.45 41.59 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.388 -0.82 . . . . 0.0 113.059 175.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.096 0 C-N-CA 124.84 1.21 . . . . 0.0 112.053 176.602 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -117.04 -16.06 6.39 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 115.324 0.89 . . . . 0.0 115.324 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.0 p -152.96 172.19 17.19 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.863 1.332 . . . . 0.0 112.935 173.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -84.32 1.26 45.8 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.259 1.824 . . . . 0.0 113.94 170.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.04 6.45 13.5 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 125.944 1.735 . . . . 0.0 116.453 -172.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 168.24 -169.92 41.77 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 126.442 1.972 . . . . 0.0 112.085 -175.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m -87.86 154.52 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.571 1.148 . . . . 0.0 112.35 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.7 t -149.96 124.48 4.67 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 126.217 1.807 . . . . 0.0 109.168 168.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.21 -9.24 19.05 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.19 2.593 . . . . 0.0 115.511 -172.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt 45.53 63.4 1.8 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.989 2.116 . . . . 0.0 113.638 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.0 pp -124.24 169.22 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.904 1.681 . . . . 0.0 112.219 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.0 mt -75.11 35.53 0.11 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.844 2.058 . . . . 0.0 114.607 -170.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -71.49 105.81 3.73 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.544 1.538 . . . . 0.0 110.623 170.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -61.61 145.83 50.88 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.746 0.818 . . . . 0.0 110.478 170.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.4 p -141.59 167.49 22.04 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -120.69 -19.64 7.33 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.231 2.213 . . . . 0.0 112.948 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -159.44 161.81 35.58 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 129.508 3.123 . . . . 0.0 109.241 -169.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -66.95 -25.2 66.23 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 121.007 -1.058 . . . . 0.0 112.746 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -71.51 -13.68 61.88 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.505 1.522 . . . . 0.0 113.557 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -74.4 -8.34 55.94 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.451 1.1 . . . . 0.0 112.986 170.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.5 m -119.49 148.6 46.08 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 125.243 1.417 . . . . 0.0 112.391 -173.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.09 167.81 21.34 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.503 2.802 . . . . 0.0 114.036 -176.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 34.5 -107.05 0.03 OUTLIER Glycine 0 CA--C 1.536 1.386 0 C-N-CA 128.302 2.858 . . . . 0.0 116.597 172.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -103.41 9.92 37.57 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.598 1.959 . . . . 0.0 113.772 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.3 m -67.32 164.86 17.54 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 122.589 1.185 . . . . 0.0 111.724 169.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.5 pt -129.81 163.52 34.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 128.801 2.841 . . . . 0.0 108.553 168.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 47.0 t -94.52 104.29 16.25 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.647 0.779 . . . . 0.0 109.15 169.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -80.75 172.0 14.3 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.579 1.552 . . . . 0.0 111.849 -169.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.11 -16.28 70.66 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.657 1.122 . . . . 0.0 114.299 -173.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -74.88 -11.08 60.05 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.425 1.49 . . . . 0.0 114.218 170.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.28 16.75 56.9 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.842 1.21 . . . . 0.0 115.066 -177.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -131.58 161.22 33.15 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.414 1.486 . . . . 0.0 112.412 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.1 m -68.77 157.6 36.05 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.702 0.801 . . . . 0.0 112.879 174.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.206 0 C-N-CA 125.262 1.41 . . . . 0.0 113.127 168.568 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -99.34 -176.57 31.52 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.119 0.866 . . . . 0.0 115.202 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.1 p -66.39 -5.2 10.0 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.772 2.029 . . . . 0.0 115.518 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.8 -28.68 64.24 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.571 1.548 . . . . 0.0 113.458 172.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.81 -7.19 82.0 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.338 1.447 . . . . 0.0 115.465 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.91 -179.2 45.33 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.763 1.173 . . . . 0.0 113.048 169.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.5 m -88.76 156.61 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.36 1.064 . . . . 0.0 112.379 172.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.5 t -135.23 133.0 20.33 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.943 1.297 . . . . 0.0 110.196 168.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -73.28 75.47 2.87 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.835 3.023 . . . . 0.0 110.652 169.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -59.43 116.2 3.79 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.559 1.944 . . . . 0.0 113.014 -175.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.0 pp -133.88 169.98 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.808 2.043 . . . . 0.0 110.465 169.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.9 mt -74.94 35.85 0.11 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.306 1.842 . . . . 0.0 114.915 -169.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -71.78 109.43 5.65 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.798 1.639 . . . . 0.0 111.898 176.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -65.09 143.8 57.67 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 168.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.0 p -140.97 171.0 14.68 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.29 -26.52 4.27 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 128.507 2.723 . . . . 0.0 111.33 173.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -135.7 158.38 44.54 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.997 2.119 . . . . 0.0 112.346 -176.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -63.58 -27.03 68.97 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.245 0.618 . . . . 0.0 111.565 169.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.1 m -66.8 -23.09 66.01 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.816 2.046 . . . . 0.0 113.242 175.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -67.87 -20.61 65.15 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 170.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.1 m -104.02 149.13 36.9 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -168.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -82.51 167.53 15.13 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 124.014 3.143 . . . . 0.0 113.421 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 45.71 -123.14 6.2 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.971 1.748 . . . . 0.0 114.495 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.8 8.73 44.21 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.921 1.688 . . . . 0.0 113.42 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.4 m -63.3 158.22 20.86 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 123.026 1.393 . . . . 0.0 112.737 171.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.6 pt -125.57 165.97 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 128.948 2.899 . . . . 0.0 108.471 169.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.6 t -85.1 101.2 12.25 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 169.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -66.73 169.08 8.42 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.22 1.808 . . . . 0.0 111.066 -174.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.07 -17.13 69.52 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.774 1.178 . . . . 0.0 114.396 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 55.1 p30 -79.15 -8.26 58.86 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.338 1.455 . . . . 0.0 114.519 173.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.4 14.72 58.24 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 124.537 1.065 . . . . 0.0 115.425 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -128.38 165.15 21.17 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.884 1.674 . . . . 0.0 111.835 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 83.3 m -70.27 143.03 52.23 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.416 -0.802 . . . . 0.0 112.484 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.093 0 C-N-CA 124.506 1.05 . . . . 0.0 112.583 171.895 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 N--CA 1.476 0.849 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -101.92 1.3 51.74 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.319 0.961 . . . . 0.0 114.174 171.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.8 m 65.97 -57.46 0.35 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 129.126 2.97 . . . . 0.0 114.759 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -62.58 -30.88 71.65 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.985 1.314 . . . . 0.0 112.894 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.61 -4.65 88.96 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.115 1.341 . . . . 0.0 114.765 172.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 110.16 -179.73 20.54 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 126.088 1.804 . . . . 0.0 113.921 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.66 112.97 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.775 1.23 . . . . 0.0 108.896 168.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.7 t -82.55 130.63 58.0 Favored Pre-proline 0 CA--C 1.545 0.784 0 O-C-N 121.931 -0.481 . . . . 0.0 111.465 170.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.08 90.82 0.55 Allowed 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.256 2.638 . . . . 0.0 109.439 167.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -56.71 144.18 33.54 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.753 2.021 . . . . 0.0 113.499 -169.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.8 pt -141.49 159.26 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 127.54 2.336 . . . . 0.0 111.162 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -80.51 29.02 0.31 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.576 1.55 . . . . 0.0 112.789 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -74.79 102.74 4.79 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.591 -1.318 . . . . 0.0 110.83 174.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -62.68 146.49 52.07 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.411 1.084 . . . . 0.0 110.973 171.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.5 p -144.17 172.04 13.46 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -175.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -126.78 -22.31 3.9 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 127.813 2.445 . . . . 0.0 112.71 171.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -145.13 171.16 14.91 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.504 1.922 . . . . 0.0 111.115 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -69.81 -23.76 63.37 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.581 0.752 . . . . 0.0 112.441 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.7 m -64.5 -20.39 66.17 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.085 1.754 . . . . 0.0 113.074 174.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -73.13 -12.03 60.75 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.5 1.12 . . . . 0.0 113.595 173.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.8 m -117.87 159.56 42.17 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.959 1.304 . . . . 0.0 113.456 -168.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.57 167.06 26.59 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.249 2.633 . . . . 0.0 112.543 175.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -39.44 -58.6 2.05 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 127.457 2.456 . . . . 0.0 117.147 -169.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.72 -15.98 56.52 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -176.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.8 m -79.57 166.74 21.59 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 123.156 1.455 . . . . 0.0 113.274 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 22.8 pt -133.86 166.08 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 130.599 3.56 . . . . 0.0 107.352 167.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 22.3 t -83.42 101.54 11.43 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 168.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -64.84 168.49 6.21 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.119 1.768 . . . . 0.0 110.973 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.42 -17.44 68.56 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.749 1.166 . . . . 0.0 114.344 -176.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -80.03 -7.04 58.64 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.493 1.517 . . . . 0.0 114.439 172.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.84 17.43 56.46 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.65 1.119 . . . . 0.0 115.347 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -130.0 161.02 31.89 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.637 1.575 . . . . 0.0 111.886 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 74.6 m -68.42 139.65 55.78 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.584 -0.697 . . . . 0.0 112.018 175.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.919 0 C-N-CA 124.84 1.21 . . . . 0.0 112.246 174.802 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.9 m . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -106.16 -58.7 0.62 Allowed Glycine 0 N--CA 1.471 0.967 0 C-N-CA 124.38 0.991 . . . . 0.0 111.875 173.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.6 m -71.25 -24.56 62.2 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 176.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.2 t70 61.28 -27.74 0.05 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 130.096 3.358 . . . . 0.0 117.326 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -84.75 9.05 66.61 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 126.267 1.889 . . . . 0.0 115.233 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.64 -175.56 15.24 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.919 1.723 . . . . 0.0 113.917 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.7 t -68.18 104.91 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.525 1.53 . . . . 0.0 112.481 -172.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.7 t -141.99 107.76 5.83 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.822 1.249 . . . . 0.0 111.17 168.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -71.32 112.83 3.43 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.196 2.597 . . . . 0.0 110.472 170.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -77.66 84.99 4.0 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.936 1.294 . . . . 0.0 111.483 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.27 166.09 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.668 1.587 . . . . 0.0 111.778 174.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.7 mt -77.32 48.92 0.67 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.751 1.62 . . . . 0.0 113.191 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -77.6 103.68 7.68 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.798 1.639 . . . . 0.0 110.153 170.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -60.8 144.53 52.36 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.995 0.918 . . . . 0.0 111.272 175.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.2 p -143.79 171.87 13.61 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.68 -28.65 4.15 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 128.552 2.741 . . . . 0.0 111.715 173.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -148.09 161.75 40.79 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 127.003 2.121 . . . . 0.0 111.298 -175.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -65.37 -22.75 66.84 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.326 -0.859 . . . . 0.0 112.576 -177.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.8 m -66.2 -17.79 64.95 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.709 1.603 . . . . 0.0 113.324 175.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -74.89 -10.26 59.33 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.069 1.348 . . . . 0.0 113.519 174.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.5 m -119.54 153.25 53.98 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 124.466 1.107 . . . . 0.0 113.471 -168.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -57.49 170.63 1.7 Allowed 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.827 3.685 . . . . 0.0 116.249 174.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -30.12 -72.25 0.06 OUTLIER Glycine 0 CA--C 1.537 1.467 0 C-N-CA 128.889 3.138 . . . . 0.0 117.668 -172.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.46 -0.5 57.27 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.59 1.156 . . . . 0.0 114.094 -176.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 54.7 m -75.76 169.21 18.58 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.628 1.204 . . . . 0.0 112.559 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.7 pt -135.12 163.49 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 128.657 2.783 . . . . 0.0 108.756 168.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 42.0 t -93.14 103.93 16.16 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 168.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -79.94 170.31 16.66 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.689 1.596 . . . . 0.0 112.007 -169.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.66 -15.86 71.42 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.778 1.18 . . . . 0.0 114.343 -173.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.8 p-10 -74.86 -10.95 59.98 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.244 1.418 . . . . 0.0 114.148 171.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.42 15.95 54.09 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.967 1.27 . . . . 0.0 114.978 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -132.33 160.41 36.36 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.328 1.451 . . . . 0.0 112.243 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 83.8 m -68.03 160.64 28.39 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.904 0.882 . . . . 0.0 112.663 173.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.053 0 C-N-CA 124.788 1.185 . . . . 0.0 113.529 168.662 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.4 t . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -104.18 2.97 43.86 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.677 1.132 . . . . 0.0 113.45 172.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m 57.87 16.44 3.63 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.988 2.115 . . . . 0.0 114.989 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -66.43 -28.02 68.28 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.178 1.391 . . . . 0.0 114.505 -170.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -157.74 18.28 0.35 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.697 1.141 . . . . 0.0 115.131 -177.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.0 -158.93 29.57 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.284 1.421 . . . . 0.0 112.408 -172.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.9 t -112.36 117.56 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.53 1.532 . . . . 0.0 109.479 171.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.7 t -79.9 132.57 60.27 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.873 -0.584 . . . . 0.0 110.279 169.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.75 8.22 0.82 Allowed 'Trans proline' 0 CA--C 1.552 1.392 0 C-N-CA 124.501 3.467 . . . . 0.0 115.895 174.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt 54.56 70.16 0.65 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 127.553 2.341 . . . . 0.0 113.729 174.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 47.9 pt -78.25 150.87 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.867 1.267 . . . . 0.0 111.085 175.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.2 mt -79.56 27.05 0.28 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.877 1.671 . . . . 0.0 113.489 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -69.02 115.15 7.98 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.035 1.334 . . . . 0.0 110.474 173.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -65.31 145.7 55.87 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.141 0.976 . . . . 0.0 110.368 171.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.1 p -148.99 171.76 15.84 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -133.83 -14.45 2.44 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.761 2.424 . . . . 0.0 112.842 169.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -131.99 152.22 51.27 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 127.758 2.423 . . . . 0.0 109.94 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -65.33 -24.07 67.17 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.411 -0.806 . . . . 0.0 111.967 169.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.4 m -67.93 -20.68 65.1 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.321 1.849 . . . . 0.0 113.165 175.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -69.12 -22.29 63.97 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.768 0.827 . . . . 0.0 113.031 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 85.9 m -103.32 155.41 36.79 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.737 1.215 . . . . 0.0 113.641 -169.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.21 159.75 43.47 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.144 2.563 . . . . 0.0 112.699 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 0.35 -84.52 0.0 OUTLIER Glycine 0 CA--C 1.537 1.467 0 C-N-CA 129.926 3.631 . . . . 0.0 118.026 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.87 -7.81 55.44 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -172.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.6 m -71.99 161.94 30.19 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 123.155 1.455 . . . . 0.0 112.77 169.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.7 pt -128.21 165.43 27.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 129.707 3.203 . . . . 0.0 107.908 168.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.2 t -85.51 103.0 13.98 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 169.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -67.42 169.62 8.74 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.952 1.701 . . . . 0.0 110.946 -176.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.47 -16.05 71.19 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.714 1.15 . . . . 0.0 114.588 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -83.7 -4.52 58.68 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.569 1.548 . . . . 0.0 114.48 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.42 23.41 43.73 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-N 119.09 0.859 . . . . 0.0 114.797 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -132.87 160.79 35.94 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.831 1.653 . . . . 0.0 111.577 176.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.1 m -69.06 146.29 52.76 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.665 -0.647 . . . . 0.0 112.058 173.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.985 0 C-N-CA 124.629 1.109 . . . . 0.0 111.777 173.287 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 89.4 p . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.25 19.77 68.6 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.317 1.437 . . . . 0.0 114.581 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.4 m 65.22 -15.65 0.1 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 128.572 2.749 . . . . 0.0 115.648 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -70.18 -18.52 63.2 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.884 1.674 . . . . 0.0 113.585 174.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.43 21.95 74.09 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.277 0.941 . . . . 0.0 114.457 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.73 171.57 11.26 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.938 1.256 . . . . 0.0 113.944 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t -71.89 84.77 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.686 1.194 . . . . 0.0 111.856 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.3 t -120.05 120.79 29.99 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 124.954 1.302 . . . . 0.0 109.611 168.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.22 93.1 0.4 Allowed 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.077 2.518 . . . . 0.0 109.439 169.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.8 mtmt -52.19 124.82 14.03 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.76 2.024 . . . . 0.0 113.42 -169.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pp -137.43 170.1 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 127.506 2.323 . . . . 0.0 111.548 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.1 mp -111.97 35.36 3.75 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.927 1.691 . . . . 0.0 111.673 178.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -64.56 123.93 20.53 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.166 0.986 . . . . 0.0 110.724 170.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -67.34 147.02 53.49 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 166.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.6 p -143.79 169.86 16.98 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -134.15 -12.37 2.49 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.804 2.041 . . . . 0.0 113.051 170.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -145.58 160.72 41.23 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.222 2.209 . . . . 0.0 110.134 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -69.89 -23.07 63.19 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.175 -0.953 . . . . 0.0 112.898 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 70.4 m -69.85 -13.66 62.37 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.951 1.3 . . . . 0.0 113.362 176.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -70.69 -13.64 62.15 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.428 1.091 . . . . 0.0 113.21 172.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.7 m -114.87 147.31 37.97 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 125.01 1.324 . . . . 0.0 113.785 -168.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -81.68 163.31 18.8 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.519 2.812 . . . . 0.0 113.402 -177.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 43.08 -117.27 1.51 Allowed Glycine 0 CA--C 1.535 1.339 0 C-N-CA 126.475 1.988 . . . . 0.0 114.568 176.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.29 -0.87 54.73 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.903 1.681 . . . . 0.0 114.156 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.3 m -61.99 161.47 10.64 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 122.713 1.244 . . . . 0.0 113.11 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.1 pt -126.76 167.01 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 128.001 2.52 . . . . 0.0 109.51 172.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.0 t -85.08 103.93 14.53 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 168.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -69.79 170.59 10.72 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.517 1.927 . . . . 0.0 110.92 -174.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.26 -16.56 73.38 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.615 1.102 . . . . 0.0 114.661 -173.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -85.01 -3.22 58.7 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.391 1.477 . . . . 0.0 114.415 175.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.76 21.53 50.21 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.202 0.906 . . . . 0.0 114.957 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -131.56 162.65 29.82 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.944 1.697 . . . . 0.0 111.583 175.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 96.2 m -69.73 151.31 45.97 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.435 -0.791 . . . . 0.0 112.962 174.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.013 0 C-N-CA 124.085 0.85 . . . . 0.0 112.869 171.518 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.476 0.833 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.66 -12.05 17.67 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.324 0.964 . . . . 0.0 114.448 170.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.0 t -149.65 154.81 39.2 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.718 1.607 . . . . 0.0 111.478 173.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -82.19 -8.28 59.64 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.287 1.435 . . . . 0.0 112.815 169.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.99 2.65 33.12 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.988 1.756 . . . . 0.0 116.502 -173.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -172.11 -176.32 40.87 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.452 1.501 . . . . 0.0 113.118 177.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.4 m -75.64 138.19 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.681 1.192 . . . . 0.0 112.66 -177.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.7 t -151.28 112.64 3.04 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 125.292 1.437 . . . . 0.0 110.081 167.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -80.05 -0.11 10.43 Favored 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.645 2.897 . . . . 0.0 115.218 -173.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 48.21 49.21 17.92 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 127.026 2.13 . . . . 0.0 113.78 -177.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.8 pt -78.88 161.19 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.388 1.475 . . . . 0.0 112.127 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.1 mt -77.75 15.98 0.76 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.647 1.979 . . . . 0.0 113.791 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -63.61 113.07 3.1 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.118 1.367 . . . . 0.0 110.762 172.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -68.97 151.25 46.76 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.686 0.794 . . . . 0.0 111.269 172.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.3 p -145.22 176.51 9.49 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.7 mmt-85 -133.37 -18.13 2.26 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 127.595 2.358 . . . . 0.0 113.242 169.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -146.13 163.81 34.17 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.885 1.674 . . . . 0.0 111.883 176.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -65.46 -22.48 66.75 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.322 -0.861 . . . . 0.0 112.539 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.9 m -68.18 -16.03 63.82 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.03 1.332 . . . . 0.0 113.284 176.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -74.33 -10.07 59.22 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.854 1.261 . . . . 0.0 113.539 173.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.2 m -123.88 150.92 63.79 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 125.091 1.357 . . . . 0.0 112.584 -169.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -79.27 166.97 22.05 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.432 2.754 . . . . 0.0 113.969 -175.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 32.81 -103.9 0.01 OUTLIER Glycine 0 CA--C 1.537 1.455 0 C-N-CA 128.62 3.01 . . . . 0.0 116.701 172.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -104.6 9.05 35.44 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.714 2.006 . . . . 0.0 113.716 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.4 m -67.52 164.51 18.78 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 122.618 1.199 . . . . 0.0 111.523 169.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.1 pt -130.54 164.4 33.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 128.65 2.78 . . . . 0.0 108.879 169.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 42.2 t -93.74 106.85 18.79 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 168.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -82.15 172.88 12.68 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.21 1.404 . . . . 0.0 111.459 -169.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.87 -17.34 71.34 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.672 1.129 . . . . 0.0 114.403 -170.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -77.79 -6.71 55.0 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.139 1.776 . . . . 0.0 114.183 171.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.73 33.09 43.45 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.147 -0.971 . . . . 0.0 113.938 -177.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -136.09 158.46 44.36 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.137 1.775 . . . . 0.0 111.531 175.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 80.0 m -69.06 158.2 35.29 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.729 0.776 . . . . 0.0 112.909 173.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.178 0 C-N-CA 125.277 1.418 . . . . 0.0 113.476 168.686 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.6 m . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.06 -7.28 0.19 Allowed Glycine 0 CA--C 1.536 1.367 0 N-CA-C 116.549 1.379 . . . . 0.0 116.549 173.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.5 t -146.73 152.58 39.05 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.238 1.519 . . . . 0.0 111.888 175.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -82.5 -8.85 59.61 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.64 1.576 . . . . 0.0 113.049 171.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.22 0.52 39.42 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.762 1.648 . . . . 0.0 116.413 -173.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -178.19 -175.44 45.32 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.485 1.517 . . . . 0.0 113.222 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.2 p -76.86 150.58 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.757 1.223 . . . . 0.0 111.652 173.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.6 t -135.5 106.46 10.03 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 125.294 1.438 . . . . 0.0 110.66 168.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -73.8 119.54 5.94 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.868 2.379 . . . . 0.0 109.416 168.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -79.18 67.89 5.02 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.191 1.396 . . . . 0.0 111.536 -174.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.8 pt -78.59 146.0 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 126.093 1.757 . . . . 0.0 111.52 -177.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 pp -75.76 22.57 0.14 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.968 1.707 . . . . 0.0 114.253 173.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -66.86 110.63 3.38 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.819 1.248 . . . . 0.0 109.392 168.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.92 142.83 58.15 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.454 0.701 . . . . 0.0 110.219 171.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.3 p -138.77 174.01 10.97 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 -135.76 -17.23 1.7 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.041 2.136 . . . . 0.0 112.871 173.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -142.82 161.56 37.79 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.65 1.98 . . . . 0.0 110.607 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -69.87 -23.75 63.31 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.299 -0.876 . . . . 0.0 112.953 -178.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.7 m -70.84 -12.75 61.73 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.821 1.248 . . . . 0.0 113.434 175.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -70.88 -15.99 62.66 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.749 0.82 . . . . 0.0 113.082 171.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.2 m -115.58 150.32 44.5 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.737 1.215 . . . . 0.0 113.556 -168.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.96 166.52 21.01 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.67 2.913 . . . . 0.0 113.976 -174.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 40.05 -113.91 0.42 Allowed Glycine 0 CA--C 1.536 1.4 0 C-N-CA 127.313 2.387 . . . . 0.0 115.535 172.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.42 9.6 42.4 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.238 1.815 . . . . 0.0 113.743 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 61.3 m -68.26 168.5 12.26 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.553 1.168 . . . . 0.0 112.394 171.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.5 pt -136.07 169.65 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 129.088 2.955 . . . . 0.0 109.004 169.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.4 t -84.8 103.26 13.73 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 167.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -67.75 168.63 11.03 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.902 1.681 . . . . 0.0 111.176 -176.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.03 -16.61 70.87 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.859 1.219 . . . . 0.0 114.367 -175.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -77.69 -9.36 58.94 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.978 1.311 . . . . 0.0 114.208 172.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.69 14.46 56.7 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.779 1.18 . . . . 0.0 115.359 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -131.09 169.04 16.41 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.672 1.589 . . . . 0.0 111.747 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.6 m -70.2 150.47 46.43 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.123 -0.985 . . . . 0.0 113.579 177.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.243 0 C-N-CA 125.372 1.463 . . . . 0.0 112.299 174.382 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 53.0 m . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.88 -1.03 34.16 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.547 1.07 . . . . 0.0 114.77 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.9 p -143.15 160.14 40.97 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.669 1.588 . . . . 0.0 112.496 175.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -67.31 105.96 1.92 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.193 1.397 . . . . 0.0 112.243 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.33 15.11 80.33 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 124.105 0.86 . . . . 0.0 115.104 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.48 164.35 25.51 Favored Glycine 0 CA--C 1.537 1.458 0 CA-C-N 118.504 1.152 . . . . 0.0 114.081 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.5 m -73.68 74.38 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.814 1.646 . . . . 0.0 112.672 174.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.5 t -125.34 113.5 25.82 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 125.603 1.561 . . . . 0.0 111.166 175.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -57.9 -12.71 12.83 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 124.964 3.776 . . . . 0.0 117.579 175.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 47.38 47.71 16.84 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 126.875 2.07 . . . . 0.0 113.774 -173.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.4 pt -78.96 148.04 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.263 1.425 . . . . 0.0 111.052 176.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.24 35.03 0.14 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.33 1.852 . . . . 0.0 113.084 176.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -70.94 113.5 8.05 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.66 1.584 . . . . 0.0 109.82 169.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.49 143.6 57.69 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.604 0.762 . . . . 0.0 110.361 171.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.0 p -145.03 171.55 14.32 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -134.21 -13.93 2.36 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 127.542 2.337 . . . . 0.0 112.931 169.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -132.93 152.44 51.91 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.666 2.386 . . . . 0.0 110.093 -176.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -66.62 -25.25 66.5 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.212 -0.93 . . . . 0.0 112.263 171.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 56.7 p -72.07 -14.55 61.89 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.833 1.653 . . . . 0.0 113.988 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -68.31 -19.47 64.68 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.235 -0.916 . . . . 0.0 112.77 169.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.3 m -109.86 149.72 40.37 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 124.889 1.275 . . . . 0.0 113.275 -169.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.33 166.34 20.35 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.609 2.873 . . . . 0.0 113.899 -175.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 38.34 -110.06 0.12 Allowed Glycine 0 CA--C 1.538 1.512 0 C-N-CA 127.591 2.52 . . . . 0.0 115.848 172.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.48 7.27 42.52 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.17 1.788 . . . . 0.0 113.747 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 61.8 m -67.59 165.54 16.75 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 122.604 1.192 . . . . 0.0 111.929 171.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.6 pt -133.79 167.48 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 129.227 3.011 . . . . 0.0 108.653 169.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.9 t -85.9 103.28 14.48 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 168.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -67.03 169.38 8.45 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.721 1.608 . . . . 0.0 111.049 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.94 -16.61 70.69 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.757 1.17 . . . . 0.0 114.522 -174.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -81.05 -6.77 59.2 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.337 1.455 . . . . 0.0 114.393 173.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.59 20.38 48.12 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.485 1.041 . . . . 0.0 115.028 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -132.31 163.71 28.05 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.723 1.609 . . . . 0.0 111.687 177.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.5 m -70.21 148.32 48.76 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.307 -0.871 . . . . 0.0 112.916 176.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.156 0 C-N-CA 125.164 1.364 . . . . 0.0 112.462 174.255 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.2 m . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 112.656 0.614 . . . . 0.0 112.656 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -96.8 161.27 21.88 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 123.78 0.705 . . . . 0.0 112.733 173.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.5 p -61.33 -57.28 12.96 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.959 1.304 . . . . 0.0 112.45 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -74.5 -23.17 58.8 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.109 1.364 . . . . 0.0 112.868 171.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.51 -48.65 42.69 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.21 1.386 . . . . 0.0 114.059 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 111.36 -174.58 16.87 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.247 1.403 . . . . 0.0 113.833 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.6 t -66.38 101.32 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.535 1.134 . . . . 0.0 110.182 172.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.6 t -86.7 130.65 48.09 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-O 119.076 -0.488 . . . . 0.0 110.567 169.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.8 92.83 0.31 Allowed 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 123.15 2.567 . . . . 0.0 109.168 167.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -54.28 137.03 42.33 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 127.229 2.211 . . . . 0.0 113.811 -168.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.0 pt -138.99 149.19 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 127.38 2.272 . . . . 0.0 110.507 174.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.26 42.77 0.76 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.049 1.34 . . . . 0.0 111.636 177.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -80.09 115.46 19.67 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.47 1.508 . . . . 0.0 110.286 174.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.85 146.68 53.52 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.96 0.904 . . . . 0.0 110.686 172.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.0 p -145.1 165.49 28.1 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 176.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -122.66 -17.14 7.0 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 127.509 2.324 . . . . 0.0 112.729 170.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -148.31 162.5 39.4 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 128.45 2.7 . . . . 0.0 110.016 -175.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -69.3 -23.22 63.78 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.146 -0.971 . . . . 0.0 112.953 -178.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.5 m -67.79 -17.3 64.48 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.555 1.542 . . . . 0.0 113.234 177.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -75.12 -10.75 59.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.17 1.388 . . . . 0.0 113.443 174.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 73.9 m -113.56 163.1 19.39 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -168.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.92 165.36 3.87 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.984 3.122 . . . . 0.0 114.096 169.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.43 -56.93 8.76 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 126.058 1.789 . . . . 0.0 115.942 -174.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.32 -14.54 55.18 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.6 m -74.53 166.6 23.26 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 123.051 1.405 . . . . 0.0 112.904 171.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 pt -132.78 167.68 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 129.139 2.976 . . . . 0.0 107.671 166.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.0 t -82.44 101.83 10.91 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.423 -0.798 . . . . 0.0 109.778 169.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.87 167.81 12.85 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.228 1.811 . . . . 0.0 111.567 -178.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.01 -15.18 76.29 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.911 1.244 . . . . 0.0 114.631 -173.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -77.37 -8.25 57.38 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.45 1.5 . . . . 0.0 114.166 173.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.23 13.86 59.68 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.737 1.16 . . . . 0.0 114.996 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -129.28 168.1 16.72 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.432 1.893 . . . . 0.0 111.064 177.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 82.4 m -74.03 153.84 39.5 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.262 -0.899 . . . . 0.0 113.242 176.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.124 0 C-N-CA 124.329 0.966 . . . . 0.0 113.451 171.283 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 63.1 m . . . . . 0 N--CA 1.477 0.894 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -98.63 -15.38 34.62 Favored Glycine 0 CA--C 1.535 1.34 0 N-CA-C 115.979 1.151 . . . . 0.0 115.979 -173.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.0 p -154.46 170.35 21.62 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.037 1.418 . . . . 0.0 113.29 175.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -80.18 -3.15 47.85 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.4 1.48 . . . . 0.0 113.426 170.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.47 2.66 57.2 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 125.711 1.624 . . . . 0.0 115.907 -175.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.11 -161.68 25.68 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 126.088 1.804 . . . . 0.0 112.16 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.7 p -125.86 151.85 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.071 1.349 . . . . 0.0 111.779 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.3 t -136.47 136.8 22.64 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 123.978 0.911 . . . . 0.0 109.555 166.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.2 -1.62 8.33 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 123.983 3.122 . . . . 0.0 115.371 172.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt 47.3 63.21 2.06 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 127.713 2.405 . . . . 0.0 113.138 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.6 pt -78.0 155.76 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.448 1.499 . . . . 0.0 111.577 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -79.69 16.54 1.08 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.228 1.811 . . . . 0.0 113.164 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.54 112.36 2.76 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.098 1.359 . . . . 0.0 110.571 169.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -65.91 143.23 57.55 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 169.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.0 p -136.45 173.49 11.65 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -175.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -136.64 -17.6 1.47 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.453 1.901 . . . . 0.0 112.577 169.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.61 155.4 39.17 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 127.846 2.458 . . . . 0.0 109.887 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -67.97 -25.76 65.6 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.223 -0.923 . . . . 0.0 112.223 169.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 77.4 p -71.33 -14.54 62.23 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.59 1.556 . . . . 0.0 114.022 175.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -65.55 -22.27 66.68 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.403 -0.81 . . . . 0.0 112.585 169.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.8 m -106.39 150.07 39.05 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -167.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -82.2 165.45 16.85 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.765 2.976 . . . . 0.0 113.523 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 44.1 -118.72 2.46 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.601 2.048 . . . . 0.0 114.877 173.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.64 7.05 47.15 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.1 1.76 . . . . 0.0 113.761 -178.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.4 m -66.03 160.04 24.61 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 123.077 1.417 . . . . 0.0 113.438 171.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.1 pt -127.55 167.3 22.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 129.505 3.122 . . . . 0.0 108.138 168.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.8 t -84.54 103.02 13.31 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 168.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -68.47 168.95 11.72 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.943 1.697 . . . . 0.0 111.073 -175.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.47 -16.41 69.46 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.659 1.123 . . . . 0.0 114.515 -176.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.8 p30 -78.77 -7.62 57.97 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.517 1.527 . . . . 0.0 114.419 173.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.33 14.54 60.07 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.649 1.119 . . . . 0.0 115.421 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -128.6 166.52 18.71 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.277 1.831 . . . . 0.0 111.866 177.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.6 m -69.38 143.1 53.79 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.476 -0.765 . . . . 0.0 112.672 174.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.167 0 C-N-CA 124.478 1.037 . . . . 0.0 112.615 171.237 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -116.65 -61.25 0.32 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.397 1.475 . . . . 0.0 113.064 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.5 m -72.57 101.53 3.03 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.172 1.389 . . . . 0.0 112.47 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -58.23 -22.07 50.62 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.526 1.53 . . . . 0.0 114.699 -176.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.54 -0.91 74.77 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 125.301 1.429 . . . . 0.0 115.445 175.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.54 -165.54 10.3 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 126.031 1.776 . . . . 0.0 113.566 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.1 p -132.33 152.39 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.52 1.528 . . . . 0.0 111.61 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.3 t -133.5 136.29 26.69 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.457 1.103 . . . . 0.0 110.664 169.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -55.83 -11.93 6.06 Favored 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 124.991 3.794 . . . . 0.0 117.044 169.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt 48.92 60.19 3.9 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 127.446 2.299 . . . . 0.0 113.195 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 36.6 pt -78.28 157.35 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 125.798 1.639 . . . . 0.0 111.688 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.0 mt -79.58 19.55 0.63 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.219 1.808 . . . . 0.0 113.712 178.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -63.83 115.58 4.96 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.179 1.392 . . . . 0.0 110.806 173.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -67.57 146.02 54.31 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.108 0.563 . . . . 0.0 110.147 169.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.9 p -139.37 172.96 12.06 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.36 -28.22 3.68 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 128.192 2.597 . . . . 0.0 111.564 174.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -148.14 164.41 33.97 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.698 1.999 . . . . 0.0 111.433 -175.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -66.92 -23.96 66.03 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.45 -0.781 . . . . 0.0 112.78 -176.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -66.7 -18.54 65.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.217 1.407 . . . . 0.0 112.825 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -71.55 -17.2 62.32 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.998 1.319 . . . . 0.0 113.219 175.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.6 m -111.31 148.67 39.25 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -167.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -81.93 163.19 18.25 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.744 2.963 . . . . 0.0 113.531 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 44.18 -119.69 2.96 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 126.332 1.92 . . . . 0.0 114.84 173.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.83 -0.86 57.81 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.694 1.598 . . . . 0.0 114.226 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.1 m -64.41 156.54 29.02 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 123.105 1.431 . . . . 0.0 113.105 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.0 pt -124.56 164.8 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 129.258 3.023 . . . . 0.0 108.562 170.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.1 t -84.41 102.84 13.07 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 168.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -67.22 169.55 8.5 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.94 1.696 . . . . 0.0 110.915 -176.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.56 -17.22 70.61 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.748 1.166 . . . . 0.0 114.605 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 56.9 p30 -81.86 -4.01 55.48 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.754 1.622 . . . . 0.0 114.375 173.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.84 29.81 45.83 Favored Glycine 0 CA--C 1.535 1.335 0 O-C-N 121.206 -0.934 . . . . 0.0 114.456 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -132.97 160.67 36.44 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.517 1.927 . . . . 0.0 111.267 172.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 77.7 m -69.0 144.55 54.07 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.817 -0.552 . . . . 0.0 112.232 172.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.04 0 C-N-CA 124.612 1.101 . . . . 0.0 111.81 172.883 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.2 m . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -94.11 -14.91 50.28 Favored Glycine 0 CA--C 1.539 1.57 0 C-N-CA 123.863 0.744 . . . . 0.0 112.45 168.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.9 t -140.12 106.45 5.27 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 127.345 2.258 . . . . 0.0 108.975 169.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -61.63 -23.46 66.05 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.735 1.214 . . . . 0.0 114.166 -173.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.72 -3.66 85.83 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.067 1.318 . . . . 0.0 115.0 175.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.78 176.87 25.25 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.522 1.534 . . . . 0.0 114.405 -177.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.1 t -75.57 93.07 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.325 1.45 . . . . 0.0 111.389 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.1 t -135.03 104.12 10.6 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.539 1.136 . . . . 0.0 111.275 169.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -57.66 -18.41 33.01 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 124.688 3.592 . . . . 0.0 117.335 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt 47.04 77.22 0.09 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 127.233 2.213 . . . . 0.0 113.596 -176.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.402 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.1 OUTLIER -123.36 169.27 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 126.054 1.742 . . . . 0.0 112.418 -177.706 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.0 mt -72.55 25.87 0.05 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.468 1.907 . . . . 0.0 114.612 -178.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -69.74 101.43 1.69 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.97 1.308 . . . . 0.0 110.402 170.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -64.45 145.26 56.37 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.235 1.014 . . . . 0.0 110.322 169.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.6 p -145.66 169.74 17.85 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.416 1.086 . . . . 0.0 113.732 -176.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -123.16 -25.26 4.53 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.53 2.332 . . . . 0.0 111.918 169.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -130.99 160.6 34.09 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.753 2.021 . . . . 0.0 110.879 -176.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -67.21 -25.51 66.15 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.438 -0.789 . . . . 0.0 112.492 173.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 56.3 p -70.7 -15.59 62.72 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.848 1.659 . . . . 0.0 113.972 175.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -68.86 -19.23 64.23 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.811 0.844 . . . . 0.0 112.937 169.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.8 m -108.25 159.86 29.13 Favored Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -168.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -57.65 167.11 4.21 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 124.509 3.473 . . . . 0.0 115.541 173.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -26.51 -72.66 0.03 OUTLIER Glycine 0 CA--C 1.536 1.344 0 C-N-CA 129.081 3.229 . . . . 0.0 117.588 -172.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.42 3.02 53.12 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.013 1.325 . . . . 0.0 113.92 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.6 m -73.14 167.06 21.93 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 122.723 1.249 . . . . 0.0 111.613 169.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.2 pt -135.16 164.64 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 129.095 2.958 . . . . 0.0 108.323 169.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.3 t -84.18 101.71 12.06 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 168.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -65.17 171.24 3.85 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.374 1.87 . . . . 0.0 111.149 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.49 -18.36 69.7 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.723 1.154 . . . . 0.0 114.451 -174.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -81.47 -6.87 59.39 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.155 1.382 . . . . 0.0 114.393 173.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.23 20.14 50.25 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 124.53 1.062 . . . . 0.0 115.266 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -130.87 161.47 31.77 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.68 1.592 . . . . 0.0 111.766 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.2 m -71.15 139.29 50.18 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.453 -0.779 . . . . 0.0 112.713 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.121 0 C-N-CA 124.499 1.047 . . . . 0.0 113.162 174.547 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -118.6 27.48 7.2 Favored Glycine 0 N--CA 1.473 1.104 0 C-N-CA 125.414 1.483 . . . . 0.0 114.716 -175.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.6 m 51.51 -88.15 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 127.856 2.462 . . . . 0.0 114.037 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -64.27 -19.59 65.5 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 119.626 1.103 . . . . 0.0 113.578 171.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.9 -9.86 86.42 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.024 1.297 . . . . 0.0 114.37 169.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.88 170.87 24.34 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 126.795 2.14 . . . . 0.0 114.402 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.6 t -76.4 110.61 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.998 1.319 . . . . 0.0 108.95 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.2 t -88.17 128.74 52.41 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 119.062 -0.494 . . . . 0.0 111.33 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -65.61 97.29 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.958 2.438 . . . . 0.0 109.169 167.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -54.37 142.07 28.12 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.228 2.211 . . . . 0.0 113.956 -168.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.3 pt -138.95 157.97 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 127.439 2.296 . . . . 0.0 110.843 176.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 90.4 mt -85.79 22.86 1.55 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.178 1.391 . . . . 0.0 113.267 178.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -68.21 109.71 3.7 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.076 1.35 . . . . 0.0 111.314 175.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -63.49 146.15 54.21 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.281 1.033 . . . . 0.0 109.73 169.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.3 p -142.09 168.54 19.51 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 38.4 mtm180 -124.19 -21.45 5.01 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 128.494 2.717 . . . . 0.0 112.428 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -154.88 163.42 40.31 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 128.81 2.844 . . . . 0.0 109.965 -174.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -67.74 -24.96 65.41 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.276 -0.89 . . . . 0.0 112.65 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.5 m -71.59 -13.91 61.92 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.729 1.212 . . . . 0.0 113.48 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -72.32 -18.64 61.75 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.832 1.253 . . . . 0.0 112.376 171.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 76.2 m -104.93 159.78 28.18 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.092 1.357 . . . . 0.0 113.724 -169.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.08 166.62 27.39 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.191 2.594 . . . . 0.0 112.659 175.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -34.14 -63.09 0.44 Allowed Glycine 0 CA--C 1.537 1.446 0 C-N-CA 127.967 2.699 . . . . 0.0 117.449 -169.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.35 -12.03 57.0 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.5 m -78.41 164.69 24.57 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 123.14 1.447 . . . . 0.0 113.204 173.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.5 pt -130.0 163.87 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 129.706 3.202 . . . . 0.0 107.72 167.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 39.7 t -89.37 102.93 15.6 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 121.612 -0.68 . . . . 0.0 109.856 171.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -82.0 173.45 12.18 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.681 1.192 . . . . 0.0 111.828 -169.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.57 -16.11 71.46 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.771 1.177 . . . . 0.0 114.32 -170.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 39.4 p-10 -77.06 -9.06 58.47 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.32 1.448 . . . . 0.0 114.273 172.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.73 16.96 57.56 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.687 1.137 . . . . 0.0 115.082 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -131.34 162.79 29.29 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.449 1.499 . . . . 0.0 112.029 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.3 m -69.89 144.85 52.36 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.717 0.807 . . . . 0.0 112.223 172.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.134 0 C-N-CA 124.416 1.008 . . . . 0.0 113.386 174.023 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -153.67 -167.15 15.55 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.583 1.087 . . . . 0.0 114.47 -171.272 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.0 m -67.35 -4.34 10.64 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.533 1.933 . . . . 0.0 115.72 -175.27 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.58 158.92 11.46 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.148 1.379 . . . . 0.0 112.843 174.142 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.38 -17.33 77.59 Favored Glycine 0 CA--C 1.54 1.651 0 O-C-N 121.112 -0.993 . . . . 0.0 115.256 179.039 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.28 -173.78 49.87 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.631 1.586 . . . . 0.0 114.086 175.561 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.2 t -122.22 117.39 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.041 1.736 . . . . 0.0 108.971 174.409 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.7 t -79.45 133.41 59.89 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.918 172.339 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.41 3.75 2.43 Favored 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 124.327 3.352 . . . . 0.0 115.466 170.669 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt 55.22 70.88 0.58 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 127.511 2.324 . . . . 0.0 113.44 171.447 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.5 pt -78.51 149.06 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.761 1.225 . . . . 0.0 111.134 175.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.2 mt -79.78 38.37 0.39 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.591 1.556 . . . . 0.0 112.912 177.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -79.53 112.22 16.57 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.06 1.344 . . . . 0.0 109.977 172.028 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -66.04 143.7 57.18 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.357 0.663 . . . . 0.0 110.567 171.176 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.9 p -149.12 170.23 18.88 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.732 1.213 . . . . 0.0 113.924 -172.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -136.26 -8.89 1.99 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.991 2.116 . . . . 0.0 112.836 169.302 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -132.41 151.42 51.88 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 127.687 2.395 . . . . 0.0 109.813 -179.349 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -66.99 -24.18 66.01 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.362 -0.836 . . . . 0.0 112.219 171.74 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.7 p -72.29 -16.34 61.9 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.765 1.626 . . . . 0.0 114.004 174.339 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -65.93 -28.25 68.78 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.099 0.863 . . . . 0.0 112.383 169.119 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.5 m -96.0 161.23 28.0 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.352 1.461 . . . . 0.0 113.295 -170.574 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -68.2 162.57 39.7 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.95 2.433 . . . . 0.0 112.136 173.084 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -36.79 -58.65 1.15 Allowed Glycine 0 N--CA 1.475 1.28 0 C-N-CA 127.607 2.527 . . . . 0.0 117.283 -169.643 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.21 -17.18 53.05 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -175.741 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.9 m -77.16 168.75 19.53 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 123.046 1.403 . . . . 0.0 113.864 171.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.8 pt -132.35 166.16 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 130.472 3.509 . . . . 0.0 107.806 168.294 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.8 t -86.26 103.92 15.32 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.557 -0.715 . . . . 0.0 109.151 169.022 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -67.77 170.57 7.73 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.194 1.798 . . . . 0.0 111.029 -175.642 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.58 -16.15 71.55 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.733 1.158 . . . . 0.0 114.604 -173.387 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -83.54 -3.11 57.36 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.45 1.5 . . . . 0.0 114.341 174.246 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.95 21.93 56.35 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.154 0.883 . . . . 0.0 114.603 -179.07 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -131.84 159.99 36.95 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.898 1.679 . . . . 0.0 111.581 175.67 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.9 m -68.63 147.27 52.14 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.638 -0.664 . . . . 0.0 112.166 176.631 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.864 0 C-N-CA 124.776 1.179 . . . . 0.0 111.449 173.814 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.6 m . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.11 178.8 17.91 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.65 1.119 . . . . 0.0 115.154 -177.029 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.8 m -66.4 -4.47 8.24 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.873 2.069 . . . . 0.0 115.847 -173.103 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -60.91 -21.0 62.93 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.476 1.51 . . . . 0.0 113.889 175.23 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.54 -5.53 60.45 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.641 1.591 . . . . 0.0 114.954 174.879 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.9 -178.71 47.25 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 124.771 1.177 . . . . 0.0 113.264 170.119 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 p -124.04 122.8 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.52 1.528 . . . . 0.0 110.103 169.899 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.9 t -90.49 119.28 69.12 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 123.541 0.736 . . . . 0.0 111.916 178.289 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -69.28 93.96 0.48 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.211 2.607 . . . . 0.0 109.949 168.839 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -57.69 151.3 17.66 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.11 1.764 . . . . 0.0 114.228 -171.424 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.22 162.2 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 128.369 2.667 . . . . 0.0 110.016 171.603 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.4 mt -78.75 28.37 0.21 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.138 1.375 . . . . 0.0 113.791 -178.946 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -70.52 103.91 2.62 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.851 -1.155 . . . . 0.0 110.776 173.0 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -67.96 142.06 56.1 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 167.577 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 p -141.1 171.03 14.63 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -171.683 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -133.39 -15.2 2.51 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.686 2.394 . . . . 0.0 112.662 174.065 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -135.06 153.62 51.98 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.329 2.252 . . . . 0.0 110.152 -176.681 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -66.4 -23.23 66.28 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.475 -0.765 . . . . 0.0 111.793 168.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.0 m -68.62 -20.46 64.49 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.779 2.032 . . . . 0.0 113.427 175.604 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -67.53 -29.95 69.49 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.681 0.792 . . . . 0.0 112.425 172.577 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.9 m -96.03 159.46 32.19 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.228 1.411 . . . . 0.0 113.702 -169.577 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.74 167.1 26.7 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.29 2.66 . . . . 0.0 112.712 175.089 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -34.85 -62.25 0.56 Allowed Glycine 0 CA--C 1.536 1.354 0 C-N-CA 128.067 2.746 . . . . 0.0 117.489 -169.817 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.05 -13.88 58.96 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -175.579 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.3 m -81.17 167.55 19.53 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 123.268 1.508 . . . . 0.0 113.722 173.735 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.5 pt -133.18 166.54 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 131.19 3.796 . . . . 0.0 107.234 167.074 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.4 t -84.91 102.75 13.38 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.408 -0.807 . . . . 0.0 108.986 169.042 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -66.82 168.0 10.43 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.93 1.692 . . . . 0.0 111.194 -174.618 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.2 -17.72 68.43 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.79 1.186 . . . . 0.0 114.325 -178.283 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -77.88 -7.73 57.11 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.499 1.519 . . . . 0.0 114.331 172.153 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.17 13.99 61.13 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.64 1.114 . . . . 0.0 115.485 178.407 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -130.28 166.05 21.16 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.031 1.733 . . . . 0.0 111.418 176.711 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.2 m -70.85 141.74 51.25 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.435 -0.791 . . . . 0.0 112.894 178.266 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.181 0 C-N-CA 125.49 1.519 . . . . 0.0 112.201 174.515 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -140.52 -73.4 0.04 OUTLIER Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.238 1.399 . . . . 0.0 112.771 -178.741 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.0 m -74.31 99.96 3.62 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.741 1.216 . . . . 0.0 111.993 -178.218 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -58.77 -21.33 55.52 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.792 1.637 . . . . 0.0 114.755 -176.227 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.23 -0.44 71.15 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.277 1.417 . . . . 0.0 115.741 177.012 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.36 -173.1 13.54 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.542 1.544 . . . . 0.0 113.896 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.4 m -107.38 138.76 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.385 1.474 . . . . 0.0 112.366 -175.557 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.4 t -131.46 105.75 14.52 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 125.414 1.486 . . . . 0.0 111.141 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.31 110.99 0.65 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.376 2.718 . . . . 0.0 110.405 167.456 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -79.23 57.25 2.24 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.612 1.165 . . . . 0.0 113.38 -172.839 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -79.09 170.65 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.786 1.635 . . . . 0.0 110.836 168.732 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -74.9 -72.0 0.32 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.349 1.06 . . . . 0.0 110.89 176.558 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm 38.82 90.41 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 128.813 2.845 . . . . 0.0 114.146 -178.8 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -54.63 136.47 45.37 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.55 -0.719 . . . . 0.0 111.504 173.816 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.4 p -140.13 169.65 17.3 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -170.457 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -119.83 -30.14 4.82 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 128.381 2.672 . . . . 0.0 111.56 -179.782 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -152.8 164.61 37.5 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 127.922 2.489 . . . . 0.0 110.694 -172.526 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -65.73 -23.8 66.83 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.512 -0.743 . . . . 0.0 112.79 -177.719 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.1 m -67.28 -18.41 65.19 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.4 1.48 . . . . 0.0 113.217 177.648 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -74.0 -13.76 60.92 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.723 1.209 . . . . 0.0 113.193 174.134 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.2 m -111.57 149.28 40.47 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 125.008 1.323 . . . . 0.0 112.897 -172.46 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -77.46 163.84 29.27 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.362 2.708 . . . . 0.0 113.846 -175.38 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 36.91 -112.29 0.15 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 127.449 2.452 . . . . 0.0 115.746 173.959 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.01 5.45 48.77 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.42 1.888 . . . . 0.0 113.909 -177.531 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.2 m -66.81 168.29 9.9 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 122.423 1.106 . . . . 0.0 112.188 174.184 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.3 pt -135.27 162.91 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 128.093 2.557 . . . . 0.0 109.745 173.863 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.2 t -86.02 103.28 14.56 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 168.849 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -65.74 169.3 6.57 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.364 1.865 . . . . 0.0 111.21 -176.582 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.51 -17.95 71.27 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.814 1.197 . . . . 0.0 114.416 -173.218 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -82.02 -5.43 58.35 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.195 1.398 . . . . 0.0 114.348 173.116 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.92 24.29 38.55 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.369 0.985 . . . . 0.0 114.931 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -133.5 164.2 27.68 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.396 1.879 . . . . 0.0 111.161 177.526 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 89.5 m -73.84 156.21 37.99 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.038 -1.039 . . . . 0.0 112.948 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.142 0 C-N-CA 124.96 1.267 . . . . 0.0 112.271 172.692 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.2 p . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -93.28 177.39 37.89 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.5 1.048 . . . . 0.0 112.709 171.348 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.8 p -62.44 -18.57 62.03 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -176.627 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -68.18 -20.01 64.83 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.789 1.636 . . . . 0.0 114.313 172.46 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 68.27 15.05 67.34 Favored Glycine 0 CA--C 1.54 1.632 0 N-CA-C 116.22 1.248 . . . . 0.0 116.22 176.203 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.17 -177.36 25.69 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.426 1.489 . . . . 0.0 114.996 -179.629 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.8 t -59.56 100.47 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 126.008 1.723 . . . . 0.0 112.179 -177.629 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.4 t -136.8 116.36 10.63 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.442 1.497 . . . . 0.0 110.41 172.637 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -72.72 -7.84 21.44 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 123.689 2.926 . . . . 0.0 114.969 -179.491 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt 49.39 45.29 23.82 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 127.014 2.126 . . . . 0.0 114.124 175.552 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.6 pp -79.5 157.34 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.508 1.523 . . . . 0.0 111.572 174.418 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.1 mt -80.04 64.18 4.79 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.535 1.534 . . . . 0.0 112.278 -174.172 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -108.91 107.21 17.51 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.957 2.103 . . . . 0.0 110.155 177.602 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -64.27 145.62 55.7 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.678 0.791 . . . . 0.0 110.093 173.453 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.3 p -141.86 168.12 20.51 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -173.828 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -116.33 -28.5 6.49 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.572 2.349 . . . . 0.0 112.016 177.374 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -151.64 172.97 15.24 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.632 2.373 . . . . 0.0 110.133 -176.819 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -70.53 -26.39 63.54 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.501 0.72 . . . . 0.0 112.532 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.7 p -68.61 -16.02 63.71 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.637 1.575 . . . . 0.0 113.858 174.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -73.61 -12.04 60.62 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.875 0.87 . . . . 0.0 113.167 169.71 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 79.8 m -112.01 158.3 37.25 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -169.071 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.74 167.11 7.26 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 124.32 3.347 . . . . 0.0 115.652 176.598 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -1.89 -86.4 0.0 OUTLIER Glycine 0 N--CA 1.477 1.388 0 C-N-CA 130.238 3.78 . . . . 0.0 117.645 177.976 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -107.86 10.53 28.57 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.239 1.415 . . . . 0.0 113.502 -178.026 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 67.2 m -66.99 167.13 12.3 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.468 1.128 . . . . 0.0 111.761 169.528 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.7 pt -133.11 161.69 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 128.03 2.532 . . . . 0.0 109.27 169.568 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.5 t -86.95 99.82 12.14 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.741 0.816 . . . . 0.0 109.65 170.335 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -77.06 174.65 10.41 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.97 1.308 . . . . 0.0 111.868 -170.698 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.39 -16.04 68.84 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.898 1.237 . . . . 0.0 114.464 -171.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -76.04 -8.05 56.09 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.589 1.556 . . . . 0.0 114.253 170.412 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.26 15.33 64.69 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.947 1.261 . . . . 0.0 114.859 -178.565 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -131.39 160.97 33.5 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.856 1.662 . . . . 0.0 112.114 -178.071 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 70.9 m -68.33 141.88 55.67 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.904 0.881 . . . . 0.0 112.211 176.967 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.068 0 C-N-CA 123.794 0.712 . . . . 0.0 113.151 176.008 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -111.05 112.46 3.21 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 169.721 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -56.21 -23.95 38.86 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -169.311 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -67.43 -27.28 66.93 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.534 1.134 . . . . 0.0 113.359 172.193 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -101.39 -32.88 5.04 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 126.412 1.958 . . . . 0.0 113.971 176.205 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 136.0 -171.74 22.63 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.066 1.317 . . . . 0.0 115.174 172.766 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.5 t -72.48 111.3 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.703 1.201 . . . . 0.0 109.069 168.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.6 t -83.59 127.78 66.56 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 122.877 0.471 . . . . 0.0 111.56 173.328 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.19 69.06 4.05 Favored 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.84 3.026 . . . . 0.0 109.729 167.826 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -61.01 140.7 57.76 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 127.986 2.515 . . . . 0.0 113.434 -169.268 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.0 pp -131.75 169.85 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 127.584 2.353 . . . . 0.0 110.629 169.284 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.3 mt -74.53 86.0 2.06 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.058 0.943 . . . . 0.0 111.849 -178.07 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -127.09 109.94 12.4 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.16 1.784 . . . . 0.0 110.8 176.087 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.83 148.09 50.22 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.812 1.245 . . . . 0.0 110.822 176.257 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.4 p -144.78 171.32 14.59 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 177.013 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -128.41 -24.55 3.06 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 128.408 2.683 . . . . 0.0 112.098 169.713 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.7 ptm85 -145.12 166.17 26.17 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.442 1.897 . . . . 0.0 111.834 178.762 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -67.58 -20.98 65.44 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.281 -0.887 . . . . 0.0 112.724 -176.135 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.2 m -67.47 -17.09 64.55 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.618 1.167 . . . . 0.0 113.182 175.75 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -74.49 -10.75 59.87 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.387 1.475 . . . . 0.0 113.347 173.662 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.5 m -119.09 158.39 48.3 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.07 1.348 . . . . 0.0 113.346 -168.668 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.08 165.97 30.67 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.123 2.549 . . . . 0.0 112.254 174.086 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -39.34 -57.7 2.15 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 127.426 2.441 . . . . 0.0 117.234 -169.768 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.03 -17.46 52.71 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -177.099 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.4 m -79.09 164.8 24.0 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 123.283 1.515 . . . . 0.0 112.752 169.686 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.9 pt -132.52 167.31 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 129.767 3.227 . . . . 0.0 107.512 167.065 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.9 t -80.08 101.61 8.84 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.299 -0.876 . . . . 0.0 109.744 169.455 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.86 169.57 12.86 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.104 1.762 . . . . 0.0 111.632 -177.669 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.45 -13.96 79.71 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.848 1.213 . . . . 0.0 114.598 -173.792 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -79.15 -6.73 57.22 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.638 1.575 . . . . 0.0 114.29 174.885 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.41 12.72 62.59 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.642 1.115 . . . . 0.0 114.805 -177.504 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -129.71 167.96 17.23 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.405 1.882 . . . . 0.0 111.031 176.392 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.2 m -70.04 152.95 43.8 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.25 -0.907 . . . . 0.0 112.679 173.664 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.973 0 C-N-CA 124.423 1.011 . . . . 0.0 113.781 171.662 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.28 9.92 73.43 Favored Glycine 0 CA--C 1.539 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 113.354 -168.961 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.5 m 71.01 -3.92 1.9 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 128.717 2.807 . . . . 0.0 115.229 -177.558 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -140.45 -0.65 1.56 Allowed 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 178.452 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.62 176.3 48.53 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.849 1.214 . . . . 0.0 115.294 -177.275 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.69 -123.24 1.57 Allowed Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.956 1.741 . . . . 0.0 113.922 -176.088 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 m -64.79 85.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 126.159 1.784 . . . . 0.0 113.014 178.787 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.6 t -131.76 113.42 15.18 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.112 1.365 . . . . 0.0 110.837 174.697 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.71 -5.55 16.11 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 123.998 3.132 . . . . 0.0 115.207 179.14 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.4 mttp 54.04 44.28 29.53 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 126.929 2.092 . . . . 0.0 114.163 171.952 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.04 160.6 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.547 1.139 . . . . 0.0 111.515 -178.357 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 90.9 mt -76.55 36.05 0.15 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.184 1.794 . . . . 0.0 113.675 -179.449 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -76.75 105.07 7.59 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.39 1.876 . . . . 0.0 109.432 169.892 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -63.63 143.75 57.57 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.997 0.919 . . . . 0.0 111.141 174.232 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 p -144.04 173.1 12.02 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.937 1.295 . . . . 0.0 114.193 -176.052 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -132.27 -20.04 2.43 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.256 2.222 . . . . 0.0 112.628 170.034 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -142.6 164.36 30.32 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.113 1.765 . . . . 0.0 111.754 178.015 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -67.4 -22.65 65.53 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.509 -0.744 . . . . 0.0 112.554 -176.751 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.0 m -66.99 -18.0 65.18 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.458 1.503 . . . . 0.0 113.128 176.423 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -74.14 -12.65 60.65 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.056 1.342 . . . . 0.0 113.371 174.952 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 81.6 m -115.99 151.18 46.23 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -168.402 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -80.58 167.37 18.99 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.662 2.908 . . . . 0.0 113.941 -174.658 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 39.8 -108.03 0.09 OUTLIER Glycine 0 CA--C 1.534 1.264 0 C-N-CA 127.644 2.545 . . . . 0.0 115.497 172.256 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.35 6.88 30.89 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.281 1.832 . . . . 0.0 113.673 -177.823 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 75.3 m -66.41 168.82 8.31 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 122.626 1.203 . . . . 0.0 112.938 175.693 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.6 pt -131.83 169.69 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 129.067 2.947 . . . . 0.0 108.962 169.061 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.9 t -87.73 108.36 19.08 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.659 -0.651 . . . . 0.0 109.333 168.091 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 -66.1 168.35 8.55 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.61 1.564 . . . . 0.0 111.451 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.51 -17.91 73.15 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.832 1.206 . . . . 0.0 114.478 -176.837 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -80.37 -5.96 57.26 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.694 1.197 . . . . 0.0 114.092 172.684 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.82 24.08 36.65 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.521 1.058 . . . . 0.0 114.972 -179.87 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -134.84 161.96 33.75 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.675 1.59 . . . . 0.0 111.9 177.125 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.5 m -69.24 144.78 53.57 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.321 -0.862 . . . . 0.0 113.319 179.797 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.035 0 C-N-CA 124.543 1.068 . . . . 0.0 113.167 179.007 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.03 172.78 15.03 Favored Glycine 0 N--CA 1.475 1.252 0 C-N-CA 123.92 0.771 . . . . 0.0 114.915 -176.69 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.5 p -64.01 -15.24 58.93 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.023 1.729 . . . . 0.0 114.935 -177.329 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -64.9 -18.3 65.08 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.338 1.455 . . . . 0.0 113.508 170.262 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.96 2.15 84.2 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.219 1.39 . . . . 0.0 114.557 -178.159 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.08 111.63 4.27 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.589 1.566 . . . . 0.0 112.017 174.448 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.8 t -68.02 99.37 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.83 1.252 . . . . 0.0 111.248 -177.582 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.0 t -82.2 141.74 46.75 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 166.863 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -50.81 13.54 0.01 OUTLIER 'Trans proline' 0 CA--C 1.553 1.444 1 C-N-CA 127.242 5.295 . . . . 0.0 119.676 169.561 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt 50.25 46.48 24.88 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 128.428 2.691 . . . . 0.0 114.745 173.887 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.5 pp -79.4 147.54 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.464 1.506 . . . . 0.0 110.018 169.707 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.0 mt -71.93 -68.66 0.44 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.396 1.078 . . . . 0.0 111.882 -178.697 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 76.3 tttt 33.63 97.29 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 129.852 3.261 . . . . 0.0 115.135 179.565 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -54.86 136.3 47.02 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.417 -0.802 . . . . 0.0 111.404 172.638 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.8 p -141.99 165.53 27.21 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.143 1.377 . . . . 0.0 114.191 -170.831 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -116.73 -19.5 9.91 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.871 2.068 . . . . 0.0 112.841 -179.069 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -160.69 163.41 32.46 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 128.863 2.865 . . . . 0.0 109.468 -169.011 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -66.95 -26.7 66.96 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.139 -0.976 . . . . 0.0 112.666 179.286 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.3 m -71.05 -15.42 62.54 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.509 1.524 . . . . 0.0 113.622 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -72.37 -22.49 61.14 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.192 0.997 . . . . 0.0 112.389 170.507 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 75.3 m -94.6 151.37 39.16 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.4 1.08 . . . . 0.0 112.813 -174.575 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.16 160.78 26.46 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.444 2.763 . . . . 0.0 113.168 -178.282 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 27.4 -99.04 0.01 OUTLIER Glycine 0 CA--C 1.536 1.348 0 C-N-CA 128.694 3.045 . . . . 0.0 116.671 174.233 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -95.92 -3.63 44.9 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 -173.122 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.3 m -68.74 165.04 20.38 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 122.992 1.377 . . . . 0.0 113.153 175.954 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.5 pt -124.21 166.17 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 129.551 3.14 . . . . 0.0 107.844 167.539 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.6 t -97.6 107.0 19.41 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.771 0.828 . . . . 0.0 108.815 169.267 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -65.1 165.81 10.57 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.619 1.168 . . . . 0.0 111.132 179.236 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.13 -16.71 71.18 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.052 1.31 . . . . 0.0 114.475 -175.803 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -77.41 -5.92 51.52 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.044 1.338 . . . . 0.0 114.027 170.801 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.62 28.26 30.06 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.487 1.041 . . . . 0.0 114.683 179.088 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -135.93 158.5 44.24 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.54 1.536 . . . . 0.0 111.862 176.743 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.9 m -77.54 163.83 25.93 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 122.124 0.964 . . . . 0.0 113.366 -179.829 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.131 0 C-N-CA 125.402 1.477 . . . . 0.0 111.897 169.652 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.25 17.18 59.8 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 124.574 1.083 . . . . 0.0 113.736 171.399 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.3 m 65.19 11.76 7.46 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 127.279 2.232 . . . . 0.0 115.239 -178.895 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.16 -26.6 68.24 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.967 1.307 . . . . 0.0 113.205 176.006 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.82 -3.42 81.09 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.695 1.617 . . . . 0.0 115.029 176.286 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.1 -165.43 37.72 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.606 1.574 . . . . 0.0 113.645 174.214 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 51.1 t -66.89 101.38 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.548 1.539 . . . . 0.0 112.555 -176.737 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.2 t -135.19 102.71 10.77 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.796 1.239 . . . . 0.0 110.391 166.955 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.06 -1.83 11.9 Favored 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 123.912 3.074 . . . . 0.0 115.206 -179.518 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt 50.69 51.17 17.48 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 127.072 2.149 . . . . 0.0 113.636 175.928 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.78 158.28 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 125.383 1.473 . . . . 0.0 112.027 178.517 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.1 mt -78.17 30.06 0.18 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.242 1.817 . . . . 0.0 113.824 -178.792 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -72.01 111.86 7.61 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 120.657 -1.277 . . . . 0.0 109.937 169.776 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -67.41 141.56 57.0 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.219 0.607 . . . . 0.0 109.976 168.955 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.5 p -141.31 171.36 14.17 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.471 1.108 . . . . 0.0 113.741 -171.97 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -136.3 -10.12 1.95 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.326 1.85 . . . . 0.0 113.158 172.692 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.3 ttt-85 -141.31 168.2 20.34 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.672 1.589 . . . . 0.0 110.451 171.66 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -72.5 -26.97 61.98 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.371 0.669 . . . . 0.0 112.253 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.0 p -70.03 -13.41 62.21 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.28 1.832 . . . . 0.0 113.82 175.481 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.58 -23.49 65.4 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.486 -0.759 . . . . 0.0 112.403 168.995 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.8 m -107.22 161.71 22.11 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 124.838 1.255 . . . . 0.0 114.137 -168.535 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -56.54 167.3 2.88 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 124.594 3.529 . . . . 0.0 115.446 173.038 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -32.09 -67.52 0.16 Allowed Glycine 0 CA--C 1.538 1.493 0 C-N-CA 128.521 2.963 . . . . 0.0 117.095 -171.82 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.38 -0.51 56.53 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -177.32 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 65.1 m -74.07 169.64 17.09 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.668 1.223 . . . . 0.0 112.044 173.517 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 24.4 pt -137.13 166.61 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 128.762 2.825 . . . . 0.0 108.707 169.966 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.6 t -86.96 104.42 16.26 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 167.875 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -66.37 169.46 7.34 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.683 1.593 . . . . 0.0 111.026 -175.906 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.71 -17.32 68.99 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.701 1.143 . . . . 0.0 114.242 -176.482 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 53.9 p30 -79.34 -6.52 56.95 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.469 1.507 . . . . 0.0 114.405 172.446 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.57 17.81 57.88 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.662 1.125 . . . . 0.0 115.22 179.885 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -130.88 161.8 31.03 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.839 1.655 . . . . 0.0 111.928 178.275 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 97.7 m -68.2 145.81 53.96 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.614 -0.679 . . . . 0.0 112.727 178.038 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.088 0 C-N-CA 124.64 1.115 . . . . 0.0 112.469 174.542 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.0 m . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -148.0 -4.33 0.35 Allowed Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.82 1.2 . . . . 0.0 115.504 173.869 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.9 t -147.62 179.72 7.49 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.137 1.775 . . . . 0.0 111.662 -178.403 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -121.76 -3.22 9.24 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 127.207 2.203 . . . . 0.0 112.595 171.83 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.37 27.5 3.21 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.249 1.88 . . . . 0.0 115.442 -176.668 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 172.61 -152.35 16.35 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.925 1.726 . . . . 0.0 112.349 -172.788 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.5 p -119.72 147.8 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.472 1.509 . . . . 0.0 111.45 176.525 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.6 t -137.0 105.72 8.79 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.277 1.031 . . . . 0.0 111.422 169.049 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -58.37 -18.32 37.83 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 124.449 3.432 . . . . 0.0 116.881 177.976 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 49.98 74.51 0.21 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 126.974 2.11 . . . . 0.0 112.722 -174.034 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.1 pt -127.83 162.57 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 126.252 1.821 . . . . 0.0 112.567 -172.948 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -68.89 22.67 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.156 2.182 . . . . 0.0 115.923 178.534 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -65.27 104.73 0.98 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.277 1.431 . . . . 0.0 109.901 169.262 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.1 145.33 53.58 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.462 1.105 . . . . 0.0 110.822 173.834 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 p -143.99 167.05 23.28 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 177.93 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -121.98 -21.52 5.98 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.674 2.39 . . . . 0.0 112.463 169.276 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.67 168.97 20.69 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.278 1.831 . . . . 0.0 111.417 177.164 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -66.23 -22.91 66.34 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.27 -0.894 . . . . 0.0 112.755 -177.51 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.2 m -66.27 -17.74 64.93 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.741 1.617 . . . . 0.0 113.378 177.471 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -74.27 -13.73 60.81 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.446 1.498 . . . . 0.0 113.747 174.133 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.5 m -117.44 159.12 43.06 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -167.469 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -56.05 168.69 1.75 Allowed 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 125.106 3.87 . . . . 0.0 116.189 172.198 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -35.66 -65.52 0.45 Allowed Glycine 0 CA--C 1.535 1.287 0 C-N-CA 128.45 2.928 . . . . 0.0 117.451 -170.633 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.46 1.8 55.75 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.635 1.174 . . . . 0.0 114.035 -178.797 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.9 m -74.97 168.21 20.4 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.777 1.275 . . . . 0.0 112.109 170.841 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.5 pt -136.58 165.15 29.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 129.586 3.154 . . . . 0.0 107.894 168.224 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.3 t -83.21 101.23 11.09 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 168.015 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -65.97 169.5 6.69 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.876 1.67 . . . . 0.0 110.748 -175.231 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.91 -16.96 69.0 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.662 1.125 . . . . 0.0 114.39 -174.751 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -79.7 -9.29 59.62 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.32 1.448 . . . . 0.0 114.454 173.841 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.43 15.74 56.53 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.667 1.127 . . . . 0.0 115.336 -178.35 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -129.67 164.86 23.0 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.513 1.525 . . . . 0.0 111.245 176.922 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.6 m -70.19 146.45 50.75 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.264 -0.898 . . . . 0.0 112.734 177.397 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.035 0 C-N-CA 125.139 1.352 . . . . 0.0 111.598 174.301 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.5 m . . . . . 0 N--CA 1.477 0.92 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.12 -9.46 20.11 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.259 0.933 . . . . 0.0 114.468 171.499 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.3 p -105.25 174.84 5.71 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.099 1.76 . . . . 0.0 112.134 173.095 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -68.98 -17.49 63.94 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.515 1.126 . . . . 0.0 113.589 174.475 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 166.83 96.75 0.11 Allowed Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.994 1.283 . . . . 0.0 112.251 -176.095 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -152.15 -172.99 21.31 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.258 1.409 . . . . 0.0 113.284 -179.552 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.3 m -67.41 74.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 126.259 1.824 . . . . 0.0 113.405 -179.066 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.8 t -129.43 106.39 17.45 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.66 1.584 . . . . 0.0 110.842 169.881 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -60.78 -13.78 28.43 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 124.318 3.345 . . . . 0.0 117.534 -178.898 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 97.7 mttt 47.61 77.73 0.09 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 127.306 2.243 . . . . 0.0 113.516 -174.782 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.405 ' H ' HD13 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -124.98 164.67 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.703 1.601 . . . . 0.0 112.477 -178.414 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 90.5 mt -74.6 29.79 0.09 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.272 1.829 . . . . 0.0 114.336 -178.072 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -70.59 99.99 1.75 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.134 1.373 . . . . 0.0 109.918 169.657 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -63.19 144.11 57.21 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.356 1.062 . . . . 0.0 110.926 171.863 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.0 p -143.9 172.6 12.63 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -175.445 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -132.63 -15.47 2.74 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 127.373 2.269 . . . . 0.0 113.649 171.166 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.5 ttp180 -144.06 170.82 15.21 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.032 1.733 . . . . 0.0 110.971 172.382 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -70.72 -24.2 62.59 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.46 0.704 . . . . 0.0 112.286 178.9 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.4 m -64.32 -20.64 66.23 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.141 1.776 . . . . 0.0 113.017 174.959 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.86 -16.03 62.67 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.443 1.097 . . . . 0.0 113.437 173.107 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 56.0 m -116.14 151.82 47.09 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.911 1.285 . . . . 0.0 113.313 -169.035 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.06 164.21 22.44 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.316 2.677 . . . . 0.0 113.592 -176.959 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 26.85 -100.9 0.01 OUTLIER Glycine 0 CA--C 1.537 1.448 0 C-N-CA 129.033 3.206 . . . . 0.0 117.307 172.429 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.69 2.11 51.72 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.791 1.636 . . . . 0.0 113.929 -174.764 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.0 m -72.04 166.16 22.81 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 122.771 1.272 . . . . 0.0 112.063 172.597 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.9 pt -135.46 166.15 28.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 129.514 3.126 . . . . 0.0 108.045 168.514 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.9 t -83.14 101.28 11.08 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 168.011 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -65.42 170.27 5.05 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.153 1.781 . . . . 0.0 110.911 -175.805 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.71 -17.4 69.09 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.648 1.118 . . . . 0.0 114.517 -173.799 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.9 p-10 -79.97 -8.04 59.13 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.379 1.472 . . . . 0.0 114.434 172.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.4 20.08 49.92 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.634 1.111 . . . . 0.0 115.091 -178.128 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -132.27 161.56 33.17 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.606 1.562 . . . . 0.0 111.761 178.287 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.6 m -70.17 140.31 52.54 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.322 -0.862 . . . . 0.0 112.565 178.236 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.077 0 C-N-CA 125.289 1.423 . . . . 0.0 111.649 175.273 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 83.7 tttt . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -66.05 145.44 55.86 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.1 0.56 . . . . 0.0 110.46 170.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.8 p -144.84 171.63 14.15 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -174.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -119.71 -28.51 5.24 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 128.205 2.602 . . . . 0.0 111.574 172.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -149.31 173.18 13.79 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.271 1.428 . . . . 0.0 112.292 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -66.09 -27.06 67.78 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.876 1.27 . . . . 0.0 112.497 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.8 m -66.36 -19.8 65.9 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.554 1.542 . . . . 0.0 112.915 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -70.04 -25.35 63.52 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 82.9 m -96.28 157.32 35.77 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.489 1.116 . . . . 0.0 113.646 -169.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.25 161.36 46.04 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.993 2.462 . . . . 0.0 112.46 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -12.34 -75.11 0.01 OUTLIER Glycine 0 N--CA 1.477 1.373 0 C-N-CA 129.506 3.432 . . . . 0.0 117.984 -173.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.51 -8.58 52.5 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -172.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.4 m -74.5 166.43 23.54 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 122.853 1.311 . . . . 0.0 113.151 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.4 pt -128.92 162.19 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 129.447 3.099 . . . . 0.0 108.599 168.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.8 t -86.19 100.15 12.03 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 169.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -65.09 171.08 3.88 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.168 2.187 . . . . 0.0 111.305 -174.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.64 -17.3 70.84 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.848 1.214 . . . . 0.0 114.6 -173.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -84.85 -2.66 58.06 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.322 1.449 . . . . 0.0 114.358 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.0 22.74 51.79 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.226 0.917 . . . . 0.0 114.884 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -130.99 159.8 36.43 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.558 1.543 . . . . 0.0 111.905 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.0 m -69.38 145.57 52.79 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.301 0.641 . . . . 0.0 112.1 175.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.781 0 C-N-CA 124.728 1.156 . . . . 0.0 111.915 174.243 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 80.8 tttt . . . . . 0 CA--C 1.537 0.46 0 CA-C-O 120.281 0.086 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -66.6 149.49 50.41 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.978 0.911 . . . . 0.0 110.236 169.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.2 p -144.73 172.17 13.37 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -128.63 -22.45 3.3 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.966 2.506 . . . . 0.0 112.23 170.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -144.38 164.03 32.01 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.482 1.913 . . . . 0.0 111.57 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -66.91 -23.08 65.95 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.394 -0.816 . . . . 0.0 112.593 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.4 m -67.4 -17.66 64.81 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.252 1.421 . . . . 0.0 113.216 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -72.9 -20.25 61.12 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.848 1.259 . . . . 0.0 113.268 173.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.4 m -106.2 163.66 16.58 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -167.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -55.84 164.4 4.67 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 124.071 3.181 . . . . 0.0 113.929 169.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.7 -54.08 18.89 Favored Glycine 0 N--CA 1.475 1.257 0 C-N-CA 125.894 1.711 . . . . 0.0 115.519 -175.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.68 -17.74 50.17 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.8 m -75.65 167.72 21.36 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 123.16 1.457 . . . . 0.0 113.192 171.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.8 pt -133.44 167.78 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 129.39 3.076 . . . . 0.0 107.467 166.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.0 t -83.89 103.05 12.83 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.479 -0.763 . . . . 0.0 109.801 169.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.38 165.67 13.75 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.794 1.638 . . . . 0.0 111.145 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.93 -14.33 75.9 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.997 1.284 . . . . 0.0 114.439 -174.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.5 p-10 -78.27 -6.18 54.22 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.643 1.577 . . . . 0.0 114.123 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.89 19.04 55.04 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.412 1.006 . . . . 0.0 114.725 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -131.56 165.02 24.55 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.063 1.745 . . . . 0.0 111.684 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 80.9 m -74.45 151.21 39.63 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.606 -0.684 . . . . 0.0 112.832 173.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.029 0 C-N-CA 124.364 0.983 . . . . 0.0 113.144 171.56 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.5 tttm . . . . . 0 N--CA 1.468 0.427 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -63.58 144.97 56.57 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.993 0.917 . . . . 0.0 110.863 172.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 p -147.21 173.47 12.51 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -174.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -133.2 -14.88 2.59 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 127.322 2.249 . . . . 0.0 113.295 172.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -144.52 163.41 33.93 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 127.096 2.158 . . . . 0.0 110.724 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -69.34 -22.55 63.75 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.615 -0.678 . . . . 0.0 112.682 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.4 m -69.51 -15.33 63.23 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.426 1.09 . . . . 0.0 113.128 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -74.1 -11.91 60.45 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.763 1.225 . . . . 0.0 113.108 174.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 76.9 m -113.73 147.58 37.95 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.597 1.159 . . . . 0.0 114.04 -168.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -80.82 160.46 21.42 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.607 2.871 . . . . 0.0 113.423 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 43.67 -118.27 2.09 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.685 2.088 . . . . 0.0 114.889 174.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.8 3.05 55.47 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.007 1.723 . . . . 0.0 113.803 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.0 m -64.5 151.84 43.36 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.764 1.269 . . . . 0.0 112.532 169.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.2 pt -120.87 164.25 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 128.203 2.601 . . . . 0.0 108.4 169.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.9 t -82.99 101.1 10.86 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 169.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -66.4 170.85 5.5 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.442 1.897 . . . . 0.0 111.1 -176.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.21 -17.63 70.34 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.721 1.153 . . . . 0.0 114.542 -173.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -82.43 -4.91 58.24 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.308 1.443 . . . . 0.0 114.369 173.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.2 22.89 46.62 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.31 0.957 . . . . 0.0 114.993 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -132.79 160.23 37.48 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.555 1.542 . . . . 0.0 111.851 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.2 m -68.98 142.51 54.64 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.602 -0.686 . . . . 0.0 112.396 176.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.111 0 C-N-CA 124.503 1.049 . . . . 0.0 112.53 172.295 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -68.38 142.78 55.34 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.239 0.616 . . . . 0.0 109.476 168.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.3 p -141.73 168.13 20.49 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -172.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -122.14 -21.04 6.04 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 127.328 2.251 . . . . 0.0 112.742 171.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.69 167.69 24.84 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.257 1.423 . . . . 0.0 111.358 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -65.92 -22.25 66.49 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.311 -0.868 . . . . 0.0 112.538 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.8 m -66.83 -19.25 65.7 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.821 1.648 . . . . 0.0 113.371 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -69.14 -30.9 69.24 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.583 1.153 . . . . 0.0 112.637 172.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.5 m -96.48 151.87 38.29 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -168.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.05 160.04 23.82 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.535 2.824 . . . . 0.0 113.079 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 23.11 -97.97 0.01 OUTLIER Glycine 0 CA--C 1.538 1.489 0 C-N-CA 129.2 3.286 . . . . 0.0 117.085 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.02 -4.28 54.7 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -173.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.5 m -72.86 163.14 28.58 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 122.905 1.336 . . . . 0.0 112.983 171.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.7 pt -130.04 165.76 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 129.642 3.177 . . . . 0.0 108.157 168.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.0 t -83.59 102.04 11.9 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 168.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -66.22 170.47 5.79 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.294 1.838 . . . . 0.0 111.251 -175.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.48 -17.89 71.15 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.709 1.147 . . . . 0.0 114.452 -173.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -82.22 -4.7 57.6 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.141 1.376 . . . . 0.0 114.337 173.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.77 20.9 52.68 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.299 0.952 . . . . 0.0 115.017 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -131.66 162.03 31.36 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.838 1.655 . . . . 0.0 111.762 176.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 75.2 m -71.86 145.36 48.62 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.523 -0.736 . . . . 0.0 112.954 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.232 0 C-N-CA 125.198 1.38 . . . . 0.0 112.08 171.825 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.0 tttm . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 119.854 -0.117 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -65.88 152.06 45.31 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.642 0.777 . . . . 0.0 111.528 174.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.4 p -147.73 169.67 19.22 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 177.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.61 -6.25 1.96 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 127.458 2.303 . . . . 0.0 113.891 169.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.4 ttt85 -144.64 170.6 15.76 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 128.356 2.662 . . . . 0.0 109.004 173.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -75.5 -24.72 56.9 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.505 -0.747 . . . . 0.0 112.297 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.6 m -66.4 -16.2 63.9 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.376 1.871 . . . . 0.0 113.173 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -73.77 -13.59 60.97 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.418 1.487 . . . . 0.0 113.834 173.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 76.7 m -113.02 146.2 34.66 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -167.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -81.83 167.39 16.53 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.907 3.072 . . . . 0.0 113.55 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 43.67 -117.48 1.79 Allowed Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.638 2.066 . . . . 0.0 114.904 174.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.98 6.59 47.5 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.954 1.701 . . . . 0.0 113.844 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.4 m -68.25 162.7 24.48 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 123.228 1.49 . . . . 0.0 113.834 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.8 pt -130.62 169.95 20.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 129.486 3.114 . . . . 0.0 107.806 168.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -82.6 104.08 12.6 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 121.7 -0.625 . . . . 0.0 109.759 168.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.06 167.84 9.28 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.186 1.394 . . . . 0.0 110.533 176.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.43 -13.93 71.41 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.818 1.199 . . . . 0.0 114.624 -174.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -79.18 -6.51 56.73 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.86 1.664 . . . . 0.0 114.399 174.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.7 23.07 56.97 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.184 0.897 . . . . 0.0 114.522 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -133.18 164.21 27.56 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.709 2.004 . . . . 0.0 111.067 173.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.6 m -71.74 147.12 47.66 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.624 -0.672 . . . . 0.0 112.524 176.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.049 0 C-N-CA 124.208 0.909 . . . . 0.0 112.038 170.61 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt . . . . . 0 N--CA 1.471 0.576 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.45 142.51 55.32 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.444 0.698 . . . . 0.0 109.447 168.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.8 p -142.83 171.39 14.12 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -134.79 -14.86 2.1 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.43 2.292 . . . . 0.0 112.482 171.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -130.31 152.18 50.0 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.402 2.281 . . . . 0.0 110.032 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -64.39 -24.19 67.55 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 121.414 -0.804 . . . . 0.0 111.936 169.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.3 m -68.24 -20.27 64.8 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.88 2.072 . . . . 0.0 113.453 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -68.08 -25.64 65.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.959 0.903 . . . . 0.0 112.988 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.6 m -101.25 152.75 38.01 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.891 1.277 . . . . 0.0 113.497 -169.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -80.81 172.22 13.46 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.717 2.945 . . . . 0.0 113.753 -174.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 44.31 -106.99 0.11 Allowed Glycine 0 CA--C 1.535 1.286 0 C-N-CA 127.281 2.372 . . . . 0.0 114.779 172.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -118.58 13.71 13.45 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.311 1.844 . . . . 0.0 113.121 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.0 m -60.72 169.16 1.94 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 122.471 1.129 . . . . 0.0 112.558 172.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.5 pt -129.52 166.92 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 128.155 2.582 . . . . 0.0 109.622 170.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.6 t -93.16 107.02 18.91 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.782 0.833 . . . . 0.0 109.579 168.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -67.91 166.74 15.02 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.053 1.741 . . . . 0.0 111.374 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.34 -16.95 73.86 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.916 1.246 . . . . 0.0 114.45 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -80.83 -4.61 55.3 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.26 1.424 . . . . 0.0 114.11 172.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.3 25.94 32.13 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.375 0.988 . . . . 0.0 114.946 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -134.71 161.91 33.82 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.874 1.669 . . . . 0.0 111.912 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.7 m -67.96 154.45 41.59 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.388 -0.82 . . . . 0.0 113.059 175.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.096 0 C-N-CA 124.84 1.21 . . . . 0.0 112.053 176.602 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.4 tttm . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 110.623 -0.14 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -61.61 145.83 50.88 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.746 0.818 . . . . 0.0 110.478 170.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.4 p -141.59 167.49 22.04 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -120.69 -19.64 7.33 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.231 2.213 . . . . 0.0 112.948 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -159.44 161.81 35.58 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 129.508 3.123 . . . . 0.0 109.241 -169.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -66.95 -25.2 66.23 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 121.007 -1.058 . . . . 0.0 112.746 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -71.51 -13.68 61.88 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.505 1.522 . . . . 0.0 113.557 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -74.4 -8.34 55.94 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.451 1.1 . . . . 0.0 112.986 170.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.5 m -119.49 148.6 46.08 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 125.243 1.417 . . . . 0.0 112.391 -173.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.09 167.81 21.34 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.503 2.802 . . . . 0.0 114.036 -176.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 34.5 -107.05 0.03 OUTLIER Glycine 0 CA--C 1.536 1.386 0 C-N-CA 128.302 2.858 . . . . 0.0 116.597 172.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -103.41 9.92 37.57 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.598 1.959 . . . . 0.0 113.772 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.3 m -67.32 164.86 17.54 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 122.589 1.185 . . . . 0.0 111.724 169.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.5 pt -129.81 163.52 34.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 128.801 2.841 . . . . 0.0 108.553 168.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 47.0 t -94.52 104.29 16.25 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.647 0.779 . . . . 0.0 109.15 169.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -80.75 172.0 14.3 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.579 1.552 . . . . 0.0 111.849 -169.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.11 -16.28 70.66 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.657 1.122 . . . . 0.0 114.299 -173.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -74.88 -11.08 60.05 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.425 1.49 . . . . 0.0 114.218 170.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.28 16.75 56.9 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.842 1.21 . . . . 0.0 115.066 -177.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -131.58 161.22 33.15 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.414 1.486 . . . . 0.0 112.412 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.1 m -68.77 157.6 36.05 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.702 0.801 . . . . 0.0 112.879 174.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.206 0 C-N-CA 125.262 1.41 . . . . 0.0 113.127 168.568 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 70.0 tttt . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -65.09 143.8 57.67 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 168.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.0 p -140.97 171.0 14.68 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.29 -26.52 4.27 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 128.507 2.723 . . . . 0.0 111.33 173.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -135.7 158.38 44.54 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.997 2.119 . . . . 0.0 112.346 -176.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -63.58 -27.03 68.97 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.245 0.618 . . . . 0.0 111.565 169.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.1 m -66.8 -23.09 66.01 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.816 2.046 . . . . 0.0 113.242 175.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -67.87 -20.61 65.15 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 170.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.1 m -104.02 149.13 36.9 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -168.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -82.51 167.53 15.13 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 124.014 3.143 . . . . 0.0 113.421 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 45.71 -123.14 6.2 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.971 1.748 . . . . 0.0 114.495 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.8 8.73 44.21 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.921 1.688 . . . . 0.0 113.42 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.4 m -63.3 158.22 20.86 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 123.026 1.393 . . . . 0.0 112.737 171.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.6 pt -125.57 165.97 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 128.948 2.899 . . . . 0.0 108.471 169.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.6 t -85.1 101.2 12.25 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 169.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -66.73 169.08 8.42 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.22 1.808 . . . . 0.0 111.066 -174.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.07 -17.13 69.52 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.774 1.178 . . . . 0.0 114.396 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 55.1 p30 -79.15 -8.26 58.86 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.338 1.455 . . . . 0.0 114.519 173.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.4 14.72 58.24 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 124.537 1.065 . . . . 0.0 115.425 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -128.38 165.15 21.17 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.884 1.674 . . . . 0.0 111.835 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 83.3 m -70.27 143.03 52.23 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.416 -0.802 . . . . 0.0 112.484 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.093 0 C-N-CA 124.506 1.05 . . . . 0.0 112.583 171.895 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.5 tttm . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 120.525 0.202 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -62.68 146.49 52.07 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.411 1.084 . . . . 0.0 110.973 171.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.5 p -144.17 172.04 13.46 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -175.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -126.78 -22.31 3.9 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 127.813 2.445 . . . . 0.0 112.71 171.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -145.13 171.16 14.91 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.504 1.922 . . . . 0.0 111.115 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -69.81 -23.76 63.37 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.581 0.752 . . . . 0.0 112.441 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.7 m -64.5 -20.39 66.17 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.085 1.754 . . . . 0.0 113.074 174.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -73.13 -12.03 60.75 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.5 1.12 . . . . 0.0 113.595 173.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.8 m -117.87 159.56 42.17 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.959 1.304 . . . . 0.0 113.456 -168.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.57 167.06 26.59 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.249 2.633 . . . . 0.0 112.543 175.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -39.44 -58.6 2.05 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 127.457 2.456 . . . . 0.0 117.147 -169.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.72 -15.98 56.52 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -176.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.8 m -79.57 166.74 21.59 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 123.156 1.455 . . . . 0.0 113.274 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 22.8 pt -133.86 166.08 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 130.599 3.56 . . . . 0.0 107.352 167.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 22.3 t -83.42 101.54 11.43 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 168.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -64.84 168.49 6.21 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.119 1.768 . . . . 0.0 110.973 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.42 -17.44 68.56 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.749 1.166 . . . . 0.0 114.344 -176.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -80.03 -7.04 58.64 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.493 1.517 . . . . 0.0 114.439 172.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.84 17.43 56.46 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.65 1.119 . . . . 0.0 115.347 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -130.0 161.02 31.89 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.637 1.575 . . . . 0.0 111.886 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 74.6 m -68.42 139.65 55.78 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.584 -0.697 . . . . 0.0 112.018 175.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.919 0 C-N-CA 124.84 1.21 . . . . 0.0 112.246 174.802 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.2 tttm . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -60.8 144.53 52.36 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.995 0.918 . . . . 0.0 111.272 175.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.2 p -143.79 171.87 13.61 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.68 -28.65 4.15 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 128.552 2.741 . . . . 0.0 111.715 173.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -148.09 161.75 40.79 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 127.003 2.121 . . . . 0.0 111.298 -175.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -65.37 -22.75 66.84 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.326 -0.859 . . . . 0.0 112.576 -177.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.8 m -66.2 -17.79 64.95 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.709 1.603 . . . . 0.0 113.324 175.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -74.89 -10.26 59.33 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.069 1.348 . . . . 0.0 113.519 174.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.5 m -119.54 153.25 53.98 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 124.466 1.107 . . . . 0.0 113.471 -168.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -57.49 170.63 1.7 Allowed 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.827 3.685 . . . . 0.0 116.249 174.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -30.12 -72.25 0.06 OUTLIER Glycine 0 CA--C 1.537 1.467 0 C-N-CA 128.889 3.138 . . . . 0.0 117.668 -172.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.46 -0.5 57.27 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.59 1.156 . . . . 0.0 114.094 -176.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 54.7 m -75.76 169.21 18.58 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.628 1.204 . . . . 0.0 112.559 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.7 pt -135.12 163.49 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 128.657 2.783 . . . . 0.0 108.756 168.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 42.0 t -93.14 103.93 16.16 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 168.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -79.94 170.31 16.66 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.689 1.596 . . . . 0.0 112.007 -169.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.66 -15.86 71.42 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.778 1.18 . . . . 0.0 114.343 -173.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.8 p-10 -74.86 -10.95 59.98 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.244 1.418 . . . . 0.0 114.148 171.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.42 15.95 54.09 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.967 1.27 . . . . 0.0 114.978 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -132.33 160.41 36.36 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.328 1.451 . . . . 0.0 112.243 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 83.8 m -68.03 160.64 28.39 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.904 0.882 . . . . 0.0 112.663 173.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.053 0 C-N-CA 124.788 1.185 . . . . 0.0 113.529 168.662 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 79.8 tttt . . . . . 0 N--CA 1.47 0.544 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -65.31 145.7 55.87 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.141 0.976 . . . . 0.0 110.368 171.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.1 p -148.99 171.76 15.84 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -133.83 -14.45 2.44 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.761 2.424 . . . . 0.0 112.842 169.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -131.99 152.22 51.27 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 127.758 2.423 . . . . 0.0 109.94 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -65.33 -24.07 67.17 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.411 -0.806 . . . . 0.0 111.967 169.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.4 m -67.93 -20.68 65.1 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.321 1.849 . . . . 0.0 113.165 175.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -69.12 -22.29 63.97 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.768 0.827 . . . . 0.0 113.031 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 85.9 m -103.32 155.41 36.79 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.737 1.215 . . . . 0.0 113.641 -169.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.21 159.75 43.47 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.144 2.563 . . . . 0.0 112.699 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 0.35 -84.52 0.0 OUTLIER Glycine 0 CA--C 1.537 1.467 0 C-N-CA 129.926 3.631 . . . . 0.0 118.026 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.87 -7.81 55.44 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -172.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.6 m -71.99 161.94 30.19 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 123.155 1.455 . . . . 0.0 112.77 169.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.7 pt -128.21 165.43 27.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 129.707 3.203 . . . . 0.0 107.908 168.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.2 t -85.51 103.0 13.98 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 169.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -67.42 169.62 8.74 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.952 1.701 . . . . 0.0 110.946 -176.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.47 -16.05 71.19 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.714 1.15 . . . . 0.0 114.588 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -83.7 -4.52 58.68 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.569 1.548 . . . . 0.0 114.48 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.42 23.41 43.73 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-N 119.09 0.859 . . . . 0.0 114.797 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -132.87 160.79 35.94 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.831 1.653 . . . . 0.0 111.577 176.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.1 m -69.06 146.29 52.76 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.665 -0.647 . . . . 0.0 112.058 173.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.985 0 C-N-CA 124.629 1.109 . . . . 0.0 111.777 173.287 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 110.724 -0.102 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -67.34 147.02 53.49 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 166.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.6 p -143.79 169.86 16.98 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -134.15 -12.37 2.49 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.804 2.041 . . . . 0.0 113.051 170.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -145.58 160.72 41.23 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.222 2.209 . . . . 0.0 110.134 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -69.89 -23.07 63.19 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.175 -0.953 . . . . 0.0 112.898 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 70.4 m -69.85 -13.66 62.37 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.951 1.3 . . . . 0.0 113.362 176.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -70.69 -13.64 62.15 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.428 1.091 . . . . 0.0 113.21 172.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.7 m -114.87 147.31 37.97 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 125.01 1.324 . . . . 0.0 113.785 -168.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -81.68 163.31 18.8 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.519 2.812 . . . . 0.0 113.402 -177.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 43.08 -117.27 1.51 Allowed Glycine 0 CA--C 1.535 1.339 0 C-N-CA 126.475 1.988 . . . . 0.0 114.568 176.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.29 -0.87 54.73 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.903 1.681 . . . . 0.0 114.156 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.3 m -61.99 161.47 10.64 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 122.713 1.244 . . . . 0.0 113.11 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.1 pt -126.76 167.01 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 128.001 2.52 . . . . 0.0 109.51 172.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.0 t -85.08 103.93 14.53 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 168.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -69.79 170.59 10.72 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.517 1.927 . . . . 0.0 110.92 -174.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.26 -16.56 73.38 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.615 1.102 . . . . 0.0 114.661 -173.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -85.01 -3.22 58.7 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.391 1.477 . . . . 0.0 114.415 175.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.76 21.53 50.21 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.202 0.906 . . . . 0.0 114.957 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -131.56 162.65 29.82 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.944 1.697 . . . . 0.0 111.583 175.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 96.2 m -69.73 151.31 45.97 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.435 -0.791 . . . . 0.0 112.962 174.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.013 0 C-N-CA 124.085 0.85 . . . . 0.0 112.869 171.518 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.1 tttm . . . . . 0 N--CA 1.469 0.508 0 CA-C-O 120.412 0.149 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -68.97 151.25 46.76 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.686 0.794 . . . . 0.0 111.269 172.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.3 p -145.22 176.51 9.49 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.7 mmt-85 -133.37 -18.13 2.26 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 127.595 2.358 . . . . 0.0 113.242 169.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -146.13 163.81 34.17 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.885 1.674 . . . . 0.0 111.883 176.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -65.46 -22.48 66.75 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.322 -0.861 . . . . 0.0 112.539 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.9 m -68.18 -16.03 63.82 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.03 1.332 . . . . 0.0 113.284 176.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -74.33 -10.07 59.22 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.854 1.261 . . . . 0.0 113.539 173.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.2 m -123.88 150.92 63.79 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 125.091 1.357 . . . . 0.0 112.584 -169.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -79.27 166.97 22.05 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.432 2.754 . . . . 0.0 113.969 -175.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 32.81 -103.9 0.01 OUTLIER Glycine 0 CA--C 1.537 1.455 0 C-N-CA 128.62 3.01 . . . . 0.0 116.701 172.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -104.6 9.05 35.44 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.714 2.006 . . . . 0.0 113.716 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.4 m -67.52 164.51 18.78 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 122.618 1.199 . . . . 0.0 111.523 169.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.1 pt -130.54 164.4 33.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 128.65 2.78 . . . . 0.0 108.879 169.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 42.2 t -93.74 106.85 18.79 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 168.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -82.15 172.88 12.68 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.21 1.404 . . . . 0.0 111.459 -169.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.87 -17.34 71.34 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.672 1.129 . . . . 0.0 114.403 -170.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -77.79 -6.71 55.0 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.139 1.776 . . . . 0.0 114.183 171.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.73 33.09 43.45 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.147 -0.971 . . . . 0.0 113.938 -177.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -136.09 158.46 44.36 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.137 1.775 . . . . 0.0 111.531 175.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 80.0 m -69.06 158.2 35.29 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.729 0.776 . . . . 0.0 112.909 173.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.178 0 C-N-CA 125.277 1.418 . . . . 0.0 113.476 168.686 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.1 tttt . . . . . 0 N--CA 1.467 0.422 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.92 142.83 58.15 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.454 0.701 . . . . 0.0 110.219 171.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.3 p -138.77 174.01 10.97 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 -135.76 -17.23 1.7 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.041 2.136 . . . . 0.0 112.871 173.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -142.82 161.56 37.79 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.65 1.98 . . . . 0.0 110.607 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -69.87 -23.75 63.31 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.299 -0.876 . . . . 0.0 112.953 -178.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.7 m -70.84 -12.75 61.73 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.821 1.248 . . . . 0.0 113.434 175.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -70.88 -15.99 62.66 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.749 0.82 . . . . 0.0 113.082 171.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.2 m -115.58 150.32 44.5 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.737 1.215 . . . . 0.0 113.556 -168.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.96 166.52 21.01 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.67 2.913 . . . . 0.0 113.976 -174.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 40.05 -113.91 0.42 Allowed Glycine 0 CA--C 1.536 1.4 0 C-N-CA 127.313 2.387 . . . . 0.0 115.535 172.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.42 9.6 42.4 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.238 1.815 . . . . 0.0 113.743 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 61.3 m -68.26 168.5 12.26 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.553 1.168 . . . . 0.0 112.394 171.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.5 pt -136.07 169.65 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 129.088 2.955 . . . . 0.0 109.004 169.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.4 t -84.8 103.26 13.73 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 167.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -67.75 168.63 11.03 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.902 1.681 . . . . 0.0 111.176 -176.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.03 -16.61 70.87 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.859 1.219 . . . . 0.0 114.367 -175.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -77.69 -9.36 58.94 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.978 1.311 . . . . 0.0 114.208 172.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.69 14.46 56.7 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.779 1.18 . . . . 0.0 115.359 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -131.09 169.04 16.41 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.672 1.589 . . . . 0.0 111.747 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.6 m -70.2 150.47 46.43 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.123 -0.985 . . . . 0.0 113.579 177.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.243 0 C-N-CA 125.372 1.463 . . . . 0.0 112.299 174.382 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 81.8 tttt . . . . . 0 N--CA 1.466 0.328 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.49 143.6 57.69 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.604 0.762 . . . . 0.0 110.361 171.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.0 p -145.03 171.55 14.32 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -134.21 -13.93 2.36 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 127.542 2.337 . . . . 0.0 112.931 169.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -132.93 152.44 51.91 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.666 2.386 . . . . 0.0 110.093 -176.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -66.62 -25.25 66.5 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.212 -0.93 . . . . 0.0 112.263 171.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 56.7 p -72.07 -14.55 61.89 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.833 1.653 . . . . 0.0 113.988 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -68.31 -19.47 64.68 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.235 -0.916 . . . . 0.0 112.77 169.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.3 m -109.86 149.72 40.37 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 124.889 1.275 . . . . 0.0 113.275 -169.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.33 166.34 20.35 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.609 2.873 . . . . 0.0 113.899 -175.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 38.34 -110.06 0.12 Allowed Glycine 0 CA--C 1.538 1.512 0 C-N-CA 127.591 2.52 . . . . 0.0 115.848 172.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.48 7.27 42.52 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.17 1.788 . . . . 0.0 113.747 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 61.8 m -67.59 165.54 16.75 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 122.604 1.192 . . . . 0.0 111.929 171.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.6 pt -133.79 167.48 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 129.227 3.011 . . . . 0.0 108.653 169.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.9 t -85.9 103.28 14.48 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 168.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -67.03 169.38 8.45 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.721 1.608 . . . . 0.0 111.049 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.94 -16.61 70.69 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.757 1.17 . . . . 0.0 114.522 -174.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -81.05 -6.77 59.2 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.337 1.455 . . . . 0.0 114.393 173.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.59 20.38 48.12 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.485 1.041 . . . . 0.0 115.028 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -132.31 163.71 28.05 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.723 1.609 . . . . 0.0 111.687 177.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.5 m -70.21 148.32 48.76 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.307 -0.871 . . . . 0.0 112.916 176.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.156 0 C-N-CA 125.164 1.364 . . . . 0.0 112.462 174.255 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.0 tttm . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.85 146.68 53.52 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.96 0.904 . . . . 0.0 110.686 172.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.0 p -145.1 165.49 28.1 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 176.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -122.66 -17.14 7.0 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 127.509 2.324 . . . . 0.0 112.729 170.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -148.31 162.5 39.4 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 128.45 2.7 . . . . 0.0 110.016 -175.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -69.3 -23.22 63.78 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.146 -0.971 . . . . 0.0 112.953 -178.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.5 m -67.79 -17.3 64.48 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.555 1.542 . . . . 0.0 113.234 177.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -75.12 -10.75 59.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.17 1.388 . . . . 0.0 113.443 174.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 73.9 m -113.56 163.1 19.39 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -168.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.92 165.36 3.87 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.984 3.122 . . . . 0.0 114.096 169.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.43 -56.93 8.76 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 126.058 1.789 . . . . 0.0 115.942 -174.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.32 -14.54 55.18 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.6 m -74.53 166.6 23.26 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 123.051 1.405 . . . . 0.0 112.904 171.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 pt -132.78 167.68 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 129.139 2.976 . . . . 0.0 107.671 166.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.0 t -82.44 101.83 10.91 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.423 -0.798 . . . . 0.0 109.778 169.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.87 167.81 12.85 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.228 1.811 . . . . 0.0 111.567 -178.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.01 -15.18 76.29 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.911 1.244 . . . . 0.0 114.631 -173.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -77.37 -8.25 57.38 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.45 1.5 . . . . 0.0 114.166 173.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.23 13.86 59.68 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.737 1.16 . . . . 0.0 114.996 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -129.28 168.1 16.72 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.432 1.893 . . . . 0.0 111.064 177.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 82.4 m -74.03 153.84 39.5 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.262 -0.899 . . . . 0.0 113.242 176.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.124 0 C-N-CA 124.329 0.966 . . . . 0.0 113.451 171.283 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.9 tttt . . . . . 0 CA--C 1.536 0.412 0 N-CA-C 110.571 -0.159 . . . . 0.0 110.571 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -65.91 143.23 57.55 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 169.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.0 p -136.45 173.49 11.65 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -175.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -136.64 -17.6 1.47 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.453 1.901 . . . . 0.0 112.577 169.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.61 155.4 39.17 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 127.846 2.458 . . . . 0.0 109.887 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -67.97 -25.76 65.6 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.223 -0.923 . . . . 0.0 112.223 169.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 77.4 p -71.33 -14.54 62.23 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.59 1.556 . . . . 0.0 114.022 175.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -65.55 -22.27 66.68 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.403 -0.81 . . . . 0.0 112.585 169.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.8 m -106.39 150.07 39.05 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -167.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -82.2 165.45 16.85 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.765 2.976 . . . . 0.0 113.523 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 44.1 -118.72 2.46 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.601 2.048 . . . . 0.0 114.877 173.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.64 7.05 47.15 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.1 1.76 . . . . 0.0 113.761 -178.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.4 m -66.03 160.04 24.61 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 123.077 1.417 . . . . 0.0 113.438 171.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.1 pt -127.55 167.3 22.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 129.505 3.122 . . . . 0.0 108.138 168.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.8 t -84.54 103.02 13.31 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 168.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -68.47 168.95 11.72 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.943 1.697 . . . . 0.0 111.073 -175.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.47 -16.41 69.46 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.659 1.123 . . . . 0.0 114.515 -176.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.8 p30 -78.77 -7.62 57.97 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.517 1.527 . . . . 0.0 114.419 173.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.33 14.54 60.07 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.649 1.119 . . . . 0.0 115.421 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -128.6 166.52 18.71 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.277 1.831 . . . . 0.0 111.866 177.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.6 m -69.38 143.1 53.79 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.476 -0.765 . . . . 0.0 112.672 174.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.167 0 C-N-CA 124.478 1.037 . . . . 0.0 112.615 171.237 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.6 tttt . . . . . 0 N--CA 1.468 0.436 0 CA-C-O 120.379 0.133 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -67.57 146.02 54.31 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.108 0.563 . . . . 0.0 110.147 169.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.9 p -139.37 172.96 12.06 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.36 -28.22 3.68 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 128.192 2.597 . . . . 0.0 111.564 174.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -148.14 164.41 33.97 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.698 1.999 . . . . 0.0 111.433 -175.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -66.92 -23.96 66.03 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.45 -0.781 . . . . 0.0 112.78 -176.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -66.7 -18.54 65.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.217 1.407 . . . . 0.0 112.825 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -71.55 -17.2 62.32 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.998 1.319 . . . . 0.0 113.219 175.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.6 m -111.31 148.67 39.25 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -167.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -81.93 163.19 18.25 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.744 2.963 . . . . 0.0 113.531 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 44.18 -119.69 2.96 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 126.332 1.92 . . . . 0.0 114.84 173.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.83 -0.86 57.81 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.694 1.598 . . . . 0.0 114.226 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.1 m -64.41 156.54 29.02 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 123.105 1.431 . . . . 0.0 113.105 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.0 pt -124.56 164.8 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 129.258 3.023 . . . . 0.0 108.562 170.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.1 t -84.41 102.84 13.07 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 168.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -67.22 169.55 8.5 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.94 1.696 . . . . 0.0 110.915 -176.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.56 -17.22 70.61 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.748 1.166 . . . . 0.0 114.605 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 56.9 p30 -81.86 -4.01 55.48 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.754 1.622 . . . . 0.0 114.375 173.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.84 29.81 45.83 Favored Glycine 0 CA--C 1.535 1.335 0 O-C-N 121.206 -0.934 . . . . 0.0 114.456 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -132.97 160.67 36.44 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.517 1.927 . . . . 0.0 111.267 172.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 77.7 m -69.0 144.55 54.07 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.817 -0.552 . . . . 0.0 112.232 172.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.04 0 C-N-CA 124.612 1.101 . . . . 0.0 111.81 172.883 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -64.45 145.26 56.37 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.235 1.014 . . . . 0.0 110.322 169.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.6 p -145.66 169.74 17.85 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.416 1.086 . . . . 0.0 113.732 -176.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -123.16 -25.26 4.53 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.53 2.332 . . . . 0.0 111.918 169.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -130.99 160.6 34.09 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.753 2.021 . . . . 0.0 110.879 -176.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -67.21 -25.51 66.15 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.438 -0.789 . . . . 0.0 112.492 173.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 56.3 p -70.7 -15.59 62.72 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.848 1.659 . . . . 0.0 113.972 175.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -68.86 -19.23 64.23 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.811 0.844 . . . . 0.0 112.937 169.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.8 m -108.25 159.86 29.13 Favored Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -168.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -57.65 167.11 4.21 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 124.509 3.473 . . . . 0.0 115.541 173.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -26.51 -72.66 0.03 OUTLIER Glycine 0 CA--C 1.536 1.344 0 C-N-CA 129.081 3.229 . . . . 0.0 117.588 -172.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.42 3.02 53.12 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.013 1.325 . . . . 0.0 113.92 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.6 m -73.14 167.06 21.93 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 122.723 1.249 . . . . 0.0 111.613 169.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.2 pt -135.16 164.64 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 129.095 2.958 . . . . 0.0 108.323 169.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.3 t -84.18 101.71 12.06 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 168.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -65.17 171.24 3.85 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.374 1.87 . . . . 0.0 111.149 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.49 -18.36 69.7 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.723 1.154 . . . . 0.0 114.451 -174.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -81.47 -6.87 59.39 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.155 1.382 . . . . 0.0 114.393 173.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.23 20.14 50.25 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 124.53 1.062 . . . . 0.0 115.266 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -130.87 161.47 31.77 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.68 1.592 . . . . 0.0 111.766 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.2 m -71.15 139.29 50.18 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.453 -0.779 . . . . 0.0 112.713 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.121 0 C-N-CA 124.499 1.047 . . . . 0.0 113.162 174.547 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 77.6 tttt . . . . . 0 N--CA 1.468 0.457 0 N-CA-C 111.314 0.116 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -63.49 146.15 54.21 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.281 1.033 . . . . 0.0 109.73 169.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.3 p -142.09 168.54 19.51 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 38.4 mtm180 -124.19 -21.45 5.01 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 128.494 2.717 . . . . 0.0 112.428 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -154.88 163.42 40.31 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 128.81 2.844 . . . . 0.0 109.965 -174.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -67.74 -24.96 65.41 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.276 -0.89 . . . . 0.0 112.65 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.5 m -71.59 -13.91 61.92 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.729 1.212 . . . . 0.0 113.48 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -72.32 -18.64 61.75 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.832 1.253 . . . . 0.0 112.376 171.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 76.2 m -104.93 159.78 28.18 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.092 1.357 . . . . 0.0 113.724 -169.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.08 166.62 27.39 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.191 2.594 . . . . 0.0 112.659 175.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -34.14 -63.09 0.44 Allowed Glycine 0 CA--C 1.537 1.446 0 C-N-CA 127.967 2.699 . . . . 0.0 117.449 -169.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.35 -12.03 57.0 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.5 m -78.41 164.69 24.57 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 123.14 1.447 . . . . 0.0 113.204 173.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.5 pt -130.0 163.87 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 129.706 3.202 . . . . 0.0 107.72 167.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 39.7 t -89.37 102.93 15.6 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 121.612 -0.68 . . . . 0.0 109.856 171.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -82.0 173.45 12.18 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.681 1.192 . . . . 0.0 111.828 -169.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.57 -16.11 71.46 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.771 1.177 . . . . 0.0 114.32 -170.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 39.4 p-10 -77.06 -9.06 58.47 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.32 1.448 . . . . 0.0 114.273 172.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.73 16.96 57.56 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.687 1.137 . . . . 0.0 115.082 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -131.34 162.79 29.29 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.449 1.499 . . . . 0.0 112.029 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.3 m -69.89 144.85 52.36 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.717 0.807 . . . . 0.0 112.223 172.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.134 0 C-N-CA 124.416 1.008 . . . . 0.0 113.386 174.023 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 81.8 tttt . . . . . 0 N--CA 1.467 0.396 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -66.04 143.7 57.18 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.357 0.663 . . . . 0.0 110.567 171.176 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.9 p -149.12 170.23 18.88 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.732 1.213 . . . . 0.0 113.924 -172.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -136.26 -8.89 1.99 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.991 2.116 . . . . 0.0 112.836 169.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -132.41 151.42 51.88 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 127.687 2.395 . . . . 0.0 109.813 -179.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -66.99 -24.18 66.01 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.362 -0.836 . . . . 0.0 112.219 171.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.7 p -72.29 -16.34 61.9 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.765 1.626 . . . . 0.0 114.004 174.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -65.93 -28.25 68.78 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.099 0.863 . . . . 0.0 112.383 169.119 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.5 m -96.0 161.23 28.0 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.352 1.461 . . . . 0.0 113.295 -170.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -68.2 162.57 39.7 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.95 2.433 . . . . 0.0 112.136 173.084 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -36.79 -58.65 1.15 Allowed Glycine 0 N--CA 1.475 1.28 0 C-N-CA 127.607 2.527 . . . . 0.0 117.283 -169.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.21 -17.18 53.05 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -175.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.9 m -77.16 168.75 19.53 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 123.046 1.403 . . . . 0.0 113.864 171.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.8 pt -132.35 166.16 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 130.472 3.509 . . . . 0.0 107.806 168.294 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.8 t -86.26 103.92 15.32 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.557 -0.715 . . . . 0.0 109.151 169.022 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -67.77 170.57 7.73 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.194 1.798 . . . . 0.0 111.029 -175.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.58 -16.15 71.55 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.733 1.158 . . . . 0.0 114.604 -173.387 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -83.54 -3.11 57.36 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.45 1.5 . . . . 0.0 114.341 174.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.95 21.93 56.35 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.154 0.883 . . . . 0.0 114.603 -179.07 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -131.84 159.99 36.95 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.898 1.679 . . . . 0.0 111.581 175.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.9 m -68.63 147.27 52.14 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.638 -0.664 . . . . 0.0 112.166 176.631 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.864 0 C-N-CA 124.776 1.179 . . . . 0.0 111.449 173.814 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt . . . . . 0 N--CA 1.471 0.613 0 CA-C-O 120.483 0.182 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -67.96 142.06 56.1 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 167.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 p -141.1 171.03 14.63 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -171.683 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -133.39 -15.2 2.51 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.686 2.394 . . . . 0.0 112.662 174.065 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -135.06 153.62 51.98 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.329 2.252 . . . . 0.0 110.152 -176.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -66.4 -23.23 66.28 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.475 -0.765 . . . . 0.0 111.793 168.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.0 m -68.62 -20.46 64.49 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.779 2.032 . . . . 0.0 113.427 175.604 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -67.53 -29.95 69.49 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.681 0.792 . . . . 0.0 112.425 172.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.9 m -96.03 159.46 32.19 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.228 1.411 . . . . 0.0 113.702 -169.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.74 167.1 26.7 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.29 2.66 . . . . 0.0 112.712 175.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -34.85 -62.25 0.56 Allowed Glycine 0 CA--C 1.536 1.354 0 C-N-CA 128.067 2.746 . . . . 0.0 117.489 -169.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.05 -13.88 58.96 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -175.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.3 m -81.17 167.55 19.53 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 123.268 1.508 . . . . 0.0 113.722 173.735 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.5 pt -133.18 166.54 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 131.19 3.796 . . . . 0.0 107.234 167.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.4 t -84.91 102.75 13.38 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.408 -0.807 . . . . 0.0 108.986 169.042 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -66.82 168.0 10.43 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.93 1.692 . . . . 0.0 111.194 -174.618 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.2 -17.72 68.43 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.79 1.186 . . . . 0.0 114.325 -178.283 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -77.88 -7.73 57.11 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.499 1.519 . . . . 0.0 114.331 172.153 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.17 13.99 61.13 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.64 1.114 . . . . 0.0 115.485 178.407 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -130.28 166.05 21.16 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.031 1.733 . . . . 0.0 111.418 176.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.2 m -70.85 141.74 51.25 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.435 -0.791 . . . . 0.0 112.894 178.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.181 0 C-N-CA 125.49 1.519 . . . . 0.0 112.201 174.515 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -54.63 136.47 45.37 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.55 -0.719 . . . . 0.0 111.504 173.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.4 p -140.13 169.65 17.3 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -170.457 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -119.83 -30.14 4.82 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 128.381 2.672 . . . . 0.0 111.56 -179.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -152.8 164.61 37.5 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 127.922 2.489 . . . . 0.0 110.694 -172.526 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -65.73 -23.8 66.83 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.512 -0.743 . . . . 0.0 112.79 -177.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.1 m -67.28 -18.41 65.19 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.4 1.48 . . . . 0.0 113.217 177.648 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -74.0 -13.76 60.92 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.723 1.209 . . . . 0.0 113.193 174.134 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.2 m -111.57 149.28 40.47 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 125.008 1.323 . . . . 0.0 112.897 -172.46 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -77.46 163.84 29.27 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.362 2.708 . . . . 0.0 113.846 -175.38 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 36.91 -112.29 0.15 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 127.449 2.452 . . . . 0.0 115.746 173.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.01 5.45 48.77 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.42 1.888 . . . . 0.0 113.909 -177.531 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.2 m -66.81 168.29 9.9 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 122.423 1.106 . . . . 0.0 112.188 174.184 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.3 pt -135.27 162.91 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 128.093 2.557 . . . . 0.0 109.745 173.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.2 t -86.02 103.28 14.56 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 168.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -65.74 169.3 6.57 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.364 1.865 . . . . 0.0 111.21 -176.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.51 -17.95 71.27 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.814 1.197 . . . . 0.0 114.416 -173.218 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -82.02 -5.43 58.35 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.195 1.398 . . . . 0.0 114.348 173.116 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.92 24.29 38.55 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.369 0.985 . . . . 0.0 114.931 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -133.5 164.2 27.68 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.396 1.879 . . . . 0.0 111.161 177.526 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 89.5 m -73.84 156.21 37.99 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.038 -1.039 . . . . 0.0 112.948 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.142 0 C-N-CA 124.96 1.267 . . . . 0.0 112.271 172.692 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.9 tttp . . . . . 0 N--CA 1.468 0.447 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -64.27 145.62 55.7 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.678 0.791 . . . . 0.0 110.093 173.453 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.3 p -141.86 168.12 20.51 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -173.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -116.33 -28.5 6.49 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.572 2.349 . . . . 0.0 112.016 177.374 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -151.64 172.97 15.24 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.632 2.373 . . . . 0.0 110.133 -176.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -70.53 -26.39 63.54 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.501 0.72 . . . . 0.0 112.532 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.7 p -68.61 -16.02 63.71 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.637 1.575 . . . . 0.0 113.858 174.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -73.61 -12.04 60.62 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.875 0.87 . . . . 0.0 113.167 169.71 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 79.8 m -112.01 158.3 37.25 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -169.071 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.74 167.11 7.26 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 124.32 3.347 . . . . 0.0 115.652 176.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -1.89 -86.4 0.0 OUTLIER Glycine 0 N--CA 1.477 1.388 0 C-N-CA 130.238 3.78 . . . . 0.0 117.645 177.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -107.86 10.53 28.57 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.239 1.415 . . . . 0.0 113.502 -178.026 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 67.2 m -66.99 167.13 12.3 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.468 1.128 . . . . 0.0 111.761 169.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.7 pt -133.11 161.69 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 128.03 2.532 . . . . 0.0 109.27 169.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.5 t -86.95 99.82 12.14 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.741 0.816 . . . . 0.0 109.65 170.335 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -77.06 174.65 10.41 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.97 1.308 . . . . 0.0 111.868 -170.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.39 -16.04 68.84 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.898 1.237 . . . . 0.0 114.464 -171.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -76.04 -8.05 56.09 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.589 1.556 . . . . 0.0 114.253 170.412 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.26 15.33 64.69 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.947 1.261 . . . . 0.0 114.859 -178.565 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -131.39 160.97 33.5 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.856 1.662 . . . . 0.0 112.114 -178.071 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 70.9 m -68.33 141.88 55.67 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.904 0.881 . . . . 0.0 112.211 176.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.068 0 C-N-CA 123.794 0.712 . . . . 0.0 113.151 176.008 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.7 tttm . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 120.386 0.136 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.83 148.09 50.22 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.812 1.245 . . . . 0.0 110.822 176.257 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.4 p -144.78 171.32 14.59 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 177.013 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -128.41 -24.55 3.06 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 128.408 2.683 . . . . 0.0 112.098 169.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.7 ptm85 -145.12 166.17 26.17 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.442 1.897 . . . . 0.0 111.834 178.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -67.58 -20.98 65.44 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.281 -0.887 . . . . 0.0 112.724 -176.135 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.2 m -67.47 -17.09 64.55 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.618 1.167 . . . . 0.0 113.182 175.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -74.49 -10.75 59.87 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.387 1.475 . . . . 0.0 113.347 173.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.5 m -119.09 158.39 48.3 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.07 1.348 . . . . 0.0 113.346 -168.668 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.08 165.97 30.67 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.123 2.549 . . . . 0.0 112.254 174.086 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -39.34 -57.7 2.15 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 127.426 2.441 . . . . 0.0 117.234 -169.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.03 -17.46 52.71 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -177.099 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.4 m -79.09 164.8 24.0 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 123.283 1.515 . . . . 0.0 112.752 169.686 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.9 pt -132.52 167.31 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 129.767 3.227 . . . . 0.0 107.512 167.065 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.9 t -80.08 101.61 8.84 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.299 -0.876 . . . . 0.0 109.744 169.455 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.86 169.57 12.86 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.104 1.762 . . . . 0.0 111.632 -177.669 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.45 -13.96 79.71 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.848 1.213 . . . . 0.0 114.598 -173.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -79.15 -6.73 57.22 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.638 1.575 . . . . 0.0 114.29 174.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.41 12.72 62.59 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.642 1.115 . . . . 0.0 114.805 -177.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -129.71 167.96 17.23 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.405 1.882 . . . . 0.0 111.031 176.392 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.2 m -70.04 152.95 43.8 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.25 -0.907 . . . . 0.0 112.679 173.664 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.973 0 C-N-CA 124.423 1.011 . . . . 0.0 113.781 171.662 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.4 tttp . . . . . 0 N--CA 1.468 0.449 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -63.63 143.75 57.57 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.997 0.919 . . . . 0.0 111.141 174.232 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 p -144.04 173.1 12.02 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.937 1.295 . . . . 0.0 114.193 -176.052 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -132.27 -20.04 2.43 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.256 2.222 . . . . 0.0 112.628 170.034 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -142.6 164.36 30.32 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.113 1.765 . . . . 0.0 111.754 178.015 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -67.4 -22.65 65.53 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.509 -0.744 . . . . 0.0 112.554 -176.751 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.0 m -66.99 -18.0 65.18 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.458 1.503 . . . . 0.0 113.128 176.423 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -74.14 -12.65 60.65 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.056 1.342 . . . . 0.0 113.371 174.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 81.6 m -115.99 151.18 46.23 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -168.402 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -80.58 167.37 18.99 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.662 2.908 . . . . 0.0 113.941 -174.658 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 39.8 -108.03 0.09 OUTLIER Glycine 0 CA--C 1.534 1.264 0 C-N-CA 127.644 2.545 . . . . 0.0 115.497 172.256 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.35 6.88 30.89 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.281 1.832 . . . . 0.0 113.673 -177.823 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 75.3 m -66.41 168.82 8.31 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 122.626 1.203 . . . . 0.0 112.938 175.693 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.6 pt -131.83 169.69 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 129.067 2.947 . . . . 0.0 108.962 169.061 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.9 t -87.73 108.36 19.08 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.659 -0.651 . . . . 0.0 109.333 168.091 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 -66.1 168.35 8.55 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.61 1.564 . . . . 0.0 111.451 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.51 -17.91 73.15 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.832 1.206 . . . . 0.0 114.478 -176.837 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -80.37 -5.96 57.26 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.694 1.197 . . . . 0.0 114.092 172.684 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.82 24.08 36.65 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.521 1.058 . . . . 0.0 114.972 -179.87 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -134.84 161.96 33.75 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.675 1.59 . . . . 0.0 111.9 177.125 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.5 m -69.24 144.78 53.57 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.321 -0.862 . . . . 0.0 113.319 179.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.035 0 C-N-CA 124.543 1.068 . . . . 0.0 113.167 179.007 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 76.3 tttt . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -54.86 136.3 47.02 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.417 -0.802 . . . . 0.0 111.404 172.638 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.8 p -141.99 165.53 27.21 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.143 1.377 . . . . 0.0 114.191 -170.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -116.73 -19.5 9.91 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.871 2.068 . . . . 0.0 112.841 -179.069 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -160.69 163.41 32.46 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 128.863 2.865 . . . . 0.0 109.468 -169.011 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -66.95 -26.7 66.96 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.139 -0.976 . . . . 0.0 112.666 179.286 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.3 m -71.05 -15.42 62.54 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.509 1.524 . . . . 0.0 113.622 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -72.37 -22.49 61.14 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.192 0.997 . . . . 0.0 112.389 170.507 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 75.3 m -94.6 151.37 39.16 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.4 1.08 . . . . 0.0 112.813 -174.575 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.16 160.78 26.46 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.444 2.763 . . . . 0.0 113.168 -178.282 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 27.4 -99.04 0.01 OUTLIER Glycine 0 CA--C 1.536 1.348 0 C-N-CA 128.694 3.045 . . . . 0.0 116.671 174.233 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -95.92 -3.63 44.9 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 -173.122 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.3 m -68.74 165.04 20.38 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 122.992 1.377 . . . . 0.0 113.153 175.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.5 pt -124.21 166.17 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 129.551 3.14 . . . . 0.0 107.844 167.539 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.6 t -97.6 107.0 19.41 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.771 0.828 . . . . 0.0 108.815 169.267 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -65.1 165.81 10.57 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.619 1.168 . . . . 0.0 111.132 179.236 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.13 -16.71 71.18 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.052 1.31 . . . . 0.0 114.475 -175.803 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -77.41 -5.92 51.52 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.044 1.338 . . . . 0.0 114.027 170.801 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.62 28.26 30.06 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.487 1.041 . . . . 0.0 114.683 179.088 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -135.93 158.5 44.24 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.54 1.536 . . . . 0.0 111.862 176.743 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.9 m -77.54 163.83 25.93 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 122.124 0.964 . . . . 0.0 113.366 -179.829 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.131 0 C-N-CA 125.402 1.477 . . . . 0.0 111.897 169.652 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt . . . . . 0 N--CA 1.469 0.485 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -67.41 141.56 57.0 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.219 0.607 . . . . 0.0 109.976 168.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.5 p -141.31 171.36 14.17 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.471 1.108 . . . . 0.0 113.741 -171.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -136.3 -10.12 1.95 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.326 1.85 . . . . 0.0 113.158 172.692 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.3 ttt-85 -141.31 168.2 20.34 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.672 1.589 . . . . 0.0 110.451 171.66 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -72.5 -26.97 61.98 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.371 0.669 . . . . 0.0 112.253 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.0 p -70.03 -13.41 62.21 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.28 1.832 . . . . 0.0 113.82 175.481 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.58 -23.49 65.4 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.486 -0.759 . . . . 0.0 112.403 168.995 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.8 m -107.22 161.71 22.11 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 124.838 1.255 . . . . 0.0 114.137 -168.535 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -56.54 167.3 2.88 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 124.594 3.529 . . . . 0.0 115.446 173.038 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -32.09 -67.52 0.16 Allowed Glycine 0 CA--C 1.538 1.493 0 C-N-CA 128.521 2.963 . . . . 0.0 117.095 -171.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.38 -0.51 56.53 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -177.32 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 65.1 m -74.07 169.64 17.09 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.668 1.223 . . . . 0.0 112.044 173.517 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 24.4 pt -137.13 166.61 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 128.762 2.825 . . . . 0.0 108.707 169.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.6 t -86.96 104.42 16.26 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 167.875 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -66.37 169.46 7.34 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.683 1.593 . . . . 0.0 111.026 -175.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.71 -17.32 68.99 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.701 1.143 . . . . 0.0 114.242 -176.482 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 53.9 p30 -79.34 -6.52 56.95 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.469 1.507 . . . . 0.0 114.405 172.446 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.57 17.81 57.88 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.662 1.125 . . . . 0.0 115.22 179.885 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -130.88 161.8 31.03 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.839 1.655 . . . . 0.0 111.928 178.275 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 97.7 m -68.2 145.81 53.96 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.614 -0.679 . . . . 0.0 112.727 178.038 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.088 0 C-N-CA 124.64 1.115 . . . . 0.0 112.469 174.542 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.1 145.33 53.58 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.462 1.105 . . . . 0.0 110.822 173.834 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 p -143.99 167.05 23.28 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 177.93 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -121.98 -21.52 5.98 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.674 2.39 . . . . 0.0 112.463 169.276 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.67 168.97 20.69 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.278 1.831 . . . . 0.0 111.417 177.164 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -66.23 -22.91 66.34 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.27 -0.894 . . . . 0.0 112.755 -177.51 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.2 m -66.27 -17.74 64.93 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.741 1.617 . . . . 0.0 113.378 177.471 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -74.27 -13.73 60.81 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.446 1.498 . . . . 0.0 113.747 174.133 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.5 m -117.44 159.12 43.06 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -167.469 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -56.05 168.69 1.75 Allowed 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 125.106 3.87 . . . . 0.0 116.189 172.198 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -35.66 -65.52 0.45 Allowed Glycine 0 CA--C 1.535 1.287 0 C-N-CA 128.45 2.928 . . . . 0.0 117.451 -170.633 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.46 1.8 55.75 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.635 1.174 . . . . 0.0 114.035 -178.797 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.9 m -74.97 168.21 20.4 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.777 1.275 . . . . 0.0 112.109 170.841 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.5 pt -136.58 165.15 29.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 129.586 3.154 . . . . 0.0 107.894 168.224 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.3 t -83.21 101.23 11.09 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 168.015 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -65.97 169.5 6.69 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.876 1.67 . . . . 0.0 110.748 -175.231 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.91 -16.96 69.0 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.662 1.125 . . . . 0.0 114.39 -174.751 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -79.7 -9.29 59.62 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.32 1.448 . . . . 0.0 114.454 173.841 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.43 15.74 56.53 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.667 1.127 . . . . 0.0 115.336 -178.35 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -129.67 164.86 23.0 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.513 1.525 . . . . 0.0 111.245 176.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.6 m -70.19 146.45 50.75 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.264 -0.898 . . . . 0.0 112.734 177.397 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.035 0 C-N-CA 125.139 1.352 . . . . 0.0 111.598 174.301 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt . . . . . 0 N--CA 1.47 0.544 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -63.19 144.11 57.21 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.356 1.062 . . . . 0.0 110.926 171.863 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.0 p -143.9 172.6 12.63 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -175.445 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -132.63 -15.47 2.74 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 127.373 2.269 . . . . 0.0 113.649 171.166 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.5 ttp180 -144.06 170.82 15.21 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.032 1.733 . . . . 0.0 110.971 172.382 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -70.72 -24.2 62.59 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.46 0.704 . . . . 0.0 112.286 178.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.4 m -64.32 -20.64 66.23 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.141 1.776 . . . . 0.0 113.017 174.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.86 -16.03 62.67 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.443 1.097 . . . . 0.0 113.437 173.107 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 56.0 m -116.14 151.82 47.09 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.911 1.285 . . . . 0.0 113.313 -169.035 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.06 164.21 22.44 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.316 2.677 . . . . 0.0 113.592 -176.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 26.85 -100.9 0.01 OUTLIER Glycine 0 CA--C 1.537 1.448 0 C-N-CA 129.033 3.206 . . . . 0.0 117.307 172.429 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.69 2.11 51.72 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.791 1.636 . . . . 0.0 113.929 -174.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.0 m -72.04 166.16 22.81 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 122.771 1.272 . . . . 0.0 112.063 172.597 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.9 pt -135.46 166.15 28.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 129.514 3.126 . . . . 0.0 108.045 168.514 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.9 t -83.14 101.28 11.08 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 168.011 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -65.42 170.27 5.05 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.153 1.781 . . . . 0.0 110.911 -175.805 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.71 -17.4 69.09 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.648 1.118 . . . . 0.0 114.517 -173.799 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.9 p-10 -79.97 -8.04 59.13 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.379 1.472 . . . . 0.0 114.434 172.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.4 20.08 49.92 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.634 1.111 . . . . 0.0 115.091 -178.128 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -132.27 161.56 33.17 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.606 1.562 . . . . 0.0 111.761 178.287 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.6 m -70.17 140.31 52.54 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.322 -0.862 . . . . 0.0 112.565 178.236 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.077 0 C-N-CA 125.289 1.423 . . . . 0.0 111.649 175.273 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -93.79 -1.91 65.31 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 123.998 0.809 . . . . 0.0 113.941 173.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.7 m 64.17 -42.92 0.27 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 129.569 3.148 . . . . 0.0 116.36 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -62.77 -30.66 71.62 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.433 1.493 . . . . 0.0 113.355 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -89.37 1.57 82.27 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.406 1.479 . . . . 0.0 114.671 174.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 113.48 -175.08 16.19 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 126.31 1.909 . . . . 0.0 112.964 -172.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 55.3 t -78.92 112.48 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.465 1.106 . . . . 0.0 110.308 170.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.8 t -79.87 139.57 53.89 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.106 168.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -55.16 -8.17 1.44 Allowed 'Trans proline' 0 CA--C 1.548 1.224 1 C-N-CA 125.503 4.135 . . . . 0.0 117.427 168.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt 51.83 64.84 1.69 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 127.35 2.26 . . . . 0.0 113.665 174.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 47.4 pt -78.84 147.85 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.701 1.201 . . . . 0.0 110.826 172.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.8 mp -80.66 42.45 0.61 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.743 1.617 . . . . 0.0 111.774 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -79.49 113.23 17.47 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.24 1.416 . . . . 0.0 109.956 173.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -66.05 145.44 55.86 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.1 0.56 . . . . 0.0 110.46 170.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.8 p -144.84 171.63 14.15 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -174.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -119.71 -28.51 5.24 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 128.205 2.602 . . . . 0.0 111.574 172.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -149.31 173.18 13.79 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.271 1.428 . . . . 0.0 112.292 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -66.09 -27.06 67.78 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.876 1.27 . . . . 0.0 112.497 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.8 m -66.36 -19.8 65.9 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.554 1.542 . . . . 0.0 112.915 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -70.04 -25.35 63.52 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 82.9 m -96.28 157.32 35.77 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.489 1.116 . . . . 0.0 113.646 -169.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.25 161.36 46.04 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 122.993 2.462 . . . . 0.0 112.46 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -12.34 -75.11 0.01 OUTLIER Glycine 0 N--CA 1.477 1.373 0 C-N-CA 129.506 3.432 . . . . 0.0 117.984 -173.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.51 -8.58 52.5 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -172.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.4 m -74.5 166.43 23.54 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 122.853 1.311 . . . . 0.0 113.151 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.4 pt -128.92 162.19 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 129.447 3.099 . . . . 0.0 108.599 168.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 19.8 t -86.19 100.15 12.03 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 169.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.5 mmm180 -65.09 171.08 3.88 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.168 2.187 . . . . 0.0 111.305 -174.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.64 -17.3 70.84 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.848 1.214 . . . . 0.0 114.6 -173.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -84.85 -2.66 58.06 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.322 1.449 . . . . 0.0 114.358 174.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.0 22.74 51.79 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.226 0.917 . . . . 0.0 114.884 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -130.99 159.8 36.43 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.558 1.543 . . . . 0.0 111.905 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.0 m -69.38 145.57 52.79 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.301 0.641 . . . . 0.0 112.1 175.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.781 0 C-N-CA 124.728 1.156 . . . . 0.0 111.915 174.243 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.7 m . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.91 153.6 17.07 Favored Glycine 0 N--CA 1.472 1.044 0 C-N-CA 124.361 0.981 . . . . 0.0 112.254 173.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.6 m -61.66 -35.54 78.26 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.434 1.093 . . . . 0.0 113.667 -175.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -88.42 -12.87 41.95 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.132 1.373 . . . . 0.0 113.337 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -91.25 -48.72 3.22 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.613 1.578 . . . . 0.0 113.762 -176.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 118.73 -170.49 13.82 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.242 1.401 . . . . 0.0 114.157 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 m -65.59 96.22 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.006 1.322 . . . . 0.0 112.307 171.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.7 t -83.87 141.84 41.44 Favored Pre-proline 0 CA--C 1.547 0.833 0 O-C-N 121.73 -0.606 . . . . 0.0 110.846 168.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.96 -4.14 0.34 Allowed 'Trans proline' 0 CA--C 1.551 1.369 1 C-N-CA 125.563 4.175 . . . . 0.0 117.392 167.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt 48.02 68.53 0.66 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 127.842 2.457 . . . . 0.0 113.527 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 45.3 pt -78.55 155.6 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.865 1.266 . . . . 0.0 111.07 174.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.9 mp -82.17 19.76 1.13 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.871 1.668 . . . . 0.0 112.808 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -66.49 117.02 8.12 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.088 1.355 . . . . 0.0 110.966 174.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -66.6 149.49 50.41 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.978 0.911 . . . . 0.0 110.236 169.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.2 p -144.73 172.17 13.37 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -128.63 -22.45 3.3 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.966 2.506 . . . . 0.0 112.23 170.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -144.38 164.03 32.01 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.482 1.913 . . . . 0.0 111.57 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -66.91 -23.08 65.95 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 121.394 -0.816 . . . . 0.0 112.593 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.4 m -67.4 -17.66 64.81 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.252 1.421 . . . . 0.0 113.216 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -72.9 -20.25 61.12 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.848 1.259 . . . . 0.0 113.268 173.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.4 m -106.2 163.66 16.58 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -167.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -55.84 164.4 4.67 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 124.071 3.181 . . . . 0.0 113.929 169.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -49.7 -54.08 18.89 Favored Glycine 0 N--CA 1.475 1.257 0 C-N-CA 125.894 1.711 . . . . 0.0 115.519 -175.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.68 -17.74 50.17 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.8 m -75.65 167.72 21.36 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 123.16 1.457 . . . . 0.0 113.192 171.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.8 pt -133.44 167.78 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 129.39 3.076 . . . . 0.0 107.467 166.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.0 t -83.89 103.05 12.83 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.479 -0.763 . . . . 0.0 109.801 169.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.38 165.67 13.75 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.794 1.638 . . . . 0.0 111.145 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.93 -14.33 75.9 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.997 1.284 . . . . 0.0 114.439 -174.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 35.5 p-10 -78.27 -6.18 54.22 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.643 1.577 . . . . 0.0 114.123 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.89 19.04 55.04 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.412 1.006 . . . . 0.0 114.725 -178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -131.56 165.02 24.55 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.063 1.745 . . . . 0.0 111.684 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 80.9 m -74.45 151.21 39.63 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.606 -0.684 . . . . 0.0 112.832 173.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.029 0 C-N-CA 124.364 0.983 . . . . 0.0 113.144 171.56 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -99.13 -6.3 55.79 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.442 1.02 . . . . 0.0 115.597 -175.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.3 t -146.14 130.4 17.57 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.97 1.308 . . . . 0.0 111.872 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -70.81 -11.35 60.9 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.917 1.287 . . . . 0.0 113.53 169.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.79 -0.06 88.91 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.405 1.479 . . . . 0.0 114.687 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -146.36 -169.28 14.08 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 126.662 2.077 . . . . 0.0 112.358 177.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.1 m -130.79 153.02 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.663 1.185 . . . . 0.0 112.785 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.4 t -141.44 140.58 20.83 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.037 1.335 . . . . 0.0 109.434 168.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -54.66 -8.62 1.33 Allowed 'Trans proline' 0 CA--C 1.547 1.148 1 C-N-CA 125.856 4.371 . . . . 0.0 118.56 171.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.5 mttp 49.69 45.2 24.67 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 127.132 2.173 . . . . 0.0 114.022 -177.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 25.4 pt -79.06 148.92 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 125.501 1.521 . . . . 0.0 111.023 176.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.1 mp -78.92 45.94 0.65 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.058 1.743 . . . . 0.0 111.324 178.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -80.93 108.5 14.65 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 125.566 1.546 . . . . 0.0 110.284 176.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -63.58 144.97 56.57 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.993 0.917 . . . . 0.0 110.863 172.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 p -147.21 173.47 12.51 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -174.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -133.2 -14.88 2.59 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 127.322 2.249 . . . . 0.0 113.295 172.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -144.52 163.41 33.93 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 127.096 2.158 . . . . 0.0 110.724 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -69.34 -22.55 63.75 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.615 -0.678 . . . . 0.0 112.682 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.4 m -69.51 -15.33 63.23 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.426 1.09 . . . . 0.0 113.128 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -74.1 -11.91 60.45 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.763 1.225 . . . . 0.0 113.108 174.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 76.9 m -113.73 147.58 37.95 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.597 1.159 . . . . 0.0 114.04 -168.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -80.82 160.46 21.42 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.607 2.871 . . . . 0.0 113.423 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 43.67 -118.27 2.09 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.685 2.088 . . . . 0.0 114.889 174.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.8 3.05 55.47 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.007 1.723 . . . . 0.0 113.803 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.0 m -64.5 151.84 43.36 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.764 1.269 . . . . 0.0 112.532 169.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.2 pt -120.87 164.25 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 128.203 2.601 . . . . 0.0 108.4 169.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.9 t -82.99 101.1 10.86 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 169.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -66.4 170.85 5.5 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.442 1.897 . . . . 0.0 111.1 -176.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.21 -17.63 70.34 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.721 1.153 . . . . 0.0 114.542 -173.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -82.43 -4.91 58.24 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.308 1.443 . . . . 0.0 114.369 173.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.2 22.89 46.62 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.31 0.957 . . . . 0.0 114.993 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -132.79 160.23 37.48 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.555 1.542 . . . . 0.0 111.851 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.2 m -68.98 142.51 54.64 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.602 -0.686 . . . . 0.0 112.396 176.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.111 0 C-N-CA 124.503 1.049 . . . . 0.0 112.53 172.295 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -102.48 -176.15 27.31 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.376 0.989 . . . . 0.0 115.313 -176.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.4 m -60.43 -12.41 9.44 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.548 1.939 . . . . 0.0 115.067 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -58.63 -28.57 65.76 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.405 1.482 . . . . 0.0 112.779 169.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 82.28 -3.02 83.22 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 125.37 1.462 . . . . 0.0 115.387 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.53 164.68 50.71 Favored Glycine 0 CA--C 1.537 1.437 0 CA-C-N 118.744 1.272 . . . . 0.0 113.203 173.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.3 t -84.78 97.67 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.166 0.986 . . . . 0.0 111.053 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.1 t -79.55 141.14 56.08 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 166.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -54.88 -6.97 0.75 Allowed 'Trans proline' 0 CA--C 1.55 1.297 0 C-N-CA 125.25 3.967 . . . . 0.0 117.953 168.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 45.66 55.89 6.35 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 127.582 2.353 . . . . 0.0 113.955 178.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.56 152.22 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.925 1.29 . . . . 0.0 111.382 176.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.0 mt -79.35 35.16 0.27 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.765 1.626 . . . . 0.0 113.362 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -70.27 112.49 6.64 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.962 -1.086 . . . . 0.0 110.086 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -68.38 142.78 55.34 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.239 0.616 . . . . 0.0 109.476 168.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.3 p -141.73 168.13 20.49 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -172.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -122.14 -21.04 6.04 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 127.328 2.251 . . . . 0.0 112.742 171.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.69 167.69 24.84 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.257 1.423 . . . . 0.0 111.358 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -65.92 -22.25 66.49 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.311 -0.868 . . . . 0.0 112.538 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.8 m -66.83 -19.25 65.7 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.821 1.648 . . . . 0.0 113.371 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -69.14 -30.9 69.24 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.583 1.153 . . . . 0.0 112.637 172.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.5 m -96.48 151.87 38.29 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -168.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.05 160.04 23.82 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.535 2.824 . . . . 0.0 113.079 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 23.11 -97.97 0.01 OUTLIER Glycine 0 CA--C 1.538 1.489 0 C-N-CA 129.2 3.286 . . . . 0.0 117.085 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.02 -4.28 54.7 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -173.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.5 m -72.86 163.14 28.58 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 122.905 1.336 . . . . 0.0 112.983 171.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.7 pt -130.04 165.76 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 129.642 3.177 . . . . 0.0 108.157 168.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.0 t -83.59 102.04 11.9 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 168.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.3 mmm180 -66.22 170.47 5.79 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.294 1.838 . . . . 0.0 111.251 -175.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.48 -17.89 71.15 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.709 1.147 . . . . 0.0 114.452 -173.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -82.22 -4.7 57.6 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.141 1.376 . . . . 0.0 114.337 173.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.77 20.9 52.68 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.299 0.952 . . . . 0.0 115.017 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -131.66 162.03 31.36 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.838 1.655 . . . . 0.0 111.762 176.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 75.2 m -71.86 145.36 48.62 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.523 -0.736 . . . . 0.0 112.954 177.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.232 0 C-N-CA 125.198 1.38 . . . . 0.0 112.08 171.825 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.5 m . . . . . 0 N--CA 1.475 0.797 0 CA-C-O 119.344 -0.36 . . . . 0.0 111.746 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -117.49 -2.41 17.48 Favored Glycine 0 N--CA 1.478 1.484 0 C-N-CA 124.541 1.067 . . . . 0.0 115.762 -174.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.4 t -143.16 144.54 32.24 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.884 1.342 . . . . 0.0 112.396 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -75.76 -14.03 60.31 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.439 1.496 . . . . 0.0 113.06 170.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.01 3.34 57.79 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.691 1.615 . . . . 0.0 115.652 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -170.66 -167.95 31.75 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.545 1.545 . . . . 0.0 113.203 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.5 t -124.96 150.84 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 126.019 1.728 . . . . 0.0 109.493 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.9 t -118.63 130.1 24.99 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.014 0.926 . . . . 0.0 111.97 171.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.26 104.95 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 124.242 3.295 . . . . 0.0 112.168 167.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -75.2 90.85 2.58 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.658 1.583 . . . . 0.0 112.011 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.44 162.96 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.727 1.611 . . . . 0.0 111.737 171.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.9 mt -78.39 76.29 4.9 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.818 1.247 . . . . 0.0 111.512 177.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -109.91 110.91 22.02 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.898 1.679 . . . . 0.0 110.769 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -65.88 152.06 45.31 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.642 0.777 . . . . 0.0 111.528 174.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.4 p -147.73 169.67 19.22 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 177.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.61 -6.25 1.96 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 127.458 2.303 . . . . 0.0 113.891 169.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.4 ttt85 -144.64 170.6 15.76 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 128.356 2.662 . . . . 0.0 109.004 173.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -75.5 -24.72 56.9 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.505 -0.747 . . . . 0.0 112.297 176.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.6 m -66.4 -16.2 63.9 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.376 1.871 . . . . 0.0 113.173 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -73.77 -13.59 60.97 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.418 1.487 . . . . 0.0 113.834 173.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 76.7 m -113.02 146.2 34.66 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 -167.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -81.83 167.39 16.53 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.907 3.072 . . . . 0.0 113.55 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 43.67 -117.48 1.79 Allowed Glycine 0 CA--C 1.537 1.43 0 C-N-CA 126.638 2.066 . . . . 0.0 114.904 174.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.98 6.59 47.5 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.954 1.701 . . . . 0.0 113.844 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.4 m -68.25 162.7 24.48 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 123.228 1.49 . . . . 0.0 113.834 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.8 pt -130.62 169.95 20.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 129.486 3.114 . . . . 0.0 107.806 168.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 8.8 t -82.6 104.08 12.6 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 121.7 -0.625 . . . . 0.0 109.759 168.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.06 167.84 9.28 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.186 1.394 . . . . 0.0 110.533 176.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.43 -13.93 71.41 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.818 1.199 . . . . 0.0 114.624 -174.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 44.3 p-10 -79.18 -6.51 56.73 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.86 1.664 . . . . 0.0 114.399 174.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.7 23.07 56.97 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.184 0.897 . . . . 0.0 114.522 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -133.18 164.21 27.56 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.709 2.004 . . . . 0.0 111.067 173.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.6 m -71.74 147.12 47.66 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.624 -0.672 . . . . 0.0 112.524 176.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.049 0 C-N-CA 124.208 0.909 . . . . 0.0 112.038 170.61 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.8 p . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.81 -8.66 7.35 Favored Glycine 0 CA--C 1.541 1.698 0 C-N-CA 125.165 1.364 . . . . 0.0 115.405 -174.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.5 t -156.42 147.66 22.31 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.921 2.089 . . . . 0.0 110.575 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -66.01 -23.07 66.49 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.096 0.958 . . . . 0.0 112.995 170.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.02 -4.38 60.08 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.445 1.498 . . . . 0.0 115.095 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.46 117.9 4.59 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-N 118.57 1.185 . . . . 0.0 112.375 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.64 96.61 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.678 1.591 . . . . 0.0 110.478 169.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 47.5 t -147.2 110.38 3.99 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 125.231 1.412 . . . . 0.0 110.759 -176.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -61.75 -0.26 1.47 Allowed 'Trans proline' 0 CA--C 1.55 1.277 0 C-N-CA 124.376 3.384 . . . . 0.0 116.977 174.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 50.01 59.26 4.67 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 127.466 2.306 . . . . 0.0 113.044 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 47.3 pt -78.28 159.57 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.071 1.348 . . . . 0.0 112.313 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.2 mt -86.41 16.94 4.07 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.014 1.726 . . . . 0.0 113.706 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -61.59 117.42 5.74 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.038 -1.039 . . . . 0.0 110.163 169.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.45 142.51 55.32 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.444 0.698 . . . . 0.0 109.447 168.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.8 p -142.83 171.39 14.12 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -134.79 -14.86 2.1 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.43 2.292 . . . . 0.0 112.482 171.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -130.31 152.18 50.0 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 127.402 2.281 . . . . 0.0 110.032 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -64.39 -24.19 67.55 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 121.414 -0.804 . . . . 0.0 111.936 169.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.3 m -68.24 -20.27 64.8 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.88 2.072 . . . . 0.0 113.453 176.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -68.08 -25.64 65.44 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.959 0.903 . . . . 0.0 112.988 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.6 m -101.25 152.75 38.01 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.891 1.277 . . . . 0.0 113.497 -169.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -80.81 172.22 13.46 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.717 2.945 . . . . 0.0 113.753 -174.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 44.31 -106.99 0.11 Allowed Glycine 0 CA--C 1.535 1.286 0 C-N-CA 127.281 2.372 . . . . 0.0 114.779 172.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -118.58 13.71 13.45 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.311 1.844 . . . . 0.0 113.121 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.0 m -60.72 169.16 1.94 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 122.471 1.129 . . . . 0.0 112.558 172.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.5 pt -129.52 166.92 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 128.155 2.582 . . . . 0.0 109.622 170.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.6 t -93.16 107.02 18.91 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.782 0.833 . . . . 0.0 109.579 168.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -67.91 166.74 15.02 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.053 1.741 . . . . 0.0 111.374 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.34 -16.95 73.86 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.916 1.246 . . . . 0.0 114.45 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -80.83 -4.61 55.3 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.26 1.424 . . . . 0.0 114.11 172.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.3 25.94 32.13 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.375 0.988 . . . . 0.0 114.946 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -134.71 161.91 33.82 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.874 1.669 . . . . 0.0 111.912 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.7 m -67.96 154.45 41.59 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.388 -0.82 . . . . 0.0 113.059 175.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.096 0 C-N-CA 124.84 1.21 . . . . 0.0 112.053 176.602 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -117.04 -16.06 6.39 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 115.324 0.89 . . . . 0.0 115.324 175.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.0 p -152.96 172.19 17.19 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.863 1.332 . . . . 0.0 112.935 173.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -84.32 1.26 45.8 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.259 1.824 . . . . 0.0 113.94 170.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -73.04 6.45 13.5 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 125.944 1.735 . . . . 0.0 116.453 -172.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 168.24 -169.92 41.77 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 126.442 1.972 . . . . 0.0 112.085 -175.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 m -87.86 154.52 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.571 1.148 . . . . 0.0 112.35 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.7 t -149.96 124.48 4.67 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 126.217 1.807 . . . . 0.0 109.168 168.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.21 -9.24 19.05 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.19 2.593 . . . . 0.0 115.511 -172.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt 45.53 63.4 1.8 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.989 2.116 . . . . 0.0 113.638 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.0 pp -124.24 169.22 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.904 1.681 . . . . 0.0 112.219 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.0 mt -75.11 35.53 0.11 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 126.844 2.058 . . . . 0.0 114.607 -170.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -71.49 105.81 3.73 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.544 1.538 . . . . 0.0 110.623 170.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -61.61 145.83 50.88 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.746 0.818 . . . . 0.0 110.478 170.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.4 p -141.59 167.49 22.04 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -120.69 -19.64 7.33 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 127.231 2.213 . . . . 0.0 112.948 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -159.44 161.81 35.58 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 129.508 3.123 . . . . 0.0 109.241 -169.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -66.95 -25.2 66.23 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 121.007 -1.058 . . . . 0.0 112.746 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -71.51 -13.68 61.88 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.505 1.522 . . . . 0.0 113.557 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -74.4 -8.34 55.94 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.451 1.1 . . . . 0.0 112.986 170.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.5 m -119.49 148.6 46.08 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 125.243 1.417 . . . . 0.0 112.391 -173.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.09 167.81 21.34 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.503 2.802 . . . . 0.0 114.036 -176.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 34.5 -107.05 0.03 OUTLIER Glycine 0 CA--C 1.536 1.386 0 C-N-CA 128.302 2.858 . . . . 0.0 116.597 172.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -103.41 9.92 37.57 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.598 1.959 . . . . 0.0 113.772 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.3 m -67.32 164.86 17.54 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 122.589 1.185 . . . . 0.0 111.724 169.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.5 pt -129.81 163.52 34.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 128.801 2.841 . . . . 0.0 108.553 168.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 47.0 t -94.52 104.29 16.25 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.647 0.779 . . . . 0.0 109.15 169.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 51.8 mtm180 -80.75 172.0 14.3 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.579 1.552 . . . . 0.0 111.849 -169.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.11 -16.28 70.66 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.657 1.122 . . . . 0.0 114.299 -173.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.7 p-10 -74.88 -11.08 60.05 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.425 1.49 . . . . 0.0 114.218 170.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.28 16.75 56.9 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 124.842 1.21 . . . . 0.0 115.066 -177.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -131.58 161.22 33.15 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.414 1.486 . . . . 0.0 112.412 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.1 m -68.77 157.6 36.05 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.702 0.801 . . . . 0.0 112.879 174.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.206 0 C-N-CA 125.262 1.41 . . . . 0.0 113.127 168.568 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -99.34 -176.57 31.52 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.119 0.866 . . . . 0.0 115.202 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.1 p -66.39 -5.2 10.0 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.772 2.029 . . . . 0.0 115.518 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -57.8 -28.68 64.24 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.571 1.548 . . . . 0.0 113.458 172.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.81 -7.19 82.0 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.338 1.447 . . . . 0.0 115.465 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.91 -179.2 45.33 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.763 1.173 . . . . 0.0 113.048 169.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.5 m -88.76 156.61 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.36 1.064 . . . . 0.0 112.379 172.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.5 t -135.23 133.0 20.33 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.943 1.297 . . . . 0.0 110.196 168.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -73.28 75.47 2.87 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 123.835 3.023 . . . . 0.0 110.652 169.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -59.43 116.2 3.79 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.559 1.944 . . . . 0.0 113.014 -175.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.0 pp -133.88 169.98 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.808 2.043 . . . . 0.0 110.465 169.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.9 mt -74.94 35.85 0.11 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.306 1.842 . . . . 0.0 114.915 -169.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -71.78 109.43 5.65 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.798 1.639 . . . . 0.0 111.898 176.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -65.09 143.8 57.67 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 168.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.0 p -140.97 171.0 14.68 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.29 -26.52 4.27 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 128.507 2.723 . . . . 0.0 111.33 173.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -135.7 158.38 44.54 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.997 2.119 . . . . 0.0 112.346 -176.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -63.58 -27.03 68.97 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.245 0.618 . . . . 0.0 111.565 169.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.1 m -66.8 -23.09 66.01 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.816 2.046 . . . . 0.0 113.242 175.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -67.87 -20.61 65.15 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 170.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.1 m -104.02 149.13 36.9 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -168.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -82.51 167.53 15.13 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 124.014 3.143 . . . . 0.0 113.421 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 45.71 -123.14 6.2 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.971 1.748 . . . . 0.0 114.495 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.8 8.73 44.21 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.921 1.688 . . . . 0.0 113.42 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.4 m -63.3 158.22 20.86 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 123.026 1.393 . . . . 0.0 112.737 171.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.6 pt -125.57 165.97 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 128.948 2.899 . . . . 0.0 108.471 169.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.6 t -85.1 101.2 12.25 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 169.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -66.73 169.08 8.42 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.22 1.808 . . . . 0.0 111.066 -174.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.07 -17.13 69.52 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.774 1.178 . . . . 0.0 114.396 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 55.1 p30 -79.15 -8.26 58.86 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.338 1.455 . . . . 0.0 114.519 173.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.4 14.72 58.24 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 124.537 1.065 . . . . 0.0 115.425 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -128.38 165.15 21.17 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.884 1.674 . . . . 0.0 111.835 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 83.3 m -70.27 143.03 52.23 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.416 -0.802 . . . . 0.0 112.484 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.093 0 C-N-CA 124.506 1.05 . . . . 0.0 112.583 171.895 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 N--CA 1.476 0.849 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -101.92 1.3 51.74 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.319 0.961 . . . . 0.0 114.174 171.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.8 m 65.97 -57.46 0.35 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 129.126 2.97 . . . . 0.0 114.759 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -62.58 -30.88 71.65 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.985 1.314 . . . . 0.0 112.894 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.61 -4.65 88.96 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.115 1.341 . . . . 0.0 114.765 172.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 110.16 -179.73 20.54 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 126.088 1.804 . . . . 0.0 113.921 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.66 112.97 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.775 1.23 . . . . 0.0 108.896 168.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.7 t -82.55 130.63 58.0 Favored Pre-proline 0 CA--C 1.545 0.784 0 O-C-N 121.931 -0.481 . . . . 0.0 111.465 170.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.08 90.82 0.55 Allowed 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.256 2.638 . . . . 0.0 109.439 167.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -56.71 144.18 33.54 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.753 2.021 . . . . 0.0 113.499 -169.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.8 pt -141.49 159.26 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 127.54 2.336 . . . . 0.0 111.162 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -80.51 29.02 0.31 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.576 1.55 . . . . 0.0 112.789 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -74.79 102.74 4.79 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 120.591 -1.318 . . . . 0.0 110.83 174.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -62.68 146.49 52.07 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.411 1.084 . . . . 0.0 110.973 171.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.5 p -144.17 172.04 13.46 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -175.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -126.78 -22.31 3.9 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 127.813 2.445 . . . . 0.0 112.71 171.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.0 ttp180 -145.13 171.16 14.91 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.504 1.922 . . . . 0.0 111.115 176.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -69.81 -23.76 63.37 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.581 0.752 . . . . 0.0 112.441 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.7 m -64.5 -20.39 66.17 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.085 1.754 . . . . 0.0 113.074 174.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -73.13 -12.03 60.75 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.5 1.12 . . . . 0.0 113.595 173.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.8 m -117.87 159.56 42.17 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 124.959 1.304 . . . . 0.0 113.456 -168.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.57 167.06 26.59 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.249 2.633 . . . . 0.0 112.543 175.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -39.44 -58.6 2.05 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 127.457 2.456 . . . . 0.0 117.147 -169.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.72 -15.98 56.52 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -176.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.8 m -79.57 166.74 21.59 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 123.156 1.455 . . . . 0.0 113.274 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 22.8 pt -133.86 166.08 30.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 130.599 3.56 . . . . 0.0 107.352 167.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 22.3 t -83.42 101.54 11.43 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 168.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -64.84 168.49 6.21 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.119 1.768 . . . . 0.0 110.973 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.42 -17.44 68.56 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.749 1.166 . . . . 0.0 114.344 -176.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -80.03 -7.04 58.64 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.493 1.517 . . . . 0.0 114.439 172.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.84 17.43 56.46 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.65 1.119 . . . . 0.0 115.347 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -130.0 161.02 31.89 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.637 1.575 . . . . 0.0 111.886 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 74.6 m -68.42 139.65 55.78 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.584 -0.697 . . . . 0.0 112.018 175.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.919 0 C-N-CA 124.84 1.21 . . . . 0.0 112.246 174.802 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.9 m . . . . . 0 N--CA 1.473 0.685 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -106.16 -58.7 0.62 Allowed Glycine 0 N--CA 1.471 0.967 0 C-N-CA 124.38 0.991 . . . . 0.0 111.875 173.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.6 m -71.25 -24.56 62.2 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 176.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 23.2 t70 61.28 -27.74 0.05 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 130.096 3.358 . . . . 0.0 117.326 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -84.75 9.05 66.61 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 126.267 1.889 . . . . 0.0 115.233 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.64 -175.56 15.24 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.919 1.723 . . . . 0.0 113.917 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.7 t -68.18 104.91 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.525 1.53 . . . . 0.0 112.481 -172.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.7 t -141.99 107.76 5.83 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.822 1.249 . . . . 0.0 111.17 168.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -71.32 112.83 3.43 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.196 2.597 . . . . 0.0 110.472 170.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -77.66 84.99 4.0 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.936 1.294 . . . . 0.0 111.483 178.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.27 166.09 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.668 1.587 . . . . 0.0 111.778 174.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.7 mt -77.32 48.92 0.67 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.751 1.62 . . . . 0.0 113.191 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -77.6 103.68 7.68 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.798 1.639 . . . . 0.0 110.153 170.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -60.8 144.53 52.36 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.995 0.918 . . . . 0.0 111.272 175.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.2 p -143.79 171.87 13.61 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 177.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -122.68 -28.65 4.15 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 128.552 2.741 . . . . 0.0 111.715 173.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -148.09 161.75 40.79 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 127.003 2.121 . . . . 0.0 111.298 -175.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -65.37 -22.75 66.84 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.326 -0.859 . . . . 0.0 112.576 -177.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.8 m -66.2 -17.79 64.95 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.709 1.603 . . . . 0.0 113.324 175.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -74.89 -10.26 59.33 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.069 1.348 . . . . 0.0 113.519 174.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.5 m -119.54 153.25 53.98 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 124.466 1.107 . . . . 0.0 113.471 -168.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -57.49 170.63 1.7 Allowed 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.827 3.685 . . . . 0.0 116.249 174.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -30.12 -72.25 0.06 OUTLIER Glycine 0 CA--C 1.537 1.467 0 C-N-CA 128.889 3.138 . . . . 0.0 117.668 -172.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.46 -0.5 57.27 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.59 1.156 . . . . 0.0 114.094 -176.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 54.7 m -75.76 169.21 18.58 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.628 1.204 . . . . 0.0 112.559 176.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.7 pt -135.12 163.49 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 128.657 2.783 . . . . 0.0 108.756 168.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 42.0 t -93.14 103.93 16.16 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 168.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -79.94 170.31 16.66 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.689 1.596 . . . . 0.0 112.007 -169.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.66 -15.86 71.42 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.778 1.18 . . . . 0.0 114.343 -173.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 50.8 p-10 -74.86 -10.95 59.98 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.244 1.418 . . . . 0.0 114.148 171.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.42 15.95 54.09 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 124.967 1.27 . . . . 0.0 114.978 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -132.33 160.41 36.36 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.328 1.451 . . . . 0.0 112.243 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 83.8 m -68.03 160.64 28.39 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.904 0.882 . . . . 0.0 112.663 173.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.053 0 C-N-CA 124.788 1.185 . . . . 0.0 113.529 168.662 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.4 t . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -104.18 2.97 43.86 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.677 1.132 . . . . 0.0 113.45 172.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m 57.87 16.44 3.63 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.988 2.115 . . . . 0.0 114.989 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -66.43 -28.02 68.28 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.178 1.391 . . . . 0.0 114.505 -170.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -157.74 18.28 0.35 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.697 1.141 . . . . 0.0 115.131 -177.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.0 -158.93 29.57 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.284 1.421 . . . . 0.0 112.408 -172.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.9 t -112.36 117.56 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.53 1.532 . . . . 0.0 109.479 171.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.7 t -79.9 132.57 60.27 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.873 -0.584 . . . . 0.0 110.279 169.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.75 8.22 0.82 Allowed 'Trans proline' 0 CA--C 1.552 1.392 0 C-N-CA 124.501 3.467 . . . . 0.0 115.895 174.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt 54.56 70.16 0.65 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 127.553 2.341 . . . . 0.0 113.729 174.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 47.9 pt -78.25 150.87 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.867 1.267 . . . . 0.0 111.085 175.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.2 mt -79.56 27.05 0.28 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.877 1.671 . . . . 0.0 113.489 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -69.02 115.15 7.98 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.035 1.334 . . . . 0.0 110.474 173.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -65.31 145.7 55.87 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.141 0.976 . . . . 0.0 110.368 171.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.1 p -148.99 171.76 15.84 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -133.83 -14.45 2.44 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.761 2.424 . . . . 0.0 112.842 169.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -131.99 152.22 51.27 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 127.758 2.423 . . . . 0.0 109.94 -177.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -65.33 -24.07 67.17 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.411 -0.806 . . . . 0.0 111.967 169.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.4 m -67.93 -20.68 65.1 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.321 1.849 . . . . 0.0 113.165 175.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -69.12 -22.29 63.97 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.768 0.827 . . . . 0.0 113.031 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 85.9 m -103.32 155.41 36.79 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.737 1.215 . . . . 0.0 113.641 -169.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.21 159.75 43.47 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.144 2.563 . . . . 0.0 112.699 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 0.35 -84.52 0.0 OUTLIER Glycine 0 CA--C 1.537 1.467 0 C-N-CA 129.926 3.631 . . . . 0.0 118.026 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.87 -7.81 55.44 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -172.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.6 m -71.99 161.94 30.19 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 123.155 1.455 . . . . 0.0 112.77 169.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.7 pt -128.21 165.43 27.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 129.707 3.203 . . . . 0.0 107.908 168.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.2 t -85.51 103.0 13.98 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 169.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -67.42 169.62 8.74 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.952 1.701 . . . . 0.0 110.946 -176.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.47 -16.05 71.19 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.714 1.15 . . . . 0.0 114.588 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -83.7 -4.52 58.68 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.569 1.548 . . . . 0.0 114.48 175.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.42 23.41 43.73 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-N 119.09 0.859 . . . . 0.0 114.797 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -132.87 160.79 35.94 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.831 1.653 . . . . 0.0 111.577 176.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.1 m -69.06 146.29 52.76 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.665 -0.647 . . . . 0.0 112.058 173.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.985 0 C-N-CA 124.629 1.109 . . . . 0.0 111.777 173.287 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 89.4 p . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 116.271 1.952 . . . . 0.0 116.271 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.25 19.77 68.6 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.317 1.437 . . . . 0.0 114.581 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.4 m 65.22 -15.65 0.1 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 128.572 2.749 . . . . 0.0 115.648 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -70.18 -18.52 63.2 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.884 1.674 . . . . 0.0 113.585 174.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.43 21.95 74.09 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.277 0.941 . . . . 0.0 114.457 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.73 171.57 11.26 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.938 1.256 . . . . 0.0 113.944 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t -71.89 84.77 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.686 1.194 . . . . 0.0 111.856 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.3 t -120.05 120.79 29.99 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 124.954 1.302 . . . . 0.0 109.611 168.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.22 93.1 0.4 Allowed 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.077 2.518 . . . . 0.0 109.439 169.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.8 mtmt -52.19 124.82 14.03 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.76 2.024 . . . . 0.0 113.42 -169.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pp -137.43 170.1 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 127.506 2.323 . . . . 0.0 111.548 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.1 mp -111.97 35.36 3.75 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.927 1.691 . . . . 0.0 111.673 178.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -64.56 123.93 20.53 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.166 0.986 . . . . 0.0 110.724 170.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -67.34 147.02 53.49 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 166.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.6 p -143.79 169.86 16.98 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -134.15 -12.37 2.49 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.804 2.041 . . . . 0.0 113.051 170.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -145.58 160.72 41.23 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.222 2.209 . . . . 0.0 110.134 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -69.89 -23.07 63.19 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.175 -0.953 . . . . 0.0 112.898 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 70.4 m -69.85 -13.66 62.37 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.951 1.3 . . . . 0.0 113.362 176.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -70.69 -13.64 62.15 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.428 1.091 . . . . 0.0 113.21 172.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.7 m -114.87 147.31 37.97 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 125.01 1.324 . . . . 0.0 113.785 -168.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -81.68 163.31 18.8 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.519 2.812 . . . . 0.0 113.402 -177.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 43.08 -117.27 1.51 Allowed Glycine 0 CA--C 1.535 1.339 0 C-N-CA 126.475 1.988 . . . . 0.0 114.568 176.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.29 -0.87 54.73 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.903 1.681 . . . . 0.0 114.156 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.3 m -61.99 161.47 10.64 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 122.713 1.244 . . . . 0.0 113.11 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.1 pt -126.76 167.01 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 C-N-CA 128.001 2.52 . . . . 0.0 109.51 172.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.0 t -85.08 103.93 14.53 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 168.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -69.79 170.59 10.72 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.517 1.927 . . . . 0.0 110.92 -174.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.26 -16.56 73.38 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.615 1.102 . . . . 0.0 114.661 -173.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -85.01 -3.22 58.7 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.391 1.477 . . . . 0.0 114.415 175.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.76 21.53 50.21 Favored Glycine 0 CA--C 1.537 1.422 0 C-N-CA 124.202 0.906 . . . . 0.0 114.957 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -131.56 162.65 29.82 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.944 1.697 . . . . 0.0 111.583 175.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 96.2 m -69.73 151.31 45.97 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.435 -0.791 . . . . 0.0 112.962 174.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.013 0 C-N-CA 124.085 0.85 . . . . 0.0 112.869 171.518 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.476 0.833 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.66 -12.05 17.67 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.324 0.964 . . . . 0.0 114.448 170.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.0 t -149.65 154.81 39.2 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.718 1.607 . . . . 0.0 111.478 173.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -82.19 -8.28 59.64 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.287 1.435 . . . . 0.0 112.815 169.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.99 2.65 33.12 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.988 1.756 . . . . 0.0 116.502 -173.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -172.11 -176.32 40.87 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.452 1.501 . . . . 0.0 113.118 177.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.4 m -75.64 138.19 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.681 1.192 . . . . 0.0 112.66 -177.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.7 t -151.28 112.64 3.04 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 125.292 1.437 . . . . 0.0 110.081 167.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -80.05 -0.11 10.43 Favored 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.645 2.897 . . . . 0.0 115.218 -173.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 48.21 49.21 17.92 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 127.026 2.13 . . . . 0.0 113.78 -177.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.8 pt -78.88 161.19 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.388 1.475 . . . . 0.0 112.127 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.1 mt -77.75 15.98 0.76 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.647 1.979 . . . . 0.0 113.791 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -63.61 113.07 3.1 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.118 1.367 . . . . 0.0 110.762 172.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -68.97 151.25 46.76 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.686 0.794 . . . . 0.0 111.269 172.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.3 p -145.22 176.51 9.49 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.7 mmt-85 -133.37 -18.13 2.26 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 127.595 2.358 . . . . 0.0 113.242 169.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -146.13 163.81 34.17 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.885 1.674 . . . . 0.0 111.883 176.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -65.46 -22.48 66.75 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.322 -0.861 . . . . 0.0 112.539 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.9 m -68.18 -16.03 63.82 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.03 1.332 . . . . 0.0 113.284 176.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -74.33 -10.07 59.22 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.854 1.261 . . . . 0.0 113.539 173.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.2 m -123.88 150.92 63.79 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 125.091 1.357 . . . . 0.0 112.584 -169.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -79.27 166.97 22.05 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 123.432 2.754 . . . . 0.0 113.969 -175.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 32.81 -103.9 0.01 OUTLIER Glycine 0 CA--C 1.537 1.455 0 C-N-CA 128.62 3.01 . . . . 0.0 116.701 172.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -104.6 9.05 35.44 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.714 2.006 . . . . 0.0 113.716 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.4 m -67.52 164.51 18.78 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 122.618 1.199 . . . . 0.0 111.523 169.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.1 pt -130.54 164.4 33.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 128.65 2.78 . . . . 0.0 108.879 169.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 42.2 t -93.74 106.85 18.79 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 168.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -82.15 172.88 12.68 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.21 1.404 . . . . 0.0 111.459 -169.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.87 -17.34 71.34 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.672 1.129 . . . . 0.0 114.403 -170.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -77.79 -6.71 55.0 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.139 1.776 . . . . 0.0 114.183 171.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.73 33.09 43.45 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 121.147 -0.971 . . . . 0.0 113.938 -177.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -136.09 158.46 44.36 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.137 1.775 . . . . 0.0 111.531 175.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 80.0 m -69.06 158.2 35.29 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.729 0.776 . . . . 0.0 112.909 173.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.178 0 C-N-CA 125.277 1.418 . . . . 0.0 113.476 168.686 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.6 m . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.06 -7.28 0.19 Allowed Glycine 0 CA--C 1.536 1.367 0 N-CA-C 116.549 1.379 . . . . 0.0 116.549 173.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.5 t -146.73 152.58 39.05 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.238 1.519 . . . . 0.0 111.888 175.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -82.5 -8.85 59.61 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.64 1.576 . . . . 0.0 113.049 171.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.22 0.52 39.42 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.762 1.648 . . . . 0.0 116.413 -173.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -178.19 -175.44 45.32 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.485 1.517 . . . . 0.0 113.222 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.2 p -76.86 150.58 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.757 1.223 . . . . 0.0 111.652 173.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.6 t -135.5 106.46 10.03 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 125.294 1.438 . . . . 0.0 110.66 168.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -73.8 119.54 5.94 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.868 2.379 . . . . 0.0 109.416 168.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -79.18 67.89 5.02 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.191 1.396 . . . . 0.0 111.536 -174.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 33.8 pt -78.59 146.0 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 126.093 1.757 . . . . 0.0 111.52 -177.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 pp -75.76 22.57 0.14 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.968 1.707 . . . . 0.0 114.253 173.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -66.86 110.63 3.38 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.819 1.248 . . . . 0.0 109.392 168.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.92 142.83 58.15 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.454 0.701 . . . . 0.0 110.219 171.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.3 p -138.77 174.01 10.97 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 -135.76 -17.23 1.7 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.041 2.136 . . . . 0.0 112.871 173.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -142.82 161.56 37.79 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.65 1.98 . . . . 0.0 110.607 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -69.87 -23.75 63.31 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.299 -0.876 . . . . 0.0 112.953 -178.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.7 m -70.84 -12.75 61.73 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.821 1.248 . . . . 0.0 113.434 175.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -70.88 -15.99 62.66 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.749 0.82 . . . . 0.0 113.082 171.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.2 m -115.58 150.32 44.5 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.737 1.215 . . . . 0.0 113.556 -168.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -79.96 166.52 21.01 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.67 2.913 . . . . 0.0 113.976 -174.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 40.05 -113.91 0.42 Allowed Glycine 0 CA--C 1.536 1.4 0 C-N-CA 127.313 2.387 . . . . 0.0 115.535 172.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.42 9.6 42.4 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.238 1.815 . . . . 0.0 113.743 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 61.3 m -68.26 168.5 12.26 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.553 1.168 . . . . 0.0 112.394 171.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.5 pt -136.07 169.65 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 129.088 2.955 . . . . 0.0 109.004 169.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.4 t -84.8 103.26 13.73 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 167.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -67.75 168.63 11.03 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.902 1.681 . . . . 0.0 111.176 -176.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.03 -16.61 70.87 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 124.859 1.219 . . . . 0.0 114.367 -175.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -77.69 -9.36 58.94 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.978 1.311 . . . . 0.0 114.208 172.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.69 14.46 56.7 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.779 1.18 . . . . 0.0 115.359 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -131.09 169.04 16.41 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.672 1.589 . . . . 0.0 111.747 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.6 m -70.2 150.47 46.43 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.123 -0.985 . . . . 0.0 113.579 177.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.243 0 C-N-CA 125.372 1.463 . . . . 0.0 112.299 174.382 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 53.0 m . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.88 -1.03 34.16 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.547 1.07 . . . . 0.0 114.77 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.9 p -143.15 160.14 40.97 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.669 1.588 . . . . 0.0 112.496 175.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -67.31 105.96 1.92 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.193 1.397 . . . . 0.0 112.243 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 74.33 15.11 80.33 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 124.105 0.86 . . . . 0.0 115.104 178.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.48 164.35 25.51 Favored Glycine 0 CA--C 1.537 1.458 0 CA-C-N 118.504 1.152 . . . . 0.0 114.081 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.5 m -73.68 74.38 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.814 1.646 . . . . 0.0 112.672 174.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 51.5 t -125.34 113.5 25.82 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 125.603 1.561 . . . . 0.0 111.166 175.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -57.9 -12.71 12.83 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 124.964 3.776 . . . . 0.0 117.579 175.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 47.38 47.71 16.84 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 126.875 2.07 . . . . 0.0 113.774 -173.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.4 pt -78.96 148.04 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.263 1.425 . . . . 0.0 111.052 176.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.24 35.03 0.14 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.33 1.852 . . . . 0.0 113.084 176.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -70.94 113.5 8.05 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.66 1.584 . . . . 0.0 109.82 169.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.49 143.6 57.69 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.604 0.762 . . . . 0.0 110.361 171.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.0 p -145.03 171.55 14.32 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -134.21 -13.93 2.36 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 127.542 2.337 . . . . 0.0 112.931 169.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -132.93 152.44 51.91 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.666 2.386 . . . . 0.0 110.093 -176.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -66.62 -25.25 66.5 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.212 -0.93 . . . . 0.0 112.263 171.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 56.7 p -72.07 -14.55 61.89 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.833 1.653 . . . . 0.0 113.988 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -68.31 -19.47 64.68 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 121.235 -0.916 . . . . 0.0 112.77 169.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.3 m -109.86 149.72 40.37 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 124.889 1.275 . . . . 0.0 113.275 -169.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.33 166.34 20.35 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.609 2.873 . . . . 0.0 113.899 -175.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 38.34 -110.06 0.12 Allowed Glycine 0 CA--C 1.538 1.512 0 C-N-CA 127.591 2.52 . . . . 0.0 115.848 172.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.48 7.27 42.52 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.17 1.788 . . . . 0.0 113.747 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 61.8 m -67.59 165.54 16.75 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 122.604 1.192 . . . . 0.0 111.929 171.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.6 pt -133.79 167.48 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 129.227 3.011 . . . . 0.0 108.653 169.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.9 t -85.9 103.28 14.48 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 168.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -67.03 169.38 8.45 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.721 1.608 . . . . 0.0 111.049 -176.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.94 -16.61 70.69 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.757 1.17 . . . . 0.0 114.522 -174.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -81.05 -6.77 59.2 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.337 1.455 . . . . 0.0 114.393 173.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.59 20.38 48.12 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.485 1.041 . . . . 0.0 115.028 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -132.31 163.71 28.05 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.723 1.609 . . . . 0.0 111.687 177.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.5 m -70.21 148.32 48.76 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.307 -0.871 . . . . 0.0 112.916 176.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.156 0 C-N-CA 125.164 1.364 . . . . 0.0 112.462 174.255 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.2 m . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 112.656 0.614 . . . . 0.0 112.656 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -96.8 161.27 21.88 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 123.78 0.705 . . . . 0.0 112.733 173.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.5 p -61.33 -57.28 12.96 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.959 1.304 . . . . 0.0 112.45 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -74.5 -23.17 58.8 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.109 1.364 . . . . 0.0 112.868 171.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -69.51 -48.65 42.69 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.21 1.386 . . . . 0.0 114.059 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 111.36 -174.58 16.87 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.247 1.403 . . . . 0.0 113.833 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.6 t -66.38 101.32 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.535 1.134 . . . . 0.0 110.182 172.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.6 t -86.7 130.65 48.09 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-O 119.076 -0.488 . . . . 0.0 110.567 169.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.8 92.83 0.31 Allowed 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 123.15 2.567 . . . . 0.0 109.168 167.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -54.28 137.03 42.33 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 127.229 2.211 . . . . 0.0 113.811 -168.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.0 pt -138.99 149.19 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 127.38 2.272 . . . . 0.0 110.507 174.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.26 42.77 0.76 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.049 1.34 . . . . 0.0 111.636 177.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -80.09 115.46 19.67 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.47 1.508 . . . . 0.0 110.286 174.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.85 146.68 53.52 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.96 0.904 . . . . 0.0 110.686 172.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.0 p -145.1 165.49 28.1 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 176.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -122.66 -17.14 7.0 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 127.509 2.324 . . . . 0.0 112.729 170.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -148.31 162.5 39.4 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 128.45 2.7 . . . . 0.0 110.016 -175.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -69.3 -23.22 63.78 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 121.146 -0.971 . . . . 0.0 112.953 -178.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.5 m -67.79 -17.3 64.48 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.555 1.542 . . . . 0.0 113.234 177.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -75.12 -10.75 59.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.17 1.388 . . . . 0.0 113.443 174.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 73.9 m -113.56 163.1 19.39 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -168.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.92 165.36 3.87 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.984 3.122 . . . . 0.0 114.096 169.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -48.43 -56.93 8.76 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 126.058 1.789 . . . . 0.0 115.942 -174.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -82.32 -14.54 55.18 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.6 m -74.53 166.6 23.26 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 123.051 1.405 . . . . 0.0 112.904 171.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 pt -132.78 167.68 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 129.139 2.976 . . . . 0.0 107.671 166.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.0 t -82.44 101.83 10.91 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.423 -0.798 . . . . 0.0 109.778 169.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.87 167.81 12.85 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.228 1.811 . . . . 0.0 111.567 -178.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.01 -15.18 76.29 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.911 1.244 . . . . 0.0 114.631 -173.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.9 p-10 -77.37 -8.25 57.38 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.45 1.5 . . . . 0.0 114.166 173.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.23 13.86 59.68 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.737 1.16 . . . . 0.0 114.996 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -129.28 168.1 16.72 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.432 1.893 . . . . 0.0 111.064 177.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 82.4 m -74.03 153.84 39.5 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.262 -0.899 . . . . 0.0 113.242 176.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.124 0 C-N-CA 124.329 0.966 . . . . 0.0 113.451 171.283 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 63.1 m . . . . . 0 N--CA 1.477 0.894 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -98.63 -15.38 34.62 Favored Glycine 0 CA--C 1.535 1.34 0 N-CA-C 115.979 1.151 . . . . 0.0 115.979 -173.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.0 p -154.46 170.35 21.62 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.037 1.418 . . . . 0.0 113.29 175.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -80.18 -3.15 47.85 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.4 1.48 . . . . 0.0 113.426 170.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.47 2.66 57.2 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 125.711 1.624 . . . . 0.0 115.907 -175.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.11 -161.68 25.68 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 126.088 1.804 . . . . 0.0 112.16 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.7 p -125.86 151.85 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.071 1.349 . . . . 0.0 111.779 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.3 t -136.47 136.8 22.64 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 123.978 0.911 . . . . 0.0 109.555 166.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.2 -1.62 8.33 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 123.983 3.122 . . . . 0.0 115.371 172.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt 47.3 63.21 2.06 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 127.713 2.405 . . . . 0.0 113.138 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.6 pt -78.0 155.76 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.448 1.499 . . . . 0.0 111.577 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -79.69 16.54 1.08 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.228 1.811 . . . . 0.0 113.164 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -63.54 112.36 2.76 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.098 1.359 . . . . 0.0 110.571 169.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -65.91 143.23 57.55 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 169.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.0 p -136.45 173.49 11.65 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -175.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -136.64 -17.6 1.47 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.453 1.901 . . . . 0.0 112.577 169.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.61 155.4 39.17 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 127.846 2.458 . . . . 0.0 109.887 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -67.97 -25.76 65.6 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.223 -0.923 . . . . 0.0 112.223 169.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 77.4 p -71.33 -14.54 62.23 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.59 1.556 . . . . 0.0 114.022 175.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -65.55 -22.27 66.68 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.403 -0.81 . . . . 0.0 112.585 169.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.8 m -106.39 150.07 39.05 Favored Pre-proline 0 CA--C 1.549 0.924 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -167.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -82.2 165.45 16.85 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.765 2.976 . . . . 0.0 113.523 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 44.1 -118.72 2.46 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.601 2.048 . . . . 0.0 114.877 173.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.64 7.05 47.15 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.1 1.76 . . . . 0.0 113.761 -178.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.4 m -66.03 160.04 24.61 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 123.077 1.417 . . . . 0.0 113.438 171.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.1 pt -127.55 167.3 22.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 129.505 3.122 . . . . 0.0 108.138 168.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 13.8 t -84.54 103.02 13.31 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 168.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -68.47 168.95 11.72 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.943 1.697 . . . . 0.0 111.073 -175.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.47 -16.41 69.46 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.659 1.123 . . . . 0.0 114.515 -176.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.8 p30 -78.77 -7.62 57.97 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.517 1.527 . . . . 0.0 114.419 173.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.33 14.54 60.07 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.649 1.119 . . . . 0.0 115.421 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -128.6 166.52 18.71 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.277 1.831 . . . . 0.0 111.866 177.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.6 m -69.38 143.1 53.79 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.476 -0.765 . . . . 0.0 112.672 174.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.167 0 C-N-CA 124.478 1.037 . . . . 0.0 112.615 171.237 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -116.65 -61.25 0.32 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.397 1.475 . . . . 0.0 113.064 -177.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.5 m -72.57 101.53 3.03 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.172 1.389 . . . . 0.0 112.47 -175.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -58.23 -22.07 50.62 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.526 1.53 . . . . 0.0 114.699 -176.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.54 -0.91 74.77 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 125.301 1.429 . . . . 0.0 115.445 175.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.54 -165.54 10.3 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 126.031 1.776 . . . . 0.0 113.566 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.1 p -132.33 152.39 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.52 1.528 . . . . 0.0 111.61 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 48.3 t -133.5 136.29 26.69 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.457 1.103 . . . . 0.0 110.664 169.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -55.83 -11.93 6.06 Favored 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 124.991 3.794 . . . . 0.0 117.044 169.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt 48.92 60.19 3.9 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 127.446 2.299 . . . . 0.0 113.195 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 36.6 pt -78.28 157.35 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 125.798 1.639 . . . . 0.0 111.688 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.0 mt -79.58 19.55 0.63 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.219 1.808 . . . . 0.0 113.712 178.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -63.83 115.58 4.96 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.179 1.392 . . . . 0.0 110.806 173.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -67.57 146.02 54.31 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.108 0.563 . . . . 0.0 110.147 169.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.9 p -139.37 172.96 12.06 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.36 -28.22 3.68 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 128.192 2.597 . . . . 0.0 111.564 174.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -148.14 164.41 33.97 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.698 1.999 . . . . 0.0 111.433 -175.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -66.92 -23.96 66.03 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.45 -0.781 . . . . 0.0 112.78 -176.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -66.7 -18.54 65.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.217 1.407 . . . . 0.0 112.825 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -71.55 -17.2 62.32 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.998 1.319 . . . . 0.0 113.219 175.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 62.6 m -111.31 148.67 39.25 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -167.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -81.93 163.19 18.25 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.744 2.963 . . . . 0.0 113.531 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 44.18 -119.69 2.96 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 126.332 1.92 . . . . 0.0 114.84 173.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.83 -0.86 57.81 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.694 1.598 . . . . 0.0 114.226 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.1 m -64.41 156.54 29.02 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 123.105 1.431 . . . . 0.0 113.105 176.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.0 pt -124.56 164.8 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 129.258 3.023 . . . . 0.0 108.562 170.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.1 t -84.41 102.84 13.07 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 168.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -67.22 169.55 8.5 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.94 1.696 . . . . 0.0 110.915 -176.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.56 -17.22 70.61 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.748 1.166 . . . . 0.0 114.605 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 56.9 p30 -81.86 -4.01 55.48 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.754 1.622 . . . . 0.0 114.375 173.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.84 29.81 45.83 Favored Glycine 0 CA--C 1.535 1.335 0 O-C-N 121.206 -0.934 . . . . 0.0 114.456 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -132.97 160.67 36.44 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.517 1.927 . . . . 0.0 111.267 172.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 77.7 m -69.0 144.55 54.07 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.817 -0.552 . . . . 0.0 112.232 172.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.04 0 C-N-CA 124.612 1.101 . . . . 0.0 111.81 172.883 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.2 m . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -94.11 -14.91 50.28 Favored Glycine 0 CA--C 1.539 1.57 0 C-N-CA 123.863 0.744 . . . . 0.0 112.45 168.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.9 t -140.12 106.45 5.27 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 127.345 2.258 . . . . 0.0 108.975 169.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -61.63 -23.46 66.05 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.735 1.214 . . . . 0.0 114.166 -173.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -85.72 -3.66 85.83 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 125.067 1.318 . . . . 0.0 115.0 175.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.78 176.87 25.25 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.522 1.534 . . . . 0.0 114.405 -177.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.1 t -75.57 93.07 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.325 1.45 . . . . 0.0 111.389 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.1 t -135.03 104.12 10.6 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.539 1.136 . . . . 0.0 111.275 169.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -57.66 -18.41 33.01 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 124.688 3.592 . . . . 0.0 117.335 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt 47.04 77.22 0.09 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 127.233 2.213 . . . . 0.0 113.596 -176.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.402 HD13 ' H ' ' A' ' 11' ' ' ILE . 0.1 OUTLIER -123.36 169.27 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 126.054 1.742 . . . . 0.0 112.418 -177.706 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.0 mt -72.55 25.87 0.05 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.468 1.907 . . . . 0.0 114.612 -178.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -69.74 101.43 1.69 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.97 1.308 . . . . 0.0 110.402 170.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -64.45 145.26 56.37 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.235 1.014 . . . . 0.0 110.322 169.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.6 p -145.66 169.74 17.85 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.416 1.086 . . . . 0.0 113.732 -176.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -123.16 -25.26 4.53 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.53 2.332 . . . . 0.0 111.918 169.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -130.99 160.6 34.09 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.753 2.021 . . . . 0.0 110.879 -176.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -67.21 -25.51 66.15 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.438 -0.789 . . . . 0.0 112.492 173.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 56.3 p -70.7 -15.59 62.72 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.848 1.659 . . . . 0.0 113.972 175.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -68.86 -19.23 64.23 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.811 0.844 . . . . 0.0 112.937 169.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.8 m -108.25 159.86 29.13 Favored Pre-proline 0 CA--C 1.553 1.068 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -168.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -57.65 167.11 4.21 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 124.509 3.473 . . . . 0.0 115.541 173.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -26.51 -72.66 0.03 OUTLIER Glycine 0 CA--C 1.536 1.344 0 C-N-CA 129.081 3.229 . . . . 0.0 117.588 -172.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.42 3.02 53.12 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.013 1.325 . . . . 0.0 113.92 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.6 m -73.14 167.06 21.93 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 122.723 1.249 . . . . 0.0 111.613 169.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.2 pt -135.16 164.64 32.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 129.095 2.958 . . . . 0.0 108.323 169.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.3 t -84.18 101.71 12.06 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 168.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -65.17 171.24 3.85 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.374 1.87 . . . . 0.0 111.149 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.49 -18.36 69.7 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.723 1.154 . . . . 0.0 114.451 -174.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -81.47 -6.87 59.39 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.155 1.382 . . . . 0.0 114.393 173.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.23 20.14 50.25 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 124.53 1.062 . . . . 0.0 115.266 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -130.87 161.47 31.77 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.68 1.592 . . . . 0.0 111.766 178.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.2 m -71.15 139.29 50.18 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.453 -0.779 . . . . 0.0 112.713 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.121 0 C-N-CA 124.499 1.047 . . . . 0.0 113.162 174.547 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -118.6 27.48 7.2 Favored Glycine 0 N--CA 1.473 1.104 0 C-N-CA 125.414 1.483 . . . . 0.0 114.716 -175.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.6 m 51.51 -88.15 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 127.856 2.462 . . . . 0.0 114.037 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -64.27 -19.59 65.5 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 119.626 1.103 . . . . 0.0 113.578 171.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.9 -9.86 86.42 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.024 1.297 . . . . 0.0 114.37 169.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.88 170.87 24.34 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 126.795 2.14 . . . . 0.0 114.402 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.6 t -76.4 110.61 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.998 1.319 . . . . 0.0 108.95 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.2 t -88.17 128.74 52.41 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 119.062 -0.494 . . . . 0.0 111.33 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -65.61 97.29 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.958 2.438 . . . . 0.0 109.169 167.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -54.37 142.07 28.12 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.228 2.211 . . . . 0.0 113.956 -168.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.3 pt -138.95 157.97 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 127.439 2.296 . . . . 0.0 110.843 176.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 90.4 mt -85.79 22.86 1.55 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.178 1.391 . . . . 0.0 113.267 178.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -68.21 109.71 3.7 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.076 1.35 . . . . 0.0 111.314 175.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -63.49 146.15 54.21 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.281 1.033 . . . . 0.0 109.73 169.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.3 p -142.09 168.54 19.51 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 38.4 mtm180 -124.19 -21.45 5.01 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 128.494 2.717 . . . . 0.0 112.428 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -154.88 163.42 40.31 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 128.81 2.844 . . . . 0.0 109.965 -174.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -67.74 -24.96 65.41 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.276 -0.89 . . . . 0.0 112.65 178.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.5 m -71.59 -13.91 61.92 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.729 1.212 . . . . 0.0 113.48 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -72.32 -18.64 61.75 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.832 1.253 . . . . 0.0 112.376 171.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 76.2 m -104.93 159.78 28.18 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.092 1.357 . . . . 0.0 113.724 -169.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.08 166.62 27.39 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.191 2.594 . . . . 0.0 112.659 175.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -34.14 -63.09 0.44 Allowed Glycine 0 CA--C 1.537 1.446 0 C-N-CA 127.967 2.699 . . . . 0.0 117.449 -169.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.35 -12.03 57.0 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -175.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.5 m -78.41 164.69 24.57 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 123.14 1.447 . . . . 0.0 113.204 173.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.5 pt -130.0 163.87 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 129.706 3.202 . . . . 0.0 107.72 167.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 39.7 t -89.37 102.93 15.6 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 121.612 -0.68 . . . . 0.0 109.856 171.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -82.0 173.45 12.18 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.681 1.192 . . . . 0.0 111.828 -169.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.57 -16.11 71.46 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.771 1.177 . . . . 0.0 114.32 -170.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 39.4 p-10 -77.06 -9.06 58.47 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.32 1.448 . . . . 0.0 114.273 172.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.73 16.96 57.56 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.687 1.137 . . . . 0.0 115.082 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -131.34 162.79 29.29 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.449 1.499 . . . . 0.0 112.029 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.3 m -69.89 144.85 52.36 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.717 0.807 . . . . 0.0 112.223 172.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.134 0 C-N-CA 124.416 1.008 . . . . 0.0 113.386 174.023 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -153.67 -167.15 15.55 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.583 1.087 . . . . 0.0 114.47 -171.272 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.0 m -67.35 -4.34 10.64 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.533 1.933 . . . . 0.0 115.72 -175.27 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -60.58 158.92 11.46 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 125.148 1.379 . . . . 0.0 112.843 174.142 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.38 -17.33 77.59 Favored Glycine 0 CA--C 1.54 1.651 0 O-C-N 121.112 -0.993 . . . . 0.0 115.256 179.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.28 -173.78 49.87 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.631 1.586 . . . . 0.0 114.086 175.561 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.2 t -122.22 117.39 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.041 1.736 . . . . 0.0 108.971 174.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.7 t -79.45 133.41 59.89 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.918 172.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.41 3.75 2.43 Favored 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 124.327 3.352 . . . . 0.0 115.466 170.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt 55.22 70.88 0.58 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 127.511 2.324 . . . . 0.0 113.44 171.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 48.5 pt -78.51 149.06 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.761 1.225 . . . . 0.0 111.134 175.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.2 mt -79.78 38.37 0.39 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.591 1.556 . . . . 0.0 112.912 177.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -79.53 112.22 16.57 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.06 1.344 . . . . 0.0 109.977 172.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -66.04 143.7 57.18 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.357 0.663 . . . . 0.0 110.567 171.176 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 28.9 p -149.12 170.23 18.88 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.732 1.213 . . . . 0.0 113.924 -172.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -136.26 -8.89 1.99 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.991 2.116 . . . . 0.0 112.836 169.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 -132.41 151.42 51.88 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 127.687 2.395 . . . . 0.0 109.813 -179.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -66.99 -24.18 66.01 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.362 -0.836 . . . . 0.0 112.219 171.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 61.7 p -72.29 -16.34 61.9 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.765 1.626 . . . . 0.0 114.004 174.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -65.93 -28.25 68.78 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.099 0.863 . . . . 0.0 112.383 169.119 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.5 m -96.0 161.23 28.0 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.352 1.461 . . . . 0.0 113.295 -170.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -68.2 162.57 39.7 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.95 2.433 . . . . 0.0 112.136 173.084 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -36.79 -58.65 1.15 Allowed Glycine 0 N--CA 1.475 1.28 0 C-N-CA 127.607 2.527 . . . . 0.0 117.283 -169.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.21 -17.18 53.05 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -175.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.9 m -77.16 168.75 19.53 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 123.046 1.403 . . . . 0.0 113.864 171.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.8 pt -132.35 166.16 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 130.472 3.509 . . . . 0.0 107.806 168.294 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.8 t -86.26 103.92 15.32 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.557 -0.715 . . . . 0.0 109.151 169.022 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -67.77 170.57 7.73 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.194 1.798 . . . . 0.0 111.029 -175.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.58 -16.15 71.55 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.733 1.158 . . . . 0.0 114.604 -173.387 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -83.54 -3.11 57.36 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 125.45 1.5 . . . . 0.0 114.341 174.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.95 21.93 56.35 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.154 0.883 . . . . 0.0 114.603 -179.07 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -131.84 159.99 36.95 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.898 1.679 . . . . 0.0 111.581 175.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.9 m -68.63 147.27 52.14 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.638 -0.664 . . . . 0.0 112.166 176.631 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.864 0 C-N-CA 124.776 1.179 . . . . 0.0 111.449 173.814 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.6 m . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.11 178.8 17.91 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.65 1.119 . . . . 0.0 115.154 -177.029 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.8 m -66.4 -4.47 8.24 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.873 2.069 . . . . 0.0 115.847 -173.103 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -60.91 -21.0 62.93 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.476 1.51 . . . . 0.0 113.889 175.23 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.54 -5.53 60.45 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.641 1.591 . . . . 0.0 114.954 174.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.9 -178.71 47.25 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 124.771 1.177 . . . . 0.0 113.264 170.119 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 p -124.04 122.8 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.52 1.528 . . . . 0.0 110.103 169.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.9 t -90.49 119.28 69.12 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 123.541 0.736 . . . . 0.0 111.916 178.289 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -69.28 93.96 0.48 Allowed 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.211 2.607 . . . . 0.0 109.949 168.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -57.69 151.3 17.66 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.11 1.764 . . . . 0.0 114.228 -171.424 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.22 162.2 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 128.369 2.667 . . . . 0.0 110.016 171.603 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.4 mt -78.75 28.37 0.21 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.138 1.375 . . . . 0.0 113.791 -178.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -70.52 103.91 2.62 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.851 -1.155 . . . . 0.0 110.776 173.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -67.96 142.06 56.1 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 167.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 p -141.1 171.03 14.63 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -171.683 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -133.39 -15.2 2.51 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.686 2.394 . . . . 0.0 112.662 174.065 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -135.06 153.62 51.98 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.329 2.252 . . . . 0.0 110.152 -176.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -66.4 -23.23 66.28 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.475 -0.765 . . . . 0.0 111.793 168.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.0 m -68.62 -20.46 64.49 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.779 2.032 . . . . 0.0 113.427 175.604 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -67.53 -29.95 69.49 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.681 0.792 . . . . 0.0 112.425 172.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.9 m -96.03 159.46 32.19 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.228 1.411 . . . . 0.0 113.702 -169.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.74 167.1 26.7 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.29 2.66 . . . . 0.0 112.712 175.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -34.85 -62.25 0.56 Allowed Glycine 0 CA--C 1.536 1.354 0 C-N-CA 128.067 2.746 . . . . 0.0 117.489 -169.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.05 -13.88 58.96 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -175.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.3 m -81.17 167.55 19.53 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 123.268 1.508 . . . . 0.0 113.722 173.735 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.5 pt -133.18 166.54 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 131.19 3.796 . . . . 0.0 107.234 167.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.4 t -84.91 102.75 13.38 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.408 -0.807 . . . . 0.0 108.986 169.042 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -66.82 168.0 10.43 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.93 1.692 . . . . 0.0 111.194 -174.618 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.2 -17.72 68.43 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.79 1.186 . . . . 0.0 114.325 -178.283 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -77.88 -7.73 57.11 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 125.499 1.519 . . . . 0.0 114.331 172.153 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.17 13.99 61.13 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.64 1.114 . . . . 0.0 115.485 178.407 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -130.28 166.05 21.16 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.031 1.733 . . . . 0.0 111.418 176.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.2 m -70.85 141.74 51.25 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.435 -0.791 . . . . 0.0 112.894 178.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.181 0 C-N-CA 125.49 1.519 . . . . 0.0 112.201 174.515 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -140.52 -73.4 0.04 OUTLIER Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.238 1.399 . . . . 0.0 112.771 -178.741 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 62.0 m -74.31 99.96 3.62 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.741 1.216 . . . . 0.0 111.993 -178.218 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -58.77 -21.33 55.52 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.792 1.637 . . . . 0.0 114.755 -176.227 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.23 -0.44 71.15 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.277 1.417 . . . . 0.0 115.741 177.012 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.36 -173.1 13.54 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.542 1.544 . . . . 0.0 113.896 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.4 m -107.38 138.76 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.385 1.474 . . . . 0.0 112.366 -175.557 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.4 t -131.46 105.75 14.52 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 125.414 1.486 . . . . 0.0 111.141 179.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -56.31 110.99 0.65 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.376 2.718 . . . . 0.0 110.405 167.456 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -79.23 57.25 2.24 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.612 1.165 . . . . 0.0 113.38 -172.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -79.09 170.65 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.786 1.635 . . . . 0.0 110.836 168.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -74.9 -72.0 0.32 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.349 1.06 . . . . 0.0 110.89 176.558 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm 38.82 90.41 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 128.813 2.845 . . . . 0.0 114.146 -178.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -54.63 136.47 45.37 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.55 -0.719 . . . . 0.0 111.504 173.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.4 p -140.13 169.65 17.3 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -170.457 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.0 mtm180 -119.83 -30.14 4.82 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 128.381 2.672 . . . . 0.0 111.56 -179.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -152.8 164.61 37.5 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 127.922 2.489 . . . . 0.0 110.694 -172.526 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -65.73 -23.8 66.83 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.512 -0.743 . . . . 0.0 112.79 -177.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.1 m -67.28 -18.41 65.19 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.4 1.48 . . . . 0.0 113.217 177.648 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -74.0 -13.76 60.92 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.723 1.209 . . . . 0.0 113.193 174.134 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.2 m -111.57 149.28 40.47 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 125.008 1.323 . . . . 0.0 112.897 -172.46 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -77.46 163.84 29.27 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.362 2.708 . . . . 0.0 113.846 -175.38 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 36.91 -112.29 0.15 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 127.449 2.452 . . . . 0.0 115.746 173.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.01 5.45 48.77 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.42 1.888 . . . . 0.0 113.909 -177.531 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 56.2 m -66.81 168.29 9.9 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 122.423 1.106 . . . . 0.0 112.188 174.184 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.3 pt -135.27 162.91 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 128.093 2.557 . . . . 0.0 109.745 173.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 29.2 t -86.02 103.28 14.56 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 168.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -65.74 169.3 6.57 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.364 1.865 . . . . 0.0 111.21 -176.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.51 -17.95 71.27 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.814 1.197 . . . . 0.0 114.416 -173.218 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -82.02 -5.43 58.35 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.195 1.398 . . . . 0.0 114.348 173.116 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.92 24.29 38.55 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.369 0.985 . . . . 0.0 114.931 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -133.5 164.2 27.68 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.396 1.879 . . . . 0.0 111.161 177.526 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 89.5 m -73.84 156.21 37.99 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.038 -1.039 . . . . 0.0 112.948 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.142 0 C-N-CA 124.96 1.267 . . . . 0.0 112.271 172.692 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.2 p . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -93.28 177.39 37.89 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.5 1.048 . . . . 0.0 112.709 171.348 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.8 p -62.44 -18.57 62.03 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -176.627 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -68.18 -20.01 64.83 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.789 1.636 . . . . 0.0 114.313 172.46 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 68.27 15.05 67.34 Favored Glycine 0 CA--C 1.54 1.632 0 N-CA-C 116.22 1.248 . . . . 0.0 116.22 176.203 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.17 -177.36 25.69 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.426 1.489 . . . . 0.0 114.996 -179.629 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.8 t -59.56 100.47 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 126.008 1.723 . . . . 0.0 112.179 -177.629 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.4 t -136.8 116.36 10.63 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.442 1.497 . . . . 0.0 110.41 172.637 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -72.72 -7.84 21.44 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 123.689 2.926 . . . . 0.0 114.969 -179.491 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt 49.39 45.29 23.82 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 127.014 2.126 . . . . 0.0 114.124 175.552 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.6 pp -79.5 157.34 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.508 1.523 . . . . 0.0 111.572 174.418 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.1 mt -80.04 64.18 4.79 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.535 1.534 . . . . 0.0 112.278 -174.172 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -108.91 107.21 17.51 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.957 2.103 . . . . 0.0 110.155 177.602 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -64.27 145.62 55.7 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.678 0.791 . . . . 0.0 110.093 173.453 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.3 p -141.86 168.12 20.51 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -173.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -116.33 -28.5 6.49 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.572 2.349 . . . . 0.0 112.016 177.374 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -151.64 172.97 15.24 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 127.632 2.373 . . . . 0.0 110.133 -176.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -70.53 -26.39 63.54 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.501 0.72 . . . . 0.0 112.532 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.7 p -68.61 -16.02 63.71 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.637 1.575 . . . . 0.0 113.858 174.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -73.61 -12.04 60.62 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.875 0.87 . . . . 0.0 113.167 169.71 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 79.8 m -112.01 158.3 37.25 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -169.071 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.74 167.11 7.26 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 124.32 3.347 . . . . 0.0 115.652 176.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -1.89 -86.4 0.0 OUTLIER Glycine 0 N--CA 1.477 1.388 0 C-N-CA 130.238 3.78 . . . . 0.0 117.645 177.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -107.86 10.53 28.57 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.239 1.415 . . . . 0.0 113.502 -178.026 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 67.2 m -66.99 167.13 12.3 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.468 1.128 . . . . 0.0 111.761 169.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.7 pt -133.11 161.69 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 128.03 2.532 . . . . 0.0 109.27 169.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 25.5 t -86.95 99.82 12.14 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.741 0.816 . . . . 0.0 109.65 170.335 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -77.06 174.65 10.41 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.97 1.308 . . . . 0.0 111.868 -170.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.39 -16.04 68.84 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 124.898 1.237 . . . . 0.0 114.464 -171.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.3 p-10 -76.04 -8.05 56.09 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.589 1.556 . . . . 0.0 114.253 170.412 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.26 15.33 64.69 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.947 1.261 . . . . 0.0 114.859 -178.565 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -131.39 160.97 33.5 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.856 1.662 . . . . 0.0 112.114 -178.071 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 70.9 m -68.33 141.88 55.67 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.904 0.881 . . . . 0.0 112.211 176.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.068 0 C-N-CA 123.794 0.712 . . . . 0.0 113.151 176.008 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -111.05 112.46 3.21 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 169.721 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -56.21 -23.95 38.86 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -169.311 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -67.43 -27.28 66.93 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.534 1.134 . . . . 0.0 113.359 172.193 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -101.39 -32.88 5.04 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 126.412 1.958 . . . . 0.0 113.971 176.205 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 136.0 -171.74 22.63 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 125.066 1.317 . . . . 0.0 115.174 172.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.5 t -72.48 111.3 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.703 1.201 . . . . 0.0 109.069 168.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.6 t -83.59 127.78 66.56 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 122.877 0.471 . . . . 0.0 111.56 173.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.19 69.06 4.05 Favored 'Trans proline' 0 CA--C 1.548 1.202 0 C-N-CA 123.84 3.026 . . . . 0.0 109.729 167.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -61.01 140.7 57.76 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 127.986 2.515 . . . . 0.0 113.434 -169.268 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.0 pp -131.75 169.85 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 127.584 2.353 . . . . 0.0 110.629 169.284 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.3 mt -74.53 86.0 2.06 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.058 0.943 . . . . 0.0 111.849 -178.07 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -127.09 109.94 12.4 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.16 1.784 . . . . 0.0 110.8 176.087 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.83 148.09 50.22 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.812 1.245 . . . . 0.0 110.822 176.257 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.4 p -144.78 171.32 14.59 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 177.013 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -128.41 -24.55 3.06 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 128.408 2.683 . . . . 0.0 112.098 169.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.7 ptm85 -145.12 166.17 26.17 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.442 1.897 . . . . 0.0 111.834 178.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -67.58 -20.98 65.44 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.281 -0.887 . . . . 0.0 112.724 -176.135 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.2 m -67.47 -17.09 64.55 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.618 1.167 . . . . 0.0 113.182 175.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -74.49 -10.75 59.87 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.387 1.475 . . . . 0.0 113.347 173.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.5 m -119.09 158.39 48.3 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.07 1.348 . . . . 0.0 113.346 -168.668 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.08 165.97 30.67 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.123 2.549 . . . . 0.0 112.254 174.086 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -39.34 -57.7 2.15 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 127.426 2.441 . . . . 0.0 117.234 -169.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.03 -17.46 52.71 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -177.099 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.4 m -79.09 164.8 24.0 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 123.283 1.515 . . . . 0.0 112.752 169.686 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.9 pt -132.52 167.31 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 129.767 3.227 . . . . 0.0 107.512 167.065 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.9 t -80.08 101.61 8.84 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.299 -0.876 . . . . 0.0 109.744 169.455 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.86 169.57 12.86 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.104 1.762 . . . . 0.0 111.632 -177.669 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.45 -13.96 79.71 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.848 1.213 . . . . 0.0 114.598 -173.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -79.15 -6.73 57.22 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.638 1.575 . . . . 0.0 114.29 174.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.41 12.72 62.59 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.642 1.115 . . . . 0.0 114.805 -177.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -129.71 167.96 17.23 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.405 1.882 . . . . 0.0 111.031 176.392 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.2 m -70.04 152.95 43.8 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.25 -0.907 . . . . 0.0 112.679 173.664 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.973 0 C-N-CA 124.423 1.011 . . . . 0.0 113.781 171.662 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.28 9.92 73.43 Favored Glycine 0 CA--C 1.539 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 113.354 -168.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.5 m 71.01 -3.92 1.9 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 128.717 2.807 . . . . 0.0 115.229 -177.558 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -140.45 -0.65 1.56 Allowed 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 178.452 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.62 176.3 48.53 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.849 1.214 . . . . 0.0 115.294 -177.275 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.69 -123.24 1.57 Allowed Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.956 1.741 . . . . 0.0 113.922 -176.088 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 m -64.79 85.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 126.159 1.784 . . . . 0.0 113.014 178.787 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 53.6 t -131.76 113.42 15.18 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.112 1.365 . . . . 0.0 110.837 174.697 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.71 -5.55 16.11 Favored 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 123.998 3.132 . . . . 0.0 115.207 179.14 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 39.4 mttp 54.04 44.28 29.53 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 126.929 2.092 . . . . 0.0 114.163 171.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -79.04 160.6 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.547 1.139 . . . . 0.0 111.515 -178.357 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 90.9 mt -76.55 36.05 0.15 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.184 1.794 . . . . 0.0 113.675 -179.449 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -76.75 105.07 7.59 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.39 1.876 . . . . 0.0 109.432 169.892 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -63.63 143.75 57.57 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.997 0.919 . . . . 0.0 111.141 174.232 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 p -144.04 173.1 12.02 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.937 1.295 . . . . 0.0 114.193 -176.052 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -132.27 -20.04 2.43 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 127.256 2.222 . . . . 0.0 112.628 170.034 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -142.6 164.36 30.32 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.113 1.765 . . . . 0.0 111.754 178.015 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -67.4 -22.65 65.53 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.509 -0.744 . . . . 0.0 112.554 -176.751 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.0 m -66.99 -18.0 65.18 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.458 1.503 . . . . 0.0 113.128 176.423 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -74.14 -12.65 60.65 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.056 1.342 . . . . 0.0 113.371 174.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 81.6 m -115.99 151.18 46.23 Favored Pre-proline 0 CA--C 1.549 0.922 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -168.402 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -80.58 167.37 18.99 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.662 2.908 . . . . 0.0 113.941 -174.658 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 39.8 -108.03 0.09 OUTLIER Glycine 0 CA--C 1.534 1.264 0 C-N-CA 127.644 2.545 . . . . 0.0 115.497 172.256 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.35 6.88 30.89 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.281 1.832 . . . . 0.0 113.673 -177.823 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 75.3 m -66.41 168.82 8.31 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 122.626 1.203 . . . . 0.0 112.938 175.693 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.6 pt -131.83 169.69 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 129.067 2.947 . . . . 0.0 108.962 169.061 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 24.9 t -87.73 108.36 19.08 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.659 -0.651 . . . . 0.0 109.333 168.091 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 -66.1 168.35 8.55 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.61 1.564 . . . . 0.0 111.451 179.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.51 -17.91 73.15 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.832 1.206 . . . . 0.0 114.478 -176.837 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -80.37 -5.96 57.26 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.694 1.197 . . . . 0.0 114.092 172.684 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.82 24.08 36.65 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.521 1.058 . . . . 0.0 114.972 -179.87 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -134.84 161.96 33.75 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.675 1.59 . . . . 0.0 111.9 177.125 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.5 m -69.24 144.78 53.57 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.321 -0.862 . . . . 0.0 113.319 179.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.035 0 C-N-CA 124.543 1.068 . . . . 0.0 113.167 179.007 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.03 172.78 15.03 Favored Glycine 0 N--CA 1.475 1.252 0 C-N-CA 123.92 0.771 . . . . 0.0 114.915 -176.69 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.5 p -64.01 -15.24 58.93 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.023 1.729 . . . . 0.0 114.935 -177.329 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -64.9 -18.3 65.08 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.338 1.455 . . . . 0.0 113.508 170.262 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.96 2.15 84.2 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.219 1.39 . . . . 0.0 114.557 -178.159 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.08 111.63 4.27 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.589 1.566 . . . . 0.0 112.017 174.448 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.8 t -68.02 99.37 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.83 1.252 . . . . 0.0 111.248 -177.582 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.0 t -82.2 141.74 46.75 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 166.863 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -50.81 13.54 0.01 OUTLIER 'Trans proline' 0 CA--C 1.553 1.444 1 C-N-CA 127.242 5.295 . . . . 0.0 119.676 169.561 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt 50.25 46.48 24.88 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 128.428 2.691 . . . . 0.0 114.745 173.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.5 pp -79.4 147.54 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.464 1.506 . . . . 0.0 110.018 169.707 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.0 mt -71.93 -68.66 0.44 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.396 1.078 . . . . 0.0 111.882 -178.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 76.3 tttt 33.63 97.29 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 129.852 3.261 . . . . 0.0 115.135 179.565 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -54.86 136.3 47.02 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.417 -0.802 . . . . 0.0 111.404 172.638 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.8 p -141.99 165.53 27.21 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.143 1.377 . . . . 0.0 114.191 -170.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -116.73 -19.5 9.91 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.871 2.068 . . . . 0.0 112.841 -179.069 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -160.69 163.41 32.46 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 128.863 2.865 . . . . 0.0 109.468 -169.011 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -66.95 -26.7 66.96 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.139 -0.976 . . . . 0.0 112.666 179.286 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.3 m -71.05 -15.42 62.54 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.509 1.524 . . . . 0.0 113.622 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -72.37 -22.49 61.14 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.192 0.997 . . . . 0.0 112.389 170.507 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 75.3 m -94.6 151.37 39.16 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.4 1.08 . . . . 0.0 112.813 -174.575 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.16 160.78 26.46 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.444 2.763 . . . . 0.0 113.168 -178.282 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 27.4 -99.04 0.01 OUTLIER Glycine 0 CA--C 1.536 1.348 0 C-N-CA 128.694 3.045 . . . . 0.0 116.671 174.233 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -95.92 -3.63 44.9 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 -173.122 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.3 m -68.74 165.04 20.38 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-O 122.992 1.377 . . . . 0.0 113.153 175.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.5 pt -124.21 166.17 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 129.551 3.14 . . . . 0.0 107.844 167.539 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 43.6 t -97.6 107.0 19.41 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.771 0.828 . . . . 0.0 108.815 169.267 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -65.1 165.81 10.57 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.619 1.168 . . . . 0.0 111.132 179.236 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.13 -16.71 71.18 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.052 1.31 . . . . 0.0 114.475 -175.803 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -77.41 -5.92 51.52 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.044 1.338 . . . . 0.0 114.027 170.801 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.62 28.26 30.06 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.487 1.041 . . . . 0.0 114.683 179.088 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -135.93 158.5 44.24 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.54 1.536 . . . . 0.0 111.862 176.743 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.9 m -77.54 163.83 25.93 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 122.124 0.964 . . . . 0.0 113.366 -179.829 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.131 0 C-N-CA 125.402 1.477 . . . . 0.0 111.897 169.652 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.25 17.18 59.8 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 124.574 1.083 . . . . 0.0 113.736 171.399 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.3 m 65.19 11.76 7.46 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 127.279 2.232 . . . . 0.0 115.239 -178.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.16 -26.6 68.24 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.967 1.307 . . . . 0.0 113.205 176.006 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.82 -3.42 81.09 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.695 1.617 . . . . 0.0 115.029 176.286 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.1 -165.43 37.72 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.606 1.574 . . . . 0.0 113.645 174.214 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 51.1 t -66.89 101.38 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 125.548 1.539 . . . . 0.0 112.555 -176.737 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.2 t -135.19 102.71 10.77 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.796 1.239 . . . . 0.0 110.391 166.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.06 -1.83 11.9 Favored 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 123.912 3.074 . . . . 0.0 115.206 -179.518 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt 50.69 51.17 17.48 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 127.072 2.149 . . . . 0.0 113.636 175.928 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.78 158.28 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 125.383 1.473 . . . . 0.0 112.027 178.517 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.1 mt -78.17 30.06 0.18 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.242 1.817 . . . . 0.0 113.824 -178.792 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -72.01 111.86 7.61 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 120.657 -1.277 . . . . 0.0 109.937 169.776 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -67.41 141.56 57.0 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.219 0.607 . . . . 0.0 109.976 168.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.5 p -141.31 171.36 14.17 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.471 1.108 . . . . 0.0 113.741 -171.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -136.3 -10.12 1.95 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.326 1.85 . . . . 0.0 113.158 172.692 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.3 ttt-85 -141.31 168.2 20.34 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.672 1.589 . . . . 0.0 110.451 171.66 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -72.5 -26.97 61.98 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.371 0.669 . . . . 0.0 112.253 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.0 p -70.03 -13.41 62.21 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.28 1.832 . . . . 0.0 113.82 175.481 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.58 -23.49 65.4 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.486 -0.759 . . . . 0.0 112.403 168.995 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.8 m -107.22 161.71 22.11 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 124.838 1.255 . . . . 0.0 114.137 -168.535 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -56.54 167.3 2.88 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 124.594 3.529 . . . . 0.0 115.446 173.038 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -32.09 -67.52 0.16 Allowed Glycine 0 CA--C 1.538 1.493 0 C-N-CA 128.521 2.963 . . . . 0.0 117.095 -171.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.38 -0.51 56.53 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -177.32 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 65.1 m -74.07 169.64 17.09 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 122.668 1.223 . . . . 0.0 112.044 173.517 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 24.4 pt -137.13 166.61 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 128.762 2.825 . . . . 0.0 108.707 169.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.6 t -86.96 104.42 16.26 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.407 -0.961 . . . . 0.0 108.407 167.875 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -66.37 169.46 7.34 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.683 1.593 . . . . 0.0 111.026 -175.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.71 -17.32 68.99 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.701 1.143 . . . . 0.0 114.242 -176.482 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 53.9 p30 -79.34 -6.52 56.95 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.469 1.507 . . . . 0.0 114.405 172.446 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.57 17.81 57.88 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.662 1.125 . . . . 0.0 115.22 179.885 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -130.88 161.8 31.03 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.839 1.655 . . . . 0.0 111.928 178.275 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 97.7 m -68.2 145.81 53.96 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.614 -0.679 . . . . 0.0 112.727 178.038 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.088 0 C-N-CA 124.64 1.115 . . . . 0.0 112.469 174.542 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.0 m . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -148.0 -4.33 0.35 Allowed Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.82 1.2 . . . . 0.0 115.504 173.869 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.9 t -147.62 179.72 7.49 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.137 1.775 . . . . 0.0 111.662 -178.403 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -121.76 -3.22 9.24 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 127.207 2.203 . . . . 0.0 112.595 171.83 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.37 27.5 3.21 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.249 1.88 . . . . 0.0 115.442 -176.668 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 172.61 -152.35 16.35 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.925 1.726 . . . . 0.0 112.349 -172.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.5 p -119.72 147.8 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.472 1.509 . . . . 0.0 111.45 176.525 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.6 t -137.0 105.72 8.79 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.277 1.031 . . . . 0.0 111.422 169.049 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -58.37 -18.32 37.83 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 124.449 3.432 . . . . 0.0 116.881 177.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 49.98 74.51 0.21 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 126.974 2.11 . . . . 0.0 112.722 -174.034 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.1 pt -127.83 162.57 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 126.252 1.821 . . . . 0.0 112.567 -172.948 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -68.89 22.67 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 127.156 2.182 . . . . 0.0 115.923 178.534 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -65.27 104.73 0.98 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.277 1.431 . . . . 0.0 109.901 169.262 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.1 145.33 53.58 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.462 1.105 . . . . 0.0 110.822 173.834 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 p -143.99 167.05 23.28 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 177.93 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -121.98 -21.52 5.98 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 127.674 2.39 . . . . 0.0 112.463 169.276 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.67 168.97 20.69 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.278 1.831 . . . . 0.0 111.417 177.164 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -66.23 -22.91 66.34 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.27 -0.894 . . . . 0.0 112.755 -177.51 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.2 m -66.27 -17.74 64.93 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.741 1.617 . . . . 0.0 113.378 177.471 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -74.27 -13.73 60.81 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.446 1.498 . . . . 0.0 113.747 174.133 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.5 m -117.44 159.12 43.06 Favored Pre-proline 0 CA--C 1.554 1.119 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -167.469 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -56.05 168.69 1.75 Allowed 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 125.106 3.87 . . . . 0.0 116.189 172.198 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -35.66 -65.52 0.45 Allowed Glycine 0 CA--C 1.535 1.287 0 C-N-CA 128.45 2.928 . . . . 0.0 117.451 -170.633 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.46 1.8 55.75 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.635 1.174 . . . . 0.0 114.035 -178.797 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.9 m -74.97 168.21 20.4 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 122.777 1.275 . . . . 0.0 112.109 170.841 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.5 pt -136.58 165.15 29.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 129.586 3.154 . . . . 0.0 107.894 168.224 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 23.3 t -83.21 101.23 11.09 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 168.015 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -65.97 169.5 6.69 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.876 1.67 . . . . 0.0 110.748 -175.231 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.91 -16.96 69.0 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.662 1.125 . . . . 0.0 114.39 -174.751 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -79.7 -9.29 59.62 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.32 1.448 . . . . 0.0 114.454 173.841 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.43 15.74 56.53 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 124.667 1.127 . . . . 0.0 115.336 -178.35 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -129.67 164.86 23.0 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.513 1.525 . . . . 0.0 111.245 176.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.6 m -70.19 146.45 50.75 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.264 -0.898 . . . . 0.0 112.734 177.397 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.035 0 C-N-CA 125.139 1.352 . . . . 0.0 111.598 174.301 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.5 m . . . . . 0 N--CA 1.477 0.92 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.12 -9.46 20.11 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.259 0.933 . . . . 0.0 114.468 171.499 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.3 p -105.25 174.84 5.71 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.099 1.76 . . . . 0.0 112.134 173.095 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -68.98 -17.49 63.94 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.515 1.126 . . . . 0.0 113.589 174.475 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 166.83 96.75 0.11 Allowed Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.994 1.283 . . . . 0.0 112.251 -176.095 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -152.15 -172.99 21.31 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.258 1.409 . . . . 0.0 113.284 -179.552 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.3 m -67.41 74.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 126.259 1.824 . . . . 0.0 113.405 -179.066 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.8 t -129.43 106.39 17.45 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.66 1.584 . . . . 0.0 110.842 169.881 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -60.78 -13.78 28.43 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 124.318 3.345 . . . . 0.0 117.534 -178.898 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 97.7 mttt 47.61 77.73 0.09 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 127.306 2.243 . . . . 0.0 113.516 -174.782 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.405 ' H ' HD13 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -124.98 164.67 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.703 1.601 . . . . 0.0 112.477 -178.414 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 90.5 mt -74.6 29.79 0.09 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.272 1.829 . . . . 0.0 114.336 -178.072 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -70.59 99.99 1.75 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.134 1.373 . . . . 0.0 109.918 169.657 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -63.19 144.11 57.21 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.356 1.062 . . . . 0.0 110.926 171.863 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.0 p -143.9 172.6 12.63 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -175.445 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -132.63 -15.47 2.74 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 127.373 2.269 . . . . 0.0 113.649 171.166 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.5 ttp180 -144.06 170.82 15.21 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.032 1.733 . . . . 0.0 110.971 172.382 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -70.72 -24.2 62.59 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.46 0.704 . . . . 0.0 112.286 178.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.4 m -64.32 -20.64 66.23 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.141 1.776 . . . . 0.0 113.017 174.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -70.86 -16.03 62.67 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.443 1.097 . . . . 0.0 113.437 173.107 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 56.0 m -116.14 151.82 47.09 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 124.911 1.285 . . . . 0.0 113.313 -169.035 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.06 164.21 22.44 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.316 2.677 . . . . 0.0 113.592 -176.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 26.85 -100.9 0.01 OUTLIER Glycine 0 CA--C 1.537 1.448 0 C-N-CA 129.033 3.206 . . . . 0.0 117.307 172.429 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.69 2.11 51.72 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.791 1.636 . . . . 0.0 113.929 -174.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 64.0 m -72.04 166.16 22.81 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 122.771 1.272 . . . . 0.0 112.063 172.597 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.9 pt -135.46 166.15 28.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 129.514 3.126 . . . . 0.0 108.045 168.514 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.9 t -83.14 101.28 11.08 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 168.011 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -65.42 170.27 5.05 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.153 1.781 . . . . 0.0 110.911 -175.805 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.71 -17.4 69.09 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.648 1.118 . . . . 0.0 114.517 -173.799 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 47.9 p-10 -79.97 -8.04 59.13 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.379 1.472 . . . . 0.0 114.434 172.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.4 20.08 49.92 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.634 1.111 . . . . 0.0 115.091 -178.128 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -132.27 161.56 33.17 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.606 1.562 . . . . 0.0 111.761 178.287 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.6 m -70.17 140.31 52.54 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.322 -0.862 . . . . 0.0 112.565 178.236 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.077 0 C-N-CA 125.289 1.423 . . . . 0.0 111.649 175.273 . . . . . . . . 0 0 . 1 stop_ save_